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ABSTRACT
Cerebral malaria is one of the severe manifestations of falciparum malaria. It has a 
high fatality rate and survivors are at risk of a variety of neurological sequelae. The 
characteristics and determinants of neurological sequelae have been extensively 
studied in children aged under five years. Survivors who are over five years are 
known to develop sequelae and indications are that they may be at higher risk. This 
study set out to identify the sequelae that are present in children and adults in 
Uganda and to examine if there were differences in the occurrence, natural history 
and determinants of deficits. The study employed a multi-centre design using study 
hospitals that were located in malaria epidemic-prone areas in Uganda so as to enrol 
patients with a wider age distribution than would have been the case in malaria 
endemic sites.
One hundred patients were enrolled between 1 January 2002 and 31st July 2003. The 
proportion of cerebral malaria among malaria admissions was 1.9% (72/3789) in 
children and 1.8% (28/1592) in adults admitted to the study hospitals. The case 
fatality ratio was low, 10%, and young children under five years of age at the time o f  
admission had the highest mortality. Thirty-five survivors were detected to have 
neurological sequelae of which 63% were of the motor-sensory kind (22 survivors), 
20% of the cognitive kind (7 survivors) and 17% had both kinds (6 survivors). The 
proportion of survivors with neurological sequelae was slightly higher in adults, 
42% (11/26) than children, 38% (24/64). The more striking age difference was the 
frequency of sequelae among survivors aged under five, 28% (11/40), and those 
aged 5 to 9 years, 54% (13/24). Deficits were present in twenty-three survivors at 
discharge (motor-sensory sequelae only) and nineteen survivors that attended review 
visits (motor-sensory and cognitive sequelae). Deficits involving muscle tone 
(detected in 18 survivors), tendon reflexes (14 survivors) and muscle power (12 
survivors) were the commonest at discharge, occurring in combination. Impaired 
muscle strength (5 cases) was the commonest motor-sensory sequela detected during 
follow-up. The commonest cognitive deficit either reported by mothers of survivors 
or detected by the cognitive tool was memory impairment which was found in 10 
survivors. The natural history of sequelae did not differ between children and adults.
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Mortality was independently associated with quinine use within 48 hours prior to 
admission, seizures while on the ward and parasite count on admission. Quinine use 
prior to admission, duration of coma, duration with a history of fever plus days in 
hospital with a high temperature and splenomegaly were independently associated 
with early-onset deficits. The detection and development of late-onset deficits was 
associated with duration of elevated body temperature, duration taken to control 
seizures and the presence of neurological deficits at discharge. It was not possible to 
examine the determinants for the outcomes in children and adults separately.
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time of admission
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and attributable to cerebral malaria
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Chapter 1
1. INTRODUCTION
Cerebral malaria is a severe manifestation of malaria. Not only does it have a high 
case fatality rate but survivors can develop neurological sequelae of various kinds 
and severities. This study examined the neurological sequelae o f cerebral malaria in 
children and adults in Uganda. I designed and carried out the study in conjunction 
with several people and groups. In this thesis, I document the background to the 
study, the methodology and findings in the next six chapters as stated below.
Chapter 2 consists of a description of the epidemiology in Uganda and its severe 
manifestations. The literature on cerebral malaria is reviewed. An account o f how 
the parasites are postulated to cause brain dysfunction is given. The findings of 
studies that have examined the neurological sequelae of cerebral malaria are 
summarised. This background leads onto the study rationale and hypotheses.
In Chapter 3 ,1 mention the study objectives, and describe the study design and study 
sites. A detailed account of the case definition and selection processes is given. The 
data collection tools are discussed including their development and usage. The 
treatment of cerebral malaria was standardised to ensure that cases received similar 
care at the study hospitals. Details are also given of the data management procedures 
and the statistical analyses conducted.
The descriptive results are presented in Chapter 4. The types of neurological 
sequelae detected in child and adult survivors are described. The natural history of 
deficits is elaborated. In doing so, the descriptive study objectives are addressed.
Results of analytic statistical procedures are summarised in Chapter 5. Factors that 
are associated with the three outcomes of the study namely, mortality, early-onset 
sequelae and late-onset sequelae, are highlighted. The findings from regression 
analyses are summarised to show the factors that are independently associated with 
the outcomes and differences between children and adults.
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Chapter 6, consists of a discussion of the major findings, their interpretation and 
relevance. Sources of error and biases are described and the ways in which they 
were avoided or reduced are given. The influences that they may have had on the 
findings are highlighted.
In Chapter 7, conclusions are made, an account of the practical study benefits is 
given and some areas that need further study are listed.
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Chapter 2
2. BACKGROUND AND STUDY RATIONALE
2.1 Malaria -  A global disease and an African burden
Malaria is recognised as the commonest parasitic infection of humankind. Around 
500 million clinical cases of malaria occur annually resulting in the death of up to 1 
million children or about 2700 deaths per day (Snow, Craig et al. 1999). Sub- 
Saharan Africa which is estimated to have a population of 682 million people at mid 
2004 (about 10% of the world population) bears about 90% of the global malaria 
burden (WHO and UNICEF 2003; UNFPA 2004). The Global Fund reports that the 
proportion of people at risk o f malaria, currently estimated at 41%, is increasing 
because of deteriorating health systems, increasing drug resistance to the commonly 
used antimalarials, and resistance to insecticides, among others (TheGlobalFund 
2004).
The situation in Africa, particularly south o f the Sahara is precarious. About 10% of 
hospital admissions and 20 to 30% of visits to doctors are malaria related 
(MalariaFoundationlntemational 1998). The most lethal of the four human species 
of plasmodia, P. falciparum, causes most of the malaria in this region. The tropical 
climate is not only conducive for the rapid reproduction of the plasmodia-carrying 
mosquitoes, the Anophelines, but is also conducive for the development of the 
malaria parasite. These factors and others have an adverse effect on not only the 
lives of people through premature death but on the quality of life through morbidity 
and reduced productivity.
2.2 Epidemiology of Malaria in Uganda -  A process in transition
Malaria is one of the major health problems in Uganda. With a Gross Domestic 
Product (GDP) in 2003 of US$ 6.2 billion, Uganda is one of the poorest countries 
(WBGroup 2004). Uganda’s 24 million citizens, 90% of whom live in highly 
malaria-endemic areas, not only have to cope with poverty but have to contend with 
other major killer diseases such as HIV/AIDS, tuberculosis and diarrhoeal illnesses 
(UBOS 2003). The under-five mortality rate (period for this derivation was not 
obtained) is estimated at 159/1000 live births of which malaria is estimated to be
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responsible for 37/1000 in high transmission areas and 18/1000 in low transmission 
areas. This translates to between 70,000 to 110,000 child deaths per year (Ministry 
of Health and WHO 1999). Malaria alone accounts for 20% of hospital admissions 
and 25-40% of all outpatient visits at health facilities in the country (RBM 2000).
Uganda lies astride the equator between 4 degrees north and 1.5 degrees south (area 
of 238,461 km2), see Figure 1 for a map of Uganda. Temperatures fluctuate between 
15 °C and 32 °C. Most parts of Uganda experience two rainy seasons; March to May 
and September to November contributing to a mean annual rainfall of 760 mm in the 
north east and 1,520 mm in the south, close to Lake Victoria. Most of Uganda is a 
plateau 900 m above sea level that lies between mountain ranges to the east and 
west, which are more than 3,000 m above sea level. About a fifth of the country is 
covered by water in the form of swamps, Lakes Victoria (the biggest fresh water 
lake in the world), George and Albert, and the River Nile. These climatic conditions 
are conducive for breeding of malaria vectors in almost all areas of the country 
below an altitude of 1,500 m. In addition, the ambient temperatures allow the speedy 
development of the parasite within the mosquito and humans. These factors enable 
high and stable malaria transmission in most parts of the country. Davidson (1955) 
measured spleen rates and crude parasite rates of all mosquito species in a 
population around Lira town, in the northern part of Uganda. His team found that 
over the four months, September to December 1962, the spleen rate ranged from 
18% in infants 2 weeks to 2 months old, to 89% in the children between 12 months 
and four years of age. The crude parasite rates ranged from 21 % in infants 2 weeks 
to 2 months old, to 98% in those aged 2 to 4 years. Figure 2 shows a climate-based 
distribution model of malaria transmission in Uganda compiled by a project called 
“Mapping Malaria Risk in Africa / Atlas du Risque de la malaria en Afrique” .
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Map 2 1: Map of Uganda showing the four districts in which the study hospitals are 
located
Source: This map is a product of the MARA/ARMA collaboration and was 
downloaded in October 2004
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Generally speaking, in the colder and higher south-western highlands of the country 
malaria transmission is unstable; Hall and Langlands (1975) reported a crude 
parasite prevalence in Kigezi, 1966-67 of 8.1%. Areas with unstable transmission 
such as the south-east highlands have experienced epidemics such as those in 1994 
(Mouchet, Manguin el al. 1998) and 1998 (Kilian, Langi el al. 1999; Lindblade, 
Walker el al. 1999). The epidemic in Kabale district (altitude of 1500-2400 m; 850- 
1200 mm of rainfall annually; average daily minimum and maximum temperatures 
of9.8-12.6°C and 23.2-24.4°C respectively) began in February 1998 and peaked in 
March. The reported malaria incidence recorded at 5 rural health clinics at the peak 
of the epidemic was about 3 times greater than the average incidence for the 
previous 5 years (about 43 clinical cases of malaria per 1000 compared with 17 
cases per 1000 between 1992-1997). The mean entomological inoculation rate 
during the epidemic, December 1997 to July 1998, was 0.41 infectious bites per 
person which the authors say was responsible for the increased incidence of malaria. 
(Lindblade, Walker el al. 1999)
All four species of Plasmodium that affect people occur in Uganda. P. falciparum is 
the predominant species with a frequency among positive blood-slides of 98.6% in 
Apac, 96.5% in Kampala, 99.3% in Rukungiri and 97.6% in Kabarole (Langi and 
Oryema 1994). P. malariae is less frequent than P. falciparum but more common 
than P. ovale and P vivax. The major malaria vectors are Anopheles gamhiae s.l. 
(the most efficient plasmodium carrier) and A. funeslus. Between May and June 
1992 and 1993, the relative indoor resting frequency of An. gamhiae s.l. was 99% in 
Rukungiri, 98.9% in Kampala, 65.6% in Apac and 94.4% in Kabarole (in their 
report the authors did not specify the mosquito-catching method used). Other 
mosquito species that do occur include A. preloriensis, A rhodesiensis, A. christyi, A. 
pharoensis and A. rivulorum.
Apart from the optimal climatic conditions for vector and parasite, and the highly 
anthropophic malaria vectors, there are other factors that have contributed to the 
widespread and increasing occurrence of malaria. The guerrilla war of the late 70s 
and mid 80s destroyed some of the health infrastructure that had been in place to 
cope with the burden of diseases in the country; malaria control efforts were
27
minimal with little motivation and few financial resources for vector control. In the 
post-war period, 1986 onwards (though there still remain some areas of insecurity in 
the northern parts o f the country) much development has occurred. Roads have been 
constructed, dams built, multi-storied buildings erected, more areas cultivated, 
swamps drained and forests cleared, to mention a few changes. Mouchet el al. 
(1998) reviewed hospital records at Kisizi Mission Hospital located in the south­
western highland area of Uganda and found that there has been a constant increase 
in the annual number of outpatients and inpatients seen at the hospital with malaria 
since 1968. Nineteen cases were treated as inpatients in 1968 and 8,580 as 
outpatients. Similar figures for 1976 (8 years later) were 215 inpatients (up 11-fold) 
and 16,219 outpatients (up 2 fold); in 1992 (16 years later) there were more than 
2,900 inpatients (up 13-fold) and 22,344 outpatients (up 1.4 times); and in 1994 (2 
years later) there were 4,875 inpatients (up 1.7 times) and 27,491 outpatients (up 1.2 
times). Some reasons for this increasing frequency the authors say include rainfall 
excesses, migratory flow (inhabitants moving down into the valleys in search of 
arable land) and the cultivation of papyrus marshes in the valleys with food crops 
providing more conducive breeding sites for A. gambiae.
Another factor which has contributed to a greater burden of malaria is the migration 
of people from rural areas with low transmission intensities like the highland areas 
into towns like Kampala, Jinja, Masaka and Mbarara in search of jobs and better 
opportunities. These “economic migrants” are likely to have little immunity to 
malaria and during the course of their stay in these towns* that are located in areas 
where malaria transmission occurs go on to experience more episodes of malaria, of 
both the simple and severe forms. The population of the country increased from 4.7 
million in 1950 to 15.5 million in 1985, at an average rate of about 3.5% per year 
(UN 1985). The increase in population size and subsequent changes in the 
population structure, placing a greater number of children at risk, will also have 
contributed to the increase in malaria frequency. The appearance of plasmodia 
resistant to chloroquine, the commonest and cheapest antimalarial in the country, 
has played a role in the increasing burden of malaria. It is not clear when 
chloroquine resistance was first noticed in the country. The East African Network 
for Monitoring Antimalarial Treatment (EANMAT) has studied the efficacy of
’ Many towns in Uganda are not very urbanised and are a diffuse collection of buildings
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chloroquine at sentinel sites in Uganda. Their results showed that using chloroquine 
in patients aged 6 to 59 months between 1998 to 2000, the proportion of late 
treatment failures (i.e. the presence of parasitaemia and fever after 4 days) was up to 
31% (EANMAT 2003). All these factors mentioned are contributing to the 
epidemiology of malaria in Uganda and changing it.
2.3 Manifestations of Severe malaria and Acquired immunity to malaria
Malaria can be classified as simple or severe (another classification is uncomplicated 
and complicated malaria). A person with a fever attributable to plasmodial infection 
is said to have simple malaria. Severe malaria on the other hand, is a collection o f 
clinical syndromes that have a high mortality (> 5%) despite adequate medical 
intervention (Newton and Krishna 1998). A list o f criteria that define a case of 
severe malaria has been compiled under the auspices of the World Health 
Organisation (Warrell, Molyneux et al. 1990; WHO 2000). A subject with any one 
of the defining manifestations listed in Table 2.1 is said to have severe malaria as 
long as the manifestation(s) are attributable to P. falciparum infection by the 
identification of asexual forms of the parasite in blood and after the exclusion of 
other conditions that can cause the manifestation(s). The other supporting 
manifestations listed in the same table are features that often accompany the 
defining criteria either singly or in combination.
Table 2.1: Manifestations of severe malaria as defined bv Warrell et al. 11990).
Defining criteria of severe disease
1. Cerebral malaria (unrousable coma)
2. Severe normocytic anaemia
3. Renal failure
4. Pulmonary oedema
5. Hypoglycaemla
6. Circulatory collapse, shock
7. Spontaneous bleeding/disseminated intravascular coagulation
8. Repeated generalised convulsions
9. Acidaemia/acidosis
10. Malarial haemoglobinurla 
Other supporting manifestations
1. Impaired consciousness but reusable
2. Prostration, extreme weakness
3. Hyperparasitaemia 
4 Jaundice
5, Hyperpyrexia________________________________ _
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Several host and parasite factors appear to operate via separate or similar 
mechanisms to result in a host’s gradual acquisition of clinical immunity to malaria 
and its severe manifestations. A hypothesis said to have first been proposed by 
Robert Koch in 1900 attributed acquired immunity to the gradual and cumulative 
build-up of an adequate repertoire of specialised immune cells (i.e. memory and 
effector cells) in response to a repertoire of parasitic antigens to which the host was 
previously exposed (Koch 1900c; a; b). Implying that the parasite does not elicit an 
adequate response from the host’s immune system until such a time that the host can 
call upon a variety of immune responses, or possibly, one large but effective 
response, for which the parasite has no answer. The development of this form of 
immunity would depend on many exposures to the parasite, to different strains of the 
parasite, to different developmental stages of the parasite in the host and of course, a 
functional host immune system. It is postulated that such exposures would have to 
be sustained over long periods of time (Baird, Jones et al. 1991). As enough clinical 
immunity is acquired the risk of severe malaria should decrease. In addition, with 
more frequent contacts with the parasites, as in areas with high malaria endemicity, a 
host should acquire clinical immunity to severe malaria at a faster rate than a host in 
an area of low endemicity. This is exemplified by observations that in hyper- 
holoendemic malaria areas the frequency of severe malarial manifestations rises to a 
peak between 2-6 years then declines steadily until about 10 to 15 years of age after 
which the occurrence of episodes of severe malaria is infrequent (Rogier and Trape 
1993).
Alternatively, clinical immunity to malaria could be more dependent on the maturity 
of the host’s immune system and less so on the number of exposures to plasmodia. 
This alternative hypothesis of age-dependent acquired immunity stems from 
observations made by some authors that adults who previously resided in non- 
malarious regions developed effective clinical immunity to malaria after only a few 
number of exposures to malaria parasites (Baird, Jones el al. 1991; Baird 1998). 
They developed clinical immunity at a faster rate than children exposed to the same 
levels of malaria transmission. It is possible that both mechanisms, i.e. exposure- 
dependent and age-dependent, are equally important and somehow the acquisition of 
immunity appears to influence the spectrum of severe disease seen in a given 
population.
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2.4 Epidemiology of Cerebral malaria
Cerebral malaria (CM) represents a clinical syndrome which Warrell et al. in 1990 
redefined as ''Unrousable coma not attributable to any other cause in a patient with 
falciparum malaria”. Warrell and Gilles (2002) more recently make a distinction 
between two definitions; a “research” definition and a “practical” one. The latter 
defines cerebral malaria as “any impairment of consciousness or convulsions in a 
patient exposed to malaria”. The research definition is more rigorous and states a 
number of requirements: i) Unrousable coma (Glasgow Coma Score < 10/14) that 
persists for more than 6 hours after a generalised convulsion, ii) Asexual forms of P. 
falciparum in the blood smear, iii) Exclusion of other causes of coma by history, 
cerebrospinal fluid examination, cultures and serology and iv) in fatal cases, 
confirmation of typical brain histopathology, sequestered infected erythrocytes, by 
post-mortem needle necropsy.
Cerebral malaria occurs in all areas w ith conditions suitable for the propagation of 
Plasmodium falciparum. There have been reports of patients in which the loss of 
consciousness has been attributable to  P. vivax in India and China (Fitz-Hugh, 
Pepper et al. 1944; Gandhi, Nayak e t al. 1990; Sachdev 1996; Beg, Khan et al.
2002). CM is a deadly disease with a  case fatality rate that can reach up to 50% 
(Warrell 1997). Studies have been able to determine the proportion of cerebral 
malaria among, paediatric admissions i.e. inpatients only, or all cases of falciparum 
malaria seen at a hospital i.e. both outpatients and inpatients. Table 2.2 summaries 
and illustrates the geographical occurrence of cerebral malaria. In children, the 
proportion of cerebral malaria among those admitted to paediatric units ranges from 
about 2.3% reported in Malawi to 25.4% in Côte d’Ivoire among children less than 5 
years (Nkhoma, Nwanyanwu et al. 1999; Pagnoni and Delacollette Lebrun 2002). If 
a more selective denominator is used, for example children admitted with falciparum 
malaria, the proportion with cerebral malaria documented is higher, 51%, as 
observed in The Gambia (Brewster et al., 1990). Murphy and Breman reviewed 35 
studies of cerebral malaria in sub-Saharan Africa and estimate the annual incidence 
of CM to be 6.1 cases per 1,000 children aged below 5 years and 2.7 cases per 1,000 
children aged 5 to 9 years (Murphy and Breman 2001).
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Table 2.2: Summary of studies that have documented the frequency and case fatality ratio of cerebral malaria
Reference Country Number of 
cases
Cerebral
malaria
definition
Denominator (population at risk) Frequency of
CM (%)
Case
Fatality
(%of
cases)
Children
Mengistu etal (1979) Ethiopia 52 Practical 435 cases of malaria seen at the study hospital 12 26.9
Steele el at. (1995) Ghana 285 Practical 2688 children aged less than 14 years 
hospitalised at the study hospital
10.6 6
Commey etal. (1980) Ghana 43 Practical All cases admitted to the paediatric unit of the 
study hospital
7 4.6
Thapa ef a/. (1988) India 40 Practical Not ascertained - 32.5
Ahmad etal. (1986) India 30 Practical Not ascertained - 20
Berkley ef at (1999) Kenya 297 Practical 555 children admitted with non-traumatic 
Impairment of consciousness
53.5 23.4
Nkhomaetal (1999) Malawi 199 Practical 8600 children aged less than 5 years 
hospitalised to the study hospitals
2.3 11.3 to 
15.3
Molyneux eta/. (1989) Malawi 131 Research Not ascertained - 15
Olumeseefa/. (1999) Nigeria 103 Research Not ascertained • 22.3
Bondi (Bondi 1992) Nigeria 78 Research Not ascertained - 20.5
Ikpattefal. (1990) Nigeria 75 Research 8,341 children admitted to the children's 
emergency room
0.9 20
Table continued overleaf
’ The case definition used was either the strict "research" one or a broader and “practical” one.
Table 2 .2  continued
Author, year Country Number of 
cases
Cerebral
malaria
definition
Denominator (population at risk) Frequency (%) Case
Fatality
(%)
Staceeta/(1982) Papua New 
Guinea
68 Practical Not ascertained - 5.9
Schmutzhard & Gerstenbran 
(1984)
Tanzania 66 Practical 7915 cases (all ages) of P. falciparum malaria 
seen at the study hospital
0.8 18.2
van Hensbroek et al. (1997) The Gambia 624 Research Not ascertained - 21.5
Brewster et al. (1990) The Gambia 308 Research 604 children admitted with falciparum malaria 51 14
Idra et al (2004) Uganda 100 Research Not ascertained - 7
Musoke (1966) Uganda 20 Practical Not ascertained - 30
Pagnoni et al. (2002)T Benin 42 Research 207 children admitted with severe malaria 14 9
Burkina Faso 13 Research 201 children admitted with severe malaria 4.7 20
Burundi 14 Research 104 children admitted with severe malaria 9.7 21
Cameron 3 Research 69 children admitted with severe malaria 4 -
Còte d'Ivoire 43 Research 139 children admitted with severe malaria 25.4 11.6
Ethiopia 16 Research 101 children admitted with severe malaria 9.7 25
Nigeria 48 Research 163 children admitted with severe malaria 22.7 10.4
Togo 11 Research 101 children admitted with severe malaria 6.6 -
Uganda 13 Research 75 children admitted with severe malaria 10 -
Adults
Zambia 15 Research 70 children admitted with severe malaria 11.5 "
Elamin (1981) Zambia 34 Practical 450 cases of falciparum malaria 7.5 -
Olwenyefa/. (1986) Zambia 56 Practical Not ascertained - 9
Lutalo & Mabuwa (1990) Zimbabwe NS Practical 162 patients aged 10 years and above treated 
for malaria at the study hospital
39.2 17
Niyongaboefa/. (1994) Burundi 31 Practical Not ascertained - 22.6
Karbwang et al. (1995) Thailand 64 Practical 102 cases of severe falciparum malaria 62.7 •
A multi-centre study conducted in ten countries and recruited a total of 1,230 children aged 6 to 59 months
In adults, the proportion of inpatients seen with falciparum malaria that have 
cerebral malaria ranges from 7.5% in Zambia to 39.2 in Zimbabwe (Elamin 1981; 
Lutalo and Mabuwa 1990). Karbwang et al. (1995) documented a proportion of 
62.7% among cases admitted with severe malaria over a two year period in 
Thailand. In the same Table, the case-fatality ratios (CFRs) of cerebral malaria are 
given and show much variation. A pooled CFR from the review by Murphy and 
Breman (2001) was calculated to be 19.2% (95% Cl 16.2-22.3, n=3,275). There 
appears to be some relation between fatality and age, in which older children and 
adults have a higher mortality (Kiszewski and Teklehaimanot 2004).
The occurrence of cerebral malaria, as well as the proportion of severe malaria 
attributable to cerebral malaria in a population, appears to be influenced by the 
prevailing level of malaria transmission. Cerebral malaria generally tends to occur 
proportionally more often than the other manifestations of severe malaria in areas of 
low transmission intensity and less so in areas with high intensity (Marsh and Snow 
1999). (Snow, Omumbo et al. 1997) In addition to this, within a population, cerebral 
malaria tends to occur at a relatively older age than severe anaemia. For example in 
an area in Senegal with low transmission the mean age of children with severe 
anaemia was 58 months and that for cerebral malaria was 102 months (Trape, 
Lefebvre-Zante el al. 1993) and in an area with high transmission in Kenya, the ages 
were 16.7 and 20.3 months respectively. (Snow, Omumbo el al. 1997)
2.5 Pathogenesis of Cerebral malaria
There have been a number o f theories about the pathogenesis of human cerebral 
malaria. In the 1940s the “permeability” hypothesis was proposed suggesting that 
the features of cerebral malaria were due to an increase in the cerebral capillary 
permeability with outward leakage of plasma causing cerebral oedema and haemo- 
concentration in the capillaries. The result would be a local reduction the micro- 
circulating blood flow (Warrell, Molyneux et al. 1990). This hypothesis has been 
superseded by others as more knowledge about the mechanisms of this 
encephalopathy has been acquired. The current hypothesis is that of “sequestration” 
in which parasitised red blood cells (PRBCs) containing mature falciparum 
trophozoites are selectively sequestered in the micro-vasculature of the brain 
(MacPherson, Warrcll el al. 1985; White and Ho 1992; Berendt, Turner et al. 1994;
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Esslinger, Picot et al. 1994). The mechanism that seems to be responsible for this 
process is cytoadherence, a property by which PRBCs express molecules on their 
surface that are responsible for their increased adhesiveness to host ligands on the 
capillary and post capillary walls. These erythrocyte surface membrane molecules 
are a high molecular mass family of proteins encoded by the var genes of P. 
falciparum. An example of such a protein is P. falciparum erythrocyte membrane 
protein-1 (Pfemp-1). It is localised primarily to parasite-induced “knobs” on the 
surface of PRBCs (Miller 1972; Aikawa, Rabbege et al. 1983; Warrell 1997; 
Newton, Hien et al. 2000). Host ligands for cytoadherence include leukocyte 
differentiation antigen CD 36, intracellular adhesion molecule-1 (ICAM-1), vascular 
adhesion molecule-1 (VCAM-1) and endothelial leukocyte adhesion molecule-1 (E- 
selectin) (Turner, Morrison et al. 1994; Cegielski and Warrell 1997b). These host 
ligands are inducible or up-regulated when endothelial cells are exposed to 
appropriate cytokine stimuli. And in fact, plasma concentrations of cytokines such 
as tumor necrosis factor a  (TNF-a) are elevated in adults and children with severe 
malaria and in some cases associated with coma. The role played by toxins such as 
TNF-a, in the overall dysfunction of the brain constitutes the “toxin” hypothesis 
(Grau, Piguet et al. 1989; Grau, Taylor et al. 1989; Kwiatkowski, Hill et al. 1990). 
The var genes seem to also be responsible for the adherence of non-parasitised red 
blood cells (NPRBCs) to parasitised ones, a property known as “rosetting” (Carlson, 
Helmby et al. 1990; Ringwald, Peyron et al. 1993; Newton and Krishna 1998). 
Other processes that are being evaluated include the accumulation of platelets in the 
microvessels of the brain (Grau, Mackenzie et al. 2003) and the role of the host’s 
protective immune responses on endothelial cells and the blood brain barrier 
(Medana, Chaudhri et al. 2001; de Souza and Riley 2002; Artavanis-Tsakonas, 
Tongren et al. 2003).
The above processes contribute to the loss of consciousness in cerebral malaria 
sufferers via a number of postulated mechanisms (Clark, Rockett et al. 1991; Clark 
and Rockett 1994). The sequestered parasites in the cerebral venules alter the 
function of the neurones via metabolic derangements in the adjacent brain cells by 
competing for substrates such as glucose for their own metabolic processes and 
producing lactic acid (Newton and Krishna, 1998). The parasites may also produce 
toxins that may interfere with neuronal metabolism (Taylor, Day et al. 1998).
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Seizures arising from the effect the parasites have on the cerebral cells can in turn 
contribute to coma. To a lesser degree, the systemic effects of P. falciparum  
infection including high-grade fever and hyponatraemia, also play a contributory 
role to the impairment of consciousness. These postulated mechanisms also 
contribute to the complications of cerebral malaria as highlighted in the next 
subsection.
2.6 Neurological sequelae of Cerebral malaria
Survivors of cerebral malaria may recover without any complications or may 
develop neurological sequelae of various kinds and severity. There is no standard 
definition for the neurological sequelae of cerebral malaria. However, in general any 
impairment o f neurological or cognitive function attributable to preceding illness 
with cerebral malaria are the “neurological sequelae of cerebral malaria” . Some 
authors have considered the neurological sequelae associated with falciparum 
malaria or severe malaria which encompasses impairments that result from the 
effects of severe malaria and not just cerebral malaria.
Neurological sequelae of CM can be gross, for example motor-sensory deficits such 
as hemiparesis; or they can be subtle, for example cognitive dysfunction such as 
attention disorders. The types of neurological sequelae which have been described 
are listed in Table 2.3. As shown, some deficits (a word I shall use interchangeably 
with sequelae) are present at discharge and others develop thereafter. Some sequelae 
are reversible and others appear to persist. There does not appear to be a clear 
distinction between the types in adults and those in children, though developmental 
sequelae occur in children by virtue o f their under-developed brains. This list is by 
no means exhaustive and only serves to highlight the variety of the sequelae and a 
few of their characteristics.
The documented frequency of sequelae in children at discharge ranges from about 5 
to 23% (Molyneux, Taylor ei al. 1989; Carme, Bouquety et al. 1993; Steele and 
Baffoe Bonnie 1995; van Hensbroek, Palmer et al. 1997; Idro, Karamagi et al. 
2004). A fewer number of studies have noted the proportion of adult survivors with 
sequelae. The proportion in this group ranges from about 5 to 10% (Warrell, 
Molyneux et al. 1990). A summary of studies that have examined the frequency of
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neurological sequelae in cerebral malaria is given in Table 2.4 (the data here does 
not include those that have looked at sequelae in severe malaria).
Table 2.3: Summary of the types and selected characteristics of neurological sequelae in 
children and adults
Neurological Sequelae
Characteristics described in the literature
Age
group'
Recovery
documented
Detectiont
A . M o to r-s e n s o ry
S p astic  hem ip a ra e s is C h ild ren Y e s A t d isch a rg e
R e sidual e p ile p sy C h ild ren No A t d isch a rg e
G e nera lised  h ypo ton ia C h ild ren A t d isch a rg e
G e nera lised  sp a s tic ity  o f  l im b s C h ild ren A t d isch a rg e
C e re b e lla r a tax ia Both Y e s A t d isch a rg e
B ila te ra l extra p yra m id a l t re m o r C h ild ren A t d isch a rg e
C e re b ra l pa lsy C h ild ren A t d isch a rg e
C o rtica l b lin dness C h ild ren Y e s A t d isch a rg e
A p hasia C h ild ren Y e s A t d isch a rg e
M o n o p a ra e s is C h ild ren Y e s A t d isch a rg e
H e m ich orea C h ild ren N o A t d isch a rg e
H e a d a ch e /d izz in e ss C h ild ren A t d isch a rg e
Facia l nerve  pa lsy C h ild ren A t d isch a rg e
M ya sth e n ia  g ra v is -like  s y n d ro m e C h ild ren A t d isch a rg e
D ysa rth ria C h ild ren Y e s A t d isch a rg e
H e aring loss C h ild ren A t d isch a rg e
B. Cognitive
P sych o syn d ro m e C h ild re n A t d isch a rg e
M e m o ry  im p a irm e n t C h ild re n A fte r d isch a rg e
A tte n tio n  d e fic it d iso rd e rs Both Y e s A fte r  d isch a rg e
R e stlessn ess Both A fte r  d isch a rg e
H a llu c in a tio n s C h ild ren Y e s A fte r d isch a rg e
A g g re ss ive  beh a v io u r C h ild ren Y e s A fte r d isch a rg e
D e p re ss ive  a ffec t A d u lts A fte r d isch a rg e
P e rso n a lity  chan ge A d u lts A fte r  d isch a rg e
S u b jec tive  d is tre ss A d u lts A fte r  d ischa rge
Im pa ired  m e m o ry A d u lts A fte r  d isch a rg e
E m otiona l lab ility A d u lts A fte r d isch a rg e
C. Developmental
M ic tu tiona l d iso rd e rs C h ild ren A t d isch a rg e
D e ve lo p m e n ta l regress ion C h ild re n N o A fte r  d isch a rg e
M enta l re ta rda tion C h ild re n N o A fte r  d isch a rg e
’ Documented in “children" aged 12 years and below or “adults” aged over 12 years or “both”
’ Detected at time of discharge or sometime after discharge in a survivor who did not seem to have 
deficit(s) at discharge
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Table 2.4: Table illustrating the proportions of survivors of cerebral malaria who developed neurological sequelae and the number whose sequelae improve or 
persist during the study period.
Study No. of survivors (Type of sequelae') No. with sequelae at No. who develop No. whose sequelae No. whose sequelae
discharge (% of sequelae later (Period improve (Period persist (Follow-up
survivors) after discharge) between detection 
and disappearance)
period)
Cross-sectional studies
(Schmutzhard and 54 children aged 6mths-15yrs (MS) 10 (within 6 months)
Gerstenbrand 1984) 
(Molyneux, Taylor eta/. 1989) 111 children aged 7mths-10yrs (MS) 12(11) 4 (4 wks) 7 (4 wks)
(Ikpatt. Asindi ef a/. 1990) 60 children aged 6mths-11 5yrs (MS) 10(17) 10 (Not specified)
(Olumese, Gbadegesin et a/. 80 children aged 11mths-5yrs (MS) 12(15) 12 (within 1 mth)
1999)
(Idro, Karamagi el al. 2004) 93 children aged 3mths-11yrs (MS) 5(5.4)
(Abdulla, Sokrab et al. 1997) A case series of 30 adults aged 16- 
57yrs with cerebellar ataxia
6 had ataxia 24 (within 3-20 days)
Retrospective studies
(Steele and Baffoe Bonnie 
1995)
Prospective studies
187 children aged <14 yrs (MS) 42(23) 17 (12 wks)
(Brewster, Kwiatkowski eta/. 265 children (MS) 35(13) 12 (24 wks) 23(24 wks)
1990)
(Bondi 1992) 62 children (MS & CS) 9(14.5) 2 (within 12 mths) 5 (within 12 mths) 6 (within 12 mths)
(Carme, Bouquety etal. 1993) 145 children (MS) 13(9) 18 (within 27 mths) 7 (within 27 mths)
(van Hensbroek, Palmer ef al. 490 children aged 1-9yrs (MS & CS) 114(23) 12(4 wks) 84 (4 wks) 42 (4 wks)
1997)
4 (24 wks) 20 (24 wks) 
17 (72 wks)
(Karbwang, Tin ef al. 1995) 64 adults aged 15-65yrs (MS) 3(46) 2 (within 1 mth)
' MS, referring to Motor-sensory sequelae; and CS, referring to Cognitive sequelae.
Survivors can develop sequelae immediately upon recovery from coma in which 
case they are detectable at time of discharge or they can occur weeks after. The table 
illustrates the timing of sequelae in studies that were able to show this. About 50% 
of survivors who are discharged with deficits have been shown to improve within 12 
months (Mung'Ala-Odera, Snow et al. 2004). The commonest deficits identified in 
children detected at various periods have been: cortical blindness within three 
months after discharge and seizures within 27 months post-discharge (Carme, 
Bouquety et al. 1993); seizures within 12 months after discharge (Bondi 1992); 
ataxia at one month after discharge, weakness of muscles (i.e. paresis) at six and 
eighteen months after discharge (van Hensbroek, Palmer et al. 1997); and paralysis 
of either the right or left side of the body (i.e. hemiplegia) at discharge (Brewster, 
Kwiatkowski et al. 1990). Detection of motor-sensory neurological deficits has 
involved neurological clinical examination by study or routine physicians. Special 
batteries of tests have been employed to detect cognitive and developmental forms 
of neurological dysfunction (Holding, Stevenson et al. 1999; Holding, Taylor et al. 
2004). To be useful, these have to be standardised to reflect the socio-economic and 
educational background of the population in which they are employed.
2.6.1 Patho-physiology o f  the neurological sequelae of cerebral malaria
The causes of neurological sequelae of cerebral malaria are largely unknown. It is 
probable that a number of factors contribute to the aetiology o f  sequelae. Sequelae 
arise because of damage or destruction of neural tissue which can either be by 
necrosis or apoptosis (Newton and Krishna 1998). The role o f  ischaemia in the 
production of brain damage is well-known. Reduced cerebral perfusion pressure 
which causes reduced delivery of blood to the enclosed brain has been associated 
with severe neurological damage in Kenyan children (Newton, Crawley et al. 1997). 
The perfusion pressure to the brain is maintained by a complex autoregulatory 
mechanism which could malfunction in cerebral malaria patients. The posterior 
parieto-temporal region of the brain is particularly prone to ischaemia when oxygen 
supply to the brain is compromised by either impaired autoregulation, severe 
anaemia, inadequate cerebral blood flow, or raised intracranial pressure. This part of 
the brain lies between the posterior and middle cerebral arteries and takes part in the 
perception o f light. Children have been observed to develop cortical blindness which
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would result from dysfunction of this aspect of the cerebral cortex. At a minute 
level, hypoxia can be generated by impaired delivery of oxygen to brain cells 
because of the congested microvessels clogged with parasitised red blood cells 
adhering to vesicular endothelia (cytoadherence) and non-parasitised cells 
(rosetting) or an interruption of the normal mechanism of oxygen transfer from the 
oxyhaemoglobin o f  the PRBC to the tissues (Maegraith 1951).
Recurrent convulsions that occur in both children and adults (although the frequency 
in children is higher than adults) during severe malarial infection can cause cerebral 
ischaemia and in turn also contribute to the coma of cerebral malaria. Crawley el al. 
(1996) found that o f the 10 children with minimal clinical features of convulsions, 5 
of them regained consciousness within 6 hours of treatment with intravenous 
diazepam suggesting that their coma was partly due to subclinical seizure activity. A 
prolonged seizure causes increased cerebral metabolism with the depletion of 
adenosine triphosphate (ATP), glucose, oxygen and the accumulation of lactic acid. 
This stimulates an increase in cerebral blood flow with a subsequent increase in 
cerebral blood volume adding to the intracranial hypertension that can potentially 
complicate cerebral malaria. The hippocampus is particularly prone to seizure- 
induced damage and this area of the brain is important for short and long-term 
memory. Furthermore the convulsions in children appear to be related to the cerebral 
dysfunction caused by falciparum malaria and not febrile convulsions since the 
majority occur at rectal temperatures less than 38°C (54%) and few of them are 
associated with either hypoglycaemia or any metabolic derangement. Crawley el al., 
(1996) in their study of 65 Kenyan children noted that 10 children (25%) had 
seizures with subtle or subclinical convulsive activity, which is a recognised feature 
of prolonged generalised status epilepticus. Thus the overall frequency of 
convulsions in children (and possibly in adults) based on observed tonic convulsive 
activity may be an underestimate of the true frequency of seizures especially since 
the ictal features can easily be missed unless sought and many of the hospitals in 
Africa do not have electroencephalogram (EEG) facilities.
Anaemia if severe, (in infants especially) would cause a generalised impairment in 
oxygen supply. If  such unconscious patients arc not adequately attended to while in 
hospital, for example ensuring a patent airway or providing appropriate blood
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oxygenation, then the ischaemic damage to the cerebral cells could be worsened or 
precipitated by underlying severe anaemia.
Toxins have been postulated to also contribute to the aetiology of neurological 
sequelae. To-date the toxins documented have been chemicals produced by the host 
cells. Using a mouse model, Clark et al. (1983) showed that reactive oxygen species 
are produced during malaria infection and proposed that if this occurs in humans as 
well, reactive oxygen species could cause coma and damage to local tissues like the 
brain. In adults, monocyte generation of reactive oxygen species has been found to 
be elevated adding some credence to Clark’s hypothesis (Dubey, Rai et al. 1991). 
Reactive oxygen species can also induce apoptosis, a process by which human cells 
respond to a programmed trigger to destroy themselves. Nitric oxide (NO) has been 
examined as a possible cause of impaired neuronal function. It is hypothesized that it 
is induced (TNF-a) in endothelial cells of the vessel walls at sites of parasite 
sequestration, diffuses through the blood brain barrier and reaches the neurones. 
This would subject the neurones to a surplus quantity of nitric oxide in addition to 
their own glutamate-induced network of nitric oxide. These additional and 
uncontrolled quantities of NO could cause impaired neurotransmission and coma as 
well as neurological damage and sequelae (Lipton, Choi et al. 1993). Other toxic 
substances that could be implicated in the causation of neuronal damage are 
excitotoxins. When produced in normal amounts, these endogenous 
neurotransmitters participate in the excitation of neurones and the transmission of 
neuronal stimuli. However when in larger than normal quantities they are toxic to 
neuronal cells. Hypoxia, hypoglycaemia and convulsions, which have been 
associated with neurological sequelae, can cause the release of these 
neurotransmitters.
Hypoglycaemia is recognised as one of the severe manifestations of falciparum 
malaria and it is a known cause of coma. It can also contribute to neuronal damage. 
Intra-erythrocytic trophozoites actively compete for glucose with erythrocytes and 
adjacent host cells potentially impairing delivery of glucose to brain cells. This 
competition for substrates may not affect homeostasis systemically but may have 
profound effects on local metabolism where PRBCs are localised to capillaries. 
Depriving the neighbouring cerebral cells of glucose in this manner would impair
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their function and could even cause them to self-destruct (apoptosis). The added 
effect of hyperinsulinaemia induced by quinine administration during therapy for 
severe malaria could amplify this situation if hypoglycaemia is not detected and 
corrected quickly enough.
2.6.2 Risk factors for neurological sequelae
Investigators have elucidated, with different degrees o f  success, some of the factors 
that determine sequelae (Bondi 1992; van Hensbroek, Palmer et al. 1997; Holding, 
Stevenson et al. 1999; Idro, Karamagi et al. 2004). In Table 2.5 is a list of some risk 
factors that have been identified thus far. Holding et al. (1999) examined 
neurological deficits of the cognitive type that occurred during follow up with 87 
matched pairs of cases and controls. Cases were children who had impaired 
consciousness (BCS < 4) due to severe malaria. Van Hensbroek et al. (1997) in their 
study in The Gambia obtained sufficient information from 145 survivors of cerebral 
malaria (90 children were followed up) to determine factors that were associated 
with neurological deficits. Factors which were consistently identified as risk factors 
are hypoglycaemia on admission, multiple seizures while in hospital (described as 
multiple witnessed seizures), and longer duration of coma.
2.7 Study rationale
Given this background information, there are possible reasons for there to be a 
difference in the frequency of sequelae in children and adults. These include:
Case fatality ratio of cerebral malaria: The CFR appears to differ between 
children and adults. In African children, the overall mortality of strictly defined 
cerebral malaria is 18.6% (95% Cl 16.3-21.0) (Newton and Krishna 1998). In adults 
the mortality for “pure” cerebral malaria i.e. without evidence of vital organ 
dysfunction, is 8%. However when associated with acute renal failure (a 
manifestation which is rare in children) and metabolic acidosis, the mortality rises to 
50% (Newton, Hien et al. 2000). If more adults are dying then there is a possibility 
that a higher proportion of adult patients die before they can develop sequelae.
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Table 2.5: A list of the risk factors for neurological sequelae of cerebral malaria specifying the comparisons groups and period during which sequelae where 
detected
Factor Definition f description of 
determinant'
Relative risk estimate 
(95% Cl) or probability of 
association (proportion)
Type of sequelae 
used as outcome
Period when sequelae 
were detected
Reference
Demography and history
Age at admission <24 mths OR 0.71 (0.20-2.57) CS 3.5 to 5.8 yrs after illness (Holding, Stevenson ef a/. 
1999)
Previous admission For severe malaria Adjusted OR 5.6 (1-31.6) MS At discharge (Idra, Karamagi et al. 2004)
Examination on admission
Body temperature Mean rectal temperature on admission 
(39.3 °C compared with 38.8 °C)
Statistically significant 
association
MS At discharge up to 18 
months later
(van Hensbroek, Palmer et al. 
1997)
Depth of coma BCS score 0 or 1 Adjusted OR 7.4 (1.8-29.7) MS At discharge up to 18 
months later
(van Hensbroek, Palmer et al. 
1997)
Laboratory information on 
admission
Hypoglycaemia Blood glucose £2.6 mmol/L OR 5.40 (1 46-19.91) CS 3.5 to 5.8 yrs after illness (Holding, Stevenson et al. 
1999)
Plasma glucose £2.2 mmol/L Statistically significant 
association (7/51)
MS&CS At discharge up to 12 
months later
(Bondi 1992)
Blood glucose <2.2mmol/L Statistically significant 
association (8/20)
MS At discharge up to 18 
months later
(van Hensbroek, Palmer et al 
1997)
Repeated hypoglycaemia Statistically significant 
association (4/20)
MS At discharge up to 18 
months later
(van Hensbroek, Palmer et al. 
1997)
Parasitaemia Hyperparasitaemia of >500,000 
parasites per 100 RBC
OR 0.48 (0.06-4.05) CS 3.5 to 5.8 yrs after illness (Holding, Stevenson et al. 
1999)
Haemoglobin concentration <5g/dL OR 1.27 (0.37-4.39) CS 3.5 to 5.8 yrs after illness (Holding, Stevenson et al. 
1999)
White blood cells Median white blood cell count (18.2 x 
109/L compared with 11.3 x 109/L)
Statistically significant 
association
MS At discharge up to 18 
months later
(van Hensbroek, Palmer et al. 
1997)
' Value in group with sequelae compared with value in group without sequelae
Table 2.5 continued
Factor Definition / description of 
determinant
Relative risk estimate 
(95% Cl) or level of 
association (proportion)
Type of sequelae 
used as outcome
Period when sequelae 
were detected
Reference
While in hospital
Witnessed seizures A total number of ¿3 seizures OR 5.18 (0.63-42.43 CS 3.5 to 5.8 yrs after illness (Holding, Stevenson et al. 
1999)
Severe seizures Statistically significant 
association (9/51)
MS&CS At discharge up to 12 
months later
(Bondi 1992)
Multiple convulsions Statistically significant 
association (13/20)
MS At discharge up to 18 
months later
(van Hensbroek, Palmer et al. 
1997)
Multiple convulsions Adjusted OR 7.1 (2.2-22.7) MS At discharge up to 18 
months later
(van Hensbroek, Palmer et at. 
1997)
Multiple convulsions Adjusted OR 9.2 (1.7-50) MS At discharge (Idra, Karamagiefa/. 2004)
Focal convulsions Adjusted OR 7.3 (1.1-50) MS At discharge (Idra, Karamagi et al. 2004)
Duration of coma ¿24 hrs to regain ability to localise 
painful stimuli
OR 3.41 (0.97-11.96) CS 3.5 to 5.8 yrs after illness (Holding, Stevenson et al. 
1999)
Mean duration of unconsciousness 
(129.3 hrs compared with 55 hrs)
Statistically significant 
association
MS&CS At discharge up to 12 
months later
(Bondi 1992)
Median coma duration before 
admission (12 hrs compared with 6 hrs)
Statistically significant 
association
MS At discharge up to 18 
months later
(van Hensbroek, Palmer et at. 
1997)
Median duration of coma (116 hrs 
compared with 24 hrs)
Statistically significant 
association
MS At discharge up to 18 
months later
(van Hensbroek, Palmer et al. 
1997)
Comatose for >48 hrs Adjusted OR 13.4 (3.4-52.4) MS At discharge up to 18 
months later
(van Hensbroek, Palmer ef al. 
1997)
Respiratory distress Had one or more episodes OR 0.51 (0.15-1.79) CS 3.5 to 5.8 yrs after Illness (Holding, Stevenson ef a/. 
1999)}
Duration of hospital stay Mean duration of hospital stay (4.34 
days compared with 2.1 days)
Statistically significant 
association
MS&CS At discharge up to 12 
months later
(Bondi 1992)
At discharge
Neurological deficits at 
discharge
OR 19.6 (4.64-84.65) CS 3.5 to 5.8 yrs after illness (Holding, Stevenson ef al. 
1999)
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Seizures: Children have a higher incidence of seizures and it is estimated that about 
50 - 80% of them present with seizures whereas the range in adults is 20 — 50% 
(Newton and Krishna 1998; Newton and Warrell 1998). Adults are less likely to 
have status epilepticus and less likely to have evidence of subtle seizure activity. If 
there is an association between seizures and neurological sequelae then this would 
predispose more child survivors to neurological sequelae than adults.
Hypoglycaemia: Hypoglycaemia is found more frequently in children (20%) than 
adults (8%) with cerebral malaria (Newton and Krishna 1998). Hypoglycaemia 
causes coma and can precipitate convulsions. In this way hypoglycaemia can be 
associated with sequelae (Brewster, Kwiatkowski et al. 1990; Bondi 1992) and 
contribute to a higher frequency of sequelae in children.
Brain development: The adult brain is more mature but less malleable than at a 
younger age. Therefore if neuronal injury and recovery is related to either or both of 
these qualities, it is feasible that the frequency of neurological deficits can differ 
between children and adults.
Immunological basis of brain injury: The role of a more competent immune 
system in the pathogenesis of cerebral malaria has been postulated. If CM affects the 
brain more severely when the immune responses are more developed as would be 
the case in older subjects, then the risk of neurological deficits in survivors who be 
related to age of onset of disease.
This study sets out to examine differences in the occurrence and characteristics of 
neurological sequelae in children and adults in Uganda in an attempt to provide 
more knowledge on the determinants o f  neurological sequelae. In this way, the study 
can contribute to a better understanding of the pathways leading to deficits and 
consequently better strategies for prevention.
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2.7.1 Study hypotheses
Null hypothesis: The characteristics (type, timing, reversibility) and risk factors of 
the neurological sequelae that follow an episode of cerebral malaria are similar in 
children and adults in Uganda.
Alternate hypothesis: The characteristics (type, timing, reversibility) and risk 
factors of neurological sequelae that follow an episode of cerebral malaria are 
dissimilar in children and adults in Uganda.
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C hapter 3
3. METHODOLOGY
3.1 Study objectives
3.1.1 General objective
To determine the natural history of neurological sequelae in Uganda children and 
adults comparing both groups for differences and determine the risk factors for 
sequelae.
3.1.2 Specific objectives
1. To determine the kinds of sequelae that occur in Ugandan children and adults
2. To determine the duration between cerebral malaria and the occurrence of 
sequelae
3. To determine the proportion of survivors of cerebral malaria who have deficits 
that go on to improve
4. To determine the duration between cerebral malaria and the regression of 
sequelae in subjects who have sequelae.
5. To identify differences in the types and characteristics of neurological sequelae in 
children and adults.
6. To determine risk factors for neurological sequelae among children and adults, 
and identify any differences.
3.2 Sample size estimation
Sample size was estimated according to the formula of Rigby and Vail for a two- 
sample comparison of proportions (Rigby and Vail 1998).
N = {p. x (1-p,)} + {p2 x (l-p2H X M
(P 1-P2 ) 2
where,
N = the number of subjects per group (assuming that each group is equal in size) 
Pi = the proportion with the outcome o f interest in group 1
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1-pi = the proportion without the outcome of interest in group 1 
P2 = the proportion with the outcome of interest in group 2 
1 -p2 = the proportion without the outcome o f interest in group 2 
M = a number derived by the authors for sample size calculations for common 
values of a  and (1-fi). The precise formula for “M” is not given by the authors. The 
value of 7.8 substituted for M corresponded to a study power (1-p) of 0.80 and 
significance level (a) of 0.05 (two-tailed).
The size of the study was that needed to detect a 3-fold difference in the proportion 
of neurological sequelae between children (5%) and adults (15%). Putting these 
values in the formula, it was estimated that a sample of 274 subjects of two equal 
groups would be sufficient. An additional 30% was added to account for deaths 
(20%) and losses to follow-up (10%) giving a total sample size of 364 patients with 
the case definition.
3.3 Study design
To enrol the required number of cases estimated from the sample size calculation 
(N=364), a multi-centre study design was adopted since none of the study sites 
visited during the preparation of the study had sufficient cases on their own. The 
combination of the five hospitals, Kabale, Mutolere, Mulago, Mbale and Masaka 
recorded 863 cases of cerebral malaria between January and December 1999 (1997 
in the case of Mulago hospital). Mulago hospital alone recorded 625 cases o f whom 
145 were above 12 years of age. Mulago, which is the national referral hospital and 
the main medical teaching hospital, was the more obvious option for such a study 
because of the large number o f  cerebral malaria cases seen there in both children and 
adults. However, the Principal Investigator, who has worked there for several years, 
did not use this site for a number or reasons. These include:
i. Mulago hospital is huge with a capacity of 1,500 beds, and the logistics of 
conducting a study o f  this nature involving the 3 paediatric and 3 adult 
medical wards would require much input in terms of time, money and 
manpower. Some staff would need to be hired to assist in case management 
since the regular staff have too much to do already.
ii. Much research is conducted at the hospital by postgraduate medical students 
as well as other staff. Some of the junior staff are fatigued by the numerous
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studies that they have to participate in and as a result, it was my personal 
opinion that this study which required intensive patient care would need an 
environment in which the staff were eager and motivated to participate.
iii. Follow-up and tracing of survivors would be difficult to organise since the 
population from which the cases are coming from is very diverse and covers a 
large catchment area.
iv. It would be difficult to determine the factors that contribute to any selection 
bias in such a heterogeneous population.
v. The additional research work could adversely affect the overall service 
delivery and output in the very busy paediatric and medical wards.
In comparison, the advantages of conducting the study at the selected district level
hospitals are:
i. They are located in or close to epidemic-prone areas where much of the 
population is supposed to be relatively non-immune to malaria and this would 
increasing the probability of getting patients who have a wide age distribution.
ii. It was anticipated that the El Nino phenomenon (ENSO) was likely to occur 
during the study period (between 2000 to 2002) and the conducive conditions 
would cause an increase in the occurrence of malaria in the epidemic-prone 
areas as was the case in Kabale in 1998 when it last occurred. I had witnessed 
the epidemic in Kabale in 1998 and this was a window of opportunity of 
which I wanted to take advantage.
iii. There is little information about cerebral malaria in the highland areas of 
Uganda and Africa as a whole and a study of this kind would shed some light 
on this topic.
iv. The workload at the district hospitals, though huge, is not a hindrance to 
additional research work especially since many of the staff have not been for 
refresher courses and are keen to acquire new skills and knowledge on the 
management of the diseases in their communities. My assumption was that 
they be more motivated to participate in the study and consequently collect 
better quality data
v. There would be some benefit to the patients since medication and some 
equipment was to be provided for the management of cerebral malaria as part 
of the study. Supplies of such items are sometimes erratic at the district level
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and the assistance from the study would help to save lives in this way. Any 
skills which the staff acquired during the study could then be utilised for other 
purposes
vi. Follow-up and tracing of survivors would be easier to arrange and conduct 
with the District Health Services who could provide personnel and vehicles for 
this purpose. The public health structure at district level is well defined 
making it easier to arrange for the follow-up of survivors using the already 
established links.
With these in mind, four district hospitals were used in the multi-centre design. The 
possibility that the sample size might not be achievable in one year (i.e. two rainy 
seasons) at the four sites was not neglected. In such a situation the contingency plans 
were to a) include a fifth site, or b) extend the enrolment phase o f  the study to one 
more rainy season, or both.
The study was to cover many aspects of patient management and as a result it was 
necessary to collaborate with other researchers on malaria in Uganda. Upon 
returning to Uganda, I visited several researchers to find out in what ways they 
could assist me in preparing the study. As a result, a number of collaborative links 
were established which will be highlighted in the course of this thesis.
The study was divided into three phases, a Pre-recruitment phase (April 2001 to 31 
December 2001), Recruitment phase ( lsl January 2002 -  31st December 2002 then 
extended to July 2003) and Follow-up phase (February 2002 to August 2003). Each 
phase involved specific activities conducted by the Principal Investigator (PI) and 
collaborating institutions. The key activities that were performed in each phase 
include the following:
3.3.1 Pre-recruitment phase
i. Development of the data collection tools Checklist I and 2, Forms l, 2, 3, and
4.
ii. Development and adaptation of case management tools.
iii. Development of training materials for the study teams.
iv. Selection of study teams comprising of laboratory, nursing and clinical staff.
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v. Training the study teams to use the data collection tools and to follow the 
management and evaluation guidelines.
vi. Piloting of data collection tools to determine their suitability and eliminate 
errors.
vii. Identification o f  deficiencies in the routine triage of patients and finding 
solutions to speed up diagnosis and treatment.
viii. Identification o f  deficiencies in the provision of medication and sundries 
required to manage cerebral malaria at the study hospitals.
ix. Putting in place systems to supplement any deficiencies that were identified 
and those that developed during the study period.
x. Obtaining clearance from various organisations to carry out the study.
xi. Procurement o f  study supplies and equipment from within and outside 
Uganda.
xii. Linking up with other malaria scientists within the country and to make them 
aware of the study.
xiii. Development o f  a tool for assessing cognitive function in survivors during 
follow-up.
3.3.2 Recruitment phase
i. Enrolment of cases that met the selection criteria.
ii. Management o f  cerebral malaria cases according to the study guidelines.
iii. Informing other health units, both government and non-government, within the 
catchment areas of the study hospitals. I looked through their records and how 
they managed severe malaria. Those without the capacity to manage cerebral 
malaria were encouraged to refer suspected cases to the study hospital as 
quickly as possible (including arranging transportation if required which 
would be paid for by the study).
iv. Maintaining a register of all admissions of malaria at the study hospitals.
v. Maintaining a record of all supplies provided to the study hospitals.
vi. Validating laboratory results and implementing quality control measures.
vii. Maintaining a bank of frozen sera at the study sites.
viii. Training new team members when there were routine changes of staff.
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3.3.3 Follow-up phase
i. Assessing survivors for neurological deficits. This occurred simultaneously 
with case enrolment.
ii. Tracing subjects who do not attend follow-up visits on schedule.
3.4 Study Sites
One consideration in selecting the sites was the need to use areas in which the age 
spectrum of subjects with cerebral malaria was wide enough to elucidate the 
influence of age-of-onset on disease. A number of areas were considered and were 
visited by the Principal Investigator in July 2000. The epidemiology of malaria is 
influenced by the level of malaria transmission so much so that the severe forms of 
malaria are more prevalent in the under 5 year olds than in those above in areas with 
moderate to high transmission. As the level of transmission declines, the occurrence 
of severe malaria shifts towards the older age groups whenever such a population is 
exposed to malaria for example during an epidemic. This background was taken into 
account when selecting the study sites. In describing the study areas, special 
attention is given to factors such as rainfall and altitude which influence the degree 
of malaria transmission. Table 3.1 provides some geographical and climatic 
characteristics of the areas visited.
Each facility was assessed to determine its suitability for the study. To make the 
process of selection systematic a “suitability score” was constructed and used to 
score each hospital. For each parameter assessed, see Table 3.2, each hospital got a 
score of zero for poor, one for good and two for very good. The table gives the 
scores each hospital obtained for each parameter. I realise that this assessment was 
based upon personal observations during one visit. The completeness of the data was 
not certain and data depended heavily on the diagnostic criterion used at each site, as 
well as the accuracy of diagnosis.
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Table 3 . 1: Summary of the physical and climatic characteristics of the towns in which possible study hospitals are situated.
Town/District Malaria endemicity Altitude
(metres)
Mean annual rainfall 
(mm)
Mean annual minimum 
temperature (degrees C)
Mean annual maximum 
temperature (degrees C)
Kabale Hypoendemic 1,830 -  2,130 890-1,020 10 25
Kisoro Hypoendemic 1,830 -  2,130 1,520-1,780 7.5 22.5
Masaka Mesoendemic 1,220-1,520 1,140-1,270 15 27.5
Mbale Hyperendemic 1,220-1,520 1,270 15 30
Torofo Hyperendemic 1,070-1,220 1,397 15 30
Kapchorwa Hypoendemic 1,830 -  2,130 1,905 12 27.5
Apac Holoendemic 760-1,070 1,397 17.5 30
Table 3 2: Parameters of the suitability score that were used to select hospitals for the study on the neurological sequelae of cerebral malaria.
Parameter Kabale Mutolere Masaka Kisoro Mbale Tororo Kapchorwa Apac
More than 50 recorded cases of cerebral malaria per year 0 1 2 0 2 2 0
Laboratory facilities to perform basic investigations 1 2 0 0 2 0 0 0
Adequate number of clinical staff to attend to admitted patients 1 0 1 0 2 0 0 0
Adequate number of nursing staff to attend to admitted patients 2 2 0 0 1 0 1 0
Clinical staff who are interested in collaborating 2 2 1 0 1 1 1 1
Conditions suitable for disease in a wider age group 2 2 0 2 1 0 2 0
Total score 8 9 4 2 9 3 4 1
’ No records available for assessment
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Three of the hospitals selected, Kabale, Mutolere and Mbale ranked highest on the 
suitability score. Kapchorwa hospital which was also selected did poorly on the 
scale but could not be left out because it is in a malaria epidemic-prone area. Four 
hospitals were therefore selected for the multi-centre study. The following 
paragraphs give a succinct account of the four study hospitals and the districts in 
which they are located.
3.4.1 Mbale District
Mbale district is situated in the Eastern region of Uganda. It is bordered by Kenya to 
the East, Tororo to the South West, Kumi to the North West and Kapchorwa to the 
North East. The district lies at altitudes between 1,299m and 1,524m above sea 
level. The average annual rainfall reaches up to 1,191mm. The population of the 
district according to the 2002 population and housing census is 720,925 (50% 
males). The main economic activities are agricultural based viz., subsistence farming 
of maize, beans, cassava, bananas, soya beans, yams, rice, and coffee; and rearing of 
cattle, goats and sheep (GOU. 2004d).
The district is unique because close to Mbale town is Wanale ridge which is at an 
altitude of about 2,270m above sea. The area is very fertile and has its own unique 
vegetation and eco-system. The people that live there are mostly farmers and 
regularly take their produce down to the markets in Mbale town.
Mbale district has one regional hospital, Mbale hospital; one district hospital, 
Bududa hospital; seven health centres; twenty-eight health centres; seventy-four 
health units and twelve first aid posts at village level. There are 438 staff employed 
in the health sector and they include health inspectors, health assistants, health 
educators and health visitors. 500 community resource personnel like traditional 
birth attendants (TBAs), community council aids, and peer educators. Some of these 
workers have been trained in health education and home visiting. They participate in 
outreach programmes, TB case tracing and immunisation. Malaria is the number one 
cause of morbidity and mortality in the district. The district has a few control 
measures in place and plans to implement more. Two entomologists are responsible 
for overseeing vector control strategies like barrier spraying (although the supply of 
insecticides is erratic) and destruction of mosquito breeding sites. Pregnant women
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and HIV infected/AIDS patients are given prophylactic chloroquine. Insecticide 
treated bednets are to be acquired and a mechanism to distribute / impregnate them 
at a subsidised price is being formulated. The Director of the District Health 
Services (DDHS) overlooks all the health issues of the district.
3.4.2 Mbale Regional and Referral Hospital
Mbale hospital offers clinical and outreach services to  the population of Mbale. Its 
catchment area extends over the entire Eastern region which is a combined 
population of 6,301,677 people. The hospital has tw o surgical wards, and three 
medical wards of which one is for children aged 12 years and below. The hospital 
has an ample number of specialists and medical officers. Two consultant 
paediatricians run the children’s ward and one consultant physician is responsible 
for running the adult medical ward. There is an ophthalmology and physiotherapy 
unit. The laboratory is fairly well-equipped with staff consisting of two senior lab 
technologists, one senior lab technician and a few lab assistants.
3.4.3 Kapcliortva District
Kapchorwa district is located in the Eastern region along the slopes of Mt Elgon 
(summit at 4,932m). The mountainous terrain lies between 1,500m and 3,000m 
above sea level. Annual rainfall ranges between 920 and 1,650mm. The duration and 
timing of the two rainy seasons varies with altitude whereby the higher the altitude, 
the longer the rains. Kapchorwa has a population o f 193,510 people (50% male), is 
served by 1 Government hospital and 26 Health centres of various levels of 
sophistication. The infant mortality rate in the district was estimated to be 104 
deaths per 1000 livebirths slightly less than the estimated national figure of 122 
deaths per 1000 livebirths (time period for this calculation was not given). The main 
cash crops grown are maize, bananas, coffee, beans, wheat, and sunflower (GOU. 
2004b).
Malaria was not a major public health problem in the district but over the past few 
years it has become a big killer. The District Health authorities attribute this to 
warmer climatic conditions and the massive deforestation that has been going on in 
the district, see Picture 1.
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Picture 1: A picture of the landscape in Kapchorwa district showing the large areas 
of forest that have been cleared for farm land (Taken by James. Tibenderanaj n  
2003 V
3.4.4 Kapchonva District Hospital
Kapchorwa hospital is a 100 bed facility. Its staff include three MOs, five clinical 
officers, ten nurses and ten midwives, one lab technician and two lab assistants. The 
hospital serves a population within the district though its catchment area includes the 
south part of Moroto district and the eastern parts of Kenya. Complicated cases that 
cannot be appropriately dealt with at the hospital are referred to Mbale hospital, a 
distance of about 60km on a recently completed all season road There are outpatient 
services such as general care, antenatal care, immunisation and Sexually 
Transmitted Infections (STI) Basic investigations are performed at the small 
laboratory. A small records unit is manned by one records clerk
3.4.5 hahale District
Kabale is situated in the south-western region It is surrounded by Rukungiri to the 
north, Kisoro to the west, Ntungamo to the north east and Rwanda to the south 
Average annual rainfall is between 1,000 and 1,480mm The district is very hilly and 
the altitude is between 1,219 to 2,347m It has a population of 471,783 people (46%
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male). Farming is the main form of livelihood. Crops grown include potatoes, 
sorghum, beans, and peas (GOU. 2004a).
The district has a weekly surveillance of five diseases, namely malaria, polio, 
cholera, dysentery, and measles. All the 46 health units in the district report the 
frequency of these diseases to the office of the Director of DHS. This surveillance 
system was put in place after the malaria epidemic in the south western parts of 
Uganda in 1998. Malaria control activities are reinforced in areas that record surges 
in malaria cases. These activities include household and barrier spraying when the 
insecticide is available, destroying the mosquitoes’ breeding sites and ensuring that 
there is an adequate amount of chloroquine at the nearest health centre. Health 
educators and sanitation teams are dispatched to these areas when the need arises. 
Another way by which they monitor the prevalence of severe malaria in the 
community is by the demand for blood transfusions at the district hospital.
3.4.6 Kabale Regional and Referral Hospital:
Kabale Hospital is a district and referral hospital situated in Kabale Municipality, 
about 400km from Kampala. The hospital has a capacity of 250 beds and its referral 
facilities serve a combined population of about six million inhabitants. It offers 
clinical services, surgical and medical; and outreach programmes such as 
immunisation and family planning.
The hospital has two paediatricians (consultant and registrar) two surgeons (surgical 
and obstetric), one physician and two Medical Officers. The hospital has a few 
nurses who carry enormous workloads. The lab is manned by two senior laboratory 
technologists. Like all hospitals in the country, a record of all inpatients and 
outpatients is kept. Basic information on each hospital attender is recorded.
3.4.7 Kisoro District
Kisoro, in the south western tip of Uganda, like Kabale is very hilly. It is at the 
border with, Rwanda to the South and the Democratic Republic of Congo to the 
West. The climate is similar to that of Kabale with an average annual rainfall of 
1,600mm. The altitude ranges between 1,200 and 2000m above sea level. The 
district has a population of 219,427 people (45.2% male). Agriculture is the main
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economic activity in the district. It is one o f  the least developed districts in Uganda 
and has poor road infrastructure (GOU. 2004c).
3.4.8 St. Francis Hospital, Mutoiere:
Mutolere Hospital is a missionary hospital that is run by the Kabale Diocese of the 
Church of Uganda. It is located in about 1 1km from Kisoro town and has a capacity 
of 220 beds. It offers only clinical services and is not a referral hospital. However 
because of inadequate medical services at Kisoro hospital (it has now been 
renovated), the only other hospital in the district, and the poor road network to 
Kabale (56km away) most patients have to go to Mutolere for their health needs.
Two consultants, a gynaecologist and paediatrician, and two medical officers run the 
hospital. The hospital has a nursing training school. An assistant laboratory 
technician runs the small but well stocked laboratory. Most basic laboratory 
investigations are carried out there. The hospital records were fairly well kept and 
up-to-date
Like all missionary hospitals in the country, patients have to pay user fees for the 
health care they receive. Though a minimal fee, these charges can be substantial if a 
family is large and its members are sick many times in a year. Those who cannot 
meet the charges are either given waivers or allowed to pay the charges at a later 
date. Arrangements were made with the hospital administration not to charge 
patients who were admitted with cerebral malaria during the study period. The costs 
of their treatment were to be paid by the study.
3.5 Study population
The population from which cases were selected resided in areas with moderate to 
low malaria transmission at the time when they were admitted to hospital. These 
areas were at altitudes above 1,200 metres. They had to be resident within the 
catchment area of the study hospital. Inclusion and exclusion criteria (incorporated 
in Eligibility Checklist l and 2) were employed to choose study cases from 
consecutive patients admitted with impaired consciousness due to non-traumatic 
causes. The attributes used in the selection process include those given by Warrell et 
al to differential patients that match the case definition for cerebral malaria from
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other unconscious patients (reference here). Other attributes such as age and 
residence, were employed to choose a group that could be assessed reliably with the 
study tools and was from within the catchment area of the study hospital (WHO 
2000). Below are the inclusion and exclusion criteria.
3.5.1 Inclusion criterion
A patient who was admitted to any of the study hospitals was enrolled into the study 
if all of the following were present:
i. Aged between 12 months and 70 years at the time of admission.
ii. Has impaired consciousness characterised by inability to localise painful 
stimuli or unawareness of the environment.
iii. Has the specified level of consciousness above for a minimum of thirty 
minutes in the case of a child (below 10 years) and one hour in the case of 
those 10 years and above.
iv. Has fever or convulsions, or a history of fever or convulsions, within the last 
week preceding admission.
v. Has a positive blood smear for P. falciparum.
3.5.2 Exclusion criterion
On the contrary, a patient with any of the following was not enrolled into the study:
i. Has had an accident or knock on the head which has caused the current loss of 
consciousness.
ii. Has evidence of other encephalopathies like bacterial meningitis.
iii. Is a known epileptic with more than 3 convulsions in the last six months 
preceding admission.
iv. Has evidence of any physical deformity that will compromise neurological 
assessment.
v. Has evidence of any neurological deficit preceding the current episode of 
coma.
vi. Resides more than one day’s travel to the hospital by whatever means of 
transportation used to get to the hospital.
vii. Is known to be pregnant at the time of admission.
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3.6 Case definitions
Cerebral malaria was defined according to the WHO definition in which a patient is 
considered to have cerebral malaria if he/she
i. is in unrousable coma
ii. has P. falciparum parasitaemia
iii. has normal cerebrospinal fluid and
iv. does not have any other identifiable cause of coma.
This definition constitutes a “definite” case of cerebral malaria (DCM). A priori, an 
additional definition was agreed to enable the inclusion of cases that either did not 
have all the features of the strict WHO definition or had altered mentation but not in 
unrousable coma.. These cases formed a group of “probable" cerebral malaria*. The 
attributes that describe both forms of cerebral malaria in this study are given in 
Table 3.3. The necessity for these two groups is to combine the strict research 
definition (DCM) with the more practical one (PCM) and facilitate the enrolment of 
more cases. Additionally, there is the need to determine whether cases of probable 
cerebral malaria are on the pathway towards definite cerebral malaria in which case 
the rapid deterioration to coma necessitates that they are managed as cerebral 
malaria. Hospitals in Uganda admit patients with life-threatening conditions. With 
regards to malaria this comprises patients with severe forms of malaria. This group 
forms the denominator when calculating the proportion of cerebral malaria among 
falciparum admissions since it was not possible to determine the size o f  the 
population from which the cases came from.
* These terms are documented in the literature Brewster, D. R., Kwiatkowski, D. and White, N. J. 
(1990). "Neurological sequelae of cerebral malaria in children." LanceI 336(8722): 1039-43. Kamble, 
M. B., Raut, P. P. and Hussain, Z. F. (2002). "Cerebral malaria in rural India." Indian Jo u rn a l o f  
P e d ia tr ic s  69(8): 659-61.
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Table 3.3: Attributes that contribute to the definitions of cerebral malaria in the study
Case Attributes
Scenario Altered mentation P. falciparum asexual forms State of cerebrospinal fluid Blood glucose Definition /
(ranked) remarks
Child
1 Unrousable coma for 230 minutes Demonstrable Aseptic Within normal range Definite
2 Unrousable coma for 230 minutes Demonstrable Not measured but no neck stiffness Within normal range Probable
3 Unrousable coma for 230 minutes Not demonstrable but has received 
quinine within the previous 48 
hours'
Aseptic Within normal range Probable
4 Unrousable coma for 230 minutes Demonstrable Aseptic Not assessed Probable
5 Unconscious but able to localise 
painful stimuli for 230 minutes
Demonstrable Aseptic Within normal range Probable
Adult
1 Unrousable coma for 2 60 minutes Demonstrable Aseptic Within normal range Definite
2 Unrousable coma for > 6 0  minutes Demonstrable Not assessed but no neck stiffness Within normal range Probable
3 Unrousable coma for 260 minutes Not demonstrable but has received 
quinine within the previous 48 
hours
Aseptic Within normal range Probable
4 Unrousable coma for 260 minutes Demonstrable Aseptic Not assessed Probable
5 Unconscious but able to localise 
painful stimuli for 2 60 minutes
Demonstrable Aseptic Within normal range Probable
‘ No case (child or adult) was included with this scenario
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3.7 Study Outcomes
The main outcomes are mortality and neurological sequelae. Mortality refers to 
death. Neurological sequelae refer to any neurological deficits that persist beyond 
the time when the subject has recovered from cerebral malaria well enough to be 
discharged from hospital. Recovery is judged in terms of regaining consciousness
i.e. a score of 5 on the BCS or 15 on the GCS. A neurological deficit refers to a 
problem with brain or nerve function that affects either a specific ability or a specific 
location. This study was designed to examine for gross motor and sensory deficits as 
well as gross cognitive abnormalities. The kinds of deficits that were sought are 
given in the list below:
Motor-sensory deficits
• Weakness of a limb or limbs
• Abnormal tone as either increased tone or reduced tone
• Abnormal gait or the inability to walk in an individual who could walk 
before the bout of cerebral malaria
• Tremor or tremors
• Cerebral palsy
• Epileptic fits
• Blindness
• Inability to vocalise properly in a child who could do so before
• Cranial nerve deficits such as facial nerve palsy
• Hearing loss
• Persistent headache
• Dizziness 
Cognitive deficits
• Memory impairment
• Attention deficit disorders
• Restlessness
• Hallucinations
• Aggressive behaviour
• Personality changes
• Depression
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The main outcome measures that were used for analyses were:
i The proportion of cases that died of cerebral malaria among the cases of 
cerebral malaria admitted during the study period
ii. The proportion of cases that developed one or a combination of neurological 
sequelae among survivors that attend examination.
3.8 Protocol Development meeting
A protocol development meeting was held in Kampala on 22nd August 2001. 
Twenty-two participants comprising some members of study teams from the four 
hospitals and other malaria researchers attended, see Picture 2 for a group photo 
taken at the end of the meeting. The main reasons for this gathering was for 
participants to get to know each other, for the principal investigator to  explain the 
study, for participants to agree management guidelines, laboratory evaluations and 
monitoring procedures, to clarify procedures for obtaining informed consent and 
HIV testing, and to find ways of cooperating between study sites and other 
researchers in the country. The case record forms were reviewed and changes 
suggested to make them more adaptable to the local settings. Additional tools were 
suggested which the principal investigator was to develop
Picture 2: Group photograph taken at the end of the Protocol 
held on 22nd August 2001 in Kampala.
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3.9 Data collection tools
The study was conducted in a clinical setting at four sites that are far apart. None of 
these sites had been involved in a clinical study before. Much of the data required 
was of a routine nature but needed to be collected in a structured and uniform 
manner. To do this, data collection tools that were appropriate for the setting were 
needed. Several kinds o f  tools were used to extract data and data collection. Below 
is a description of these tools.
3.9.1 Case record Forms
I visited Kemri/Kilifi, in Kenya, in July 2001 to see how they had organised their 
studies on cerebral malaria. I obtained copies of their case record forms (CRFs) and 
adapted them with permission before returning to Uganda to prepare the ground for 
this study. I presented the adapted copies at the Protocol Development meeting and 
several changes were suggested by the participants. To take on the suggestions, I 
had to redesign the forms paying particular attention to the following requirements:
i. Clarity -  The forms were written in English since this is the official language 
in Uganda. However it is not the first language for most people, more so at a 
district hospital in a semi-rural environment where the staff are used to 
communicating in the local languages. The instructions and questions 
therefore had to be phrased in sentences with little or no ambiguity.
ii. Easy to complete - The additional burden of collecting these data had to be 
minimised so that team members were co-operative. To do this, the CRFs 
needed to be easy to complete with well sequenced questions so that one did 
not have to jump from one page to the other and back again. Instructions on 
how to carry out the various examinations needed to be on the forms even at 
the expense of the length of the questionnaire.
iii. Separate tools for each level of patient management — Since it was agreed 
that case management would be levelled with different cadres of staff 
participating, each CRF had to be tailored to fit the level at which it would be 
used. Therefore Eligibility checklist 1 and Form 1, which were completed by 
the nurse-on-duty had to contain questions that reflected the nurse’s duties and
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knowledge whereas Eligibility checklist 2 and Form 2 which were completed 
by the Medical Officer contained more technical terminology.
iv. Uniform data quality -  This was a multi-centre study and consequently, team 
members needed to understand the questions in similar ways and respond as 
accurately yet as consistently as possible. To achieve this, closed-ended 
questions were used where possible. A combination of dichotomous and 
multiple-choice responses were provided. Item check-lists were also employed 
for example, the Eligibility checklists I and 2.
v. Visually appealing -  The forms contained many questions and instructions. 
Consequently, much care was taken in their layout to prevent the pages from 
appearing congested. Some forms, for example the observation chart, were 
printed on coloured paper to be easily identifiable.
vi. Layout that would allow data to be extracted easily -  The forms were 
designed so that electronic forms with a similar layout could be designed in 
MS Access. This would allow data be extracted more easily from the hard 
copies to the electronic ones with fewer mistakes.
3.9.2 Consent Form
This was a one-paged form that was translated into the local languages that were 
common in that area. An Information sheet that provided a summary of the study 
was also translated. Copies of the data collection tools, information sheets and 
consent forms can be found at the end of the end of this document in Appendix I.
3.9.3 Aide memoirs
There was a need to develop aide memoirs of guidelines on some aspects of data 
collection and case management. These would not only serve as reminders to team 
members but also provide a standard by which all teams had to abide. Posters of the 
following guidelines were made and placed on all wards, copies of which can be 
found in Appendix II.
i. Management of the patient with cerebral malaria -  This was adapted from 
International guidelines compiled by Warrell et al. (1990). 
ii. Evaluations of the patient with cerebral malaria — This specified 
chronologically the forms to be completed and the laboratory investigations to 
be performed.
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iii. How to measure blood glucose using a glucometcr — This gave a step-by- 
step account of how to use the glucometer provided. None of the hospitals 
used a portable glucometer routinely. Therefore once the staff were trained 
how to use the glucometer, there was a need for such a reminder.
iv. How to measure blood pressure using an automatic sphygmomanometer — 
An automatic BP machine was provided to each ward. This was a new piece of 
equipment and to facilitate its use, step-by-step instructions were compiled 
onto a poster and placed on a visible part of the ward.
3.9.4 Piloting o f data collection tools
The data collection tools were piloted at Mbale hospital between 1 and 31st 
December 2001. Thirteen patients who were suspected to have cerebral malaria were 
recruited and managed. Six cases during this same period were managed at 
Kapchorwa hospital and used to pilot the data collection tools and streamline patient 
triage procedures. Completed forms were reviewed to determine any amendments 
that needed to be made to the tools, recruitment procedures, triage or management 
methods. Some errors were noted and appropriate corrections made. Final copies of 
the tools were printed and distributed to study sites based on these amendments. It 
was not possible to pilot the tools at all four study sites during the same period 
because of the availability o f patients fitting the selection criteria. Cases matching 
the selection criteria did not attend the other two hospitals until much later. It was 
decided to use the first five or so cases that were admitted at these two hospitals 
when ever they became available to try the data collection tools and get the study 
teams familiar to them and the data management guidelines. Five cases met the 
selection criterion of Checklist 1 at Kabale hospital between April and July 2002. 
These were the initial cases admitted to that hospital that appeared to have cerebral 
malaria. They were used to pilot the data collection procedures and tools. Similarly 
two cases were used to pilot study materials at Mutolere hospital. Form 5 which was 
developed in the course of the study was not piloted.
3.10 Data collection procedures
At all study hospitals, the major participating units were the paediatric and medical 
units. Patients who were deemed to be suitable for the study were triaged according 
to procedures that were put in place by the study teams and PI. Management was
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staged in to five levels to enable different kinds of data be collected by different 
cadres of staff over the period of time during which the subject was on the ward. In 
this manner, the responsibilities of care and data collection were distributed over 
different personnel and over time reducing the additional burden that a study of this 
nature places on already busy staff. The stages of case management were assigned 
five levels as:
3.10.1 Level One
Initial case selection was conducted by the admitting nurse, who completes 
Eligibility checklist 1 within 2 hours of the patients admission to the ward. Nurses 
are usually the first contact that a patient has at most hospitals in Ugandan. This is 
due to the relative scarcity of doctors at hospitals vis-à-vis the large number of 
admissions. The nurse took a history using a structured questionnaire, Form 1 and 
determined among others a) if the patient could localise pain, b) the concentration of 
blood glucose using a glucometer and c) body temperature. A thick smear of blood 
is made and sent to the laboratory to determine the presence of P. falciparum.
3.10.2 Level Two
A second check was carried out within 6 hours by the Medical Officer who filled in 
Eligibility checklist 2. This assessment takes into account the results of laboratory 
investigations such as a blood smear and random blood sugar which may have been 
performed after the nurses assessment. Cases who met the requirements at this level 
continued into the study. Those who did not, stopped contributing information to the 
study but continued to be managed according to the guidelines laid out. Those who 
were eligible underwent a detailed clinical examination conducted by the Medical 
Officer who completed Form 2, see Picture 3.
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Picture 3; A Medical Officer in Kapchorwa hospital examines one o f the study 
patients in Level 2 (Taken by James Tibenderana. 2003)
3.10.3 Level Three
At Level 1 a thick smear for screening is carried out on all patients that fulfilled the 
Eligibility checklist 1 Those with a preliminary positive smear were further 
evaluated according to a defined protocol in which a number of confirmatory 
investigations are done These include thick and thin blood smears, random blood 
glucose, CSF analysis, full haemogram, and urinalysis A specimen of serum was 
stored and dried blood spots made These procedures constituted Level 3 and all data 
collected were entered into Form 3 Repeated measurements of vital signs, depth of 
coma and parasite density were performed to monitor each case’s progress and 
recoded on the observations chart A study nurse was responsible for obtaining 
consent from survivors when they had regained full consciousness Those who gave 
consent for their data to be used for the study proceeded to the next level. Level 4
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3.10.4 Level Four
Once a survivor regained consciousness, the study doctor carried out the first 
detailed neurological assessment of the subject. Form 4 contains structured 
examination questions. It was used at this level to extract information about the 
neurological status of the case. When the subject has completed a seven-day course 
of quinine, he/she is discharged if the blood smear is clear of asexual forms of 
Plasmodia on a minimum of two consecutive occasions 24 hours apart. A date for 
the first follow-up visit is given and the subject discharged. This constituted Level 4.
3.10.5 Level Five
The final stage of data collection and case management was Level 5. During this 
stage each patient is invited for two visits one month apart to have a detailed 
neurological assessment. Assessments are performed by a study doctor. Form 5 is 
used to extract the required information. Motor-sensory deficits were sought. 
Cognitive function was also assessed using a primitive tool that was developed for 
the study. Unfortunately due to time and financial constraints, only a simple attempt 
was made to test the validity of the cognitive tool in the study setting.
3.11 Case management
The management of a cerebral malaria case involved treatment (definitive and 
ancillary), nursing and supportive care, laboratory evaluation, and follow-up. For 
cases from the hospitals to be similar with respect to survival it was imperative that 
the care that they received was uniform at all the study sites. For this purpose, time 
was spent developing protocols for case management which study teams would 
follow. Below is a list of which were used.
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Table 3.4. Guidelines for the Management of the Cerebral Malaria Patient
1. Ensure that the patient has a clear and patent airway
2. Place the patient in the semi-prone position, changing sides every 4 hours
3. Do a quick but thorough examination and determine the depth of coma.
4. Take a thick smear to confirm P. falciparum parasitaemia.
5. Do a blood glucose estimation with the stix method
6. Weigh the patient if possible
7. Start quinine therapy in 5% dextrose (use a volume of 10ml/kg for a child and 200mls for an adult patient). The regimen of quinine is:
(a) Loading dose of 20mg/kg over 4 hours if the patient has not received quinine in the preceding 48 hours
(b) Maintenance dose of 10mg/kg over 4 hours given 8hourly. (If it is not possible to set-up an IV line, then give the quinine dose as a deep IM 
injection and give the dextrose via an NGT. then set-up the IV line)
(c) Start on an oral dose of quinine as soon as the patient can swallow. Give 10mg/kg of quinine orally. Observe the tablets being taken.
(d) Treat the patient with quinine for 7 days ensuring that the patient receives the full course.
(e) Reduce the dose of quinine by l/3rd if the patient is unconscious for more than 3 days
8. If the patient is hypoglycaemic with a blood glucose equal to or less than 2.2 mmol/L, give lml/kg of 50% dextrose IV (diluted to make twice 
the volume) over 5 minutes before commencing quinine therapy. Give 10% dextrose infusion at 4ml/kg/hr. Repeat the blood glucose measurements 
after 1 hour. If the blood glucose is still low then repeat the treatment above until the patient improves.
Table continued overleaf
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Table 3.4 continued
9. If the patient has repeated convulsions lasting more than 10 minutes, control them with diazepam. Give:
(a) Child -  Diazepam 0.15mg/kg slow IV injection
(b) Adult -  Diazepam 1 Omg slow IV injection
Alternatively, diazepam can be given via the rectal route in subjects over 10kg at a dose of 0.5mg/kg (do not combine with rectal paracetamol). 
Treatment can be repeated after 30 minutes to control further convulsions.
10. If the patient has a fever (axillary' temperature above 38.5°C) give paracetamol orally if the subject can swallow. Give
(a) Child -  Paracetamol 90mg/kg/24 hours given 4 or 6 hourly
(b) Adult -  Paracetamol lg given 6 hourly
If the subject is vomiting give the same dose via the rectal route (but do not combine with rectal diazepam).
11. Treat severe anaemia (Hct < 15% or Hb < 5 g/dL) with a transfusion of packed cells at a dose of lOml/kg. If packed cells are not available then 
use fresh whole blood at a dose of 20ml/kg.
12. If the subject is in shock (systolic blood pressure < 50mmHg in children 1-5 years or < 70 mmHg in older subjects) give an appropriate dose of 
crystalloids.
13. If there is a suspicion of bacterial meningitis, administer appropriate antibiotic cover suited to the local sensitivity patterns. A stiff neck and 
strong focal neurological signs like a facial nerve palsy and dense hemiplegia are suggestive.
Table continued overleaf
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Table 3.4 continued
14. Perform a lumbar puncture as soon as this is possible. Do not carry out an LP if:
(a) Glasgow Coma Scale is 6 or less
(b) Blantyre Coma Scale is 3 or less then 3
(When the score improves the LP can be performed)
(c) there is papilloedema on fundoscopy
(d) there was a history of projectile vomiting, headache and impaired vision
15. Perform further laboratory investigations specified in the study protocol and any others related to the associated medical problems.
16. Take repeated observations as specified below.
Parameter Frequency
Unconscious phase Recovery phase
Axillary temperature 6 hourly
Pulse and Blood pressure 6 hourly
Respiratory rate 6 hourly
Level of consciousness 6 hourly
12 hourly 
12 hourly 
As required
At discharge
Blood glucose 
Parasite density
6 hourly or more frequently if there is hypoglycaemia 
Daily and at the completion of treatment
17. Discharge after the completion of 7 days on quinine treatment when the blood smear is negative for falciparum parasites and the subject has 
regained full consciousness (i.e. scoring 14 and above on the Glasgow Coma Scale or 5 on the Blantyre Coma Scale). Make sure that the subject is 
able to feed properly.
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3.11.1 Treatment
It was agreed that quinine would be given as the definitive form of treatment starting 
with a loading dose of 20ml/kg body weight for those who had not received quinine 
within the preceding 48 hours then lOmg/kg body weight 8 hourly for a total of 
seven days. This dosage is that recommended by Warrell in his supplement on the 
Severe and Complicated Malaria (Warrell, Molyneux et al. 1990). A shorter course 
for five days was combined with Fansidar® (locally available brand of SP) when the 
patient could not tolerate the full course. To facilitate compliance, survivors were 
kept on the ward for seven days and observed swallowing their tablets*. Treatment 
commenced with IV quinine and was followed with oral quinine as soon as the 
patient could take orally. It was vital that quinine was started early and it was agreed 
that the nurse-on-duty could begin treatment without waiting for the doctor to 
prescribe as long as the guidelines were adhered to. To ensure that the quinine given 
was good quality, all cases received quinine which was procured by the Principal 
Investigator from the Joint Medical Stores (one of the two medical stores that 
procure essential drugs on behalf of the MOH for its health facilities). All other 
medication were also obtained from the same unless not available there. All 
medication was given free-of-charge.
3.11.2 Nursing care
The nursing of an unconscious patient is intensive. The guidelines clearly stated 
what needed to be done and nurses revised and practised how to carry them out 
before the study started. While the patient was unconscious, the depth of coma was 
monitored by determining whether he/she could localise a painful stimulus. This 
simple test could be performed by the nurses. A portable glucometer was used to 
monitor blood glucose while an automatic BP machine was used to measure blood 
pressure and pulse. Fever was measured with digital thermometers, see Picture 4.
' Nurses had reported that they suspected mothers were saving some tablets intend for the sick child 
for their other child. This they thought occurred when the sick child had improved but was still 
getting oral medication.
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Picture 4: A comatose child whose axillary temperature is being measured with a 
digital thermometer (Taken bv James Tibenderana. 2003)
3.11.3 Laboratory evaluations
Cases were evaluated in a systematic manner according to a protocol which was 
developed with the study teams, see Appendix II Activities such as laboratory 
evaluations were specified by the day from admission, i.e. Day 0 represented the day 
of admission and Day 7 represented seven days since admission This schedule only 
served as a guide and some events could occur later or earlier than stated in the aide 
memoir The procedures used in carrying out some of the laboratory evaluations are 
standard ones as described by Cheesebrough (1998) and are outlined in Appendix 
III
3.11.4 Informed Consent
A senior nurse administered the Information sheet to the adult subject in the 
presence of a relative then sought consent from the subject In the case of a child, 
who in Uganda is legally defined as one who is less then 18 years, consent is sought 
from the next-of-kin Consent was obtained for two activities; (a) to include the
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subject in the study and (b) to carry out HIV-1 serology on a stored sample of blood. 
A subject could agree to be included in the study but refuse to have HIV serology. 
Alternatively a subject could agree to both in which case he/she can decide whether 
he/she would like to be given his/her result. The next-of-kin was asked to provide 
consent for patients who do not survive. This was done before the relatives leave the 
hospital.
3.11.5 Support
Physiotherapists, Ophthalmologist and occupational therapists participated in case 
management when required and when available. Unfortunately, district hospitals do 
not always have these cadres of staff. The study doctors offered as much support in 
this case by giving appropriate advice or referrals.
3.11.6 Follow-up
During the follow-up period survivors were treated for any ailments they had when 
they came for their visits. A transport refund was given to them at each visit. In 
Kapchorwa district, those who did not turn up for their appointed visits were visited 
at home by one of the study nurses and requested to attend follow-up at the study 
hospital. A full clinical and neurological assessment was carried out. Fundoscopy 
was performed; visual acuity tested; and an audiometer used to test hearing. 
Cognitive function was assessed with the tools developed (see section 3.12). As was 
the practice I saw at Kilifi, subjects were given a mug of tea containing sugar (with 
or without milk according to preference) and sugar-containing biscuits before they 
underwent the examination. This was done to minimise the effect of a low blood 
glucose (hunger) on cognitive function. It also enabled the young subjects to be less 
nervous about the examination. Staff did not wear clinical attire to make the session 
less of a clinical interaction. Young children were assessed on a floor mat if the 
assessor felt it would make the child more cooperative.
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3.12 Development of tools for cognitive assessment
A number of tests of cognitive function were considered. None of them appeared to 
be useable for the assessment of survivors (Berch, Krikorian el al. 1998; 
Bogousslavsky and Fisher 1998; Fisher 2001). I sought advice from the two clinical 
neurologists at Mulago Hospital on how to adapt the tests to suit the local setting in 
the country. With their advice. Form 5 was developed to assess for cognitive 
functions such as memory, language, comprehension and expression.
3.12.1 Child version o f  cognitive tool
A combination of questions and tasks were employed to examine cognitive function 
in children aged 3 years and above. Mothers (or the person who usually lives with 
the child) are asked about some aspects of the child’s behaviour before and after the 
episode of cerebral malaria, see RC in Form 5. The child is asked to carry out some 
simple instructions such as naming common objects (cup, spoon, comb, plate, pencil 
and plastic container used to keep water, locally called a jerry can) and what they are 
used for. These objects were supplied solely for the assessment and all study 
hospitals had similar objects. Each child is also asked to carry out simple tasks like 
putting a spoon in a cup. In this manner language and verbal comprehension was 
assessed. Memory was assessed by asking the child to point at six objects laid out in 
a set pattern after the assessor had shown the subject what to do, see MEM in Form
5. An object was then hidden away and the subject asked to find it and return it to 
where it was. For each task a score of 1 was given if it was carried out correctly and 
0 i f  otherwise. A maximum of three attempts were allowed without prompting.
The consultant paediatric neurologist and I used these cognitive tools to assess 29 
children that had been attending the neurological clinic at New Mulago Hospital. A 
study nurse trained to use the tools assessed 21 children in Kapchorwa town at their 
homes. Table 3.5 below summarises the characteristics of both groups.
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Table 3.5: General characteristics of neurological cases and controls used in the trials of 
Form 5.
Characteristic Known neurological 
cases(n-29)
Controls (n=21)t P-value / Remark
Median age (years) 6 years (range 2-11) 5 years (range 2-8) 0.139
Ethnic groups Ankole, Teso, Ganda, Gisu, Kikuyu, Nandi, Sabiny Come from different
Soga ethnic groups
Proportion who go to school 55% (n=11) 52% (n=16) 0.845
Modal level of education of Completed primary Educated up to 4th year at Level higher In
mother school (7 mothers) secondary school (7 mothers) mothers of controls
Median score for Items 
found at home* 
5 (range 2-10) 4 (range 1-12) 0.593
Median number of siblings 3 (range 0-9) 2 (range 1-6) 0.311
Cases and controls differed in the composition of their ethnic groups and the level of 
education of mothers. Neither of these factors are known to be related to cognitive 
deficits in the communities. The median score for items owned a proxy measure for 
socioeconomic status was larger among cases than controls but this was not 
significantly different (p>0.05). The children version o f the cognitive tool consisted 
of six instructions to carry with each instruction in turn consisting of six questions. 
A score of one was given if the question was carried out successfully and zero if it 
was failed (within three attempts). The scores for the neurological cases and their 
controls are given in Table 3.6. As shown there variation in scores between both 
groups was not large. One instruction language and verbal comprehension 2 had 
different distributions between cases and controls. Controls all scored six on 
language and verbal comprehension 2 whereas cases scored between zero and six.
In the memory section of the tool, neurological cases and controls had a median 
score of 3 on memory instruction 2 but controls had about half the variance in their 
score compared to cases.
* Group matched by age of controls
* Proxy measure of socio-economic status
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Table 3.6: The scores obtained in a  trial o f a questionnaire to determine differences in 
cognitive function between cases and controls.
Instruction Median scores on first attempt 
(range; variance)
P-value
Cases (n=29) Controls (n=21)
LGVC1 6 (0-6; 2.0) 6 (0-6; 2.0) 0.918
LGVC2 6 (0-6; 1.8) 6 (6-6; 0) 0.015
LGVC3 6 (0-6; 4.0) 6 (3-6; 0.9) 0.963
LGVC4 6 (0-6; 6.5) 6 (0-6; 4.5) 0.446
LGVCtotal§ 24 (0-24; 47.3) 24(11-24; 14.2) 0.637
MEM1 3 (0-5; 5.2) 5 (0-5; 4.6) 0.219
MEM2 3(0-3; 1.7) 3 (0-3; 0.8) 0.071
MEMtotal" 6(0-8; 11.2) 8 (0-8; 7.9) 0.143
Having known the results from the trial of the child version of the cognitive tool in 
neurological cases and controls an attempt was made to calculate the sensitivity and 
specificity of the various instructions of the tool. The scores were considered in two 
age groupings, children aged 1 to 4 years and those between 5 and 10 years, since it 
was very likely that the ability to perform the instructions could be associated with 
age in a broad sense. A number o f cut-off scorest+ were assessed using Receiver 
Operating Characteristic curve (ROC curves) to determine the proportion of 
neurological cases with cognitive dysfunction that were correctly identified by the 
instruction. Table 3.7 lists the sensitivities and specificities for a selection of cut off 
scores for instructions of the cognitive tool divided into those aged under 5 years 
and those aged 5 years and above.
The cut-offs that were selected for use in the study were language and verbal 
comprehension 2 equal to 5 or less, language and verbal comprehension total equal 
to 18 or less, and memory total equal to 6 or less. The cut offs that were able to 
identify a higher proportion of cases with cognitive dysfunction among the two age 
groups were used which were those with the higher sum of sensitivity and 
specificity. This approach was used to screen for children likely to have cognitive 
dysfunction and was not a confirmatory tool.
1 Total score obtained by adding the scores for LGVC 
’ Total score obtained by adding the scores for memory 
H Higher scores indicate belter performance
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Table 3.7: Receiver Operating Characteristics (ROCi of a selection of cut-off scores of a 
questionnaire tried on children with known neurological deficits and community controls.
Instruction Sensitivity % Specificity % Correctly 
classified (%)
ROC area
Aged less than 5 years (16 observations)
LGVC1 score 0.48
<=0 0 100 44
<=5 22 71 44
LGVC2 score 0.21
<=0 100 0 56
<=4 0 43 19
<=5 100 0 44
LGVCtotal score 0.36
<=11 67 29 50
<=18 33 43 38
<=22 11 71 38
MEM2 0.29
<=0 100 0 56
<=2 33 29 31
<=3 22 43 31
MEMtotal 0.33
<=0 100 0 56
<=6 33 57 44
Aged 5 years and above (31 observations)
LGVC1 score 0.51
<=2 100 0 39
<=5 8 95 61
LGVC2 score 0.42
<=3 100 0 39
<=4 0 84 52
<=5 0 100 61
LGVCtotal score 0.43
<=15 17 74 52
<=20 8 74 48
<=22 0 84 52
MEM2 0.39
<=0 100 0 39
<=1 0 100 61
<=3 0 79 48
MEMtotal 0.40
<=0 100 0 39
<=6 0 79 48
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3.12.2 Validation child version of cognitive tool
An attempt was made to validate the cognitive tool. There was no gold standard test 
or combinations of tests that have been used in Uganda to identify cognitive deficits 
in children or adults. To validate the current tool, the only available option was to 
assess children clinically for cognitive deficits. This was done by reviewing their 
medical records at the neurological clinic. The paediatric neurologist examined the 
records (consisting of clinical notes made at regular visits at the outpatient 
neurology clinic) of thirty children to determine whether they had any cognitive 
deficits by the date of their most recent visit and if so, to grade them on a scale o f no 
incapacity (score of 0), mild incapacity i.e. has one deficit that is subtle (score o f  1), 
moderate i.e. has two / three deficits that do not affect daily activities (score o f  2) or 
severe i.e. has a deficit/s that do not allow normal daily activity (score o f 3). A 
questionnaire was used for this purpose. At the time o f this exercise the paediatrician 
was not aware of the scores that the children had gotten on the cognitive tool. The 
table below, Table 3.8, summarises Kappa statistics results for data from 26 children 
with scores on the cognitive tool and the paediatrician's review. The paediatrician’s 
expert opinion did show good agreement with some components of the cognitive 
tool and not with others. Having no better alternative, the cognitive tool was used for 
the assessment of study cases during follow-up.
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Table 3.8: Agreement between the median cognitive scores obtained by a sample of children 
with neurological dysfunction and their degree (on a  scale ofOto 3) of cognitive incapacity 
determined by assessment of their case notes by a  senior consultant paediatric neurologist
Component of 
cognitive tool
Age group Degree of Cognitive Incapacity 
determined by retrospective review of 
case records
None Mild Moderate Severe
Kappa
Inter­
agreement
P value 
for
Kappa
Number o f 
subjects
26 14 3 4 5
LGVC1 All 6 6 6 6 0.08 0.05
£ 5 yrs (n=8) 6 6 - 4.5 0.18 0.01
> 5 yrs (n=18) 6 6 6 6 0.03 0.28
LGVC2 All 6 4 6 6 0.14 0.01
£ 5 yrs 6 4 - 6 0.39 <0.001
> 5 yrs 6 4.5 6 6 0.03 0.28
LG VC 3 All 6 5 6 6 0.17 0.01
£ 5 yrs 6 3 - 3.5 0.49 <0.001
> 5 yrs 6 5.5 6 6 0.05 0.18
LGVC4 All 6 6 6 6 0.25 <0.001
£ 5 yrs 2 0 - 6 0.79 <0.001
> 5 yrs 6 6 6 6 0.05 0.18
LGVCtotal All 24 20 24 22 0.07 <0.001
£ 5 yrs 16 13 - 14 0.18 <0.001
>5 yrs 24 22 24 22 0.02 0.001
MEM1 All 3.5 1 5 0 0.45 <0.001
£ 5 yrs 1 0 - 1.5 0.82 <0.001
> 5 yrs 5 3 5 0 0.33 <0.001
MEM2 All 3 1 3 3 0.34 <0.001
£ 5 yrs 2 0 - 1.5 0.80 0.001
> 5 yrs 3 2 3 3 0.19 0.03
M E M to ta l All 6.5 2 8 3 0.40 <0.001
£ 5 yrs 3 0 - 3 0.83 <0.001
> 5 yrs 8 5 8 3 0.24 <0.001
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3.12.3 Adult version o f cognitive tool
The adult version involved identification and recall of ten pictures of a variety of 
objects and recall of six digits. The details of how this was done can be found in the 
adult version of Form 5 in Appendix I. Copies of the pictures which were used are 
given in Appendix IV. Children aged ten years and above, that were attending the 
paediatric neurological clinic at New Mulago were sought to try the tool on. During 
the trial period only two children came to the clinic meeting the age requirement. 
Their scores are summarised in Table 3.9.
Table 3.9: Summary scores of two children with known cognitive deficits who attended the 
paediatric neurological clinic and performed the cognitive assessment diagnostic tool.
Age of child Number of pictures Number of pictures Number of Digits
correctly identified correctly recalled correctly recalled
1« set of 2nd set 
ten of ten
1“  set 2nd set 1** set 2nd set
13 years 3 4 0 3 0 0
10 years 8 10 8 6 2 0
It was not considered worthwhile to try the tool in community controls since very 
few known cases with cognitive dysfunction had been assessed and there was 
already literature about the performance of children on the two components o f the 
tool. The results of adult survivors would be ranked to determine performance.
3.13 Quality control
A study of this nature required adequate attention to quality control. Measures were 
put in place at the clinical level, in the laboratory and in data entry.
Quality control in the clinical setting: Procedures for the clinical examination and 
neurological assessments were standardised. Study members were trained before the 
onset of recruitment on all aspects of data collection. Doctors were repeatedly 
checked to determine if they were using the GCS and BCS as taught. Items that were 
needed for conducting the clinical and neurological examinations were uniform for 
all hospitals i.e. stethoscopes, glucometers, digital thermometers, and 
ophthalmoscopes. Batteries were changed regularly and calibrations done.
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Quality control in the laboratory: The laboratory procedures were standardised 
and the laboratory staff trained to follow them. They were encouraged to clean and 
calibrate their equipment regularly. Slides from one laboratory were taken to another 
laboratory to validate the parasite counts. On one occasion, the laboratory technician 
from Mutolere hospital spent four days at Mbale hospital to practice staining and 
identification of parasites because it was not clear why cases with suspected cerebral 
malaria in Mutolere continued to have smears in which the technician was not 
finding parasites.
Quality control during data entry: CRFs were examined at intervals by the PI to 
assess the information recorded. The accuracy of the recorded information was 
checked and any errors queried. The study teams were informed of errors in order to 
avoid committing them again. When designing the electronic forms for data entry, 
limits were set to prevent the entry of implausible values.
3.14 Clinical standards
It was important to maintain uniform clinical standards at all four sites. Good 
Clinical Practice guidelines were taught to the clinical staff and they were 
encouraged to abide by them (Hutchinson 1997; ICH 1999).
3.15 Ethical clearance and considerations
A number of ethical issues were taken into consideration when designing and 
conducting the study. These are highlighted below:
i. Informed Consent -  The difficulty was to obtain consent at an 
appropriate time when the condition of the patient was not too worrying 
to place the next-of-kin in a position in which consent would be 
unethical to seek. It was decided that consent would be obtained when 
the patient had regained full consciousness. However a serum sample 
would be obtained on admission, which could either be used if consent 
was given or discarded if consent was refused. In this way there would 
be a sample of blood that represented the situation the patient was in on 
admission instead of only getting a sample when the patient had 
regained consciousness at the time when consent could be obtained.
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ii. HIV serology - HIV testing was carried out on stored sera which were 
collected from study patients on admission. If a subject preferred to 
know their sero-status then pre and post-test counselling was arranged 
on the ward or during follow-up. If a subject did not want to know their 
sero-status then the results were kept confidential by the PI.
iii. Confidentiality - Each study subject was allocated a unique research 
number. This number was used on each CRF. Form 1 is the only CRF 
that contained the name of a subject. Results like HIV serology which 
required confidentiality were requested using study numbers with no 
personal identifiers. Other requests were made in the standard fashion 
using names as the identifier. A log of subjects’ names and their research 
numbers was kept by the PI and a register kept by the nurse-in-charge of 
the ward.
iv. Blood samples - In order to carry out all the necessary haematological 
investigations and save some sera for future evaluations, a quantity of 
blood that was both sufficient and ethically appropriate was calculated. 
On admission 3mls was collected from an adult patient (10 years and 
above) whereas only 2mls was taken from a child. In this way, patients 
were not bled repeatedly and neither were unnecessary amounts of blood 
taken. Daily blood smears were carried out to determine parasite counts. 
This was stopped after two consecutive smears in which no parasites are 
counted. A pin-prick blood sample is used for the smear.
v. Lumbar puncture - It is routine practice to perform a lumbar puncture 
in an unconscious patient who is suspected to have a 
meningoencephalitis or cerebral malaria. There are two exceptions 
however, (a) when fundoscopy reveals papilloedema, a sign of raised 
intracranial pressure and (b) when the patient is almost moribund 
(Glasgow coma score of 6 or less). These exceptions were upheld in this 
study. Aseptic cerebrospinal fluid is vital in making a definite diagnosis 
of cerebral malaria. Therefore, study clinicians were facilitated to lumbar 
puncture all suspected cases unless the above contraindications existed.
vi. Use of study supplies - The study provided items that are necessary to 
investigate and manage a suspected case of cerebral malaria. Most 
hospitals in Uganda experience shortages of some supplies. Study
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supplies were not withheld from a patient who was unconscious and did 
not meet the eligibility criteria. Supplies were also not withheld from a 
non-participating patient with a medical emergency who would benefit 
from their use e.g. a patient in a diabetic coma who required blood 
glucose estimation.
vii. Transport refunds - At each follow-up visit subjects’ are provided with 
a two-way transport refund. This was given to facilitate their travel to 
hospital and not as an incentive to participate in the study.
3.16 Study site preparation
The following were conducted at all four sites in order to prepare them for the study:
i. Needs Assessment — I visited all four hospitals to determine the gaps in 
terms of staffing, performance, triage, supplies, equipment, knowledge, 
and skills. I gathered information by direct observation and consultations 
with clinical, nursing, laboratory and administrative staff. Meetings 
between staff were also conducted to enable exchange of ideas on what 
they felt were the gaps and to propose solutions.
ii. Selection of study teams -  Study teams were selected at each site. They 
consisted of the following cadres:
a. Two laboratory staff were selected to perform laboratory evaluations 
of study cases. Arrangements were made so that they could cover the 
laboratory 24 hours of the day.
b. It was agreed that it would be better to allow all the nurses attached to 
each study ward i.e. the paediatric and adult wards, to participate in 
patient management and monitoring. This would avoid the situation 
in which a nurse who is not part of the team does not monitor study 
cases on the premise that he or she is not a member of the team. 
Additionally, most wards in question are understaffed and using only 
a few of them would place even more pressure on the staff.
c. Three clinicians per ward assisted in the management o f study cases 
according to the protocol. This comprised of a senior clinician and 
two other members of staff such as a Medical Officer and a Junior 
Houseman.
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iii. Training — Having identified that the staff needed up-to-date 
information about malaria, good clinical practice procedures and how to 
participate in a research study, 1 went ahead to arrange training sessions 
for the staff. Much time, effort and resources were invested in this 
because of the strict requirement of performing to  international standards 
and ensuring that all four study sites functioned in unison. Training was 
done in groups as follows:
a. A laboratory training session was held at the Assessment Centre of 
Mulago Hospital on 3rd of November 2001. It was facilitated by staff 
of the Haematology Laboratory of Makerere University Medical 
School in collaboration with Dr Sarah Staedske, who was conducting 
a study on malaria at Mulago Hospital. The study lab teams spent a 
day revising quality control in a research lab, making a thick and thin 
blood smear, staining a thick and thin blood smear with Giemsa stain, 
malaria parasite count using the WBC technique, malaria parasite 
identification, and making dried bloodspots on filter paper. Six team 
members took part.
b. Training sessions were held for the nursing teams at each site. The 
Principal Investigator facilitated the training sessions and took the 
staff through general knowledge about malaria presentation, 
treatment, prevention and control, how to complete the Eligibility 
checklist 1 and Form 1, how to obtain informed consent, how to 
measure blood pressure using the automatic blood pressure machine, 
how to measure blood glucose using a glucometer, how to make a 
thick blood smear, and how to manage and monitor a patient with 
cerebral malaria according to the study guidelines.
c. Dr J. Byarugaba (a senior consultant paediatric neurologist) and Dr E. 
Dumba (a senior consultant neurologist) gave clinical sessions on the 
neurological assessment of the patient with cerebral malaria. Two 
sessions were conducted at Mbale hospital, on the 28th (Paediatric) 
and 30th (Adult) of November 2001. Two clinicians from Kapchorwa 
attended both sessions. Dr Dumba gave an adult session at Kabale 
hospital on 4th January 2002. Two Medical Officers from Mutolere 
Hospital took part. Dr Byarugaba was not able to give the paediatric
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session. These visits gave both Senior Consultants from Mulago 
Hospital, who are also study collaborators, the opportunity to visit the 
study sites and interact with the study teams.
iv. Stocking of supplies - It was vital that patients received appropriate 
laboratory evaluations and uninterrupted management. To achieve this, it 
was noted that some items had to be provided to the wards and the 
laboratories facilitated with reagents and supplies. Some items were 
procured from the UK and the majority within the country. These 
facilities and treatments were provided to patients free. Inventory forms 
were designed to keep record of items given.
a. The laboratories were facilitated to carry out the following 
evaluations: Malaria parasite counts using Giemsa stain [GIBCOBRL 
KaryoMax® Giema Stain, Improved R66 Solution Gurr Lot No 
1020344]; Malaria parasite staging and speciation; Glucose 
estimation in blood and cerebrospinal fluid using the colorimeter 
method [Glucose GOD-PAP]; Serum separation and storage [Clot 
Activator Vacuette®]; Urinalysis [Bayer® Multistix 10SG reagent 
strips for urinalysis]; Fixation and storage of blood slides [DPX 
mountant, coverslips, frosted slides, microscope slide cases]; and 
White blood cell counts, total and differential [Neubauer® counting 
chamber, counting chamber coverslips].
b. The wards were provided with the following pieces of equipment: 
ACCU-CHEK® Advantage® Roche glucometer; ACCU-CHEK® 
Advantage II/Advantage Comfort glucose test strips; Omron® Blood 
Pressure Monitor HEM-712C automatic with adult and paediatric 
cuffs; Littmann® Classic II SE/Paediatric Stethoscope; Gowllands® 
Diagnostic set; Patellar hammer - Adult/Paediatric; Examination 
torch; and Omron® MC3B digital thermometers.
c. Pharmaceutical items and sundries were purchased from the Joint 
Medical Stores which is one of the major importers of essential 
medical supplies for the whole country. A list of most of the items 
purchased is given in the Appendix.
v. Liaising with other hospitals and community leaders -  Contact was 
made with other hospitals in the district and health centres to let them
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know of the study. Staff were requested to refer cases of cerebral malaria 
to the study hospital. Community and appropriate District leaders were 
given information about the study. Their permission was sought to carry 
out the study in their communities or districts as the case may be.
3.17 Data management
Case record forms were kept in plastic folders with the identification number of the 
case clearly labelled on each. The folders were colour coded by centre i.e. Mbale 
had red folders, Kapchorwa blue ones, Kabale green ones and Mutolere white ones. 
Each centre had a numerical code that preceded the subject’s identification number. 
A log containing personal identifiers and study numbers of all cases that were 
eligible for the study was kept by the PI. A register of all cases seen on the wards 
with cerebral malaria was kept by the nurse-in-charge. Another log was kept of all 
cases of severe malaria that were admitted to the study hospitals during the study 
period by the records unit of the hospital. Other aspects of data management 
included:
3.17.1 Storage
Case record forms were stored at study site. At regular intervals the Principal 
Investigator would collect them and keep them at a central location. Before this, he 
would check them for completeness and any queries on the data were checked. He 
would then extract basic information from the forms into the enrolment log.
3.17.2 Con fide n tiality
Data which was entered into the CRFs was only accessible to the study team 
members. Information on HIV status was not entered onto the CRFs. The laboratory 
request for HIV testing had the identification number and no personal identifiers. 
The lab technician would record the results in a log which was passed onto the 
Principal Investigator, who would then link the results to the subject. If the results 
were needed for post-test counselling they would be given to the nurse-in-charge of 
the ward who would be responsible for linking the results to the patient, counselling 
the patient or next-of-kin and giving the results.
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3.17.3 Data entry
Data was entered into MS Access using electronic forms designed by the Principal 
Investigator. Their layout was similar to the layout o f  the case record forms to ease 
data entry and to reduce errors while entering data. Data entry was conducted by one 
of the Medical Officers (at Kapchorwa Hospital) and the Principal Investigator (in 
London). The data from the databases was converted into MS Excel files and 
examined for consistency. Responses were grouped where necessary and coded. 
Missing values were coded. Responses that were not applicable for that question 
were coded to differentiate them from missing values. Data documentation involved 
labelling all variables and values. It was important to document the data because 
there were many variables per patient. Clinical signs with findings on the left and 
right sides of the body were recoded separately.
3.17.4 Data cleaning
At each stage of data collection and entry there are sources of mistakes. It was 
therefore very important to systematically examine the data for various kinds of 
errors. The following was done:
i. Missing data: Single-variable frequency tables of the data were used to 
search for missing information. The CRFs of cases without complete 
number o f variables or observations were checked to determine why data 
was missing. Every attempt was made to find the information and when 
found entered onto a spreadsheet and transferred into STATA or in some 
instances entered directly into STATA. It was possible to infer the value 
of some missing variables from the responses of other variables that were 
inter-related or providing similar information. In the case of a continuous 
variable such as body temperature, where ten percent or less of cases had 
information missing, the mean for all observations was calculated and 
used to impute missing values. Imputing missing values using the mean 
would have the effect of reducing the variation of the values of the 
variable with imputed values and this was minimised by not carrying this 
out when more the ten percent of the data was missing. In the case of the 
missing values for pulse rate and respiratory rate which were measured 
repeatedly, the missing value was replaced with the next measurement. If
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the next measurement was missing as well then the value was imputed 
from the mean for that age group. Where it was not possible to find 
missing information or to assign sample means or if the proportion of 
missing observations for that variable was greater than 10%, a separate 
category for missing observations was created and labelled “missing 
info”. This category was useful because a) cases with missing 
information could constitute a group with unique features, b) it allowed 
assessment of having information on that variable related to not having it 
vis-à-vis the outcome and c) the direction of bias caused by the missing 
data could be appreciated. Another reason for using these measures to 
eliminate missing values was to maintain a constant sample size 
throughout all analyses.
ii. Data entry errors: In some instances, despite all precautions some 
errors were made while entering information in the electronic forms. 
Some questions on the electronic forms had "yes/no’ option buttons with 
the default set to enter ‘no’ when not entered. This meant that there was 
no way of differentiating from the databases when the answer was ‘no’ 
because the question had a negative response or the question was not 
answered because the information was not looked for. Fortunately, much 
of the data is interlinked with some variables feeding their results into 
each other. By reviewing the CRFs these errors were identified and 
rectified.
iii. Appropriate data values: All categorical variables were checked to 
ensure that the recorded data values and codes were correct: for example, 
if there were three options for a value and a fourth one was erroneously 
entered. Any such errors that were identified were corrected after 
checking the CRFs and other variables in the datasets that could shed 
light on the correct response. A corresponding check for values outside 
the ranges of continuous variables was done. Some ranges are limited by 
the study: for example, children aged above one year, and others are 
biologically set: for example, random blood glucose far exceeding 11 
mmol/L on a single occasion without any identifiable reason would be 
implausible. Such out-of-range values that were not supported by other 
data were re-entered as missing. Outliers were identified using box and
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scatter plots. If their values were consistent with other information then 
they were left as recorded. If however, their values were not supported 
then they were re-recorded as missing.
iv. Date and time variables: Several variables consisted of information on 
date and time. They were checked to ensure that the information was 
accurate and that any derived values that were based on a date/time 
variable corresponded accordingly. Errors occurred because of the failure 
to make STATA read the date and time variables when converting the 
MS Access databases into STATA-readable format. These were rectified 
by exporting the date/time variables into Excel, formatting them and then 
converting the spreadsheets into STATA readable format.
3.17.5 Data screening
After ensuring that the data were a good representation of the information obtained 
from all cases, steps were taken to determine other useful characteristics of the data. 
The distribution of continuous data was assessed to determine their compatibility 
with a normal distribution. Pictorial assessment was carried out with frequency 
histograms and kernel density plots.
3.18 Statistical analyses
Statistical analyses were performed with STATA version 8.1. A plan of analysis was 
decided upon based on the hypothesis and study objectives. Explanatory factors 
were defined and variables that met the definitions determined. A list of known and 
potential risk factors was made. Variables that represented these risk factors were 
determined either by using existing variables or by generating new ones.
New variables were generated by combining other variables that represented similar 
data. For example, possibility of shock was determined by combining information 
on systolic and diastolic pressure, state of extremities, and capillary refill time. It 
was clear that because of the small number of subjects enrolled into the study it was 
not feasible to use data from many o f the variables as they had been collected. 
Therefore data had to be combined in a logical manner to create variables with 
larger numbers of observations per group that would allow more robust analyses. 
Parametric tests were used where possible and non-parametric tests where the
9 2
former were not appropriate, such as when comparing medians of two groups with 
data not normally distributed.
Continuous variables were assessed to determine whether they should be 
categorised. Categorisation went ahead if i) natural categorises existed that were 
defined in the study protocol or elsewhere in the literature, and ii) creating groups 
would enhance the quality of the statistical analyses for example when the 
distribution o f the variable is non-parametric. In instances in which there were no 
defined groupings, cut-offs were used to create categories of fairly equal sizes. No 
more than four categories per variable were made.
The definitions of some variables were decided upon at the preparation stage of the 
study in which case they were similar to those in previous studies. Other variables 
were defined according to the data they represented as well as how they had been 
categorised. Table 3.10 illustrates how the outcome/dependent variables were 
defined and created. The explanatory/independent variables were grouped into a) 
Demographic and history information, b) Clinical examination on admission, c) In- 
hospital non-laboratory information d) Laboratory-based information and e) Follow­
up information. Table 3.11 provides a list of these variables, with their definitions 
and how they are categorised. The table also indicates the method used to create 
each variable, whether directly from the case record forms or as a summary of other 
variables.
The threshold for “statistical significance” was an alpha level of 0.05 and two-tailed 
tests were used in calculating P values. The “clinical significance” of observed 
differences was also taken into consideration even if they did not achieve “statistical 
significance” (Lang and Secic 1997). Clinically significant differences were those 
that had important clinical relevance (or usefulness) either because o f their large 
effect (increased or reduced risk by a factor of at least 3).
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Table 3.10: Summary of dependent variables, their definitions, data codes and how they were created.
Variable Definition Code How created
1. Outcome of admission at 72 hours 
after admission
The result of managing the case upon admission to the ward up to 72 hours after; grouped as 
survived or did not survive
deaths Included in case record forms (CRFs)
2. Earty-onset neurological sequelae Neurological deficits of a gross nature detectable between recovery of consciousness (i.e. GCS 
>14/15 or BCS 24/5) and discharge from the ward
edefs2 Created by combining other variables 
from the CRFs.
3. Late-onset neurological sequelae Neurological deficits of a gross nature detectable after discharge up to 45 weeks after discharge. Idefs Created by combining other variables 
from the CRFs
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Table 3 . 11: List of Independent study variables showing their format, definition, code and method used to collect information on them
Variable (units) Format Definition 1 Comments Code Creation'
A Demographic and history information
1 Centre Nominal Study hospital where cases was managed -  either Mbale or Kapchorwa centre Not created
2 Age (years) Ordinal i) Grouped as 1-4yrs, 5-9yrs, 10 & older agegrp2 Reported
Ordinal ii) Grouped as 1-9yrs, 10 & older agegrp3
3 Seizures before admission (non-epileptic) Ordinal Number prior to admission -  grouped as none, 1-3,4-20. nseiz24grp Reported
4 Quinine given before admission (mg) Nominal Whether quinine was given within 24 hours prior to admission (No/Yes) q48 Reported
5 Previous medical admission Nominal History of a previous admission for a medical reason with last year (No/Yes) prevadm Reported
B Clinical examination on admission
1 Body temperature (°C) Ordinal Body temperature measured in the axilla on admission -  grouped as min-38.5, 
38.6-39.4,39.6-42.0
atemplgrpl Measurement
2 Depth of unconsciousness Nominal Able to localise painful stimuli on admission -  Level 2 (No/Yes) loca2 Finding
Ordinal i) Depth of coma on admission determined by the score on the Blantyre coma 
scales -  Level 2; grouped as 0-2,3-5
bcslgrp Measurement
Ordinal ii) Depth of coma on admission determined by the score on the Glasgow coma 
scale -  Level 2; grouped as 3-8,9-12,1315
gcslgrp Measurement
3 Anaemia Nominal Presence of moderate to severe anaemia defined by a Hb concentration of less 
than 10 g/dL and or the clinical suspicion of moderate to severe anaemia on 
examination at Level 2 (No/Yes).
anemia Summation
4 Jaundice Nominal Presence of jaundice on clinical examination -Level 2 (No/Yes) jaun2 Finding
5 Dehydration Nominal Clinical finding of moderate to severe dehydration on examination at Level 2 dhydrl Finding
6 Pulse rate (beats/min) Ordinal Number of beats per minute -  grouped as 50-84,85-119,120-154,155-max pul 1 grp Finding
Table continued overleaf
Manner used to collect information that allowed creation of the variable: Reported-Information was given by the attendant; Finding-Information was obtained during history
taking or clinical examination; Measurement-Information was measured either once or several times; Derived-Information was calculated; Summation-Information was
summarised from a collection of other variables.
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Table 3.11 continued
Variable (units) Format Definition / Comments Code Creation^
7 Pulse pressure (mmHg) Ordinal Difference between systolic and diastolic pressure -  Level 1; grouped as 20-39, 
40-79
pulpresslgrp Derived
8 Shock Nominal Presence of shock as defined by cold extremities with abnormal capillary refill, 
and or a pulse pressure of 20 mmHg or less (Likely/Unlikely)
shock2 Summation
9 Respiratory rate (breaths/min) Ordinal Number of breaths per minute -  grouped as 10-29,3049,50-max rrlgrp Finding
10 Respiratory abnormality Nominal Any respiratory abnormality such as irregular rhythm, shallow or deep breaths, 
respiratory distress, or abnormal breath sounds (No/Yes).
respabnorm Summation
11 Respiratory distress Nominal Likelihood of respiratory distress defined clinically by flaring of nostrils and chest 
indrawing (Likely/Not likely).
rdistress Summation
12 Presence of extra heart sounds Nominal Presence of extra heart sounds such as added sounds and murmurs on clinical 
examination
hearts2 Summation
13 Organomegaly Nominal Presence of enlarged spleen or liver on clinical examination at Level 2 (No/Yes). organol Finding
14 Spleen size (centimetres) Nominal i) Presence of enlarged spleen (No/Yes) spleen2 Finding
Ordinal ii) Size of spleen; grouped as Not enlarged, 2-3,4-5 spleen 1 grp Measurement
15 Liver size (centimetres) Nominal i) Presence of enlarged liver (No/Yes) Iiver2 Finding
Ordinal li) Size of liver; grouped as Not enlarged, 2, 3-5 liverlgrp Measurement
16 Muscle tone changes Nominal Changes in muscle tone of upper and lower limbs at Level 2 tonel Finding
Changes In tendon reflexes Nominal Changes In the tendon reflexes namely biceps, triceps, knee jerk and ankle jerk, 
at Level 2
reflexesl Finding
17 Neck stiffness Nominal Presence of a stiff neck at Level 2 (No/Yes) necksl Finding
C
1
In-hospital non-laboratory information
Seizures (non-epileptic) Ordinal i) Number witnessed during first episode of seizure activity while on admission -  
grouped as none, 1-3,4-20.
nseiz2grp Finding
Nominal ii) Presence of seizures while in hospital (No/Yes). seizurel Summation
2 Seizure stoppage time (days) Ordinal Duration between the date of onset of seizures and date after which there are 
three days without any visible seizure activity -  grouped as 1-2,3-max
seizstoplgrp Derived
Table continued overleaf
* Manner used to collect information that allowed creation of the variable: Reported-Information was given by the attendant; Finding-Information was obtained during history
taking or clinical examination; Measurement-Information was measured either once or several times; Derived-Information was calculated; Summation-Information was
summarised from a collection of other variables.
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Table 3.11 continued
Variable (units) Format Definition / Comments Code Creation*
3 Total Seizure stoppage time (days) Ordinal Seizure stoppage time plus the number of days prior to admission during which 
the patient reportedly had seizures -  grouped as 1- 2 ,3-max.
totalseiztimegrp
4 Fever clearance time (days) Ordinal Number of days between date of admission and date when the body temperature 
is 37 °C and below for two consecutive days -  grouped as 1,2-3,4-max.
temptimelgrp Derived
5 Total fever clearance time (days) Ordinal Fever clearance time plus the number of days prior to admission for which the 
patient reportedly had a fever -  grouped as 14,5-6,7-20.
totalfevtimegrp Derived
6 Coma recovery time (days) Ordinal Duration between date of admission and date when fully conscious -  grouped as 
1-2,34,5-max.
comatimelgrp Derived
7 Total coma recovery time (days) Ordinal Coma recovery time plus the number of days prior to admission for which the 
patient was reportedly unconscious -  grouped as 1-2,34,5-max.
totalcomatimegrp Derived
8 Quinine given (mg) Nominal Whether a loading dose of quinine was prescribed (No/Yes) q bolus Finding
Ordinal The total amount of quinine prescribed for the first day of treatment (includes 
loading dose); grouped as <570,570 and above
qdailylgrp Finding
D Measurements on admission and in- 
hospital
1 Random blood glucose (mmol/L) Nominal Presence of hypoglycaemia defined as random blood glucose of <2.2mmol/l 
(No/Yes).
hypoglyl Measurement
Interval First measurement of random blood glucose -  grouped as 04.9,5-6.9,7-max bglulgrp Measurement
2 Parasitaemia (number of parasites per piL) Ordinal Parasite count determined on admission -  grouped as min-50,000, >50,000. parai grp Measurement
3 Parasite clearance time (days) Ordinal Duration between day of admission and day when no parasites are detectable on 
blood smear for two subsequent days -  grouped as 1,2,3-max.
paraclearl grp Derived
4 Haemoglobin concentration (g/dL) Ordinal Haemoglobin (Hb) concentration on admission as estimated by Sahl's method -  
Measured in patients who were suspected to have a low Hb concentration; 
grouped as min-9.9,10-max.
hblgrp Measurement
5 White blood cell count (cells per L) Ordinal Total white blood cell count on admission -  grouped as 20004700,4701-6700, 
6701-max.
wbccgrp Measurement
Table continued overleaf
• Manner used to collect information that allowed creation of the variable: Reported-Information was given by the attendant; Finding-Information was obtained during history
taking or clinical examination; Measurement-Information was measured either once or several times; Derived-Information was calculated; Summation-Information was
summarised from a collection of other variables.
97
Table 3.11 continued
Variable (units) Format Definition / Comments Code Creation?
6 Serum sodium concentration (mmol/L) Ordinal Sodium serum concentration -  grouped as <135,135-146, >146 sodiumgrp Measurement
7 Serum chloride concentration (mmol/L) Ordinal Calcium serum concentration -  grouped as <2,2-3, >3 calciumgrp Measurement
8 Serum calcium concentration (mmol/L) Ordinal Chloride serum concentration -  grouped as <95,95-105, >105 chloridegrp Measurement
9 HIV infection Nominal Sero-positive for HIV-1 (No/Yes) or known HIV-positive allhiv Measurement
? Manner used to collect information that allowed creation of the variable: Reported-Information was given by the attendant; Finding-Information was obtained during history
taking or clinical examination; Measurement-Information was measured either once or several times; Derived-Information was calculated; Summation-Information was
summarised from a collection of other variables.
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3.18.1 Descript! ve sta tistics
Categorical variables: Single-variable frequency tables were made to show the 
distribution of independent and dependent variables among cases. Contingency 
tables were used to show the frequencies of categorical variables between i) definite 
and probable cases (case definition), ii) Mbale and Kapchorwa (study centre), and 
iii) aged one to nine years, and ten years and above (age group). A second age group 
of one to four years, five to nine years and ten years and above was employed in 
some instances to better understand the influence of age. Contingency tables were 
also used to test the null hypothesis of associations between groups. Fisher’s exact 
test was used for all comparisons because of the small number (5 cases or less) of 
expected observations in some cells. Variables with associations that were 
“statistically significant” at the alpha level were noted and were the first variables to 
be used in the bivariate comparisons as described below.
Continuous variables: Measures of central tendency (means and medians) were 
calculated for continuous variables (normally and not normally distributed data 
respectively). The Student’s t-test for two samples was used to compare means 
between groups. This was done when the variances of the two groups were fairly 
equal. When the variances were different, the t-test for unequal variances was 
employed. For continuous variables that were not normally distributed the Mann- 
Whitney-Wilcoxon test was used for comparing medians between two groups. When 
there was need to compare more than two groups the Kruskal-Wallis test was 
employed. Correlation analysis between continuous variables used either Pearson’s 
correlation or Spearman’s rank correlation.
3.18.2 A Italyses in volving statistical inference
The next step was to calculate measures of association between the outcome 
variables and the explanatory variables. This was performed in three stages 
corresponding to the kinds o f outcomes; mortality, early-onset deficits and late-onset 
deficits. Variables used for these analyses were all in the categorical form.
Univariate associations were examined first. Stratum-specific odds of outcome were 
determined and used to calculate odds ratios (ORs). P-values were obtained from the 
Wald test for each comparison and used to determine how likely it was that the
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association between the outcome and factor occurred by chance. Univariate analysis 
was useful in identifying variables that would be used in multivariable analyses.
The crude ORs obtained above were adjusted for age (as a categorical variable) to 
find out if age influenced the association between factors and outcome. The 
magnitude of the adjusted OR’s were compared with the univariate OR’s to 
determine the size of any differences. This process was repeated separately by 
adjusting the univariate ORs for study centre and for case definition. When the 
difference between the crude ORs and adjusted OR was large, then the adjusting 
variable (age, study hospital, or case definition) was considered to confound that 
association between the factor and the outcome. The variables which were shown to 
be associated with age, centre or case definition in the contingency tables were the 
first to be considered in bivariate analyses.
Multivariable analysis was carried out using logistic regression for the two outcomes 
mortality and early-onset neurological deficits (separately). Explanatory variables 
were assessed for colinearity and if any were found to be correlated then the variable 
with the strongest relationship with the outcome was used. A forward stepwise 
process was used to develop a model containing risk factors for the outcome (at 
three stages). The plan of analysis followed a systematic manner. Age was first 
placed in the model since the study hypothesis related age to outcome. Next, study 
hospital or case definition were included if they had been shown to be confounding 
variables. Next, explanatory variables which have already been described as risk 
factors for the outcome were included one after the other. Each time a variable was 
added, its P value (from the Wald test) in the model was examined. If its P value 
was statistically significant at the 5% level it remained in the model. If on the other 
hand its P value was greater than 0.05 but less than 0.1 then the Likelihood Ratio 
test was used to compare likelihood ratios of the model without the variable against 
the model with the variable. If the LR test showed that both models differed 
significantly at the alpha level of 0.05%, then the variable remained in the model. 
The LR test was also used to decide whether to leave or remove categorical 
variables that had more than two levels because these had more than one P value 
(Wald test) whereas the LR test examined all categories as a unit.
100
After assessing all known risk factors, other factors which were thought to be related 
to the outcome were added one after the other starting with those with the lowest P 
values (Wald test) in univariate analyses up to those with P values of 0.2. Finally, 
variables which were considered to have clinical significance were then included 
into the model. If their clinical effect remained then they stayed in the model.
Survival analysis was used to develop a model for late-onset neurological deficits. 
This kind of analysis was used because it could take in to account the time taken to 
the detection of deficits. Stratified incidence rates were calculated for children and 
adults separately. Incidence rate ratios were used to compare the stratum-specific 
incidence rates for adults and children to determine any differences. Next, hazard 
ratios were calculated and adjusted separately for age, study hospital and case 
definition. In this way it was possible to determine whether any of the three factors 
were confounders for the associations between explanatory variables and late-onset 
deficits. Finally a survival-based model was developed in the same manner as the 
logistic models previously described.
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Chapter 4
I present the results of the analyses in the next two chapters; divided in to 
descriptive and analytical results. My approach will be to present most of the results 
here and provide other supporting findings in the Appendix. As well as mentioning 
my results in a sequential manner, I will in a few instances elaborate key findings 
and link them with others in order to make this section easier to read and understand.
4. DESCRIPTIVE RESULTS
Descriptive findings are presented to give an overview of study cases and 
neurological sequelae. Some objectives of the study are achieved with the findings 
documented in this chapter.
4.1 Case enrolment
Case enrolment began on lsl January 2002. Mbale hospital was the first site to get 
patients with features suggestive of cerebral malaria. Kapchorwa hospital followed 
suit. The other two sites, Mutolere and Kabale hospitals, admitted a few cases at the 
onset of the study that were used as pilots. By the end of the first twelve months (i.e. 
after two rainy seasons March-May and September-November), there were 
insufficient cases meeting the selection criteria to end fieldwork. The decision to 
continue enrolment and cover one more rainy season was taken. By 31st July 2003, 
when enrolment at all sites ceased, a total of 158 patients with features suggestive of 
cerebral malaria and meeting the requirements of Checklist 1 had been admitted to 
all four sites. Forty-nine cases were disqualified because they could not satisfy the 
requirements o f  checklist 2. The reasons why they failed to do so are listed in Table 
4.1. This left 109; cases all were from Mbale and Kapchorwa hospitals. After 
assessment o f the data for accuracy and completeness nine cases with incomplete 
case record forms were excluded leaving 100 cases with sufficient information for 
statistical analyses. The findings presented henceforth are from these one hundred 
cases. No subject refused to participate in the study.
102
Table 4.1: List of the reasons for which cases who met Checklist 1 were excluded from the 
study
Reason for exclusion
Mbale
Number of patients 
Kapchorwa Kabale Mutolere Total
Diagnosis not clear 6 3 3 2 14
No malaria parasites demonstrable on 6 0 5 2 13
thick blood smear
Below lower age limit 5 0 0 0 5
Diagnosis not cerebral malaria
Malaria with hyperpyrexia 3 0 0 0 3
Uncomplicated malaria 2 2 0 0 4
Hyperparasitaemia 2 0 0 0 2
Malaria with hypoglycaemia 2 0 0 0 2
Meningitis 2 0 0 0 2
Typhoid fever 1 0 0 0 1
Taken away by relatives 2 0 0 0 2
Died on admission before examination 1 0 0 0 1
Total 32 s 8 4 49
4.2 Occurrence and monthly frequency of cerebral malaria
The proportion of cerebral malaria among falciparum malaria admissions (aged 1 to 
70 years) during the study period 1st January 2002 to 31st July 2003, was 1.9% 
(100/5381). It was 1.8% (70/3998) in Mbale hospital and 2.2% (30/1383) in 
Kapchorwa hospital. By age group, the proportion in Mbale was 1.5% (1-4 yrs, 
41/2,708), 4.5% (5-9 yrs, 13/286) and 1.6% (10-70 yrs, 16/1,004); the values for 
Kapchorwa were 0.8% (1-4 yrs, 5/656), 9.4% (5-9 yrs, 13/139) and 2.0% (10-70 yrs, 
12/588).
The monthly frequency of study cases is illustrated in Figure 4.1. The largest 
number of cases were seen in July 2002. Towards the end of fieldwork the frequency 
had declined to zero. Figure 4.2 gives the monthly frequency by study centre and by 
case definition. March, April and June 2002 had the maximum numbers of cases 
managed at Kapchorwa whereas in Mbale it was July 2002.
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Figure 4.1: Monthly frequency of cerebral malaria cases enrolled at all sites between P  Jan 2002 and 31s' July 2003.
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Fioure 4 2: Histogram of the number of patients with cerebral malaria enrolled into the study between i"  Jan 2002 and 31' July 2003 showing the site to which 
they were admitted and their case definition
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4.3 Correlation between cerebral malaria and selected weather indices
Historical weather records from the Department of Meteorology, Ministry of Water, 
Lands and Environment (Government of Republic of Uganda), for the study areas 
were examined to determine any correlations between selected weather indices and 
the frequency of cases. Monthly means for rainfall and temperature measurements 
from periods with continuous information were used. Much of the weather data for 
the more recent periods was erratic and could not be used for these comparisons. As 
a result, different time periods and durations were used to determine the mean 
monthly rainfall and temperature values. Table 4.2 gives a summary of the findings. 
The calendar year is divided into quarters of three monthly periods to coincide with 
the two rainy seasons in Uganda.
The mean monthly minimum rainfall measured at Mbale town weather station 
(altitude 1,153m) between 1908 and 1970 had the highest correlation with case 
frequency (41%). The information from Sipi and Kapkwata weather stations were 
used to represent Kapchorwa. Mean total monthly rainfall (measured between 1947 
and 1979) had a correlation of 33% with the monthly frequency of cases seen at 
Kapchorwa hospital
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Table 4.2: The correlation between mean monthly measurements of rainfall and temperature as three monthly categories, and the number of cerebral malaria 
cases seen during a 12-month period.
Mbale Total Minimum Maximum Daily Maximum Minimum Number of
rainfall’ rainfall (mm) rainfall (mm) temperature °Ct temperature °C temperature °C cerebral 
malaria cases
December -  February 42 0 183 31 37 16 17
March - May 143 29 307 29 35 17 12
June -  August 122 49 245 28 32 16 21
September -  November 88 15 217 29 34 16 8
Correlation with frequency o f ■0.04 0.41 ■4.14 ■0.1 ■0.3 0.0 -
cerebral malaria cases
Kapchorwa Total Minimum Maximum Daily Maximum Minimum Number of
rainfall* rainfall (mm) rainfall (mm) temperature °C§ temperature °C temperature °C cerebral 
malaria cases
December -  February 47 0 207 25 26 13 5
March -  May 189 4 366 24 25 13 15
June -  August 209 21 444 22 23 12 9
September -  November 175 15 467 23 24 12 0
Correlation with frequency o f 
cerebral malaria cases
0.33 ■0.22 ■0.11 0.02 ■0.04 0.28 *
' Rainfall measurements at Mbale municipal weather station for the period 1908-1970
* Temperature measurements at Mbale municipal weather station for the period 1931-1951
* Rainfall measurements at Sipi weather station for the period 1947-1979
s Temperature measurements at Kapkwata weather station for the period 1979-1985
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4.4 Geographic distribution of study cases
Mbale hospital is a district as well as a referral hospital. As a result some of the 
cases that were managed there lived within the district (45 cases) and others in the 
neighbouring ones, namely Sironko (14 cases), Pallisa (7 cases), Bugiri, Kapchorwa, 
Kumi and Tororo (1 case from each). All the cases managed at Kapchorwa hospital 
were resident in Kapchorwa district.
4.5 General characteristics of all study cases
Explanatory factors were classified into broad groups to reflect the kind of 
information they represent and the period in patient management when data was 
collected on them. The broad groups are a) Demographic and history information, 
see Table 4.3 b) Frequency of symptoms and signs noted during the clinical 
examination at Levels 1 and 2, see Table 4.4, and c) Frequency of in-hospital 
features and laboratory-based information, see Table 4.5.
4.5.1 Demography and History information
Fifty-eight cases met the strict definition of cerebral malaria, i.e. unrousable coma 
due to malaria, as defined in the previous chapter. Forty-two cases were classified as 
probable cases i.e. impaired consciousness due to malaria. Seventy cases were 
enrolled at Mbale Regional Hospital, which is a large hospital compared to 
Kapchorwa Hospital where thirty cases were enrolled. The majority of cases (72%) 
were aged between one (the lower limit) and nine years, with only 28% aged ten 
years and above. The median age was 6 years (71.5 months) with a range of 1 to 54 
years (13-648 months).
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Table 4.3 :  General characteristics of cases enrolled into the study -  Demography and History
Information
Characteristic (N=100) Measure
A. CATEGORICAL DATA Frequency (n)
Case definition
Definite 58
Probable 42
Centre
Mbale 70
Kapchorwa 30
Age grouping 1
< 10 years 72
2 10 years 28
Age grouping 2
<5 46
5-9 26
2 10 years 28
Gender
Male 55
Female 45
Quinine given within 2 days before admission 38
Antlmalarial given in last month before admission" 57
Chloroquine only 50
Quinine only 19
Quinine & chloroquine 12
S/P 2
Previous medical admission 14
Attended follow-up visits 52
B. CONTINUOUS DATA Median
Age (months)
(range)
71.5(13-648)
Duration between discharge and visit (days)
1sl visit (n=53) 33 (2-219)
2nd visit (n=38) 66 (36-276)
Not including use of quinine in the last 48 hours before admission
1 0 9
The ratio of males to females was 1.2:1. (1:1 for all malaria admissions in the same 
period). A greater proportion of cases were admitted in the second 6-hour period of 
the day, i.e. 06:01 -  12:00 hours, as illustrated in the pie chart in Figure 4.3 There 
was no detectable association between time of admission and outcome (P value was 
not statistically signifiant). Half o f the cases that did not survive were admitted 
between 12:01 and 18:00 hours (n=5) and 3 fatal cases did not have a record of the 
time of their admission All cases that were prematurely taken away were admitted 
between 06:01-18:00 hours
Figure 4.3: Pie chart i 1 during four 6  hour periods
of day
Seventy-six cases had a reported history of seizures in the last 24 hours before 
admission Of these, 43 were reported to have had between I and 3 convulsions and 
33 were reported to have had between 4 and 20 convulsions, see Figure 4.4 for 
histogram showing the frequency of reported seizures Twenty-four cases did not 
have a history of convulsions. Thirty-eight percent of all cases were reported by 
their attendants to have received quinine within one day before being admitted to 
hospital There was an association between having seizures and receiving quinine 
before admission Of those who reported receiving quinine, 10% (n=4) did not 
report convulsions before admission, 53% (n=20) had 1-3 seizures and 37% (n=14)

20
Number o f seizures
■ Reported seizures 0  Witnessed seizures
Figure 4.4: The frequency of seizures in cases who either gave a history of seizures within 24 hours before admission (n=76) or had seizures (first episode) while 
admitted in hospital (n-46)
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When attendants were asked about the drugs given to the patient over the last month 
before admission, 50 reported giving chloroquine only, 19 said quinine only was 
given, 12 reported giving both chloroquine and quinine and 2 said SP was given. 
The proportion of cases followed up was 52%, who had a median duration between 
discharge and the first follow-up visit of 33 days (range 2 to 219 days) whereas the 
duration between discharge and the second follow-up visit for the 38 cases that 
attended was 66 days (range 36 to 276 days). Fourteen cases had been admitted to 
hospital before for a variety of paediatric medical conditions the most frequent of 
which were febrile illnesses. Of those who were admitted to hospital before, most 
did not report quinine use in the 24 hours preceding this admission (n=9, 64%).
4.5.2 Frequency o f  symptoms and signs noted around time o f admission 
(Levels 1 and 2)
Fever was the commonest symptom with 87% of relatives reporting a history of 
fever. A history of loss of consciousness occurred in 66% while the proportion with 
confusion, a lesser degree of impaired consciousness, was 56% (some cases having a 
history of both symptoms). Loss of appetite was reported in 56 cases, headache in 55 
cases and vomiting in 42 cases. Cough (39 cases), diarrhoea, rigors and chills (12 
cases each) were less frequent. A history of excessive bleeding was not reported as a 
symptom. These symptoms are not mutually exclusive. At the next stage of 
management, Level 2, some additional symptoms were noted. Five patients reported 
having suffered from general body weakness before losing consciousness, two cases 
lost their ability to speak, and one each, had complained of neck, chest and 
abdominal pain.
The ability to localise painful stimuli was assessed at Level 1 by the admitting nurse 
and a few hours later at Level 2 by the admitting doctor. On the first assessment, 52 
cases were not able to localise pain whereas on the second assessment this number 
went up to 75 cases. The depth of unconsciousness was scored on either the Blantyre 
coma score (in children aged 5 years or less) or Glasgow coma scale (in those aged 
over 5 years) at Level 2. Thirty-one cases scored 2 or less on the Blantyre coma 
score (BCS) which corresponds to the inability to localise painful stimuli.
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Table 4.4: Frequency of symptoms and signs noted during the clinical examination of cases 
around time of admission (Levels 1 and 21
Characteristic (N=100) Measure
A. CATEGORICAL DATA Frequency (n)
Symptoms documented at Level 1
Fever 87
Unconsciousness 66
Confusion and unawareness of surroundings 56
Loss of appetite 56
Headache 55
Vomiting 42
Cough 39
Diarrhoea 12
Rigors and chills 12
Excessive bleeding 0
Additional complaints recorded at Level 2
General body weakness 5
Loss of speech 2
Neck pain 1
Chest pain 1
Abdominal pain 1
Signs noted at both Levels
Unable to localise painful stimuli on admission' 52
Blantyre Coma Score on admission (excluding 54 cases)
0-2 31
3-5 10
Not scored with BCS 5
Glasgow Coma Scale on admission (excluding 46 cases)
3-8 19
9-12 22
13-15 5
Not scored with GCS 8
Body temperature
35-38.5 63
38.6-39.4 28
39.5-42 9
Moderate-severe anaemia 49
Jaundice 14
Moderate to severe dehydration 8
Pulse rate (beats per minute)
50-84 21
85-119 34
120-154 37
155-190 8
Systolic blood pressure
80-99 12
100-119 12
120-139 7
Missing info 69
Diastolic blood pressure
40-59 9
60-79 19
80-99 3
Missing info 69
Table continued overleaf
‘ From the Simple tool used at Level I by the admitting nurse
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T a b le  4 .4  c o n t in u e d
Characteristic (N=100) Measure
Pulse pressure
20-39 14
40-79 17
Missing info 69
Shock 5
Respiratory rate (breaths per minute)
10-29 27
30-49 55
50-89 18
Respiratory abnormality 42
Respiratory distress 5
Extra heart sounds
No 72
Yes 13
Missing info 15
Organomegaly 35
Spleen size (cm)
Not enlarged 82
2-3 13
4-5 5
Liver size
Not enlarged 80
2 6
3-5 14
Muscle tone changes (n=90) 51
Changes in tendon reflexes (n=86) 44
Neck stiffness 10
B. CONTINUOUS DATA Mean (95% Cl)
Body temperature 38.1 (37.9-38.3)
Pulse rate 112(106-117)
Respiratory rate 38(36-41)
Systolic blood pressure (n=31) 106(101-110)
Diastolic blood pressure (n=31) 64(61-68)
1 1 5
Ten cases scored between 3 and 5, and five cases were not scored with this scale 
despite being 5 years and below. Nineteen cases scored between 3 and 8 on the 
Glasgow Coma scale (GCS) which represents those not able to localise painful 
stimuli. Twenty-two cases scored between 9 and 12, and only five cases were found 
to have mild unconsciousness, i.e. a score of 13-15. Eight cases aged over 5 years 
were not scored with the GCS despite being in the right age group. Scoring was 
repeated daily both using the standard scales (BCS and GCS) and by simply 
determining the ability of the patient to localise painful stimuli. The scores on the 
first assessment are shown in Table 4.4.
The mean o f  the first measurement of body temperature (measured in the axilla) was 
38.1°C [95% Cl 37.9-38.3]. When temperature was categorised, sixty-three patients 
had temperatures between 35 and 38.5 °C, twenty-eight patients had temperatures 
between 38.6 and 39.4 °C, and nine had hyperthermia with temperatures between
39.5 and 42.0 °C. Moderate to severe anaemia was present in 49 cases of whom 11 
cases also had clinical signs of jaundice. A total of fourteen cases had clinical signs 
suggestive of jaundice (Level 2). Three cases did not have either clinical or 
laboratory features of anaemia. Eight children appeared to have moderate to severe 
dehydration. The first count of the pulse and respiratory rate produced means of 112 
beats per minute (95% Cl 106-117) and 38 breaths per minute (95% Cl 36-41) 
respectively. The frequency of cases by category of pulse and respiratory rates are 
given in the table. The pulse rate was imputed in 7 cases using the age-group 
specific means (as mentioned in the methods, missing values were imputed within 
categories on which they were not analysed). This was also done for 9 observations 
without information on respiratory rate. Blood pressure was measured in 31 cases. 
The mean o f the first measurement was 106 mmHg (95% Cl 101-110) for systolic 
pressure and 64 mmHg (95% Cl 61-68) for diastolic pressure. The mean of the 
difference between systolic and diastolic pressure, the pulse pressure, was 41 mmHg 
(95% Cl 37-46). These measurements were categorised, as shown in the table, and 
included a category for missing values to elucidate if cases with missing information 
formed a unique group.
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The possibility of shock was likely in 5 cases (two cases had pulse pressures of 20 
mmHg and in three cases blood pressure was not measured but had other clinical 
signs of shock). Abnormalities in respiration which included flaring of the alae nasi, 
use of accessory muscles of respiration, shallow or deep respirations, and abnormal 
breath sounds were noted in 42 cases. Of these only 5 were likely to have been in 
respiratory distress because of their extreme features. Extra heart sounds such as 
added sounds or murmurs were heard in 13 cases and serve as a proxy measure for 
examination by a doctor since it took some clinical expertise to auscultate and 
identify added heart sounds. Organomegaly, noted in the form of an enlarged spleen 
or liver or both was found in 35 cases. Of these the lower margin of the spleen was 2 
cm or more below the left costal margin in 18 cases. Similarly 20 cases had palpable 
liver 2 cm or more below the right costal margin. Nine cases had both an enlarged 
spleen and liver.
The examining doctor carried out a basic neurological examination on admission. At 
this time many of the cases were unconscious. 10 cases had a stiff neck and in two 
of these Kerning’s sign was present. Muscle tone changes, either hypotonia or 
hypertonia, were observed in 51 cases (10 cases were not examined for tone). Hypo 
or hyper-reflexia of the tendon reflexes (biceps, triceps, knee jerk and ankle jerk) 
were found in 44 cases out of 86 cases whose reflexes were examined. Thirty-five 
cases had both changes in tone and reflexes, nine cases were noted to have changes 
in reflexes but no changes in tone and fifteen cases had changes in tone but no 
changes in reflexes.
4.5.3 Frequency o f in-hospital features and laboratory-based information 
(Levels 2 and 3)
Following admission, the number of seizures that occurred on the first and 
subsequent days were recorded. The numbers of witnessed seizures during the first 
episode (i.e. number of seizures on the first day when seizures occurred) are 
summarised in Table 4.5. Of the forty-six cases who had seizures (median 2, range 
1-11) while on the ward, 31 had between 1 and 3 seizures and 15 had between 4 and 
20 seizures, see Figure 4.4. The number of days it took for seizures to be controlled, 
the seizure stoppage time, was 1 to 2 days for thirty-six cases and 3 to 48 days for 
ten cases (median for all 46 cases was 2 days, range 1-47).
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Table 4.5: Frequency of in-hospital features and laboratory-based information
Characteristic (N=100) Measure
A. CATEGORICAL DATA Frequency (n)
In-hospital features
Seizures witnessed (non-epileptic)
Had none 54
Had any number 46
Number of seizures witnessed (n=46)
1-3 31
4-20 15
Seizure stoppage time (days)
1-2 36
3-48 10
Total seizure stoppage time (days)
1-2 48
3-48 33
No history of seizures or witnessed seizures 19
Fever clearance time
1 31
2-3 40
4-9 25
Missing info 4
Total fever clearance time
1-4 39
5-6 32
7-15 29
Coma recovery time (days)
1-2 25
3-4 33
5-12 14
Missing info or not in coma on admission 28
Total coma recovery time (days)
1-2 31
3-4 28
5-15 30
Missing info or no history of loss of consciousness 11
Quinine loading dose given on admission
Not given 76
Given 7
Missing info 17
Dose of quinine given on Day 0
3-8.9 mg/kg 7
9.0-10.9 mg/kg 19
11.0-20.9 mg/kg 18
Missing info 56
Hypoglycaemia (£2.2mmol/L) 8
Random blood glucose (mmol/L)
0.5-4.9 22
5-6.9 26
7-14.9 22
Missing info 30
Tabic continued overleaf
T a b le  4 .5  c o n t in u e d
Characteristic (N=100) Measure
Parasite count on Day 0 (parasites/pL)
100-50,000 52
50,001-595,000 33
Missing 15
Haemoglobin concentration (g/dL)
3-9.9 38
10-14.9 30
Missing info 32
White blood cell count (cells/L)
2,000-4,700 25
4,701-6,700 26
6,701-27,000 25
Missing info 24
Serum sodium concentration (mmol/L)
50-134 33
135-146 20
147-220 8
Missing info 39
Serum chloride concentration (mmol/L)
80-95 4
95-105 10
106-126 36
Missing info 50
Serum calcium concentration (mmol/L)
0-1.9 15
2.0-3.0 12
3.1-6.0 26
Missing info 47
Sero-positiveforHIV-1
No 32
Yes 4
Missing info 64
B. CONTINUOUS DATA Mean (95%
Cl)
Number of seizures prior to admission (median, n=76) 3(2-4)
Number of witnessed seizures -  1sl episode (median, n=46) 2(1-3)
Fever clearance time (n=78 survivors) 2.8 (2.4-3,2)
Total fever clearance time (n=82 survivors) 5.5(50-6.1)
Coma recovery time (n=67 survivors) 3.5 (3-4)
Total coma recovery time (n=89 survivors) 4.1 (3.6-47)
Random blood glucose-geometric mean (mmol/L, n=70) 5.6 (5.0-6.3)
Parasite count-geometric mean (parasites/pL, n=85) 15,973 (9,634-
26,482)
Parasite clearance time (days, n=82) 1.8(1.6-2.0)
Haemoglobin concentration (g/dl, n=68) 9.3 (8.8-9 9)
White blood cell count-geometric mean (cells/L, n=76) 6,046 (5 461-
6,695)
Serum sodium concentration-geometric mean (mmol/L, n=61) 127(121-134)
Serum chloride concentration-geometric mean (mmol/L, n=50) 108(105-111)
Serum calcium concentration-geometric mean (mmol/L, n=53) 2.2(1.6-2.9)
1 1 9
The median of the total seizure stoppage time which included the number o f days 
prior to admission for which the case reportedly had fits, was 2 days (range 1 -48). 
Thirty-five cases had histories of seizures but did not have any witnessed ones. The 
mean fever clearance time was 2.7 days (95% Cl 2.0-2.5). The frequency o f  cases 
who took one day, 2 to 3 days and 4 to 9 days to clear their fever was 31, 40 and 25 
cases respectively. When the numbers of days with fever before admission were 
added, the mean increased to 5 days (95% Cl 4-6). The category-specific 
frequencies are indicated in the table.
Twenty-five cases took 1 to 2 days to regain consciousness whereas thirty-three 
cases took 3 to 4 days, and fourteen took 5 to 12 days. The mean coma recovery 
time (n=72) was 3.5 days (95% Cl 3-4) and when the number of days prior to 
admission for which the patient was reportedly unconscious were added, the mean 
increased to 4 days (95% Cl 3.4-4.5). Seventeen cases with a history o f loss of 
consciousness were not scored on admission and in eleven cases no information was 
documented on history of loss o f consciousness or depth of coma on admission. The 
minimum total daily amount of quinine prescribed was 225 mg per day and the 
maximum was 1800 mg per day (this excludes the loading dose). In 19 cases, there 
was no information in the case record forms of the dose of quinine prescribed. Fifty- 
two cases were weighed (median 17 kg [95% Cl 13-20]) and the amount of quinine 
given per kilogram body weight per dose (three doses given per day) was calculated 
for forty-four of these cases as shown in the Table. The mean amount of quinine per 
unit body weight given as a first dose was 11.4 mg/kg (95% Cl 10.4-12.4). Three of 
the seven cases that received a loading dose of quinine were given 18.8 mg/kg (1 
case) and 20 mg/kg (2 cases) as a first dose. It was not possible to determine the 
dose of quinine given in the remaining four cases.
Hypoglycaemia was found in 8 cases on admission. Twenty-two cases had random 
blood glucose concentrations between 0.5 to 4.9 mmol/L, twenty-six cases had 
concentrations from 5 to 6.9 and twenty-two had concentrations from 7 to 14.9 
mmol/L. Blood glucose was not measured in 30 cases. The parasite count measured 
on the first day of treatment (Day 0), ranged from 131 to 590,400 parasites per pL. 
The mean (geometric) parasite count on Day 0 was 15,970 parasites per pL (95% Cl 
9,630-26,480); on Day 1 it was 16,050 parasites per pL (95% Cl 8,090-31,820); Day
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2 it was 2,170 (95% Cl 410-1 1,590) and Day 3 it was 1,540 (95% Cl 60-36,840) By 
the fourth day, all the cases that had parasitaemia on admission had become 
aparasitaemic Figure 4 5 shows box plots of the median log parasite count on Day 0 
to Day 3 (box borders are the 25Ul and 75lh percentiles and the whiskers represent the 
lower and upper values) . The mean parasite clearance time (n=82) was 18 days 
(95% Cl 1.6-2.0). All study cases were positive for P. falciparum parasitaemia on 
the first thick smears carried out on admission as a screening tool Eighty-five cases 
had repeated smears to determine their parasite counts on Day 0, seventy-two had 
repeat smears on Dayl, sixty-three on Day 2, forty-three on Day 3, twenty-four on 
Day 4, ten on Day 5 and 2 on Day 6.
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Figure 4.5: Box plots showing the decline in median daily levels of parasitaemia (as log of 
parasite count) starting with Day 0 (labelled as IgparaD to Day 3  (Igpara4).
The mean haemoglobin concentration was 9 3 g/dL [95% Cl 8 8-9 9] Thirty-eight 
cases had haemoglobin concentrations (Hb cone) below 10 g/dL (considered to be 
the upper limit for anaemia) However, the number deemed clinically to have 
anaemia was forty-nine because detection of anaemia involved either finding clinical 
signs such as pale mucous membranes (a commonly accepted method used in 
Ugandan hospitals) or laboratory detection White blood cell counts varied widely 
between 2000 and 27000 cells/L The mean total white cell count (n=76) was 6,046
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(95% CI 5,461-6,695). Four cases (11%) were sero-positive for the Human 
Immunodeficiency Virus-1 (HIV-1). Initially nineteen samples tested at Mbale 
hospital were seronegative using ELISA. The stored sera of these 19 cases plus 8 
others were retested at the Uganda Virus Research Institute (UVRI) in Entebbe. Two 
ELISA tests (Murex® and Ani-Labsystems®) were carried out on each sample. Two 
cases not tested at Mbale had positive results on both occasions. Two cases that 
tested sero-negative in Mbale had discordant results and the findings had to be 
confirmed with Western Blot which proved that they were sero-positive*. The values 
of the electrolyte concentrations were not very reliable because of inadequate 
calibration of the brand new Vilalab Selectra E analyzer that was used to analyse the 
stored sera specimens. As a result of this and the storage process, some of the values 
are not compatible with the clinical picture of the patients.
4.6 Characteristics of subjects according to case definition
As mentioned earlier in the methodology, cases were divided into two groups 
according to case definition. Definite cases comprised those with the classic 
definition of cerebral malaria whereas probable cases comprised those with lesser 
degrees of impaired consciousnesses or those who were in unrousable coma but did 
not have cerebrospinal fluid analysed to exclude meningitis. Comparisons between 
groups were made to examine if any of the explanatory factors differed greatly 
between the two groups and to determine if the differences were large enough to 
take them into account during analyses.
The characteristics of cases by case definition groups, 58 definite cases and 42 
probable cases are summarised in Table 4.6. Mbale hospital contributed 72% (n=42) 
of definites while Kapchorwa contributed 28% (n=16). Of probable cases, 67% (28 
cases) were seen at Mbale hospital and 33% (14 cases) at Kapchorwa hospital. The 
case fatality rate was 17% amongst definite cases
’ Three other samples that were collected from patients that eventually were excluded from the study 
also had discordant results on the ELISA tests done at UVRI. All three were confirmed to be negative 
with Western blot.
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Table 4.6: Characteristics of cases by case definition (N=100 cases)
Characteristics
n
Definite
(n=58)
Percentage n
Probable
(n=42)
Percentage
P-
valuet
A. CATEGORICAL DATA 
Demographic & History information
Centre Mbale 42 72 28 67 0.65
Kapchorwa 16 28 14 33
Age grouping 1 <10 years 44 76 28 67 0.37
2 10 years 14 24 14 33
Age grouping 2 <5 31 54 15 36 0.22
5-9 13 22 13 31
210 14 24 14 33
Gender Male 29 50 26 62 0.30
Female 29 50 16 38
Outcome Survived 46 79 36 86 0.002
Died 10 17 0 O
Taken away 2 4 6 14
Seizures within 24hrs before admission
None 11 19 13 31 0.09
1-3 23 40 20 48
4-20 24 41 9 21
Quinine given before admission 21 36 17 42 0.68
Previous medical admission 8 14 6 14 1.00
Clinical examination on admission
Symptoms at Level 1
Fever 50 86 37 88 1.00
Unconsciousness 40 69 26 62 0.52
Confusion/Unawareness 28 48 28 67 0.10
Convulsions 48 83 27 64 006
Headache 29 50 26 62 0.30
Vomiting 29 50 13 31 0.07
Loss of appetite 32 55 24 57 1.00
Diarrhoea 6 10 6 14 0.55
Cough 22 38 17 4 0 0.83
Rigors and chills 20 34 13 31 0.83
Signs at Level 2
Unable to localise painful stimuli 57 98 18 43 <0.001
Blantyre coma score on admission (aged s  5 yrs)
0-2 27 84 3 18 <0.001
3-5 2 6 8 4 7
Not scored with BCS 3 10 6 35
Glasgow Coma score (aged >5 yrs)
3-8 17 65 2 8 <0.001
9-12 7 27 15 60
13-15 0 0 5 20
Not scored on GCS 2 8 3 12
Moderate-severe anaemia 32 55 17 40 0.16
Jaundice 8 14 6 14 1.00
Moderate-severe dehydration 5 9 3 7 1.00
Pulse pressure 20-39 7 12 7 17 0.07
40-79 6 10 11 26
Missing info 45 78 24 57
Shock 3 5 2 5 1.00
Table continued overleaf
* From Fisher’s exact test
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T a b le  4 .6  c o n t in u e d
Characteristics Definite Probable P-
(n=58) (n=42) value*
n Percentage n Percentage
Respiratory abnormality 28 48 14 33 0.15
Respiratory distress 1 2 4 10 0.15
Extra heart sounds 8 14 5 12 0.62
Organomegaly 24 41 11 26 0.14
Enlarged spleen 13 22 5 12 0.19
Enlarged liver 14 24 6 14 0.31
Muscle tone changes (n=90) 34 63 17 47 0.19
Changes in tendon reflexes (n=86) 27 50 17 47 0.83
Neck stiffness
In-hospital non-laboratory information
Seizures -  1st episode
5 9 5 12 0.73
None 25 43 29 69 0.04
1 - 3  seizures 23 40 8 19
4 - 2 0  seizures 10 17 5 12
Attended follow-up 31 53 21 50 0.68
Quinine loading dose given on Day 0 6 10 1 2 0.12
Sequelae on discharge at Level 4 
B. CONTINUOUS DATA
15 31 8 19 0.23
Not normally distributed n Median n Median P-
(95% Cl) (95% Cl) values
First dose of quinine given (mg/kg) 30 10(10-11) 14 11 (10-14) 0.89
Age on admission (months) 58 51 (1 4 - 42 78(13- 0.31
180) 648)
No. of witnessed seizures -  1st episode 33 2 (1-3) 13 1 (1-4) 0.74
Seizure stoppage time (n=44 survivors) 31 1 (1-2) 13 1 (1-2) 0.70
Total seizure stoppage time (n=70 survivors) 44 2 (2-3) 26 2(2-3) 0.70
Fever clearance time (n=78 survivors) 45 3 (2-3) 33 2(1-3) 0.24
Total fever clearance time (n=82 survivors) 46 5 (5-6) 36 5(3-7) 0.25
Coma recovery time (n=67 survivors) 43 3(3-4) 24 2(2-4) 0.11
Total coma recovery time (n=78 survivors) 46 4 (4-5) 32 3(2-4) 0.03
Normally distributed n Mean (95% n Mean (95% P-
Cl) Cl) value"
Temperature (°C) 58 38 4 (38.1- 42 37.7 (37.4- 0.005
387) 38.1)
Respiratory rate (breaths/minute) 58 43 (39-47) 42 32 (29-35) <0.001
Pulse rate (beats/minute) 58 119(111- 42 103 (94- 0.004
126) 111)
Systolic blood pressure (mmHg, n=31) 13 105 (97- 18 106(100- 0.779
113) 113)
Diastolic blood pressure (mmHg, n=31) 13 66 (59-72) 18 63 (59-68) 0.581
Haemoglobin concentration (g/dL, n=68) 42 9.4 (8.7- 26 9.2 (8.4- 0.699
10.1) 10.0)
Parasite count (parasites/pL, n=85) 52 13,277 33 21,374 0.355
Geometric mean (6,896- (9,336-
25,560) 48,933)
Random blood glucose (mmol/L, n=70) 40 5.8(5.1-66) 30 5.3 (4 3-6.5) 0473
Geometric mean
White blood cell count (cells/L, n=76) 43 6,785 33 5,203 0.03
Geometric mean (5,881- (4,553-
7,828) 5,948)
5 From Fisher’s exact test 
s From Mann Whitney test
"  From Student t-test except if the geometric mean was calculated in which case the Mann Whitney 
test was used
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In both groups most were aged less than 10 years (i.e. children), 76% of them 
definite and 67% of them probable cases (n=44 & 28 respectively). The median age 
was 51 months (about 4 years) amongst definite cases and 78 months (six and a half 
years) among probable cases. Cases that died after meeting the selection criterion of 
Checklist 1 were included in the definite group resulting in no deaths recorded as 
probable cases.
The symptoms reported by relatives did not vary much between the two groups. 
Convulsions occurred more often in definite cases, 83% (n=48) compared to 64% 
(n=27) in probable cases. This difference was unlikely to be accidental (P = 0.06). 
Similarly, vomiting was noted more frequently in definite cases, 50% (n=29), than in 
probable cases, 31% (n=13) producing a P value of 0.07. The frequency of signs 
noted by the clinician at Level two were fairly evenly distributed between both 
groups. Ninety-eight percent (n=57) of definite cases were not able to localise 
painful stimuli, i.e. in unrousable coma. The one case who could localise pain by 
this stage was already recovering from unrousable coma at Level one.
The first episodes of seizures were noted and the number of seizures grouped as 
shown in the Table. Twenty-three definite cases (40%) had between 1 and 3 seizures 
and ten (17%) had between 4 to 20 seizures. Eight probable cases (19%) had 
between 1 to 3 seizures and only five (12%) had 4 or more. This difference between 
groups was significant when compared by categories of number of seizures. As a 
continuous variable the median number of seizures, excluding those without 
seizures, was 2 (95% Cl 1-3) for definite cases and 1 (95% Cl 1-4) for probable 
cases. However, the difference in medians was not statistically significant. Fifty- 
three percent (n=31) of the definite cases attended follow-up compared to fifty 
percent (n=21) of probable cases. A similar proportion of definite (36%) and 
probable (42%) cases were reportedly given quinine in the 24 hours preceding 
admission. There was no difference between both groups in the proportion of cases 
who were hospitalised before this occasion.
The depth of coma was one of the distinguishing (and defining) features between 
definite cases and probable cases. As a result, 98% of the definite cases were not 
able to localise pain on admission. When the coma scales were used to determine
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depth of coma, the majority of definite cases scored lower than the probable cases**. 
The proportions of moderate to severe anaemia, jaundice and moderate to severe 
dehydration did not differ in both groups. The differences in the proportions with 
respiratory abnormalities, respiratory distress, extra heart sounds and organomegaly 
between groups were not different (features that could only be identified by a doctor 
and therefore are proxy measures of the presence of a clinician). Muscle tone 
changes occurred in 47% of probable cases and in 63% of definite cases. Changes in 
tendon reflexes were noted in 50% of definites compared to 47% of probables. Neck 
stiffness occurred fairly equally in both groups.
There was a significant difference in the number of witnessed seizures between 
groups. The majority of probable cases did not have seizures (69%), and of those 
who did, 19% had between 1 to 3 seizures and 12% had between 4 and 20 seizures. 
In contrast, 43% of the other group did not have seizures, with 40% having 1 to 3 
seizures and 17% having 4 to 20 seizures on the first day when their seizures 
commenced. Five definite cases and 1 probable case were given loading doses of 
quinine although the first dose of quinine, which includes the loading dose, was 
similar for both groups. Early-onset neurological sequelae were noted at the time of 
discharge in a greater proportion of definite cases (31%) than probable cases (19%).
Definite cases had a significantly higher mean body temperature than probable cases 
(38.4 °C [38.1-38.7] compared to 37.7 °C [95% Cl 37.4-38.1]). The respiratory rate 
differed significantly as well, with definite cases having a higher rate (43 breaths per 
minute [95% Cl 39-47]) than probable cases (32 breaths per minute [95% Cl 29- 
35]). The mean pulse rate in definite cases was 119 beats per minute (95% Cl 111- 
126). The same measurement was 103 beats per minute (95% C l 94-11) in probable 
cases. This difference produced a P value of 0.004. Mean haemoglobin 
concentration was similar in the two groups, 9.4 g/dL (95% Cl 8.7-10.) and 9.2 g/dL 
(95% Cl 8.-10.0) in definite and probable cases respectively. Probable cases had a 
greater parasite count, 21,374 parasites/pL (95% Cl 9,336-48,933), compared to 
definite cases, 13,277 parasites/pL (95% Cl 6,896-25,560), though the difference 
was not found to be statistically significant. The random glucose measured at Level
”  One case aged over 5 years was scored on the BCS instead of the GCS and was not included in 
these comparisons
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1 showed no difference between the two groups. The mean white blood cell count 
on the other hand differed between both. Definite cases had the greater mean white 
cell count than probable cases (P = 0.03).
4.7 Characteristics of cases according to study centre
The characteristics of cases were compared between study centres to determine if 
there are any differences between study centres in order to take them into 
consideration during subsequent analyses. Table 4.7 summarises the findings of the 
comparisons. O f the seventy cases seen at Mbale hospital, 42 (60%) were definite 
and 28 (40%) were probable cases. Thirty cases were seen at Kapchorwa hospital of 
whom 16 (53%) were definite and 14 (47%) were probable cases.
Seventy-seven percent (n=54) of cases at Mbale were aged less than 10 years 
whereas sixty percent (n=18) of cases at Kapchorwa were of the same age group. A 
greater proportion of cases seen at Kapchorwa were 10 years and older (i.e. adults), 
40% (n=12), compared to only 23% (n=16) in Mbale (P = 0.09). The median age is 
also significantly different between the two groups with Kapchorwa cases being 
older, 8 years (95% Cl 6-12), than Mbale cases, 4 years (95% Cl 3-6). The case 
fatality rate at Kapchorwa was higher, 13% (n=4), than Mbale, 9% (n=6). However, 
the proportion o f  cases known to have survived at Kapchorwa, 87% (n=26) was 
higher than at Mbale hospital, 80% (n=56) because it was not known if the 8 cases 
taken away by relatives survived or not. Assuming that they did survive, then 91% 
of Mbale cases survived. Seizures before admission were more frequently reported 
in Mbale (81%) than in Kapchorwa (63%, P = 0.01) with a greater proportion of 
cases admitted to Mbale (19%) having been previously admitted to hospital.
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Table 4.7 . Characteristics of cases by centre (N=100 cases)
Characteristics
n
Mbale
(n=70)
Percentage n
Kapchorwa
(n=30)
Percentage
P-
valuett
CATEGORICAL DATA 
Demographic & History information
Case definition Definite 42 60 16 53 0.65
Probable 28 40 14 47
Age group 1 <10 years 54 77 18 60 0.09
2  10 years 16 23 12 40
Age group 2 <5 years 41 59 5 17 <0.001
5-9 years 13 18 13 43
2 10 years 16 23 12 40
Gender Male 40 57 15 50 0.52
Female 30 43 15 50
Outcome Survived 56 80 26 87 0.15
Died 6 9 4 13
Taken away 8 11 0 0
Seizures within 24 hours before admission
None 13 19 11 37 0.01
1-3 28 40 15 50
4-20 29 41 4 13
Quinine given before admission 26 37 12 40 0.82
Previous medical admission 13 19 1 3 0.06
Clinical examination on admission
Symptoms at Level 1
Fever 61 87 26 87 1.00
Unconsciousness 50 71 16 53 0.11
Confusion/Unawareness 31 44 25 83 <0.001
Convulsions 54 77 21 70 0.46
Headache 30 43 25 83 <0.001
Vomiting 27 39 15 50 0.37
Loss of appetite 30 43 26 87 <0.001
Diarrhoea 8 11 4 13 0.74
Cough 29 41 10 33 0.50
Rigors and chills 12 17 21 70 <0.001
Signs at Level 2
Unable to localise painful stimuli 52 74 23 77 1.00
Blantyre coma score on admission (aged £5 yrs)
0-2 27 63 3 50 0.70
3-5 9 21 1 17
Not scored with BCS 7 16 2 33
Glasgow Coma score (aged >5 yrs)
3-8 13 48 6 25 0.004
9-12 6 22 16 67
13-15 5 19 0 0
Not scored on GCS 3 11 2 8
Moderate-severe anaemia 39 56 10 33 0.05
Jaundice 13 19 1 3 0.06
Moderate-severe dehydration 8 11 0 0 0.10
Pulse pressure 20-39 6 9 8 27 <0.001
40-79 7 10 10 33
Missing info 57 81 12 40
Shock 5 7 0 0 0.31
Table continued overleaf
sî From Fisher’s exact test
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T a b le  4 . 7  c o n t i n u e d
Characteristics Mbale Kapchorwa P-
(n=70) (n=30) value«
n Percentage n Percentage
Respiratory abnormality 37 53 5 17 0.001
Respiratory distress 5 7 0 0 0.31
Extra heart sounds 11 16 2 7 0.50
Organomegaly 24 34 11 37 0.82
Enlarged spleen 16 23 2 7 0.08
Enlarged liver 16 23 4 13 0.41
Muscle tone changes (n=90) 37 58 14 54 0.81
Changes in tendon reflexes (n=86) 30 47 14 54 0.64
Neck stiffness
In-hospital non-laboratory information
Seizures -  1sl episode
5 7 5 17 0.16
None 34 48 20 67 0.23
1 - 3  seizures 25 36 6 20
4 -2 0  seizures 11 16 4 13
Attended follow-up 28 40 24 80 <0.001
Quinine loading dose given on Day 0 7 10 0 0 0.06
Sequelae on discharge at Level 4 (n=90) 17 26 6 23 0.79
B. CONTINUOUS DATA 
Not normally distributed Median Median P-
(95% Cl) (95% Cl) value"
First dose of quinine given 32 10(10-11) 12 11 (10-12) 0.95
Age on admission (months) 70 48 (36-68.7) 30 96 (72- 0.001
142.5)
No. of witnessed seizures -  1sl episode (n=46) 36 2 (2-3) 10 1 (1-4) 0.39
Seizure stoppage time (n=44 survivors) 34 1 (1-2) 10 1.5 (1-2) 0.79
Total seizure stoppage time (n=70 survivors) 49 2 (2-3) 21 2(1-3) 0.29
Fever clearance time (n=78 survivors) 53 3(2-4) 25 2(1-3) 0.04
Total fever clearance time (n=82 survivors) 56 5 (4-6) 26 5 (3-6) 0.36
Coma recovery time (n=67 survivors) 44 3(3-4) 23 2(2-4) 0.95
Total coma recovery time (n=78 survivors) 54 4(3-5) 24 3(2-5) 0.73
Normally distributed Mean (95% Mean (95% P-
Cl) Cl) valuettt
Temperature (°C) 70 38.1 (37.8- 30 38.1 (37.7- 0.81
38.4) 38.6)
Respiratory rate (breaths/minute) 70 40 (37-43) 30 35 (30-40) 0.11
Pulse rate (beats/minute) 70 113(106- 30 110(100- 0.63
120) 119)
Systolic blood pressure (mmHg, n=31) 13 103 (96- 18 108(101- 0.30
109) 115)
Diastolic blood pressure (mmHg, n=31) 13 66 (61-71) 18 63(56-69) 0.53
Haemoglobin concentration (g/dL, n=68) 47 9 4 (8.8- 21 9.2 (8.2- 0.66
10.1) 10.1)
Parasite count (parasites/pL, n=85) 58 12,683 27 26,215 0.16
Geometric mean (6,836- (10,581-
23,531) 64,956)
Random blood glucose (mmol/L, n=70) 49 6.2 (5 5-7.0) 21 4 9 (4.0-5.8) 0.03
Geometric mean
White blood cell count (cells/L, n=76) 51 6,056 25 6,028 0.80
Geometric mean (5,326- (5,043-
6,886) 7,206)
^ From Fisher’s exact test 
From Mann Whitney test
,ft From Student t-test except if the geometric mean was calculated in which case the Mann Whitney 
test was used
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As expected, fever was the commonest symptom that was reported. It was recorded 
in the histories of 87% of cases at both Mbale and Kapchorwa hospitals (n= 61 & 26 
respectively). Loss of consciousness preceding admission occurred in 50 cases 
(71%) at Mbale and 16 cases (53%) at Kapchorwa. Confusion was significantly 
more frequent in cases seen in Kapchorwa (83%) compared to Mbale (44%). 
Headache (83%) and loss of appetite (87%) were more commonly reported in 
Kapchorwa hospital than Mbale hospital (43% for each symptom). Vomiting and 
diarrhoea were as frequent in Mbale cases (39% and 11% respectively) as those in 
Kapchorwa (50% and 13% respectively). Twenty-nine Mbale cases (41%) and ten 
Kapchorwa cases (33%) had a cough. Rigors and chills were noted in 70% (n=21) of 
cases at Kapchorwa compared to only 17% (n=12) o f those at Mbale (P < 0.001).
Although the proportions o f cases at both centres that could not localise painful 
stimuli did not differ, there was a difference in the proportions with low scores on 
the GCS but not the BCS. A greater proportion o f those managed at Mbale, 48% 
(n=13), scored 3-8 on the GCS compared to only 25% (n=6) at Kapchorwa whereas 
50% (n=3) of Kapchorwa cases scored 2 or less on the BCS compared to 63% 
(n=27) in Mbale. Anaemia (56%, P = 0.05) and jaundice (19%, P = 0.06) were more 
common in Mbale. The mean pulse rate was higher in Mbale (113 beats/min [95% 
Cl 106-120]) than in Kapchorwa (110 beats per min [95% Cl 100-119]) although 
this difference was not significant. Likewise the mean respiratory rate was higher in 
Mbale than Kapchorwa. A low pulse pressure (20-39 mmHg) occurred in 27% of 
Kapchorwa cases and 9% o f  Mbale cases. Most cases from Mbale, many of whom 
were children (41 cases aged 1-4 years and 13 cases aged 5-9 years), did not have 
measurements for blood pressure resulting in 57 cases (81%) with missing 
information on pulse pressure. Blood pressure cuffs that were not appropriate for 
very young children had been mistakenly ordered and it was impossible to get the 
right-sized ones despite several attempts. Shock and respiratory distress did not vary 
much between centres. However, 37 cases (53%) were noted to have one respiratory 
abnormality or the other in Mbale and only 5 cases (17%) in Kapchorwa (P = 
0 001). There was a notable difference in the spleen size, with more cases in Mbale, 
16 cases (23%), having enlarged spleens compared to Kapchorwa, 2 cases (7%).
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Comparing the numbers of witnessed seizures showed no significant differences 
whether the number of witnessed seizures were categorised or left as continuous 
data. The proportion of survivors who were followed-up was 80% (n=24) in 
Kapchorwa and only 40% (n=28) in Mbale. None of the patients in Kapchorwa 
received loading doses of quinine on Day 0 whereas five cases in Mbale did (P value 
was not statistically significant). The proportion of early-onset sequelae (i.e. at time 
of discharge) did not vary between centres.
Changes in musculo-skeletal tone and reflexes were not different in patients at both 
centres. 5 Mbale cases (7%) and 5 Kapchorwa cases (17%) had complained of neck 
stiffness. 77% of cases (n=23) at Kapchorwa in unrousable coma at Level 2 
compared to 74% of cases (n=52) at Mbale. Thirty-six Mbale cases had seizures 
(median = 2 [95% Cl 2-3]) and ten Kapchorwa cases (median = 1 [95% Cl 1-4]). On 
average Mbale cases took longer to clear their fevers, median of 3 days (95% Cl 2- 
3), compared to 2 days (95% Cl 1-3) in Kapchorwa, a difference which did not 
persist when the number of days reported with a fever before admission were added. 
The mean haemoglobin concentrations and parasite counts varied little between both 
groups. The mean Hb concentration was higher in Mbale than Kapchorwa (9.4 g/dL 
compared to 9.2 g/dL) but the mean parasite count in Mbale was lower than in 
Kapchorwa (12,683 parasites/pL compared to 26,215 parasites/pL). However both 
differences did not reach statistical significance. The random blood glucose was 
much higher in Mbale with a mean of 6.2 mmol/L than Kapchorwa where the mean 
was 4.9 mmol/L (P = 0.03).
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4.8 Characteristics of cases by age group.
The major objectives of the study were to examine some of the age-related 
differences in the presentation and complications of cerebral malaria. A priori it was 
decided to use age as two categories, those between 1 year and 10 years (referred to 
as children), and those aged 10 years and above (referred to as 'adults’ since after 
this age they should have clinical immunity to severe forms of malaria). An 
alternative was to group age on admission into three categories, namely 1 to 4 years 
(referred to as younger children), 5 to 9 years (referred to as older children), and 10 
years and above. This second grouping o f age was used when it was necessary to 
understand better what was happening within the ‘children’ category. Descriptive 
comparisons between children and adults were performed to identify any differences 
and elucidate factors that could influence the associations between age and 
outcomes. The results of comparisons are tabulated in Table 4.8.
Seventy-two cases were children and twenty-eight adults at the time o f admission. 
The majority of those aged less than 10 years were definite cases whereas those in 
the older age group were equally distributed i.e. 50% definite and 50% probable. 
The male to female ratio amongst the younger group was 1:1 and in the older group 
it was 2.1:1. A greater proportion of adult cases survived (89%, n=25) compared to 
children (79%, n=57). The case fatality rate was 11% (n=8) in the children and 7% 
(n=2) in adults. Seven children were taken away from hospital prematurely. This 
contrasts with only one adult case. A greater proportion of children, 75% (n=54) 
were managed at Mbale hospital compared to 57% (n=16) of the adults. Only 25% 
(n= 18) of the younger cases were managed at Kapchorwa and a greater proportion, 
43% (n=12) of the older cases.
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Table 4.8: Characteristics of cases by age group (N=100 cases)
Characteristics
CATEGORICAL DATA 
Demographic & History
Case definition Definite
Probable
Gender Male
Female
Outcome Survived
Died
Taken away
Centre Mbale
Kapchorwa
Seizures with 24 hours before admission 
None 
1-3 
4-20
Quinine given before admission 
Previous medical admission 
Clinical examination on admission 
Symptoms at Level 1
Fever
Unconsciousness
Confusion/Unawareness
Convulsions
Headache
Vomiting
Loss of appetite
Diarrhoea
Cough
Rigors and chills
Signs at Level 2
Unable to localise painful stimuli
Blantyre coma score on admission (aged s5yrs)
0-2
3-5
Not scored with BCS 
Glasgow Coma score (aged >5yrs)
3-8
9-12
13-15
Not scored on GCS
Moderate-severe anaemia 
Jaundice
Moderate-severe dehydration 
Pulse pressure 20-39
40-79 
Missing info
Shock_______________________________________
Table continued overleaf •*
n
<10 years 
(n=72) 
Percentage n
i  10 years 
(n=28) 
Percentage
P-
valuetu
44 61 14 50 0.37
28 39 14 50
36 50 19 68 0.12
36 50 9 32
57 79 25 89 0.57
8 11 2 7
7 10 1 4
54 75 16 57 0.09
18 25 12 43
15 21 9 32 0.11
29 40 14 50
28 39 5 18
26 36 12 43 0.64
11 15 3 11 0.75
60 83 27 96 0.10
49 68 17 61 0.49
34 47 22 79 0.01
55 76 20 71 0.61
31 43 24 86 <0.001
28 39 14 50 0.37
35 49 21 75 0.02
9 13 3 11 1.00
34 47 5 18 0.01
18 25 15 54 0.01
58 81 17 61 0.07
30 61 . . .
10 21 - -
9 9 • -
11 48 8 29 0.03
8 35 14 50
0 0 5 18
4 17 1 3
41 57 8 29 0.01
13 18 1 4 0.10
5 7 3 11 0.68
6 8 8 29 <0.001
4 6 13 46
62 86 7 25
3 4 2 7 0.61
•** From Fischer’s exact test
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T a b le  4 . 8  co n t in u e d
Characteristics < 10 years £10 years P-
(n=72) (n=28) values«
n Percentage n Percentage
Respiratory abnormality 39 54 3 11 <0.001
Respiratory distress 5 7 0 0 0.31
Extra heart sounds 11 15 2 7 0.04
Organomegaly 27 38 8 29 0.48
Enlarged spleen 16 22 2 7 0.09
Enlarged liver 17 24 3 11 0.17
Muscle tone changes (n=90) 40 63 11 41 0.06
Changes in tendon reflexes (n=86) 32 51 12 44 0.64
Neck stiffness 5 7 5 18 0.13
In-hospital non-laboratory information
Seizures-1sl episode
None 38 53 16 57 0.39
1-3 seizures 21 29 10 36
4-20 seizures 13 18 2 7
Attended Follow-up 38 53 14 50 0.82
Quinine loading dose given on Day 0 6 8 1 4 0.78
Sequelae on discharge at Level 4 (n=90) 17 24 6 21 0.83
Not normally distributed Median (95% Median (95% P-
Cl) Cl) value”
First dose of quinine given 32 10(10-11) 12 11(9-14) 0.64
No. of witnessed seizures -  1sl episode (n=46) 34 3(2-4) 12 1 (1-1) 0.005
Seizure stoppage time (n=44 survivors) 32 2(1-2) 12 1 (1-3) 0.48
Total seizure stoppage time (n=70 survivors) 49 2 (2-3) 21 2(1-4) 0.66
Fever clearance time (n=78 survivors) 55 3 (2-3) 23 2(1-3) 0.03
Total fever clearance time (82 survivors) 57 5(4-6) 25 5(4-6) 0.87
Coma recovery time (n=67 survivors) 45 3(2-4) 22 3(3-4) 0.54
Total coma recovery time (n=78 survivors) 54 4(3-4) 24 4(3-5) 0.31
Measurements taken on admission Mean (95% Mean (95% P-
Cl) Cl) valuetttt
Temperature (°C) 72 38.2 (38-38.4) 28 38 (37-38.5) 0.45
Respiratory rate (breaths/minute) 72 43 (40-46) 28 27 (24-29) <0.001
Pulse rate (beats/minute) 72 116(110-123) 28 101 (90-111) 0.01
Systolic blood pressure (mmHg, n=31) 10 107 (97-117) 21 105(100-111) 0.79
Diastolic blood pressure (mmHg, n=31) 10 66 (57-75) 21 64 (59-68) 0.53
Haemoglobin concentration (g/dL, n=68) 48 9.0 (8.3-96) 20 10.3 (9.6- 0.02
11.0)
Parasite count (parasites/pL, n=85) 61 16,936 24 13,764 0.61
Geometric mean (9,136- (5,416-
31,397) 34,979)
Random blood glucose (mmol/L, n=70) 49 5.5 (47-6.4) 21 5.9 (5.2-67) 0.91
Geometric mean
White blood cell count (cells/L, n=76) 53 6,583 (5,813- 23 4,970 (4,231- 0.01
Geometric mean 7,456) 5,838)
### From Fisher’s exact test 
From Mann Whitney test
,m  From Student t-test except if the geometric mean was calculated in which case the Mann Whitney 
test was used
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Of the ten symptoms asked for at Level 1, confusion (79%, n=22), headache (86%, 
n=24), loss of appetite (75%, n=21), and rigors and chills (54%, n=15) were more 
frequently reported by relatives o f cases in the older group. Cough (47%, n=34) was 
more frequently reported in the younger group. Fever, unconsciousness, 
convulsions, vomiting, and diarrhoea did not differ between groups. Of those who 
could not localise painful stimuli the greater proportion were in the younger age 
group 81%, compared to 61% in the older group (P = 0.07). Most of those in the 
younger age group were scored using the BCS and the GCS was used for the older 
children over 5 years. Moderate to severe anaemia was more common in the under 
tens (57%) compared to those ten years and above (29%). When the age grouping 
with three categories was used, it showed that anaemia (determined by clinical 
examination or laboratory tests) was more frequent in those aged between 1 and 4 
years (66%), than in those aged 5 to 9 years (18%) and those aged 10 years and 
above (16%). This was reflected in the value of the mean haemoglobin concentration 
which was significantly higher in the older group, 10.3 g/dL [95% Cl 9.6-11], 
compared to the younger one, 8.9 g/dL [95% Cl 8.2-9.6], Jaundice did not however 
show this distribution, nor did dehydration.
The vital signs measured showed some differences between groups. Mean 
temperature did not differ (38.2 °C versus 38 °C), however in children, the mean 
respiratory rate, 44 breaths/minute (95% Cl 41-47), and pulse rate, 117 beats/minute 
(95% Cl 110-124) were higher than in adults, 27 breaths/min (95% Cl 24-30) and 
102 beats/min (95% Cl 91-112) respectively, differences that are physiological. 
Many cases had missing values for blood pressure but of those measured both age 
groups had similar mean systolic and diastolic pressures. A greater proportion of 
cases in the older age group had lower pulse pressures. Respiratory abnormalities 
and extra heart sounds were more frequently found in children. Thirty-nine cases 
(54%) below 10 years had respiratory abnormalities and eleven cases (15%) had 
extra heart sounds detected. Respiratory distress was not found in any of the older 
children whereas shock was as frequent in both age groups. Twenty-two percent 
(n=16) of children had an enlarged spleen compared to two adult cases (7%).
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Changes in musculo-skeletal tone were more frequently noted in younger (63%) 
cases than older ones (41%). However the same was not true of changes in their 
tendon reflexes which were noted fairly equally. Five cases (7%) in the younger 
group and five (18%) in the older group had neck stiffness on admission. Eight-one 
percent (n=58) of cases aged less than ten were in unrousable coma on admission 
compared to sixty-one percent (n=17) of cases aged ten and above. Younger cases 
had on average 3 seizures (95% Cl 2-4) compared to older cases who on average had 
1 seizure. Follow-up was attended by 38 cases, i.e. 53% of the younger group, and 
14 cases, i.e. 50% o f the older group. Around time of discharge, 24% of those less 
than 10 and 21% of those in the other group still had one neurological deficit or the 
other.
Children took on average 3 days to clear their fevers, a longer clearance time than 
the adult cases who took on average 1 and a half days (P = 0.02). The total fever 
clearance time however was 5 days in both age groups. The coma recovery time and 
seizure stoppage time were not very different between both groups. Likewise the 
mean parasite count and random blood glucose did not differ between groups. 
Younger cases had a larger mean white blood cell count than older cases (P = 0.01).
4.9 Summary of the differences of the characteristics of cases between case 
definition, study centre and age group.
The comparisons made thus far show much similarity of cases when categorised 
according to case definition, centre and age group. Some factors however were 
different between groups and as a result can modify the degree of associations 
between case definition, or study centre or age on the outcomes. Table 4.9 
summarises the factors that differed within any group and gives the findings of 
comparisons in the other groups as well. These differences are taken into account in 
the analytical analyses in the next chapter.
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Table 4.9: Statistical significance of effects of age group, centre, and differences between 
definite and probable cases.
Difference of comparison group
Variable Case Centre Age group
definition
Age on admission 0 ++ NA
Gender 0 0 +
Outcome 4 4 0 0
Study centre 0 NA ■4
Seizures prior to admission + 4 4 +
Previous medical admission 
History of
0 4 0
Fever 0 0 4-
Unconsciousness 0 4 0
Confusion/Unawareness ♦ 4 4 4- 4-
Headache 0 4 4 4- +
Convulsions 4 0 0
Vomiting + 0 0
Loss of appetite 0 4 4 ++
Cough 0 0 4- +
Rigors and chills 0 4 4 4- 4-
Unable to localise painful stimuli 
Depth of coma among cases aged
++ 0 4-
5 years and below ++ 0 NA
Over 5 years 4 4 4 4 4- 4-
Presence of moderate to severe anemia 0 0 4- 4-
Presence of jaundice 0 0 4 -
Pulse pressure + 4 4 4- 4-
Presence of any respiratory abnormality 0 4 4 4- 4-
Presence of any extra heart sounds 0 0 4- 4-
Presence of organomegaly (enlarged spleen and liver) 4 0 0
Presence of enlarged spleen 0 4 4-
Presence of muscle tone changes 0 0 4 -
Presence of neck stiffness 0 0 4-
Attended follow-up 0 4 4 0
Quinine loading dose given on Day 0 + 4 0
Median number of witnessed seizures -  first episode 4 4 0 4-4
Median fever clearance time 0 4 4 4 4
Mean body temperature 4 4 0 0
Mean respiratory rate 4 4 4 4 4
Mean pulse rate 4 4 0 4 4
Mean haemoglobin concentration 0 0 4 4
Mean random blood glucose concentration 0 4 4 0
Mean white blood cell count 4 4 0 4 4
Key
++ = statistically significant difference with p £0.05 
+ = borderline difference with p >0.05 £ 0.1 
0 = no difference with p>0.1 
NA = not applicable
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4.10 Description of the three study outcomes
The three neurological outcomes of interest namely mortality, early-onset sequelae 
and late-onset sequelae are described in detail in the following subsections
4.10.1 Mortalit}'
Eighty-two cases are known to have survived and were discharged Ten definitely 
died and eight cases were taken away from the ward by relatives before the 
completion of treatment However one such case is known to have survived because 
the patient later returned to the hospital for follow-up The pie chart in Figure 4 6 
illustrates the frequency of the outcome of management
Unknown
8%
Figure 4.6: Pie chart illustrating the proportion of cerebral malaria cases who survived, died or 
whose outcome of management was unknown
The overall case fatality rate was 10% (if the 7 cases with unknown outcome are 
removed from the denominator the CFR is 11%) Post-mortems were not performed 
on cases that died because there were no facilities to do so It was therefore not 
possible to determine the causes of death
138
Two cases died within a few hours of admission to the ward (case 1026 aged 10 
years and case 1050, aged 2'A years). Since they did not spend a day their duration 
of stay was coded as 0.3. Table 4.10 below shows the survivor functions by length 
of stay up to 8 days. As can be seen, the predicted probability of survival decreases 
from 1 to 0.98 on Day 0 to 0.92 on Day 2. It remains constant thereafter to Day 48 
which was the longest duration of stay.
Table 4.10: Duration of stay and the survivor function of study cases up to Day 8
Duration of 
stay (days)
Number of 
cases in study
Died Lost Survivor
function
Standard
Error
0.3«« 100 2 0 0.98 0.01
1 98 5 1 0.93 0.03
2 92 3 0 0.90 0.03
3 89 0 4 0.90 0.03
4 85 0 4 0.90 0.03
5 81 0 17 0.90 0.03
6 64 0 18 0.90 0.03
7 46 0 21 0.90 0.03
8 25 0 11 0.90 0.03
Figure 4.7 provides a further illustration of the predicted probability o f survival in 
the form of a Kaplan-Meier graph. Each orange tick on the horizontal part of the 
step represents the number of censored patients on that day. Analysis time is the 
duration of inpatient stay for individual patients and is not constant. The longest 
duration of analysis time was 48 days but is not shown in the Figure. After Day 2, 
the survival function did not change. It is therefore plausible that those cases that 
were prematurely taken away by relatives stood a greater chance of surviving since 
all except one case, spent the first crucial 72 hours as inpatients (range 1-12 days). 
The one case (case number 1043) who was lost on Day 1, was 4 years old, was 
classified as a probable case (scored 3 on the BCS on admission), and was showing 
some signs of improvement before being taken away. As a result of these 
observations, mortality was considered within the first 72 hours as this was the 
maximum period during which mortality occurred and deaths could be verified. 
Even though there was no way of verifying the outcome of treatment in the eight 
cases who were prematurely taken away, it was assumed that since they spent the 
most crucial period of treatment on the ward and that they had began treatment, they 
were likely to have survived that episode of illness. And so, in subsequent analyses,
:::! Only used as a code and has no statistical importance
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mortality refers to deaths within 72 hours on the ward and cases taken away 
prematurely were considered most likely to have survived
Figure 4.7: The estimated probability of survival (as Kaplan-Meier survival estimate) on Day 0 
of treatment until Dav 15
The estimated probability of survival by study centre (Figure 4 8) and age group 
(Figures 4 9) are illustrated in the graphs Each tick mark on the horizontal part of 
the steps represents a censored patient The numbers could not be represented clearly 
without congesting the graph Figure 4 8 shows the survival curves for both 
hospitals and those for the three age groups in Figure 4 9
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Figure 4.8: The estimated probability of survival las Kaolan-Meier survival estimate) in 100 
cases o f cerebral malaria admitted to Mbale and Kaochorwa hospitals beginning on Day 0 of 
treatment until Day 15
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Figure 4 9: The estimated probability of survival (as Kaolan-Meier survival estimate) in 10Q 
cases o f cerebral malaria aged 1 to 4 years. 5  to  9  years, and 10 years and above, on Day.Q 
of treatment until Dav 15
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4.10.2 Early-onsel neurological sequelae
Survivors were examined for neurological deficits of the motor-sensory kind at 
discharge. Twenty-three cases were found to have deficits (17 from Mbale and 6 
from Kapchorwa hospitals). They had a median age of 72 months (95% Cl 41-105) 
and a median between admission and detection of sequelae was 8 days (95% Cl 6- 
9). Deficits occurred either singly (3 cases, 13%) or in combinations (20 cases, 87%) 
as shown in Table 4.11. The most common type of early-onset deficit was an 
abnormality of tone in the limbs (18 cases). Case number 2040 (a 6 years old child 
who spent 11 days on the ward) had seven types of deficits, the highest number 
recorded in combination. Case number 1055 (a 6 year old child who spent 48 days 
on the ward) had the next frequent number of deficits in one patient. By tying the 
deficits to form clinical pictures, the following neurological entities can be described 
(ranked in order of frequency):
• Generalised flaccidity of the limbs (cases 1067, 1340, 1118. 2040, 2090)
• Generalised spasticity of limbs (cases 1022, 1055, 1127)
• Paraparesis (cases 1126, 1137)
• Generalised hypotonia (case 1135, 1340)
• Weakness o f upper limbs (case 2008)
• Hyperreflexia in one limb (cases 2019)
• Hypertonia in one limb (case 1108)
• Spastic hemiparaesis (case 1138)
• Hypertonia of the upper limbs (case 1105)
• Hypotonia o f the lower limbs (case 2029)
• Monoparaesis in upper limb (case 1143)
• Monoparaesis in lower limb (case 2012)
• Cerebellar ataxia (case 1142)
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Table 4.11: List of the twenty-three cases who had neurological deficits at discharge showing 
the types of deficits present.
Type of neurological deficit at discharge»«
Case
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Aged 1 -4 years on admission
1022 X X X X X 5
1108 X X X X X 5
1129 X X 2
1135 X X X 3
1137 X X X 3
1138 X X X X X 5
1142 X 1
1340 X X X X X 5
Aged 5-9 years on admission
1055 X X X X X X 6
1105 X X 2
1106 X 1
1118 X X X X X —
5
1126 X X X 3
2008 X X X 3
2012 X X X X X 5
2029 X X 2
2040 X X X X X X X 7
Aged > 10 years on admission
1067 X X X 3
1079 X 1
1127 X X X X 4
1143 X X X 3
2019 X X 2
2090 X X X X X 5
TOTAL 18 14 12 8 8 12 1 2 1 1 3 1
X signifies that the deficit was identified. A blank space means that the deficit was either absent 
or in a few cases that the deficit was not sought.
...... ID  numbers beginning with ‘ 1 ’ are from Mbale hospital while those beginning with ‘ 2 ’ are from
Kapchorwa hospital
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Abnormalities of gait were observed in 12 patients. The patient with cerebellar 
ataxia (who was 4 years and spent 5 days) had an ataxic gait whereas two patients 
cases 1108 (2 years old and spent 7 days) and 1340 (16 months old and spent 10 
days) were not able to walk at all. Case 2012 who was 8 years old (spent 11 days), 
had a weak right leg and had a limping gait. The eight other cases with gait 
abnormalities were able to walk but showed signs of weakness of their lower limbs. 
Two cases were not able to follow an object shown in front of them (a sign of visual 
impairment) but were not blind (cases 1055 and 1106, the latter was 6 years old and 
was on the ward for 5 days). Only one case, case number 1022, was blind at 
discharge. Case 1022 (16 months old and stayed 7 days), also appeared to have 
problems with hearing (the 8lh cranial nerve tested with the distraction test). Cases 
1079 aged 16 years old (no recorded information on duration of stay), and 1138 
aged 3 years old (stayed 8 days), had facial nerve palsies (7lh cranial nerve) on the 
left and right sides respectively. Both palsies were of the upper motor neurone type. 
Case 2040 had weakness on the left side when asked to turn the head or shrug the 
shoulders against resistance, i.e. a deficit of the 11th cranial nerve.
In analytical analyses, the types of deficits or the severity of deficits could not be 
taken into consideration because of the small sample size and the few number of 
cases with early-onset sequelae.
4.10.3 Late-onset neurological sequelae
Follow-up visits were conducted at the study hospitals by the Principal Investigator 
at Kapchorwa hospital and the senior consultant paediatrician at Mbale hospital. 
During each visit a full clinical and neurological examination was conducted under 
the conditions specified in the methodology. Although the target was to assess for 
sequelae at 4 weeks, 8 weeks and 12 weeks after discharge, the duration between 
discharge and follow-up visits varied greatly. The median duration between 
discharge and the first visit in the 53 cases that attended was 4.7 weeks (range 2 
days to 31.3 weeks) whereas the median duration between discharge and the second 
visit in 37 cases who returned was 9.4 weeks (range 5 to 39.4 weeks). This meant 
that the median duration between the first and second visits was 5 weeks (range 2.4 
to 25 weeks). Six cases were assessed a third time and the median duration between 
discharge and visit was 19 weeks (range 14 to 36.4 weeks). The durations were
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examined to determine if they were associated with the study centre, age grouping 
and case definitions. The median duration between the first visit was not associated 
with study centre (P = 0.9), age in two categories (P = 0.3), age in three categories 
(P = 0.6), and case definition (P = 0.7). The median duration between the second 
visit was not associated with age as two categories (P =0.1), age as three categories 
(P = 0.2) and case definition (P = 0.2) but had some association with study centre, (P 
= 0.07). The median was 9 weeks in Mbale (n=18) and 15 weeks in Kapchorwa 
(n=19).
Table 4.12 below summarises the findings of the examinations of 10 cases that had 
neurological features suggestive of sequelae (i.e. 19% of cases that attended the first 
visit or 11% who survived). Five cases seen at Mbale hospital (17% of those who 
attended first visit; or 8% of those who survived) and five cases seen at Kapchorwa 
(21% of those who attended first visit; or 19% of those who survived) during follow­
up were noted to have one kind of deficit or the other. The median age of the ten 
cases with late-onset deficits was 1'A years (range 1 'A to 13 years). As described in 
the table the features of the sequelae varied in severity, character and timing.
Case 1029 (classified as a definite case), had mild weakness in all limbs that was not 
incapacitating. By the second visit, six weeks later, no deficits were detectable by 
clinical examination. The examining doctor did not detect any deficits in Case 1040 
(a probable case) on the first visit. Five weeks later, the subject had developed 
repeated generalised seizures. Incapacitating sequelae were detected in Case 1055 (a 
definite case). These deficits had developed during the episode of cerebral malaria 
and by the first and second visits (2 and 7 weeks later respectively) there was no 
improvement. Case 1138 (a definite case) also had incapacitating complications 
which developed with cerebral malaria and had not recovered five weeks after 
discharge. Case 1143 (a definite case) had one episode of noctambulation that had 
not occurred before.
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Table 4.12: A description of the findings of the neurological assessments often cases who had tate-onset' neurological sequelae and the duration between their 
discharge date and follow up visit.
Case
Number
Age' Duration between 
discharge and visit 
(weeks)
Findings
1a 2™1
Aged 1-4 years on admission
1040 1 year 6 
months
6 1st visit on 17/4/02 Complaints of cough noted.
11 2™“ visit on 15/5/02. Complaints of an eye discharge and 3 convulsions noted. Description matched that for generalised convulsions.
1138 3 years 5 
months
1
5
1st visit on 25/9/02. Not able to speak. Had right-sided hemiplegia. Power reportedly recovering from immediate post-admission levels. 
Right eye was deviated to the left and had right-sided facial nerve palsy.
2™“ visit on 23/10/02. Still not able to speak. Had right-sided weakness of the limbs. Still had leftward deviation of right eye and facial 
nerve palsy.
Aged 5-9 years on admission
1055 6 years 4 
months
2 1st visit on 3/7/02 Reportedly less attentive than prior to illness. Was having on average one convulsion per week since discharge. 
Description matched that of generalised convulsions. Reportedly not able to speak and hear as well as before. Could not walk and was 
not able to perform the finger-nose test. Neurological examination could not be conducted property because the subject was inattentive 
and not cooperative.
7 2™“ visit on 7/8/02. Was still having convulsions although their frequency had reduced. Not able to talk and reportedly did not hear 
properly. Had rotatory nystaqmus. Was not able to carry instructions for the neurological examination.
1029 7 years 5 1“  visit on 17/4/02. Reduced power detectable in all limbs but more in left arm.
11 2nd visit on 29/5/02. Power noted to be normal in all limbs.
2040 7 years 1 1a visit on 16/1/03. Reported not to be able to stand upright and not able to dress up without help. Had headaches on and off and got 
tired easily. Had left-sided hemiplegic gait Had a right-sided squint (which developed on the 3rd day as an inpatient) and left-sided 
facial nerve palsy. Had left-sided hemiparaesis. A pan-systolic murmur was detectable*.
8 2nd visit on 6/3/03. No squint visible. Strength in the left leg had improved and was equal to the right leg Complained of left-sided chest 
pain. Had a pan-systolic murmur. Chest X-ray showed an enlarged heart.
Table continued ove rle a f
’ Age on the first follow-up visit 
’  Child with a cardiac lesion
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Table 4 .1 2  continued
Case
Number
Age* Duration between 
discharge and visit 
(weeks)
Findings
1« 2nd
2011 7 years 4 
months
29 1st visit on 28/11/02. Reportedly had general weakness that had not improved since illness. Experienced one restless night. Power was 
noted to be normal.
36 2™* visit on 16/1/03. Reportedly had more strength but still weaker than state before bout of cerebral malaria. Power was noted to be 
normal in all limbs.
Aged > 10 years on admission
1143 11 years 
6 months
4 1st visit on 6/11/02. Complaints of cough. Had dizziness after recovering from cerebral malaria which improved over time and is no 
longer there.
9 2"d visit on 11/12/02. Had began to wake up at night and walk about (I.e. sleep walk)
2020 12 years 21 1s1 visit on 30/11/02. Reportedly not able to remember events/people/things as well as prior to illness. Was less attentive when spoken 
too and did not carry out instructions given as well as prior to illness. Had headaches on and off.
28 2nd visit on 17/1/03. No improvement in memory or ability to follow instructions No longer had headaches
2090 12 years 4 1st visit on 6/2/03. Reported not able to remember events/people/things as well as prior to illness of cerebral malaria. Had headaches 
on and off. Also noted to be less attentive when spoken to. Walked with a stagger and was abnormal for the heel-to-toe test. But no 
other signs of cerebellar ataxia
19 2"d visit on 16/5/03 Reported less forgetful although memory had not completed recovered to pre-illness capacity. Headaches were 
redudnq in frequency and intensity Was walking normally and was able to do the heel-to-toe test properly.
2025 14 years 
7 months
23 1st visit on 28/11/02. Reportedly not able to remember events/people/things as well as prior to illness. Was more emotionally labile 
than before. Had headaches on and off.
30 2nd visit on 16/1/03. Was less forgetful. Headaches had reduced in frequency and intensity
Age on the first follow-up visit
The cases examined at Kapchorwa showed a similar pattern to those seen at Mbale. 
Case 2011 (a probable case) reportedly had general body weakness suggestive of 
reduced muscle strength that had improved by the first visit (29 weeks later). There 
was a history of an episode of hallucinations at night but no other relevant complaint 
by the second visit (7 weeks after the first visit). Memory dysfunction was reported 
in Case 2020 (a definite case) by the first visit (21 weeks later). Loss of 
concentration, a cognitive function, was also a complaint. Both functions had not 
improved by the second visit, 7 weeks later. On the first review, Case 2025 (a 
probable case) had reported memory impairment with a tendency to become very 
emotional. Thirty weeks after discharge there was improvement in memory and was 
having fewer headaches. Case 2040 (a definite case) had incapacitating 
complications that began during disease and were still present at the first and second 
visits, although some improvement in muscle strength had occurred by the second 
visit. The subject had a concomitant cardiac lesion. Case 2090 (a probable case) 
reportedly had memory and concentration loss since illness. The subject had 
weakness of the lower limbs which had recovered by the second visit. Memory 
function has also improved but not fully recovered.
Some cases with detectable late-onset deficits were detected to have early-onset 
deficits as well suggesting that the term Mate-onset’ sequelae as defined a priori is 
inappropriate. Four cases who had deficits by the first visit also had deficits on 
discharge (cases 1055, 1138, 2040, and 2090) and one case who had early deficits 
did not have deficits at the first visit (case 1143). By the second visit the one case 
who had early deficits but none at the first visit (case 1143) developed late deficits. 
Four cases who did not have detectable deficits at discharge went on to develop 
deficits by the first visit (cases 1029, 2011, 2020, and 2025). One case, who did not 
have deficits at discharge and at the first visit had developed deficits by the second 
visit (case 1040). Clinical examination at discharge detected early-onset deficits and 
was 50% sensitive enough to identify cases that had deficits at the first visit 
(specificity of 50%, positive predictive value of 80% and negative predictive value 
of 20%).
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Audiometry was performed in 50 cases during follow-up on the first visit. One case 
(case 1055) was found to have hearing deficits in both ears. None of the cases 
(n=51) whose visual acuity was tested showed any visual impairment. Case 1022 
who was blind on admission had improved by the first follow-up visit about 5 weeks 
later. Case 1055 who had visual impairment at discharge improved by the first visit 
about 2 weeks later. The other case with visual impairment, case 1106, did not 
attend follow-up. No case had any identifiable abnormalities on fundoscopy either 
during follow-up.
Thus far the 'late-onsef sequelae that have been described are mostly of the motor- 
sensory kind. The findings o f  cognitive assessment are given separately because 
their identification involved a separate process as documented in the methodology.
4.10.4 C ogn itive sequelae d e te rm in e d  w ith  the co g n itive  to o l f o r  ch ildren
One version of the cognitive tool was used to assess children that attended follow up 
visits. Twenty-four children did the language and verbal comprehension sections 
(LGVC) and nineteen children did the memory sections (MEM). Their average 
scores on both visits are tabulated in Table 4.13. *
Table 4.13: The median scores obtained during follow-up in children who were assessed for 
cognitive function
Instruction Median (variance)
First visit Second visit
LGVCT(n=24) 6(1.5) 6(1.5)
LGVC2 6(1.5) 6(1.6)
LGVC3 6(1.5) 6 (3.0)
LGVC4 6(3.1) 6(1.6)
LGVCtotalt 24 (25.0) 24 (25.8)
MEM1> (n=19) 5(2.1) 5(3.1)
MEM2 3(13) 3 (0.6)
MEMtotal§ 8 (5.5) 8(5.1)
’ l anguage and verbal comprehension instruction number I and so on. 
' Sum of the four LGVC scores.
♦ Memory lest instruction number 2 and so on
* Sum of the two memory scores
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The median scores did not vary between visits. Some of the individual instructions 
had narrow distributions (small variance) among the children whereas others such as 
language and verbal comprehension 3, language and verbal comprehension 4. and 
memory 1 had wider distributions (large variances). The totals, language and verbal 
comprehension total and memory total, also had wide distributions.
The cut-off scores described in the methodology were used to classify subjects into 
two groups, namely those who are likely to have cognitive dysfunction and those 
who are unlikely to have cognitive dysfunction. A summary of the findings are 
given in Table 4.14. Ten children (11% of survivors and 26% of children aged less 
than ten years that attended follow-up) were classified by the cognitive tool to have 
some cognitive dysfunction. The median age of the ten children was 6 years (range 
3-8 years) and the ratio of males to females was 1:1. Six children attended Mbale 
hospital and four Kapchorwa hospital. Five cases identified with cognitive deficits 
were found to have motor-sensory deficits on discharge i.e. early-onset deficits. Four 
children identified with cognitive deficits also had motor-sensory deficits that were 
identified during follow-up i.e. late-onset deficits. Three survivors, cases 1055, 1138 
and 2040 had motor-sensory deficits at discharge and during follow-up and were 
identified to have cognitive sequelae by the cognitive tool.
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Table 4.14: Summary of the neurological sequelae identified by clinical examination and 
cognitive assessment ( using the child version" )  among survivors of cerebral malaria.
Case Early- Late-onset Cognitive deficits identified
Number onset deficits MEMtotal LGVC2 LGVCtotal
deficits identified**
identifiedtt 1« visit 2nd 1« visit 2nd 1*' visit 2nd 1« visit 2nd
visit visit v is it visit
Child
1021 No No No Yes No No No No No
1022 Yes No No NA§5 NA NA NA NA NA
1029 No Yes No No No No No No No
1033 No No No Yes Yes No No No No
1040 No No Yes NA NA NA NA NA NA
1055 Yes Yes Yes Yes Yes Yes Yes Yes Yes
1105 Yes No No NA NA NA NA NA NA
1106 Yes No No NA NA NA NA NA NA
1108 Yes No No NA NA NA NA NA NA
1117 No No No No No No Yes No No
1118 Yes No No NA NA NA NA NA NA
1126 Yes No No NA NA NA NA NA NA
1129 Yes No No NA NA NA NA NA NA
1135 Yes No No Yes Yes No No No No
1137 Yes No No NA NA NA NA NA NA
1138 Yes Yes Yes Yes Yes No No Yes Yes
1142 Yes No No NA NA NA NA NA NA
1143 Yes No Yes No No No No No No
1340 Yes No No NA NA NA NA NA NA
2008 Yes No No NA NA NA No NA No
2011 No Yes No No Yes No No No No
2012 Yes No No Yes Yes No No No No
2029 Yes No No NA No NA No NA No
2040 Yes Yes Yes Yes No No No No No
2041 No No No No Yes No No No No
Adult
1067 Yes No No NA NA NA NA NA NA
1079 Yes No No NA NA NA NA NA NA
1127 Yes No No NA NA NA NA NA NA
2019 Yes No No NA NA NA NA NA NA
2020 No Yes Yes NA NA NA NA NA NA
2025 No Yes Yes NA NA NA NA NA NA
2090 Yes Yes Yes NA NA NA NA NA NA
Total
positive
23 8 8 7 7 1 2 2 2
"  Some adults have been included here that were not assessed with either version of the cognitive 
tool.
Motor-sensory deficits were examined for at discharge 
!s Motor-sensory deficits were examined for during follow-up and some cognitive deficits were 
reported by the relative who accompanied the subject for follow-up.
,s Not applicable because the instruction/test was not performed either because the subject did not 
come for the visit or the tool was not available for assessment.
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4.10.5 C o g n itiv e  sequelae d e term in ed  with the a d u lt version o f  th e  cogn itive to o l
Ten adult subjects (all seen at Kapchorwa) were assessed using the adult version of 
the cognitive tool. Their results are summarised in Table 4.15. One subject did not 
score the maximum score on the orientation score because she was shy during the 
assessment. The two subjects who ranked highest on picture identification and 
recall, and digit recall did not have reported changes that suggested any cognitive 
dysfunction after the episode of cerebral malaria. The other subjects except case 
number 2022, who ranked below the first two did less well on the tests and also had 
reported behaviour changes suggestive of either memory impairment (6 subjects) or 
attention deficits (4 subjects). Case 2022 was shy during the assessment and did not 
score highly. Case 2013 was not assessed with the cognitive tool, As a result of 
these findings, six cases (cases 2020, 2021, 2025, 2087, 2089, 2090) were classified 
as having or having had some cognitive dysfunction after cerebral malaria (median 
age 12'A years, range 11-14). Three cases with cognitive sequelae had late-onset 
deficits (cases 2020, 2025 and 2090). Case 2090 had early-onset deficits as well.
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Table 4.15: Summary of the findings of adult subjects who were assessed with the adult version of the coon ¡five tool and ranked in decreasing order of 
performance on their first visit.
Case Age on Reported Orientation score* Number of pictures Number of pictures Number of digits Remarks
number first behaviour correctly identified correctly recalled correctly recalled
visit changes on out of ten out of ten out of six
(years) 1s1 visit’
1 a visit 2nd visit 1s* visit 2nd visit 1 a visit 2nd visit 1 a visit 2nd visit
2017 13 No 5 5 10 10 9 8 3 2 No seizures reported
2018 13 No 5 5 10 9 9 8 3 4 No seizures reported
2025 15 Yes 5 5 10 10 6 9 2 0 No seizures reported; Reportedly was forgetful after 
illness and was more emotional than before illness.
2021 14 Yes 5 NA* 9 NA 7 NA 3 NA No seizures reported; Reportedly was forgetful after 
illness, was iess attentive and sometimes not able to 
speak properly.
2090 12 Yes 3 4 9 7 7 5 1 6 No seizures reported; Was shy during 1s' assessment. 
Reportedly was forgetful after illness and was not as 
attentive.
2022 13 No 5 NA 9 NA 5 NA 4 NA No seizures reported; Was shy during assessment.
2087 13 Yes 5 5 8 10 7 10 3 6 No seizures reported; Reportedly was forgetful after 
illness and less attentive
2089 13 Yes 5 NA 8 NA 5 NA 4 NA No seizures reported; Reportedly was forgetful after 
illness.
2020 12 Yes 5 5 8 6 5 4 3 0 No seizures reported; Was shy during both 
assessments. Reportedly was forgetful after illness 
and was not as attentive.
2013 13 No 5 5 NA NA NA NA NA NA No seizures reported; Cognitive tool was not used for 
assessment
’ Five questions were asked about subjects’ behaviour comparing memory, attention, and emotions before illness with cerebral malaria and the period after.
* Maximum score of five and minimum of zero 
’ Not applicable because the test was not performed.
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Chapter 5
This chapter contains the analytical results of univariate, bivariate and multivariable 
analyses. Apart from presenting the findings, as I did in the previous chapter, I will 
on a few occasions relate the findings with each other in order to make the text 
easier to read.
5. ANALYTICAL RESULTS
The analyses focused on a) elucidating the association between age of onset of 
disease and outcomes, i.e. the study hypothesis, b) identifying independent risk 
factors for the outcomes c) and quantifying the magnitude o f important measures of 
associations. Measures of association between explanatory factors and the outcomes 
are presented as relative risk estimates. As a result of the small sample size and the 
low frequency of outcomes, the ability of the study to estimate the strength and 
magnitude o f associations is limited. Reference will be made to statistically and 
clinically significant relationships as well as important null results.
5.1 Risk factors for mortality
Relative risk estimates as crude odds ratios are presented first. Bivariate results in 
which the crude ORs are adjusted for hospital, or case definition or age are presented 
next. The findings of fitting logistic models to the data are given finally.
5.1. /  R e la tiv e  risk estim ates determ in ed  b y  u n ivaria te  analysis  
All one hundred cases were used to determine those factors which were associated 
with mortality within 72 hours of admission. Table A in Appendix V gives the 
number of deaths, survivors, and the odds for death for relevant explanatory 
variables. Table 5.1 below shows the odds ratios for death (derived from odds) for 
categories that contained events.
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Table 5.1: Univariate odds ratios for mortality among cases admitted with cerebral malaria 
(N=100)
Variable CoGff iciont Standard P- Odds Lower Upper
error value ratio 95% Cl 95% Cl
Demographic & History information
Centre (Mbale/Kapchorwa) 0.4953 0.686 0.47 1.64 0.42 6.36
Age (less than 10 years/10 and above) -0.4855 0.824 0.55 0.62 0.12 3.13
1-4 years 1
5-9 years -0.5878 0.856 0.49 0.55 0.10 3.02
10 and above -0.6678 0.854 0.43 0.51 0.09 2.79
Seizures within 24 hours prior to 
admission
None 1
1-3 seizures -1.6854 0.881 0.05 0.19 0.03 1.12
4-20 seizures -0.9676 0.786 0.21 0.38 0.08 1.84
Quinine given prior to admission 
(No/Yes)
-1.8379 1.075 0.09 0.16 0.02 1.38
Previous medical admission to hospital 
(No/Yes)
-0.4183 1.095 0.70 0.66 0.08 5.71
Clinical examination on admission
Able to localise painful stimuli at Level 1 
(No/Yes)
Body temperature
-0.8472 0.721 0.24 0.43 0.10 1.80
35.0-38.5 °C 1
38.6-39.4 °C -0.3137 0.850 0.71 0.73 0.14 3.91
39.5-42.0 °C 0.9985 0.909 0.27 271 0.44 16.61
Moderate -  severe anaemia (No/Yes) -0.4055 0.679 0.55 0.67 0.17 2.55
Clinical signs of moderate -  severe 
dehydration (No/Yes)
Presence of extra heart sounds 
(No/Yes)
0.2757 1.125 0.80 1.32 0.14 12.09
None 1
Yes 0.3483 1.161 0.76 1.42 0.14 13.99
Missing info 2.1400 0.751 0.004 8.50 1.75 41.19
Pulse pressure
20-39 mmHg -0.2076 1.462 088 0.81 0.05 14 28
40-79 mmHg 1
Missing info 0.5335 1.103 0.62 1.70 0.20 14.83
Respiratory abnormality (No/Yes) 
In-hospital non-laboratory information
-0.0918 0.679 0.89 0.91 0.23 3.48
First episode of witnessed seizures 
(none/any number)
-2.3250 1.070 0.03 0.10 0.012 0.80
None 1
1-3 seizures -1.9196 1.075 0.04 0.15 0.02 1.29
Quinine loading dose prescribed on 
admission
No 1
Yes 1.0986 1.196 0.35 300 028 32.15
Missing 0.9444 0.765 0.21 2.57 0.56 11.76
Total amount of quinine given on Day 0
225 -  569 mg 1
570-1800 mg -0.7732 0896 0.38 0.46 0.08 2.73
Missing info 0.8754 0.771 0.25 2.40 0.51 11.21
Fable continued overleaf
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T a b le  5.1 c o n t in u e d
Variable Coefficient Standard
error
P-
value
Odds
ratio
Lower 
95% Cl
Upper 
95% Cl
Laboratory based information
Random blood glucose on Day 0
Less than 5 mmol/L 0.9163 1.261 046 2.50 0.21 29.60
5 -  6.9 mmol/L 1
7 and above 0.1743 1.444 0.90 1.19 0.07 20.21
Missing info 1.8326 1.117 0.10 6.25 0.70 55.84
Parasite count on Day 0
50,000 parasites/pL and 1
below
> 50,000 parasites/pL 1.4961 0.869 0.08 4.46 0.78 25.67
Missing info 1.8325 0.967 0.06 6.25 0.87 45.14
Haemoglobin concentration
3.0-9.9 g/dL 0.58 1.65 0.28 9.83
10.0-15.0 g/dL 1
Missing info 0.1941 0.751 0.44 2.00 0.33 12.09
Serum Sodium concentration
<135 mmol/L 0.39 2.62 0.26 26.2
135-146 mmol/L -0.9634 1.156 1
>146 mmol/L 0.0351 1.194 0.49 2.71 0.14 53.62
Missing info -0.1881 0.750 0.49 2.17 0.22 21 44
Serum Calcium concentration
2-3 mmol/L 1
Missing info 16.4435 0.753 0.67 0.62 0.07 5.84
Serum Chloride concentration
95-105 mmol/L 1
>105 mmol/L 15.5321 1.074 0.15 4.25 0.48 37.53
Missing info 16.3729 0.902 0.50 1.83 0.31 10.99
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The case fatality rate was higher in Kapchorwa and as a consequence the risk of 
death as estimated by the odds ratio showed that those cases managed at Kapchorwa 
hospital had a 64% greater risk of death than those managed in Mbale (OR=1.64 
[95% Cl 0.42-6.36]). Adults were about 40% less likely to die than children. Those 
cases that did not have a history of seizures within 24 hours before admission were 
at greater risk of death compared to cases who reportedly had 1 -3 seizures or 4-20 
seizures. Cases that received quinine prior to admission were less likely to die than 
those who did not, OR 0.16 (95% Cl 0.02-1.38). Of those who received quinine 
prior to admission (n=38), 10% did not report any seizures within 24 hours before 
admission, 53% reported 1-3 seizures and 37% reported more than 3 seizures (P = 
0.04 from Fisher’s exact test). However the median number o f reported seizures 
among those who gave a history of quinine use and those who did not was not 
significantly different. On admission, cases who could not localise painful stimuli 
were just over 50% more likely to die than those who were in less deep coma. 
Having a temperature over 39.6°C was more likely to predispose to death (OR 2.71 
[95% Cl 0.44-16-61 ]) than having temperatures between 35-38.5 °C. There was little 
difference in risk of those with temperatures between 38.6-39.4 and the lower 
category.
The presence of moderate to severe anaemia appeared to be associated with a lower 
risk of death by 33% though the study did not have sufficient power to identify this 
association as a real one. The opposite occurred in those who had moderate to severe 
dehydration. Dehydrated cases had an odds ratio of 1.32 (95% Cl 0.14-12.09) 
compared to those who were not found to be dehydrated. The detection of extra 
heart sounds was associated with a 42% increase in risk compared to those without 
extra heart sounds. Those who were not examined for extra heart sounds were at 
greater risk of death (OR 8.50 [95% C l 1.75-41.19]) than those who did not have 
extra sounds (auscultation was always done by a doctor). Similarly, those with 
missing information on pulse pressure had a greater odds ratio (OR 2.1 [95% Cl 
0.24-18.4]) when compared to those with a pulse pressure 40-79 mmHg. Those with 
pulse pressures in the lower range, 20-39 mmHg had a greater risk (OR 1.23 [95% 
Cl 0.07-22.71]) than those in the middle category (blood pressure, pulse rates and 
respiratory rates were determined by a nurse).
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When the occurrence of tonic-clonic seizures was compared with the absence of 
seizures, an OR of 0.10 (95% Cl 0.02-1.29) was obtained, that is to say, death 
appeared less likely in those with seizures. The fever clearance times and parasite 
clearance times were not used in these analyses because these two features did not 
have sufficient time to resolve before death occurred. Giving a loading dose of 
quinine when compared against not giving a loading dose produced a risk estimate 
of 3 (95% Cl 0.28-32.15). Those without recorded information about whether they 
received a loading dose of quinine had a risk estimate of 2.57 (95% Cl 0.56-11.76) 
compared to those who did not receive a loading dose.
Using the reference concentration of 5-6.9 mmol/pL for random blood glucose, 
comparisons were made with other glucose concentrations. Those with less than 5 
mmol/pL had a 2.5 fold (95% Cl 0.02-30.83) greater risk of death, and those with 
concentrations over 7 mmol/pL had 1.2 fold (95% Cl 0.07-20.83) greater risk of 
death. Those with no information on random blood glucose were at the highest risk 
of death with an OR of 6.25 (95% Cl 0.64-61.00).
The higher parasite counts on Day 0 were associated with a greater risk of death. 
The risk increased by about 4 times when the count was over 50,000 parasites/pL. It 
was even higher if the count was not done (OR=6.25). Patients with HB 
concentrations in the lower category when compared with those with Hb 10-15 g/dL 
had an OR of 1.65 and those without information on Hb concentration had an OR of 
2.0 when compared to the same group. Lower than normal serum sodium 
concentrations were associated with a higher risk of death (OR 2.62 [95% Cl 0.26- 
26.2]) compared to those within the normal range. Those with higher concentrations 
or missing information were also at a higher risk (OR 2.71 [95% Cl 0.14-53.62] and 
OR 2.17 [95% Cl 0.22-21.44] respectively). In contrast, those with no information 
on serum calcium had a lower OR (0.62 [95% Cl 0.07-5.84]) than those within the 
normal range. Cases with serum chloride above 105 mmol/L were 4 times at risk of 
death compared to those with a normal range of chloride. Cases that did not have 
their serum chloride concentration estimated were about 2 times more likely to die.
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5.1.2 Adjusted relative risk estimates determined by bivariate analysis
The effect of case definition (N=58), study centre and age (N=100) on the risk 
factors for mortality were examined separately. The adjusted odds ratios resulting 
from these analyses are summarised in Table 5.2. A number of factors were 
excluded from these analyses because, either i) cases with the outcome did not 
accrue sufficient information on the factor, such as coma score, or ii) it was not 
considered relevant to include them, such as the kinds of symptoms. Factors that 
were shown to differ within each group (i.e. between centre, case definition and age 
group) in the descriptive analyses were examined first, since they had a greater 
potential to influence the associations between explanatory factors and mortality.
A number of associations were influenced by the hospital where the patient was 
managed. The relative risk slightly decreased among the older children when centre 
was controlled for. Patients who received a loading dose of quinine were twice as 
likely to die as those who did not although this was not statistically significant. This 
adjusted estimate of relative risk was less than the unadjusted one although the 
confidence interval was narrower. The adjusted risk when the parasite count was 
over 50,000 parasites/pL was about 4 times greater compared to 50,000 parasites/pL 
and below. This risk was even greater when the degree of parasitaemia was not 
assessed.
The relative risk estimates after adjusting for age are also presented in the same 
Table. Univariate estimates which were modified either in terms of the value of the 
estimate or reducing the width of the confidence intervals, are whether a loading 
dose of quinine was given prior to admission, random blood glucose concentration, 
absence of a history of seizures prior to admission, absence of seizures on the ward, 
higher degree of parasitaemia and greater time taken to clear the parasitaemia. Those 
who did not have a history of seizures were less likely to die than those who had a 
history of between 1 to 3 seizures.
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Table 5.2: Adjusted Odds ratios for mortality.
Variable adjusted for
Risk factor Case definition Centre Age group
Unadjusted
OR
OR 95% Cl OR 95% Cl OR 95% Cl
Factors shown to have differences in the descriptive analyses
Centre
Mbale 1 1 NA - 1
Kapchorwa 
Age group 1
1.64 2.00 0.47-8.50 " 1.80 0.467.12
£ 10 yrs 1 1 1 NA -
> 10 years 
Age group 2
0.62 0.75 0.14-4.10 0.55 0.11-2.87 - -
1-4 yrs 1 1 1 NA -
5-9 yrs 0.55 0.76 0.13-4.46 0.24 0.02-3.17 - -
10 yrs and above 0.51 0.69 0.12-4.06 0.44 0.07-2.77 - -
Seizures within 24 
hours before admission 
Number of seizures 
within 24 hours prior to 
admission
0.27 0.14 0.03-0.73 0.27 0.061.18 0.25 0.061.00
None 1 1 1 1
1-3 seizures 0.19 0.11 0.01-0.93 0.20 0.03-1.23 0.19 0.03-1.10
4-20 seizures 0.38 0.17 0.03-1.09 0.39 0.06-2.51 0.29 0.05-1.60
Admitted to hospital 
before
Body temperature
0.66 0.65 0.07-6.10 0.75 0.08-7.01 0.63 0.07-5.68
35.0-38.5 °C 1 1 1 1
38.6-39.4 °C 0.73 0.44 0.08-2.55 0.70 0.13-3.87 0.77 0.14-4.17
39 5-42.0 °C 2.71 1.33 0.21-8.57 2.67 0.42-16 97 2.85 048-16.93
Presence of moderate 
to severe anaemia
0.67 0.48 0.12-1.96 0.72 0.18-2.90 0.61 0.17-2.19
Presence of any 
respiratory abnormality 
Presence of any extra 
heart sounds
0.91 0.67 0.162.71 1.10 0.22-5.42 0.79 0.24-2.63
No 1 1 1 1
Yes 1.42 1.39 0.13-14.74 1.32 0.13-13.93 1.22 0.18-8.05
Missing info 8.50 24.38 2.36
258.82
8.19 1.73-38.73 5.77 1.41-23.66
Pulse pressure
20-39 mmHg 1.23 0.83 0.04-19.25 1.20 0.08-18.3 5 1.05 0.03-33.52
40-79 mmHg 1 1 1 1
Missing info 2.10 1 08 0.11-10.80 2.26 0.39-13.21 3.41 0.14-79.53
Had witnessed 0.10 0.06 0.00-0.61 0.11 0.01-1.08 0.11 0.01-0.99
seizures
Had 1-3 witnessed 
seizures on first 
episode
Loading dose of 
quinine given on 
admission
0.15 0.08 0.01-0.87 0.17 0.02-1.62 0.17 0.02-1.50
No 1 1 1 1
Yes 3.00 1.30 0.13-13.45 2.08 0.19-22.43 1.75 0.17-18.19
Missing info 2.57 4.88 0.80-29.74 2.34 0.48-11.51 2.40 0.54-10.72
Fable continued overleaf
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T a b le  5 .2  c o n t in u e d
Variable adjusted for
Risk factor Case definition Centre Age group
Unadjusted
OR
OR 95% Cl OR 95% Cl OR 95% Cl
Random blood glucose 
< 5 mmol/L 2.50 2.18 0.17-27.56 2.43 0.20-28.91 2.27 0.18-28.54
5-6.9 mmol/L 1 1 1 1
27 mmol/L 1.19 0.92 0.05-1646 1.33 0.08-23.20 1.11 0.06-19.38
Missing info 
Haemoglobin 
concentration
6.25 6.00 0.62-57.68 6.46 0.72-58.11 5.82 0.63-53.93
3.0-9.9 g/dL 1.65 1.27 0.20-8.08 1.69 0.27-10.64 1.77 0.27-11.41
10.0-15.0 g/dL 
Missing info
1
2.00
1
2.33 0.34-15.90
1
2.18 0.35-13.58
1
1.85 0.27-12.46
Other explanatory factors
Quinine given prior to 0.16 0.16 0.02-1.45 0.15 0.02-1.40 0.16 0.02-1.41
admission 
Parasite count
S 50,000 1 1 1 1
parasites/pL 
> 50,000 4.46 5.54 0.87-35.26 4.08 0.87-19.18 4.32 0.78-23.92
parasites/pL 
Missing info 6.25 15.50 1.31-
183.14
7.97 0.91-70.14 6.56 0.83-51.66
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A parasite count over 50,000 parasites/pL was associated with a fourfold increase in 
risk of not surviving compared to a count less than that. When the count was not 
done the risk was six and a half times greater than if the count was in the lower 
category and about one and a half times (OR 1.28 [95% Cl 0.29-6.62]) greater than 
if the count was in the higher category.
The effect of the case definition on the association between factors and survival was 
examined and the result shown in Table 5.2. The number of cases used for this 
analysis is 58 because probable cases did not contribute to this outcome. Even with 
this restriction the strength of the associations shown in the table were not 
significantly modified. Kapchorwa cases were twice as likely not to survive 
compared to Mbale cases, an increase from the unadjusted estimate. A history of 
seizures within 24 hours prior to admission was associated with a reduced OR of 
0.14 (95% Cl 0.03-0.73) when compared to those without such a history (P = 0.01). 
The OR remained smaller with increasing levels of seizure numbers.
Case definition modified the magnitude of the risk estimate between outcome and 
body temperature. Those with temperatures in the highest category were at greater 
risk of not surviving (OR 1.33 [95% Cl 0.21-8.57]) which was less than the finding 
in univariate analysis (OR 2.71 [95% Cl 0.44-16.61]). Those with temperatures 
between 38.6-39.4°C were about 50% less likely to die than those with temperatures 
between 35.0-38.5 °C which was similar to the unadjusted value. The presence of 
severe to moderate anaemia was less likely to be associated with risk for the 
outcome (OR 0.48) than its absence although this finding was not found to be 
statistically significant.
Having any number of seizures while on the ward resulted in a smaller relative risk 
even among the definite cases. This finding was unlikely to be accidental and the P 
value was low (P < 0.001). The relationship between the degree o f  parasitaemia and 
survival was examined among definite cases. The adjusted OR was 5.54 (95% Cl 
0.87-35.26) if those in the higher group were compared to those in the lower group; 
an increase from the crude value. When those without a parasite count were 
compared to the referent category, the adjusted OR was 15.5 (95% Cl 1.31-183.14).
1 6 2
5.1.3 Risk f a c to r s  f o r  m orta lity  de term in ed  by m u ltivariab le  logistic  regression
Three logistic models are shown in Table 5.3. The models were constructed first by 
adding age, as a categorical variable, then in a forward-stepwise manner other 
factors which are likely to influence the associations between age and mortality, 
such as study centre. These factors remained in the final model. Other factors not 
already included in the model were added as described in the methodology and if 
found to have significant Likelihood ratio tests, remained in the final model.
The first model, Model 1, used data from all one hundred cases whereas Model 2 
was restricted to definite cases only. All probable cases survived and as a result the 
outcome, mortality, was restricted to definite cases hence the presentation of 
findings from the two models. In both models, adults were less at risk of death than 
children. The effect was more pronounced in Model 2. Quinine use before admission 
was identified as a risk factor when quinine was not given, and was significant in 
both models. Those cases that had seizures while on the ward were about 90% less 
likely to die than those who did not. A third model, Model 3, used only data for 
definite cases to fit the logistic regression. In addition to the factors identified by the 
previous models, this one identified parasite count as a risk factor. The parasite 
count when over 50,000 parasites/pL was associated with an eightfold increase in 
mortality compared to those with a lesser degree of parasitaemia. Those without 
counts were at even greater risk (P = 0.05). Adding parasite count to the model 
modified the ORs for mortality in Kapchorwa hospital as shown. The relative risk 
for mortality amongst the adult cases was even lower. Quinine given prior to 
admission became more protective.
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Table 5.3: Risk factors for mortality by logistic regression
Risk factor OR Lower 
95% Cl
Upper 
95% Cl
LR Test'
Model 1 (N= 100)
Aged ten years and above 0.51 0.09 2.86 0.43
Managed in Kapchorwa hospital 1.63 0.38 7.10 0.51
Quinine given prior to admission 0.14 0.02 1.23 0.03
Had seizures while on the ward 0.11 0.01 0.91 0.01
Model 2 (N=58)t
Aged ten years and above 0.24 0.02 2.55 0.20
Managed in Kapchorwa hospital 3.92 0.44 35.36 0.20
Quinine given prior to admission 0.08 0.01 1.04 0.02
Had seizures while on the ward 0.05 0.01 0.48 <0.001
Model 3 (N=58)* 
Aged ten years and above 0.11 0.01 1.50 0.07
Managed in Kapchorwa hospital 5.60 0.54 57.49 0.13
Quinine given prior to admission 0.04 0.00 1.12 0.01
Had seizures while on the ward 0.05 0.00 0.66 0.01
Parasite count
s  50,000 parasites/pL 
> 50,000 parasites/pL
1
8.36 0.86 80.84
0.04
Missing info 25.03 0.98 636.18
Likelihood ratio test comparing models with the factor and without the factor
* Variables from Model I but restricted to defin ite  cases 
s Model fitted by adjusting for case definition at the onset
The three logistic models were a good fit of the data. The goodness-of-fit tests 
(Hosmer-Lemeshow test because of the small sample size) yielded the following 
results:
• Model 1: Hosmer-Lemeshow chi2 (6 degrees of freedom) = 1.41, P = 0.96. 8 
groups. Figure A in Appendix VI is a regression diagnostic plot of the 
Hosmer and Lemeshow influence (H-L dx2) plotted for each case (as index 
numbers 1 to 100).
• Model 2: Hosmer-Lemeshow chi2 (5 degrees of freedom) = 2.18, P = 0.82, 7 
groups. Figure B in Appendix VI shows a diagnostic plot.
• Model 3: Hosmer-Lemeshow chi2 (8 degrees of freedom) = 2.15, P = 0.95, 9 
groups. Figure C in Appendix VI shows a diagnostic plot. This had better fit 
than the other two models.
Table C in the Appendix V summarises the results of Cox regression (time-to-event 
analysis) to show how they compared with the logistic models which do not take 
‘time-to-event’ into account. The Cox models had similar findings to the logistic 
ones but with narrower confidence intervals.
5.2 Risk factors for carly-onset neurological sequelae
The results here are derived from analyses of 23 cases with early-onset deficits of 90 
cases who survived an episode of cerebral malaria. Univariate results are presented 
first. Bivariate and multivariate results follow.
5.2.1 R elative risk  estim a tes determ in ed  b y  univariate a n a ly s is
Table B which gives the number of subjects with deficits and those without by 
categories of explanatory variable can be seen in Appendix V. The odds of having 
early-onset deficits are also presented. Table 5.4 summaries the findings from 
univariate comparisons of the odds to give crude odds ratios.
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Table 5.4: Univariate odds ratios for earlv-onset neurological sequelae among patients who 
survived an episode of cerebral malaria. IN=90)
Variable Coefficient Standard P Odds Lower Upper
error value ratio 95% Cl 95% Cl
Demographic & History information
Centre (Mbale/Kapchorwa) -0.1870 0.544 0.73 0.83 0.28 2.43
Age (less than 10 years/10 and above) -0.1870 0.544 0.73 0.83 0.28 2.43
1-4 years 1
5-9 years 0.8754 0.578 0.13 2.40 0.75 7.68
10 and above 0.1823 0.610 0.76 1.20 0.36 4.01
Seizures within 24 hours prior to 
admission (None/Any number)
1.2726 0.791 0.10 3.57 0.76 16.84
None 1
1-3 seizures 1.1368 0.826 0.16 3.12 0.59 16.42
4-20 seizures 1.4469 0.841 0.08 4.25 0.76 23.87
Quinine given prior to admission 
(No/Yes)
1.0905 0.498 0.03 2.98 1.08 8.18
Previous medical admission to hospital 
(No/Yes)
Clinical examination on admission
0.7171 0.6304 0.25 2.05 0.59 7.16
Able to localise painful stimuli at Level 2 
(No/Yes)
Coma depth measured on Blantyre 
Coma Scale (cases aged 5 yrs and 
below)
-0.1147 0.546 0.83 0.89 0.30 2.62
0-2 -0.3567 0.832 0.66 0.7 0.14 3.58
3-5 1
No Score/Missing info - - - - - -
Coma depth measured on Glasgow 
Coma Scale (cases aged over 5 yrs)
3-8 0.3747 0.697 0.59 1.45 0.37 5.71
9-12 1
13-15 - - - - - -
No Score/Missing info 0.9808 1.108 0.37 2.67 0.30 23.42
Has a stiff neck 
Body temperature
0.7610 0.696 0.27 2.14 0.55 8.39
35.0-38.5 °C 1
38.6-39.4 °C -0.5794 0.575 0.31 0.56 0.18 1.76
39.5-42.0 °C -0.9361 1.118 0.40 0.39 0.04 3.62
Moderate -  severe anaemia (No/Yes) -0.1169 0.483 0.80 0.89 0.34 2.31
Clinical signs o f jaundice (No/Yes) 0.1823 0.648 0.77 1.20 0.33 4.31
Clinical signs of moderate -  severe 
dehydration (No/Yes)
Presence of extra heart sounds 
(No/Yes)
-0.7719 1.108 0.48 0.46 0.05 4.13
None 1
Yes -1.6602 1.076 0.12 0.19 0.02 1.57
Missing info - - - - - -
Pulse pressure
20-39 mmHg 0.2384 1.000 0.81 1.27 0.18 9.02
40-79 mmHg 1
Missing info 0.8339 0.818 0.30 2.30 0.46 11.45
Table continued overleaf
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Variable Coefficient Standard
error
P
value
Odds
ratio
Lower 
95% Cl
Upper 
95% Cl
Respiratory abnormality (No/Yes) -0.1715 0.493 0.72 0.84 0.31 2.23
Respiratory distress (Not likely/Likely) -0.3342 1.145 0.77 0.71 0.07 6.85
Presence of Organomegaly (No/Yes) 1.1168 0.498 0.03 3.06 1.11 8.40
Enlarged spleen (No/Yes) 1.1119 0.556 0.05 3.04 0.99 9.34
Enlarged liver (No/Yes) 0.1431 0.592 0.81 1.15 0.36 3.71
In-hospital non-laboratory information
First episode of witnessed seizures 0.1169 0.483 0.81 1.12 0.43 2.97
(none/any number)
None 1
1-3 seizures -0.4810 0.600 0.42 0.62 0.19 2.03
4-20 seizures 0.9949 0.623 0.11 2.70 0.77 9.53
Seizure stoppage time
1-2 days 1
3-48 days 0.8109 0.760 0.28 2.25 0.49 10.37
Total seizure stoppage time
1-2 days 1
3-48 days 0.8159 0.528 0.12 2.26 0.78 6.52
Duration of unrousable coma
Not in unrousable coma on 1
admission
For less than 48 hours 0.0645 0.617 0.91 1.07 0.31 3.62
For 48 hours or more 0.6286 0.624 0.31 1.88 0.54 6.54
Missing info - - - - - -
Coma recovery time
1-2 days 1
3-4 days 0.6286 0.672 0.35 1.88 0.49 7.17
5 and above 1.8971 0.769 0.01 6.67 1.24 35.90
Missing Info -0.5306 0.926 0.56 0.59 0.09 3.72
Total coma recovery time
1-2 days 1
3-4 days 0.5108 0.787 0.51 1.67 0.35 7.97
5 and above 2.0369 0.714 0.004 7.67 1.63 36.09
Missing info - - - - - -
Fever clearance time
1 day 1
2-3 days -0.9734 0.608 0.10 0.38 0.11 1.29
4-9 days -0.4626 0.626 0.46 0.63 0.18 2.19
Missing info 0.6360 1.081 0.55 1.89 0.21 16.53
Total fever clearance time
1 day 1
2-3 days -1.0986 0.611 0.07 0.33 0.10 1.15
4-15 days -0.7884 0.587 0.18 0.45 0.14 1.48
Quinine loading dose prescribed on
admission
No 1
Yes -0.2776 1.182 0.81 0.76 0.07 7.82
Missing - - - - - -
Dose of quinine given on Day 0
3-8.9 mg/kg 0.2513 0.899 0.78 1.29 0.22 7.50
9.0-10.9 mg/kg 1
11.0-20.9 mg/kg -0.4165 0.709 0.55 0.66 0.16 2.65
Missing info -1.0191 0.614 0.09 0.36 0.11 1.20
Table continued overleaf
167
Table 5.4 continued
Variable Coefficient Standard
error
P
value
Odds
ratio
Lower 
95% Cl
Upper 
95% Cl
Duration of hospital stay
Less than 6 days -0.5520 0.636 0.38 0.58 0.17 2.00
6 to 8 days 1
More than 8 days 1.1527 0.628 0.06 3.17 0.92 10.86
Laboratory based information
Random blood glucose on admission -0.0323 0.854 0.97 0.97 0.18 5.22
(>2.2/£2.2 mmol/L)
Less than 5 mmol/L 0.5390 0.698 0.44 1.71 0.44 6.74
5 -  6.9 mmol/L 1
7 and above 1.0986 0.666 0.10 3.0 0.81 11.08
Missing info -0.5596 0.794 0.48 0.57 0.12 2.71
Parasite count
50,000 parasites/piL and 1
below
> 50,000 parasites/piL 0.2364 0.533 0.65 1.27 0.44 3.63
Missing info 0.0540 0.744 0.94 1.06 0.24 4.60
Parasite clearance time
1 day 1
2 days -09555 0.612 0.11 0.38 0.11 1.32
3-4 days 0.715 1.00 1.00 0.24 4.13
Missing info -0.6061 0.748 0.41 0.55 0.12 2.43
Haemoglobin concentration
3.0-9.9 g/dL -0.4339 0.553 0.43 0.65 0.22 1.92
10.0-15.0 g/dL 1
Missing info -1.2040 0.668 0.07 0.30 0.08 1.11
HIV infection
No 1
Yes 0.4055 1.241 0.74 1.50 0.13 17.83
Missing 1.0186 0.610 0.09 2.77 0.81 9.43
Serum Sodium concentration
<135 mmol/L 0.7963 0.876 0.36 2.22 0.40 12.37
135-146 mmol/L 1
>146 mmol/L 1.2237 1.122 0.27 3.40 0.38 30.66
Missing info 1.6139 0.825 0.05 5.02 1.00 25.32
Serum Calcium concentration
<2 mmol/L 0.4308 1.295 0.73 1.54 0.12 19.47
2-3 mmol/L 1
>3 mmol/L 1.0217 1.164 0.38 2.78 0.28 27.21
Missing info 1.7525 1.097 0.11 5.77 0.67 49.61
Serum Chloride concentration
<95 mmol/L 0.8473 1.573 0.59 2.33 0.11 50.98
95-105 mmol/L 1
>105 mmol/L 0.4054 1.159 0.72 1.50 0.15 14.57
Missing info 1.2867 1.115 0.24 3.62 041 32.22
White blood cell count
2000-4700 cells/L 2.0005 0.852 0.02 7.39 1.39 39.27
4701-6700 cells/L 1
6701-27000 cells/L 1.6802 0.867 0.05 5.37 0.97 29.40
Missing info 1.3437 0.900 0.13 3.83 0.65 22.37
1 6 8
Patients seen at Kapchorwa hospital had a similar probability of having deficits at 
discharge when compared with those seen at Mbale hospital (OR 0.83 [95% Cl 
0.28-2.43]). Likewise children aged 10 years and above had fairly similar chances of 
having early deficits. When smaller age groups were used, children aged 5 to 9 years 
were just over twice (OR 2.40 [95% Cl 0.75-7.68]) as likely to have deficits 
compared to those aged below 5 years. Those aged 10 and above when compared to 
those less than 5 had an OR of 1.20 (95% Cl 0.36-4.01). A history of any number of 
seizures in the 24 hours prior to admission was associated with a greater likelihood 
of deficits compared to a negative history for seizures (OR 3.57 [95% Cl 0.76- 
lb.84). The relative risk for deficits increased with increasing number of seizures (P 
= 0.09 for test of trend). Those who had between 4-20 seizures prior to admission 
having 4 times the potential for sequelae compared to those without (P = 0.09) and 
those who had between 1-3 seizures having 3 times the same potential (P = 0.17). 
Cases that were given quinine prior to admission were almost 3 times more likely to 
have early deficits than those that did not receive quinine prior to admission (P = 
0.03). Cases that had been admitted to hospital before were at greater risk of deficits 
OR 2.05 (95% Cl 0.59-7.16).
Patients with a greater degree of unconsciousness as indicated by the inability to 
localise pain did not seem to be at greater risk of developing deficits. Using the two 
coma scales the effect of knowing the depth of coma was assessed. With the 
Blantyre Coma Score (n=42), those that scored 0-2 and 3-5 had fairly similar 
magnitudes of risk. None of the six cases who were not scored developed deficits. 
On the Glasgow coma scale (n=48), those in the lowest category 3-8, were 45% 
more likely to be at risk compared to those with scores 9-12. It was not possible to 
use the higher category as the referent one because none o f the five cases in this 
group, who were classified as probable cases, developed deficits. Increasing levels 
of body temperature appeared to be protective when compared to those with 
temperatures between 35°C and 38.5°C. The odds ratio for those in the 38.5-39.4°C 
category was 0.56 (95% Cl 0.18-1.76) and was 0.39 (95% Cl 0.04-3.62) for those 
with hyperthermia, i.e. a core temperature of 40°C and above (core body temperature 
is equal to temperature taken in axilla plus 0.5°C). The presence of moderate to 
severe anaemia was associated with a smaller relative risk for sequelae compared to 
those without (OR 0.89 [95% Cl 0.34-2.31]) but the presence of jaundice had the
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opposite effect; those with jaundice having a higher OR of 1.2 (95% Cl 0.33 4.31) 
than those without. Cases who did not have clinical signs of moderate to severe 
dehydration were about 50% more likely to develop deficits compared to those with 
signs of moderate to severe dehydration (P value was not significant). The detection 
o f extra heart sounds appeared to decrease the relative risk of deficits (OR 0.19 
[95% Cl 0.02-1.57]) probably not a directly related process but a proxy indication o f  
the influence of a doctor who was around to auscultate the heart and in so doing 
provide additional medical support. None of the cases had clinical signs suggestive 
of shock. Using the pulse pressure category o f 40-79 mmHg as the referent group 
the relative risk for deficits was 1.27 (95% Cl 0.18-9.02) when the pulse pressure 
was between 20-39 mmHg and 2.30 (95% Cl 0.46-11.45) when blood pressure was 
not measured. The presence of any respiratory abnormality or the presence o f  
respiratory distress were associated with a reduction in the risk of deficits compared 
to the absence o f the feature (OR 0.84 [95% Cl 0.31-2.23] and 0.71 [95% Cl 0.07- 
6.85] respectively). Organomegaly on the other hand was associated with a 3 fold 
increase in relative risk (P = 0.03). An enlarged spleen was responsible for the effect 
of organomegaly.
Comparing the number of seizures showed that those with 4 or more seizures during 
the first episode of witnessed seizures were more than 2 times likely to have deficits 
compared to those who did not have seizures. Those who had 1-3 seizures were less 
likely to have deficits compared to those without. Comparing those with 4 or more 
seizures, with those with less than 4 seizures resulted in an OR of 4.38 (95% C l 
0.99-19.43), further illustrating the trend of increased risk with a greater number o f  
seizures. The correlation between number o f seizures within 24 hours before 
admission and number of witnessed seizures on the first episode was 43% which 
was not a high correlation. The duration taken to control the seizures (i.e. seizure 
stoppage time) showed that having seizures for 3 or more days increased the 
potential for deficits two fold (95% Cl 0.49-10.37) compared to less than 3 days. 
The relative risk (OR 2.26 [95% Cl 0.78-6.52]) remained similar when the number 
of days for which the subject was reported to have had seizures were added to the 
number of days with witnessed seizures (i.e. total seizure stoppage time).
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Cases in unrousable coma for less than 48 hours did not differ in their potential for 
deficits when compared with those not in unrousable coma (i.e. unconscious but able 
to localise pain). However those who were in coma for 48 hours or more were about 
2 times more likely to have deficits than the same referent group (OR 1.88 [95% Cl 
0.54-6.54]) or if the referent group was unrousable coma for less than 48 hours (OR 
1.76 [95% Cl 0.55-5.61]). The coma recovery time, which is obtained by using the 
coma scales showed similar findings. Those in coma for 5 days and more, had a 
relative risk of 6.67 (P = 0.01) compared to those in coma for 1 to 2 days. The 
relative risk increased in a stepwise fashion with increasing categories of coma 
recovery time except when information was missing (P = 0.01 for test for trend 
excluding category with missing values). When the reported number of days in 
coma prior to admission were added, patients in coma for 5 days or more had a 
relative risk of 7.67 compared to those in coma for 1 to 2 days (P < 0.001). The test 
for trend using this variable was also statistically significant (P = 0.04). A fever 
clearance time of 1 day was used as the referent group to estimate the relative risk of 
having a fever for 2 to 3 days and 4 to 9 days. The odds ratios respectively were 0.38 
(95% Cl 0.11-1.29) and 0.63 (95% Cl 0.18-2.19). The risk for deficits was greater 
when information on the duration of fever was missing. The total fever clearance 
time showed a similar trend even though all cases contributed information.
Cases who received a loading dose of quinine on admission had about 20% less 
potential for deficits compared to those without such a prescription. None of the 
cases without this information developed early deficits. The higher amounts of 
quinine in contrast, 570-1800 m g of quinine given on Day 0, were associated with 
an OR of 1.16 (95% Cl 0.42-3.15) compared to the lower category of 225-569 mg. 
Cases in whom this information was not available when compared to the lower 
category had an OR of 0.19 (95% Cl 0.02-1.74). Of the forty-four cases with 
information that allowed quinine dosage to be calculated i.e. quinine amount by 
body weight per dose, those given 3 to 8.9 mg/kg (n=7) compared to those given 9 
to 10.9 mg/kg (n=19) had a relative risk of 1.29 (95% Cl 0.21-7.79). Those given 11 
to 20 mg/kg (n=18) had a relative risk of 0.66 (95% Cl 0.16-2.72) compared to those 
in the referent group. Those without sufficient information to calculate the dosage 
(n=56) also had a smaller risk (OR 0.36 [95% Cl 0.10-1.25]) compared with the 
referent group. The target duration of hospital stay was 7 days. The duration of 6 to
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8 days of hospital stay was used as the referent group to estimate the relative risk of 
deficits in those who spent less or more than this duration. Those who spent less 
than 6 days had an OR of 0.58 (95% Cl 0.17-2.00) and those who spent more than 8 
days had an OR of 3.17 (95% Cl 0.92-10.86).
The study was not able to detect an association between hypoglycaemia and early- 
onset sequelae. Cases with random blood glucose concentration in the lower 
category as shown in the table had a relative risk of 1.71 (95% Cl 0.44-6.74) 
compared to those in the middle category (5-6.9 mmol/L). Those with 
concentrations over 7 mmol/L had an even greater risk estimate of 3.0 (95% Cl 
0.81-11.08) compared with the middle category (P = 0.10). Cases without blood 
glucose estimates were at less risk with an OR of 0.57 (95% Cl 0.12-2.71). A 
parasite count over 50,000 parasites/pL was associated with a slightly greater 
likelihood for deficits than parasite counts below that degree. There was little 
difference when those without counts were compared with the lower degree of 
parasitaemia. The parasite clearance time did not show a trend in relative risk. The 
odds o f deficits among cases with the lower category of haemoglobin concentration, 
3.0-9.9g/dL, was compared with the odds of deficits among cases with Hb 
concentrations between 10.0 and 15.0 g/dL. The odds ratio obtained was 0.65 (95% 
Cl 0.22-1.92). Few cases tested HIV-1 positive however the relative risk for deficits 
was greater among them than the negative cases. Those who were not tested also had 
a greater relative risk compared with the seronegative cases.
There was a general trend in the relative risk for deficits when the normal range of 
the serum concentrations of the three electrolytes were compared with 
concentrations either below or above. The out of normal ranges were associated with 
greater potential for deficits as shown by the larger ORs in each comparison. These 
trends were statistically significant for sodium (P = 0.02) and calcium (P = 0.02) but 
not for chloride (P = 0.1). The estimates o f relative risks increased when the lower 
and upper categories of total white blood cell count were compared with the middle 
one. Cases with counts below 4,700 cells/L were about 7 times more at risk than 
those with counts between 4701 and 6700 cells/L (P = 0.02). Those with counts over 
6700 cells/L were about 5 times more at risk than the same referent group (P =
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0.05). Cases lacking information on white cell count were almost 4 times more at 
risk (P = 0.14).
5.2 .2  A d ju s te d  rela tive risk  estim a tes de term in ed  with b ivaria te  analysis
The adjusted odds ratios for early onset neurological deficits are summarised in 
Table 5.5 below. The relative risk estimates for age as 3 categories when controlled 
for case definition caused the crude ORs to increase in magnitude. This effect was 
greater when centre was adjusted for. The risk for deficits if there was a history of 
seizures within 24 hours before admission did not differ even when controlled for 
differences in case definition, study centre or age group. However when the actual 
numbers of seizures reported were considered the relative risks showed an 
increasing trend. Controlling for case definition, the magnitude o f the risk estimates 
were less extreme, i.e., tending towards one, with an OR of 2.90 (95% Cl 0.55- 
15.35) if the number of seizures were 1-3 and 3.21 (95% Cl 0.53-19.44) if the 
number of seizures were 4-20. The unadjusted OR and the trend with number of 
seizures were not modified by study site or age group. The risk o f  deficits was two 
times greater if there was a previous history of admission irrespective of case 
definition, centre or age group. There was a change in the direction of the risk 
among cases who were unable to localise pain when case definition was taken into 
account. Whereas the unadjusted OR was less than one, it increased above one to 
1.82 (95% Cl 0.42-7.78) when adjusted for case definition but not when adjusted for 
centre or age. Cases who scored in the lower category of coma depth in the Blantyre 
and Glasgow coma scales had opposite chances of developing deficits as shown by 
the ORs. However, those who were not scored on either scale were less likely to 
develop deficits when compared to the referent group as shown in the table.
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Table 5.5 . Adjusted Odds ratios for earlv-onset neurological sequelae
Variable adjusted for
Risk factor
Unadjusted
OR
Case definition Centre Age group
OR 95% Cl OR 95% Cl OR 95% Cl
Factors shown to have differences in the descriptive analyses
Centre
Mbale 1 1 NA - 1
Kapchorwa 0.83 0.89 0.31-2.55 - - 0.86 0.29-2.54
Age group 1
£ 10 yrs 1 1 1 1
> 10 years 0.83 0.88 0.30-2.62 0.86 0.29-2.54 NA -
Age group 2
1-4 yrs 1 1 1 NA -
5-9 yrs 2.40 2.94 0.86-10.06 3.00 0.76-11.86 - -
10 yrs and above 1.20 1.51 0.42-5.42 1.58 0.40-6.23 - -
Seizures within 24 3.57 3.12 0.63-15.56 3.57 0.71-18.00 3.57 0.71-18.00
hours before admission 
Number of seizures 
within 24 hours prior to 
admission
None 1 1 1 1
1-3 seizures 3.12 2.90 0.55-15.35 3.18 0.59-17.21 3.09 0.57-16.70
4-20 seizures 4.25 3.21 0.53-19.44 4.25 0.65-27.89 4.69 0.74-29 83
Admitted to hospital 2.05 2.10 0.57-7.67 2.02 0.55-7.40 1.98 0.59-6.68
before
Unable to localise 0.89 1.82 0.42-7.78 0.89 0.30-2.61 0.92 0.31-2.7 5
painful stimuli
Blantyre Coma Scores
0-2 0.7 - - 0.78 0.15-4.11 0.82 0.16-4 15
3-5 1 1 1 1
Missing info 0.76 0.64 0.14-2.97 0.75 0.15-3.67 0.82 0.16-4.15
Glasgow Coma Score"
3-8 1.45 2.70 0.36-2022 1.39 0.31-6.29 1.38 0.35-5.45
9-12 1 1 1 1
13-15 - - - - - - -
Missing Info 0.84 0.79 0.24-2.54 0.42 0.07-2.45 0.52 0.10-2.62
Has a stiff neck 2.14 2.06 0.58-7.25 2.30 0.55-9.61 2.30 0.55-961
Body temperature
35.0-38.5 °C 1 1 1 1
38.6-39.4 °C 0.56 0.47 0.16-1.40 0.56 0.18-1.79 0.56 0.18-1.77
39.5-42.0 °C 039 0.21 0.02-2.45 0.39 0.04-3.74 0.39 0.04-3.75
Presence of moderate 0.89 0.79 0.31-2.04 0.86 0.32-2.27 0.84 0.32-2.22
to severe anaemia
Presence of jaundice 1.20 1.17 0.32-4.3 5 1.15 0.31-4 33 1.15 0.31-4.33
Table continued overleaf
* Children aged 5 years and below 
"  Children aged over 5 years
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T a b le  5 .5  c o n t in u e d
V a ria b le  ad ju s te d  fo r
Risk factor Case definition Centre Age group
Unadjusted
OR
OR 95% Cl OR 95% Cl OR 95% Cl
Presence of any 
respiratory abnormality 
Presence of any extra 
heart sounds
0.84 0.74 0.27-2.05 0.79 0.28-2.18 0.75 0.27-2.08
No 1 1 1 1
Ves 0.19 0.21 0.03-1.56 0.17 0.02-1.62 0.16 0.02-1.48
Presence of 3.06 2.83 1.00-8.04 2.95 1.11-7 82 3.02 1.09-8.32
organomegaly 
Presence of enlarged 
spleen 
Pulse rate
3.04 2.78 0.87-8.90 3.07 0.96-9.82 3.06 0.96-9.71
50-84 beats/min 1 1 1 1
85-119 beats/min 3.60 3.17 0.76-13.23 3.39 0.82-14.00 3.60 0.88-14.61
120-154 beats/min 2.00 2.01 0.42-9.60 1.91 0.47-7.77 1.31 0.25-6.89
Respiratory rate
10-29 1 1 1 1
30-49 2.67 2.42 0.68-8.67 2.62 0.75-9.09 3.12 0.70-14.02
50-90 1.38 1.30 0.16-10.84 1.12 0.19-6.75 1.75 0.14-21.62
Pulse pressure
20-39 mmHg 1.27 0.91 0.14-6.05 0.79 0.10-6.14 0.73 0.09-5 84
40-79 mmHg 1 1 1 1
Missing info 2.30 1.40 0.33-5.86 2.01 0.42-9.61 2.40 0.49-11.68
Had witnessed 
seizures
Number of witnessed 
seizures on first 
episode
1.12 0.88 0.33-2.38 1.10 0.42-2 90 1.11 0.43-2.90
None 1 1 1 1
1-3 seizures 0.62 0.55 0.17-1.72 0.61 0.18-2.11 0.62 0.19-2.03
4-20 seizures 2.70 1.99 0.51-7.85 2.67 0.77-9.27 2.86 0.78-10.53
Fever clearance time
1 day 1 1 1 1
2-3 days 0.38 0.39 0.12-1.29 0.38 0.11-1.29 0.34 0.10-1.23
4-9 days 0.63 0.45 0.11-1.86 0.71 0.18-2.82 0.73 0.19-2.72
Missing info 1.89 3.00 0.22-40.05 1.85 0.24-14.30 1.87 0.21-17.07
Was given a loading 
dose of quinine on 
admission
0.76 0.37 0.04-3.78 0.43 0.04-4.07 0.46 0.06-3.31
Has hypoglycaemia 
Random blood glucose
0.97 0.99 0.18-5.32 0.94 0.17-5.21 0.94 0.17-5.21
< 5 mmol/L 1.71 0.60 0.15-2.50 0.59 0.15-2.35 1.03 0.22-4.92
5-6.9 mmol/L 1 1 1 1
27 mmol/L 3.00 1.70 0.45-6.49 1.57 0.40-6.18 1.72 0.47-6.26
Missing info 
Haemoglobin 
concentration
0.57 0.34 0.07-1.73 0.40 0.08-1.95 0.35 0.08-1.57
3.0-9.9 g/dL 0.65 0.65 0.22-1.93 0.65 0.21-1.98 0.66 0.21-2.04
10.0-15.0 g/dL 1 1 1 1
Missing info 0.30 0.31 0.08-1.25 0.29 0.07-1.17 0.28 0.07-1.15
White blood cell count
2,000-4,700 7.39 7.27 1.18-44 74 7.35 1.19-45.59 9.05 1.19-68 94
4,701-6,700 1 1 1 1
6,701-27,000 5.37 4.99 0.78-31.97 5.82 086-39.18 4.69 0 82-26 65
Missing info 3.83 3.24 0.48-22.09 3.33 0.51-21.82 3.78 0.60-24.06
Table continued overleaf
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Table 5.5 continued
V a ria b le  adjusted fo r
Risk factor Case definition Centre Age group
Unadjusted
OR
OR 95% Cl OR 95% Cl OR 95% Cl
Other explanatory factors
Quinine given prior to 
admission 
Duration taken to 
localise pain
2.98 3.02 108-8.46 2.99 1.08-8.28 3.03 1.09-8.45
Localises pain on 
admission
1 1 1 1
£ 48 hours 1.07 0.67 0.06-7.16 1.06 0.34-3.35 1.06 0.31-3.63
> 48 hours 1.88 1.11 0.09-13.30 1.83 0.54-6.21 1.85 0.52-6.54
Coma recovery time
1-2 days 1 1 1 1
3-4 days 1.88 2.25 0.48-10.61 1.86 0.48-7.15 1.99 0.52-7.61
5 and above 6.67 6.33 1.15-34.93 6.40 1.14-35.78 6.57 1.20-36.01
Missing Info 0.59 0.64 0.12-3.28 0.51 0.07-3.63 0.57 0.09-3.77
Total coma recovery 
time
1-2 days 1 1 1 1
3-4 days 1.67 1.81 0.35-9.38 1.72 0.39-7.56 2.44 0.47-12 58
5 and above 7.67 6.96 1.39-34.97 7.43 1.58-34.92 7.36 1.52-35.65
Dose of quinine given 
on Day 0
3-8.9 mg/kg 1.29 1.29 0.22-7.68 1.34 0.22-8.01 1.43 0.21-986
9.0-10.9
mg/kg
1 1 1 1
11.0-20.9 0.66 0.60 0.14-2.62 0.67 0.16-2.75 0.64 0.15-2 81
mg/kg 
Missing info 0.36 0.47 0.14-1.60 0.36 0.11-1.26 0.38 0.11-1.32
Duration of hospital 
stay
< 6 days 0.58 0.61 0.17-2.21 0.55 0.16-1.91 0.58 0.16-2.09
6-8 days 1 1 1 1
> 8 days 3.17 3.82 1.00-1462 3.44 089-10.94 3.12 089-1094
Parasite count
< 50,000 
parasites/pL
1 1 1 1
> 50,000 
parasites/pL
1.27 1.29 0.45-3.73 1.36 0.43-4.24 1.23 0.43-3.52
Missing info 1.06 2.01 0.41-9.98 0.91 0.20-4.13 1.06 0.26-4 29
Parasite clearance 
time
1 day 1 1 1 1
2 days 0.38 0.34 0.08-1.36 0.37 0.10-1.30 0.36 0.10-1.24
3-4 days 1.00 1.09 0.24-4.85 1.12 0.26-4.86 0.90 0.23-3.55
Missing info 0.55 1.48 0.34-6.54 0.53 0.11-2,50 0.58 0.14-2.47
Table continued overleaf
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T a b le  5 .5  c o n tin u ed
V ariab le a d ju s te d  fo r
Risk factor Case definition Centre Age group
Unadjusted
OR
OR 95% Cl OR 95% Cl OR 95% Cl
HIV infection
No 1 1 1 1
Yes 1.50 2.75 0.12-63.16 1.92 0.15-24.60 3.12 0.04-
229.46
Missing 2.77 2.85 0.82-9.98 3.46 0.92-13.11 3.05 0.84-11.03
Serum Sodium 
concentration
<135 mmol/L 2.22 2.04 0.47-8.82 1.97 0.44-8.85 2.31 0.38-13.88
135-146
mmol/L
1 1 1 1
>146 mmol/L 3.40 2.86 0.40-20.37 3.57 0.46-27.86 3.50 0.33-37.66
Missing info 5.02 5.24 0.91-30.10 3.69 0.94-14.48 6.35 0.95-42.18
Serum Calcium 
concentration
<2 mmol/L 1.54 0.67 0.04-11.38 2.86 0.19-42.53 1.09 0.08-15.69
2-3 mmol/L 1 1 1 1
>3 mmol/L 2.78 1 83 0.19-17.66 3.85 035-42.46 250 0 22-28 74
Missing info 5.77 6.35 0.55-73.04 5.29 0.52-53.91 5.52 0.62-4903
Serum Chloride 
concentration
<95 mmol/L 2.33 2.00 0.13-31.98 4.00 0.07-
218.59
1.67 0.06-45 44
95-105 1 1 1 1
mmol/L 
>105 mmol/L 1.50 1.20 0.13-11.32 1.00 0.09-11.04 1.58 0.15-17.05
Missing info 3.62 3.40 0.44-26.46 3.60 0.38-34.11 3.49 0.37-32.40
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Cerebral malaria with moderate to severe anaemia was less likely to predispose to 
early-onset deficits than cerebral malaria only. This finding remained even after 
adjusting for case definition, centre or age. The presence of jaundice had the 
opposite effect. Higher pulse rates and higher respiratory rates when compared with 
the lower categories had a greater relative risk even when adjusted for the three 
factors separately. The pulse and respiratory rates had a correlation coefficient of
0.32. Controlling for case definition altered the direction of the relative risk when 
those with witnessed convulsions were compared to those without. Cases who had 
1-3 witnessed seizures had less probability for deficits compared to those without 
seizures even when controlled for case definition or age. However, when the number 
of seizures was over 4, the relative risk was greater when controlled for any of the 
three factors although less so when controlled for case definition. The adjusted ORs 
for fever clearance times were not modified significantly, however when no 
information was collected on temperature, the OR increased significantly almost 
doubling when adjusted for case definition. The risk o f deficits was 0.43 (95% Cl
0.04-4.07) when a loading dose of quinine was given and study site taken into 
account. This differed slightly from the unadjusted value and was similar when 
adjusted for age. Adjusting for case definition made the risk more extreme, i.e. away 
from one.
The adjusted risk estimates for the three comparison categories of random blood 
glucose were less than the unadjusted values. Those for the two comparison 
categories for Hb did not differ from the unadjusted ones. Cases with parasite counts 
over 50,000 parasites/pL continued to have a risk estimate close to the unadjusted 
value (OR 1.27) when adjusted for case definition, or the other two factors. When 
those without parasite counts were compared with the referent group, the adjusted 
OR doubled to 2.01 (95% Cl 0.41-9.98) when adjusted for case definition but not for 
the other factors. The same effect occurred with the parasite clearance time. 
Kapchorwa cases were not assessed for HIV, therefore the OR adjusted for centre, 
comparing HIV sero-positives with sero-negatives was different from the unadjusted 
estimate which took all cases into account. The estimate was even greater when age 
was controlled for (OR 3.12 [95% Cl 0.04-229.46) although the confidence intervals 
were very wide.
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regression
Multivariable analyses as described previously were conducted to test the hypothesis 
that age o f  onset of cerebral malaria is related with early-onset sequelae and to 
elucidate any risk factors for the outcome. First age was used as two categories 
(Models la  and lb in Table 5.6) and then as three categories (Models 2a and 2b in 
Table 5.7). It was possible to use both age groups at this level because the frequency 
of the outcome, early-onset deficits, was greater than the frequency of outcome, 
mortality, in the previous analyses.
As shown in Table 5.6, the factors that were significantly associated with greater 
potential for early-onset sequelae were quinine given prior to admission, coma 
recovery time for subjects aged 5 years and above, and the presence of 
organomegaly. Those factors which were significantly associated with less risk were 
total fever clearance time for more than 1 day, and Hb concentrations between 3 and 
9.9 g/dL. Adults were at less risk for deficits in Models la and 2a but when age was 
in three categories there was a reversal o f  the risk estimates. Cases that received 
quinine prior to admission had a fourfold chance of getting early deficits. This 
finding was fairly constant in all the models although the effect of controlling for 
case definition further increased its magnitude. A coma recovery time between 1 and 
2 days was used as the referent group to determine the relative risk for greater 
durations of coma. Controlling for the other variables in Model la, the OR was 3.10 
(95% Cl 0.56-17.19) when the duration was between 3-4 days, and 22.81 (95% Cl 
2.69-193.71) when the duration was 5 days and more. Cases without information on 
coma duration were at less risk than the referent group. The effect of using the other 
age grouping modified the risk estimates as shown. Organomegaly when present 
was a risk factor as illustrated in all the models. The OR was greater when the case 
definition was included in the model resulting in a tenfold probability for deficits.
5.2.3 Risk factors fo r  early-onset sequelae determined by multivariable logistic
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Table 5.6: Risk factors for earlv-onset deficits by logistic regression (N=90)
Risk factor OR Lower 
95% Cl
Upper 
95% Cl
LR test«
Model 1a
Aged 10 years and above 0.79 0.18 3.50 0.75
Managed in Kapchorwa 0.54 0.12 2.44 0.41
Quinine given prior to admission 4.51 1.20 17.00 0.02
Coma recovery time 0.01
1-2 days 1
3-4 days 3.10 0.56 17.19
5 and above 22.84 2.69 193.71
Missing Info 0.90 0.08 9.65
Total fever clearance time 0.002
1 day 1
2-3 days 0.07 0.01 0.42
4-15 days 0.11 0.02 0.61
Haemoglobin concentration 0.01
3.0-9.9 g/dL 0.27 0.06 1.27
10.0-15.0 g/dL 1
Missing info 0.07 0.01 045
Has organomegaly 6.16 1.40 27.06 0.01
Model 1b«
Age group 0.14
1-4 yrs 1
5-9 yrs 6.92 0.88 54.29
10 yrs and above 2.23 0.33 15.06
Managed in Kapchorwa 0.29 0.05 1.60 0.13
Quinine given prior to admission 4.69 1.20 18.40 0.02
Coma recovery time 0.003
1-2 days 1
3-4 days 2.47 0.43 14.22
5 and above 21.43 2.48 185.33
Missing Info 0.38 0.02 6.42
Total fever clearance time 0.01
1 day 1
2-3 days 0.09 0.01 0.58
4-15 days 0.14 0.02 0.81
Haemoglobin concentration 0.04
3.0-9.9 g/dL 0.39 0.07 2.04
10.0-15.0 g/dL 1
Missing info 0.10 0.01 0.69
Has organomegaly 10.44 1.84 59.21 0.002
tf Likelihood ratio test comparing the model with the factor and without the factor 
51 Using age in three categorises
Table 5 .7 .  Risk factors for earlv-onset deficits by logistic regression and adjusting for case 
definition (N-90)
Risk factor OR Lower 
95% Cl
Upper 
95% Cl
LR test«
Model 2a~
Aged 10 years and above 0.84 0.19 3.71 0.81
Managed in Kapchorwa 0.65 0.14 3.06 0.57
Quinine given prior to admission 4.65 1.23 17.58 0.02
Coma recovery time 0.01
1-2 days 1
3-4 days 2.41 0.37 15.54
5 and above 20.42 2.38 175.32
Missing Info 0.99 0.09 10.81
Total fever clearance time 0.002
1 day 1
2-3 days 0.06 0.01 0.39
4-15 days 0.11 0.02 0.61
Haemoglobin concentration 0.01
3.0-9.9 g/dL 0.26 0.05 1.25
10.0-15.0 g/dL 1
Missing info 0.08 0.01 0.50
Has organomegaly 5.93 1.35 26.12 0.01
Model 2bttt
Age group 0.12
1 -4 yrs 1
5-9 yrs 7.88 0.98 63.35
10 yrs and above 2.71 0.38 19,57
Managed in Kapchorwa 0.35 0.06 1.97 0.21
Quinine given prior to admission 5.13 1.28 20.63 0.02
Coma recovery time 0.01
1-2 days 1
3-4 days 1.68 0.25 11.33
5 and above 17.41 2.01 150.57
Missing Info 0.41 0.02 7.51
Total fever clearance time 0.01
1 day 1
2-3 days 0.07 0.01 0.49
4-15 days 0.14 0.02 0.81
Haemoglobin concentration 0.06
3.0-9.9 g/dL 0.39 0.07 2.09
10.0-15.0 g/dL 1
Missing info 0.12 0.02 0.78
Has organomegaly 10.43 1.79 60.72 0.003
88 Likelihood ratio test comparing the model with the factor and without the factor 
Adjusted for case definition
m  Adjusted for case definition and using age categories into three groups
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The results of goodness-of-fit tests (using the Hosmer-Lemeshow test) are as 
follows:
• Model 2a: H-L chi2 (8 degrees of freedom) = 3.55, P = 0.89, 10 groups. 
Figure E in Appendix VI shows a diagnostic plot
• Model 2b: H-L chi2 (8 degrees of freedom) =1.61, P = 0.99, 10 groups.
• Model lb: H-L chi2 (8 degrees of freedom) = 4.78, P = 0.78, 10 groups.
• Model la: H-L chi2 (8 degrees of freedom) = 7.70, P = 0.46, 10 groups. 
Figure D in Appendix VI is a diagnostic plot for the model.
The results show that the logistic models were appropriate for the data.
5.3 Risk factors for late-onset neurological sequelae
The results presented here are from survival analyses consisting of 90 survivors of 
cerebral malaria of whom 52 attended follow-up and 19 had late-onset sequelae. 
Survivors are considered as two groups, children and adults in order to determine 
any differences between both in terms of the rates of deficits.
5 .3 .1  The in cidence rates o f  la te -o n se t defic its  a m o n g s t ch ildren  a n d  a d u lt 
su rv ivors o f  cerebra l m a la r ia  stra tified  b y  ex p la n a to ry  variables.
Twelve children and seven adults were classified as having late-onset neurological 
sequelae. Their Kaplan-Meier ‘survival’ estimates are illustrated in Figure 5.1. The 
‘events’ for these time-to-event analyses are the late-onset deficits, i.e. a subject 
'fails’ if a deficit is detected and a subject ‘survives’ if no deficit is detected at the 
time of assessment. The analysis time is the period from discharge to the detection 
o f late-onset deficits and is variable from one subject to the other (although there 
were targets for the period between discharge and follow-up visits as described in 
the methodology). The figure does not appear to show any consistent difference 
between the two groups (P = 0.99 from the log-rank test). The incidence rate of 
deficits in children during the study period was 2.45 deficits per person-year 
compared to a rate in adults of 2.16 deficits per person-year. Table 5.8 contains the 
incidence rates of deficits in children and adults stratified by explanatory factors. 
The incidence rate ratios comparing rates between children and adults are also given. 
The table shows that children had a higher incidence o f  late-onset sequelae in 
Kapchorwa than Mbale.
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----------  age = 1 -9  yrs -------------  age = 10-60 yrs
Figure 5.1 Kaplan Meier survival' curves showing the probability of not having late-onset 
sequelae during the follow-up period (analysis time) in weeks for child (1-9 vrs) and adult ( IQ- 
60 vrs) survivors who attended follow up visits (N=90)
Adult cases in Kapchorwa had a higher frequency of deficits than children 
(IRR=1 21 [95% Cl 0 29-5 82]) Children that did not have a history of seizures 
within 24 hours before admission had a higher rate of deficits than adults without 
histories o f  reported seizures However, when a history of 1 to 3 seizures was given, 
the incidence of deficits was greater in adults A greater number of seizures was 
associated with a higher incidence of sequelae in children (1RR=0.62 [95% Cl 0.06- 
3 79]). Adult cases with a previous history of admission before the current illness 
had an incidence rate of 11 69 deficits per person-year Child cases with a similar 
history had a rate of 2 25 deficits per person-year Survivors who on admission 
could localise pain were more likely to have deficits if they were adults than 
children, (IRR=4 11 [95% Cl 0 09-36 74])
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Table 5.8: Summary of the stratified incidence rates and rate ratios for late-onset neurological deficits amonqst child and adult survivors of cerebral malaria who 
attended follow-up ln=52l
Variable
No. of 
events
Children 
Discharge 
to 1a visit 
(person 
years)'
Incidence rate 
(per person- 
year)
No. of 
events
Adults 
Discharge 
to 1a visit 
(person 
years)
Incidence rate 
(per person- 
year)
Incidence rate 
ratio (Adults / 
Children)
Lower 
95% Cl
Upper 
95% Cl
Overall 12 4.88 2.46 7 3.23 2.16 0.88 0.29 2.43
Demographic & History information
Centre
Mbale 8 2.50 3.21 1 0.27 3.76 1.18 0.27 8.80
Kapchorwa 4 2.39 1.67 6 2.97 3.02 1.21 0.29 5.82
Seizures within 24 hours prior to admission 
(None/Any number)
None 3 0.54 5.59 1 0.89 1.12 0.2 0.00 2.49
1-3 seizures 4 2.57 1.56 4 1.19 3.35 2.15 0.40 11.57
4-20 seizures 5 1.78 2.81 2 1.15 1.75 0.62 0.06 3.79
Quinine given prior to admission
No 8 2.94 2.72 5 2.55 1.96 0.72 0.19 2.49
Yes 4 1.94 2.06 2 0.68 2.94 1.43 0.13 9.98
Previous medical admission to hospital
No 11 4.44 2.48 6 3.15 1.91 0.77 0.23 2.27
Yes 1 0.44 2.25 1 0.09 11.69 5.20 0.07 408 44
Clinical examination on admission
Case definition
Definite 5 1.86 2.69 4 2.51 1.59 0.59 0.12 2.75
Probable 7 3.03 2.31 3 0.72 4.16 1.80 0.30 7.88
Table continued overleaf
* Cumulative duration between discharge and the first follow-up visit; The duration was variable for each patient.
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Table 5 .8  continued
Variable
No. of 
events
Children 
Discharge 
to 1s1 visit 
(person 
yearsjt
Incidence rate 
(per person- 
year)
No. of 
events
Adults 
Discharge 
to 1st visit 
(person 
years)
Incidence rate 
(per person- 
year)
Incidence rate 
ratio (Adults / 
Children)
Lower 
95% Cl
Upper 
95% Cl
Able to localise painful stimuli at Level 2 
No 7 2.79 2.50 6 3.12 1.92 0.76 0.21 2.66
Yes 5 2.09 2.39 1 0.10 9.67 4.11 0.09 36.74
Body temperature
35.0-38.5 °C 7 3.01 2.33 3 1.40 2.14 0.92 0.15 4.04
38.6-39 4 °C 3 1.53 1.96 4 1.74 2.30 1.17 0.20 8.00
39.542.0 °C 2 0.34 5.82 0 0.09 NA NA NA NA
Moderate -  severe anaemia
No 7 1.62 4.33 5 2.69 1.86 0.43 0.11 1.57
Yes 5 3.27 1.53 2 0.54 3.67 2.40 0.23 14.66
Clinical signs of jaundice
No 11 4.40 2.50 7 3.15 2.23 0.89 0.29 2.51
Yes 1 0.49 2.05 0 0.00 NA NA NA NA
Clinical signs of moderate -  severe 
dehydration (No/Yes)
No 11 4.86 2.26 7 3.23 2.17 0.96 0.31 2.70
Yes 1 0.02 44.33 0 0.00 NA NA NA NA
Presence of extra heart sounds
None 8 3.43 2.33 7 3.04 2.30 0.99 0.30 3.12
Yes 2 0.95 2.11 0 0.20 NA NA NA NA
Missing info 2 0.51 3.93 0 0.00 NA NA NA NA
Table continued overleaf
* Total of cumulative durations between discharge and the first follow-up visit for all patients; The duration was variable for each patient.
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Table 5 .8  continued
Variable _____________ Children___________________________Adults_____________  Incidence rate Lower Upper
No. of Discharge Incidence rate No. of Discharge Incidence rate ratio (Adults / 95% Cl 95% Cl
events to 1a visit (per person- events to 1st visit (per person- Children)
(person year) (person year)
Possibility of shock 
Unlikely 
Likely
10
2
4.50
0.38
2.22
5.25
7
0
_ __
3.23
0.00
2.17
NA
0.97
0
0.31
0
2.83
0
Pulse pressure
20-39 mmHg 1 0.82 1.22 1 1.01 0.99 0.81 0.01 63.61
40-79 mmHg 0 0.23 NA 3 1.86 1.61 NA NA NA
Missing info 11 3.83 2.87 3 0.35 8.46 2.95 5.3 11.15
Respiratory abnormality
No 6 2.36 2.54 7 3.07 2.28 0.90 0.26 3.23
Yes 6 2.52 2.38 0 0.17 NA NA NA NA
Possibility of respiratory distress
Unlikely 12 4.53 2.65 7 3.23 2.17 0.82 0.27 2.25
Likely 0 0.35 NA 0 0.00 NA NA NA NA
Presence of Organomegaly
No 8 3.31 2.42 3 0.88 3.40 1.41 0.24 5.88
Yes 4 1.57 2.54 4 2.35 1.70 0.67 0.12 3.59
Enlarged spleen
No 10 4.26 2.35 6 2.55 2.36 1.00 0.30 3.05
Yes 2 0.62 3.21 1 0.69 1.46 0.45 0.01 8.68
Enlarged liver (No/Yes)
No 10 4.06 2.46 6 2.26 2.65 1.08 0.32 3.28
Yes 2 0.82 2.44 1 0.97 1.03 0.42 0.01 8.09
Table continued overleaf
• Total of cumulative durations betw een discharge and the first follow-up visit for all patients; The duration was variable for each patient.
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Table 5 .8  continued
Variable
No. of 
events
Children 
Discharge 
to 1s* visit 
(person 
years )$
Incidence rate 
(per person- 
year)
No. of 
events
Adults 
Discharge 
to 1s1 visit 
(person 
years)
Incidence rate 
(per person- 
year)
Incidence rate 
ratio (Adults / 
Children)
Lower 
95% Cl
Upper 
95% Cl
In-hospital non-laboratory information
Had witnessed seizures
No 8 2.57 3.11 5 1.77 2.82 0.91 0.23 3.16
Yes 4 2.31 1.73 2 1.47 1.36 0.79 0.07 5.50
Number of witnessed seizures (1SI episode)
None 8 2.57 3.11 5 1.77 2.83 0.91 0.23 3.16
1-3 seizures 2 1.15 1.74 2 0.90 2.21 1.27 0.09 17.57
4-20 seizures 2 1.16 1.73 0 0.56 NA NA NA NA
Seizure stoppage time
1-2 days 2 2.00 1.00 1 1.02 0.98 0.98 0.02 18.82
348 days 2 0.31 6.43 1 0.44 2.24 0.35 0.01 6.70
No seizures recorded 8 2.57 3.11 5 1.77 2.82 0.91 0.23 3.16
Total seizure stoppage time
1-2 days 5 2.91 1.72 4 1.37 2.92 1.70 0.34 7.90
348 days 5 1.47 3.40 2 1.17 1.70 0.50 0.05 3.06
No seizures recorded 2 0.50 3.99 1 0.69 1.46 0.36 0.01 7.00
Duration of unrousable coma
Not in unrousable coma on admission 5 2.26 2.22 0 0.10 NA NA NA NA
For less than 48 hours 3 1.64 1.83 3 1.47 2.04 1.12 0.15 8.36
For 48 hours or more 3 0.80 3.75 4 1.67 2.40 0.64 0.11 4.36
Missing info 1 0.18 5.41 0 0.00 NA NA NA NA
Table continued overleaf
* Total of cumulative durations between discharge and the first follow-up visit for all patients; The duration was variable for each patient.
187
Table 5 .8  continued
Variable
No. of 
events
Children 
Discharge 
to 1st visit
(person 
years)"____
Incidence rate 
(per person- 
year)
No. of 
events
Adults 
Discharge 
to 1s1 visit 
(person 
years)
Incidence rate 
(per person- 
year)
Incidence rate 
ratio (Adults / 
Children)
Lower 
95% Cl
Upper 
95% Cl
Coma recovery time
1-2 days 2 1.32 1.51 1 0.70 1.42 0.94 0.02 18.06
3-4 days 5 2.21 2.26 4 2.03 1.97 0.87 0.17 4.04
5 and above 2 0.50 4.04 2 0.50 4.02 0.99 0.07 13.72
Missing Info 3 0.86 3.50 0 0.00 NA NA NA NA
Total coma recovery time
1-2 days 4 1.85 2.16 0 0.60 NA NA NA NA
3-4 days 3 1.73 1.73 4 1.79 2.23 1.29 0.22 8.78
5 and above 5 1.22 4.11 3 0.84 3.58 0.87 0.14 4.47
Missing info 0 0.09 NA 0 0.00 NA NA NA NA
Fever clearance time
1 day 2 1.29 1.55 3 0.99 3.02 1.95 0.22 23.38
2-3 days 4 2.34 1.71 4 2.24 1.79 1.04 0.19 5.60
4-9 days 6 1.17 5.14 0 0.00 NA NA NA NA
Missing info 0 0.09 NA 0 0.00 NA NA NA NA
Total fever clearance time
1-4 days 4 2.03 1.97 3 0.36 8.45 4.28 0.63 25.33
5-6 days 1 1.04 0.96 3 2.24 1.34 1.39 0.11 73.14
7-15 days 7 1.82 3.85 1 0.64 1.56 0.41 0.01 3.16
Quinine loading dose prescribed on 
admission
No 11 4.10 2.68 7 2.48 2.83 1.05 0.35 2.97
Yes 0 0.26 NA 0 0.00 NA NA NA NA
Missing 1 0.53 1.89 0 0.76 NA NA NA NA
Table continued overleaf
Total of cumulative durations between discharge and the first follow-up visit for all patients; The duration was variable for each patient.
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T able 5 .8  continued
Variable
No. of 
events
Children 
Discharge 
to 1st visit 
(person 
years)tt
Incidence rate 
(per person- 
year)
No. of 
events
Adults 
Discharge 
to 1st visit 
(person 
years)
Incidence rate 
(per person- 
year)
Incidence rate 
ratio (Adults f 
Children)
Lower 
95% Cl
Upper 
95% Cl
Dose of quinine given on Day 0
3-8.9 mg/kg 4 0.95 4.19 1 0.59 1.71 0.41 0.01 4.11
9.0-10.9 mg/kg 1 0.22 4.54 1 0.09 11.69 2.58 0.03 202.57
11.0-20.9 mg/kg 2 1.46 1.37 1 1.01 0.99 0.72 0.01 13.81
Missing info 5 2.25 2.22 4 1.55 2.58 1.16 0.23 5.41
Duration of hospital stay
Less than 6 days 0 0.17 NA 0 0.00 NA NA NA NA
6 to 8 days 7 3.41 2.05 6 3.06 1.96 0.96 0.27 3.32
More than 8 days 5 1.31 3.83 1 0.08 11.72 3.07 0.06 27.40
Laboratory based information
Hypoglycaemia present on admission
No 11 4.72 2.33 7 3.23 2.17 0.93 0.31 2.62
Yes 1 0.17 6.03 0 0.00 NA NA NA NA
Random blood glucose on admission
Less than 5 mmol/L 5 1.48 3.38 1 0.41 2.42 0.72 0.02 6.41
5 -  6.9 mmol/L 3 0.75 4.02 4 1.69 2.37 0.59 0.10 4.02
7 -14.9 mmol/L 2 1.22 1.63 1 0.69 1.45 0.89 0.02 17.10
Missing info 2 1.44 1.39 1 0.45 2.25 1.61 0.03 30.93
Parasite count
50,000 parasites/piL and below 8 2.44 3.28 4 1.70 2.36 0.72 0.16 2.68
> 50,000 parasites/pL 3 2.05 1.46 2 1.36 1.47 1.00 0.08 8.76
Missing info 1 0.39 2.54 1 0.17 5.76 2.27 0.03 178.17
Table continued overleaf
M Total of cumulative durations between discharge and the first follow-up visit for all patients; The duration was variable for each patient.
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Table 5 .8  continued
Variable
No. of 
events
Children 
Discharge 
to 1st visit 
(person 
years)«
Incidence rate 
(per person- 
year)
No. of 
events
Adults 
Discharge 
to 1st visit 
(person 
years)
Incidence rate 
(per person- 
year)
Incidence rate 
ratio (Adults 1 
Children)
Lower 
95% Cl
Upper 
95% Cl
Parasite clearance time
1 day 4 0.80 4.96 1 1.53 0.66 0.13 0.00 1.33
2 days 5 2.62 1.91 3 1.44 208 1.09 0.17 5.60
3-4 days 2 1.08 1.85 1 0.09 11.70 6.34 0.11 121.76
Missing info 1 0.37 2.63 2 0.18 11.17 4.25 0.22 250.51
Haemoglobin concentration
3.0-9.9 g/dL 4 2.63 1.53 2 0.54 3.67 241 0.22 16.83
10.0-150 g/dL 6 1.48 4.05 1 0.77 1.31 0.32 0.01 2.66
Missing info 2 0.78 2.57 4 1.92 2.08 0.81 0.12 8.92
HIV infection
No 3 1.03 2.91 0 0.00 NA NA NA NA
Yes 0 0.10 NA 1 0.45 2.24 NA NA NA
Missing 9 3.75 2.40 6 2.79 2.15 0.90 0.26 2.82
Serum Sodium concentration
<135 mmol/L 5 1.18 4.24 2 0.62 3.22 0.76 0.07 4.63
135-146 mmol/L 2 1.67 1.19 0 0.09 NA NA NA NA
>146 mmol/L 0 0.29 NA 0 0.00 NA NA NA NA
Missing info 5 1.75 2.86 5 2.52 1.98 0.69 0.16 3.01
Serum Calcium concentration
<2 mmol/L 2 0.93 2.15 1 0.50 2.00 0.93 0.02 17.84
2-3 mmol/L 0 0.09 NA 0 0.00 NA NA NA NA
>3 mmol/L 3 1.18 2.54 4 1.13 3.52 1.39 0.23 9.46
Missing info 7 2.69 2.61 2 1.60 1.25 0.48 0.05 2.52
Table continued overleaf
** Total of cumulative durations between discharge and the first follow-up visit for all patients: The duration was variable for each patient.
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T ab le  5 .8  con tin u ed
Variable
No. of 
events
Children 
Discharge 
to 1s1 visit 
(person 
years)»
Incidence rate 
(per person- 
year)
No. of 
events
Adults 
Discharge 
to 1st visit 
(person 
years)
Incidence rate 
(per person- 
year)
Incidence rate 
ratio (Adults / 
Children)
Lower 
95% Cl
Upper 
95% Cl
Serum Chloride concentration 
<95 mmol/L 1 0.27 3.71 0 0.00 NA NA NA NA
95-105 mmol/L 2 0.44 4.57 1 0.61 1.65 0.36 0.01 6.92
>105 mmol/L 2 1.32 1.32 3 1.02 2.93 1.93 0.22 23.12
Missing info 7 2.86 2.86 3 1.60 1.87 0.76 0.13 3.35
White blood cell count
2000-4700 cells/L 3 1.08 2.79 4 1.36 2.95 1.06 0.18 7.22
4701-6700 celisi 4 1.44 2.78 0 1.26 NA NA NA NA
6701-27000 cells/L 4 1.96 2.04 0 0.36 NA NA NA NA
Missing info 1 0.41 2.95 3 0.26 11.73 4.84 0.39 254.02
At discharge
Has early-onset neurological deficits
No 7 3.73 1.88 5 2.99 1.67 0.89 0.22 3.26
Yes 5 1.16 4.32 2 0.25 8.07 1.87 0.18 11.43
» Total of cumulative durations between discharge and the first follow-up visit for all patients; The duration was variable for each patient.
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The rate of deficits in children with hyperthermia was 5.82 deficits per person-year. 
The rate decreased with increasing categories of body temperature in both children 
and adults. Older cases with signs of moderate to severe anaemia had just over 2 
times the rate of sequelae than younger cases. Children who had clinical features 
suggestive of shock had a higher frequency of deficits than those who did not have 
features suggestive of shock. Cases who did not have a palpable or enlarged spleen 
had similar rates of deficits between children and adults. Adults with enlarged 
spleens had a lower rate of deficits than children (IRR=0.45 [95% Cl 0.01-8.68]).
Witnessed seizures in hospital were associated with a reduced frequency of sequelae 
during follow-up in both children and adults. However longer seizure stoppage times 
were associated with increased incidence rates of sequelae. Child cases who were 
unconscious for 48 hours and more had an incidence rate of 3.75 deficits per person- 
year which was higher than the rate in adult cases, 2.40 deficits per person-year. As 
the coma recovery time increased, so did the rate of sequelae in both groups. A total 
fever clearance time of 1 to 4 days resulted in a four-fold rate of late-onset deficits in 
adults compared with children. Longer durations were associated with a smaller 
ratio. Children who were given the lower dose of quinine on Day 0 had a higher 
incidence compared to adults. The opposite was found in cases given the standard 
dose of quinine. Adults had twice the rate of deficits. The higher doses of quinine 
were associated with smaller rates within both groups and fairly similar rates 
between groups. Those cases who stayed for more than 8 days in hospital had the 
higher rates of deficits than those who spent shorter durations. Adults who spent 
more than 8 days were more likely to develop late-onset deficits compared to 
children.
Blood glucose concentrations between 7 and 14 mmol/L were associated with a 
lesser frequency of deficits in both children and adults. A shorter duration of parasite 
clearance time was associated with a greater risk of deficits in children. The reverse 
was found in adults, who had more deficits with increasing clearance times. As a 
consequence, the incidence rate ratio between children and adults was 6.34 if the 
parasite clearance time was 3 to 4 days, the maximum period it took to clear 
parasites in the study. Adult cases who had sequelae at discharge had an incidence
192
rate of late-onset deficits that was almost twice the rate in children who were 
discharged with early-onset sequelae.
5 .3 .2  C rude a n d  ad ju sted  re la tive  risk  estim a tes f o r  la te -on se t neu ro log ica l 
sequelae.
Time-to-event analysis using regression on the Weibull distribution was employed 
to determine the association between explanatory variables and late-onset deficits. 
This distribution was considered more appropriate than an exponential or constant 
hazard to model the data because it did not assume that the risk for the event, in this 
case the detection of late-onset deficits, was constant during the follow-up period. It 
appeared from the data and the literature that the risk for late-onset deficits was 
likely to decline with increasing time after cerebral malaria. Crude and adjusted 
hazard ratios (adjusted for case definition, centre or age) are given in Table 5.9. 
Centre was highly associated with outcome. Kapchorwa survivors, who were in 
general older, had a reduced risk for deficits compared to those from Mbale. This 
association was not modified by adjusting for case definition, or age. Adult 
survivors had a hazard ratio of 0.76 compared to children although this was not 
significant at the 5% level. The risk declined with age when it was categorised into 
three groups. The lower group was not used as the referent one because none of the 
younger children had late-onset deficits. The decline was modified when centre was 
adjusted for as shown.
The number of reported seizures in the 24 hours before admission did not seem to be 
independently associated with deficits. A previous history o f admission though not 
highly associated with outcome, had a 2 fold effect on the risk estimate. The depth 
of coma when expressed as the inability to localise a painful stimulus was not 
associated with any increase in the hazard ratio, crude or adjusted. However, when 
coma was expressed in terms of coma scores, survivors who had lower scores were 
more likely to have late-onset deficits compared to those who were less comatose. 
Hyperthermia resulted in a hazard ratio of about 3 when compared with 
temperatures below 38.5 °C. This clinically important effect was not modified by 
case definition, centre or age and was not statistically significant at the 5% level.
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Table 5.9: Crude and adjusted hazard ratios for late-onset neurological sequelae among survivors of cerebral malaria who attended a follow-up visit In -521
Risk factor
Crude HR Rvalue
Case definition 
HR 95% Cl
Variable adjusted for 
Centre
HR 95% Cl HR
Age group 
95% Cl
Factors shown to have differences in the
descriptive analyses
Centre
Mbale 1 1 NA' - 1
Kapchorwa 0.30 0.04 0.30 0.09-0.95 - - 0.27 0.07-1.01
Age group 1
S 10 yrs 1 1 1 NA -
>10 years 0.76 0.56 0.80 026-2.43 1.17 0.39-3 50 - -
Age group 2
1-4 yrs 1.31 0.66 1.37 038-4.88 0.61 0.16-2.26 NA -
5-9 yrs 1 1 1 - -
10 yrs and above 0.82 0.71 0.91 0.26-3.13 1.05 0.35-3.14 NA -
Number of seizures within 24 hours prior to
admission
None 1 1 1 1
1-3 seizures 0.77 0.67 0.67 0.19-2.41 0.83 0.25-2.76 0.68 0.19-2.38
4-20 seizures 0.85 0.79 0.79 0.23-2.76 0.74 0.22-2.54 0.76 0.22-2.70
Admitted to hospital before 2.05 0.35 1.99 044-897 1.21 0.25-5.76 1.94 0.43-8.82
Unable to localise painful stimuli 1.18 0.73 1.03 0.29-3.67 1.08 0.40-2.89 1.02 0.32-3.21
Table continued overleaf
Not applicable
T able 5 .9  continued
Variable adjusted for
Risk factor Case definition_________ Centre___________ Age group
Crude HR P value HR 95% Cl HR S5% Cl HR 95% Cl
Blantyre Coma Score*
0-2 1.10 0.93 1.38 0.11-17.69 1.32 0.12-14.77 1.11 0.10-12.32
3-5 1 1 1 1
Missing info 1.39 0.75 1.57 019-12.79 3.77 0.45-31.40 1.65 0.20-13.25
Glasgow Coma Score*
3-8 1.62 0.38 2.14 0.61-7.49 0.78 0.16-3.67 1.78 0.57-5.54
9-12 1 1 1 1
Missing info 1.71 0.41 1.85 0.51-6.67 0.46 0.07-3.25 1.52 0.41-5.73
Body temperature
35 0-38.5 °C 1 1 1 1
38.6-39.4 °C 0.85 0.74 1.02 0.34-3.09 0.98 0.36-2.64 0.90 0.33-2.44
39 542.0 °C 2.68 0.22 348 0.59-20.39 2.36 0.49-11.37 2.66 0.55-12.93
Presence of moderate to severe anaemia 0.72 0.50 0.67 0.25-1.76 0.49 0.18-1.34 0.55 0.19-1.57
Presence of jaundice 0.92 0.93 0.92 0.12-7.22 0.60 0.07-4.76 0.88 0.11-6.95
Presence of any respiratory abnormality 1.09 0.86 1.05 0.38-2.89 0.65 0.22-1.95 0.94 0.31-2.85
Presence of any extra heart sounds
No 1 1 1 1
Yes 0.76 0.71 0.73 0.16-3.23 0.66 0.15-2.90 0.70 0.15-3.15
Missing info 2.14 0.32 2.03 0.43-9.56 1.33 0.28-6.40 1.93 0.40-928
Presence of organomegaly 0.70 0.45 0.73 0.26-2.04 0.82 0.32-2.11 0.75 0.27-2.06
Presence of enlarged spleen 0.99 0.99 1.08 0.30-3.92 0.90 0.26-3.11 1.06 0.30-3.74
Table continued overleaf
Children aged 5 years and below 
Children aged over 5 years
Table 5 .9  continued
Risk factor
Crude HR P value
Case definition 
HR 95% Cl
Variable adjusted for 
Centre
HR 95% Cl HR
Age group 
95% Cl
Pulse pressure
20-39 mmHg 0.67 0.66 0.67 0.11-4.01 0.65 0.11-3.89 0.88 0.15-5.35
40-79 mmHg 1 1 1 1
Missing info 3.00 0.09 3.33 0.85-12.98 2.30 0.55-9.63 8.40 1.49-47.28
Had witnessed seizures 0.55 0.23 0.56 0.21-146 0.52 0.20-1.37 0.56 0.21-1.47
Number of witnessed seizures on first episode
None 1 1 1 1
1-3 seizures 0.74 0.60 0.75 0.24-2.3 5 0.62 0.20-1.98 0.77 0.24-2.44
4-20 seizures 0.37 0.19 0.37 0.08-1.64 0.39 0.09-1.75 0.36 0.08-1.62
Fever clearance time
1 day 1 1 1 1
2-3 days 0.75 0.61 0.75 0.25-2.30 0.81 0.26-2.53 0.74 0.24-2.28
4-9 days 3.27 0.06 3.23 0.90-11.58 2.35 0.57-9.69 3.45 0.89-13.31
Total fever clearance time
14 days 1 1 1 1
5-6 days 0.40 0.13 0.25 0.06-1.08 0.43 0.13-1.49 0.34 0.08-1.39
7-15 days 1.13 0.81 1.16 0.42-3.19 1.04 0.37-288 1.07 0.38-3.04
Has hypoglycaemia 3.55 0.23 3.54 0.45-28.13 3.25 0.41-2 5.53 3.31 0.41-26.65
Random blood glucose
<5mmol/L 1.13 0.82 1.08 0.36-3.27 1.11 0.37-3.29 0.89 0.26-3.02
5-6.9 mmol/L 1 1 1 1
>7 mmol/L 0.52 0.35 0.52 0.13-2.01 0.48 0.12-1.86 0.44 0.11-1.82
Missinq info 0.61 0.47 0.58 0.15-2.30 0.48 0.12-1.92 0.48 0.11-2.08
Haemoglobin concentration
3.0-9.9 g/dL 0.63 0.40 0.61 0.20-1.8 3 0.55 0.18-1.65 0.58 0.19-1.77
10.0-15 0 g/dL 1 1 1 1
Missing info 0.67 0.47 0.69 0.23-2.08 0.60 0.20-1.80 0.77 0.24-2.48
Table con tinu ed  o v er lea f
Table 5 .9  continued
Risk factor
Crude HR P value
Case definition 
HR 95% Cl
Variable adjusted for 
Centre
HR 95% Cl HR
Age group 
95% Cl
White blood cell count
2,000-4,700 1.77 0.36 1.65 0.47-5.82 2.38 0.66-8.63 1.74 0.50-6.00
4,701-6,700 1 1 1 1
6,701-27,000 1,20 0.79 1.09 0.26-4.56 1.49 0.36-6.10 1.01 0.23-431
Missing info 6.11 0.02 6.02 1.36-26.64 4.45 1.01-19.67 5.81 1.32-25.63
Other explanatory factors
Quinine given prior to admission 1.03 0.94 1.00 0.37-2.67 0.95 0.36-2.53 0.97 0.36-2.63
Presence of moderate to severe dehydration 44.72 0.001 50.74 4.97-517.91 44.73 4.45-449.30 43.15 4.40-423.04
Likely to be in shock 2.54 0.21 2.43 0.51-11.57 1.26 0.25-6.36 2.36 0.52-10.79
Duration taken to localise pain
Localises pain on admission 1 1 1 1
< 48 hours 0.94 0.91 1.21 0.27-5.41 1.04 0.31-3.44 1.22 0.34-4.45
> 48 hours 1.36 0.59 1.70 0.43-6.70 1.54 0.48-4.93 2.06 0.50-8.49
Missing info 3.34 0.28 3.30 0.37-29.69 3.27 0.37-29.23 3.62 0.40-33.11
Coma recovery time
1-2 days 1 1 1 1
3-4 days 1.29 0.70 1.25 0.33-4.73 1.67 0.44-6 38 1.29 0.35-4.86
5 and above 2.78 0.18 2.84 0.63-12.74 3.37 0.74-15.31 2.91 0.64-13.12
Missing Info 2.21 0.33 1.97 0.36-10.64 2.71 0.54-13.61 1.95 0.37-10.30
Total coma recovery time
1-2 days 1 1 1 1
3-4 days 1.08 0.91 1.05 0.30-3.65 1.47 0.40-5.41 1.13 033-3.94
5 and above 2.94 0.08 3.18 0.92-11.05 2.90 0.85-981 3.20 0.92-11.14
Seizure stoppage time
1-2 days 1 1 1 1
3-48 days 3.91 0.09 3.80 0.75-19.15 4.03 0.81-19.97 4.43 0.87-22.63
No recorded seizures 2.88 0.10 2.86 0.81-10.08 3.10 0.88-10.93 2.93 0.83-10.32
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Table 5 .9  continued
Variable adjusted for
Case definition_________ Centre___________ Age group
Crude HR P value HR 9 5%  C l HR 95%  C l HR 95% C l
Total seizure stoppage time 
1-2 days 
3-48 days
No recorded seizures
1
1.22
1.15
0.69
0.83
1
1.21
1.19
0.45-3.25
0.32-4.42
1
1.25
1.17
0.46-337
0.32-4.35
1
1.28
1.28
0.47-3.47
0.33-4.90
Dose of quinine given on Day 0
3-8.9 mg/kg 2.56 0.27 2.94 0.52-16.54 2.55 0.48-13.60 2.49 0.47-13.25
9.0-10.9 mg/kg 1 1 1 1
11.0-20.9 mg/kg 0.31 0.11 0.31 0.07-1.34 0.37 0.09-1.58 0.31 0.07-1.32
Missing info 0.61 0.39 0.55 0.17-1.76 0.80 0.25-2.54 0.60 0.19-1.85
Parasite count
£ 50,000 parasites/pL 1 1 1 1
> 50,000 parasites/pL 0.47 0.15 0.46 0.16-1.32 0.59 0.19-1.79 0.45 0.16-1.30
Missing info 1.60 0.55 1.50 0.31-7.31 1.12 0.23-542 1.58 0.33-7.46
Parasite clearance time
1 day 1 1 1 1
2 days 0.92 0.88 0.87 0.25-3.05 0.94 0.31-2.89 0.83 0.25-2.73
3-4 days 1.25 0.76 1.16 0.23-5.69 1.33 0.32-5.59 1.02 0.21-5.08
Missing info 3.59 0.10 3.32 0.62-17.89 2.51 0.54-11.73 3.25 0.68-15.48
HIV infection
No 1 1 1 1
Ves 0.46 0.51 0.40 0.04-4.24 090 0.08-9.69 0.53 0.05-6.11
Missing 0.62 0.47 0.62 0.17-2.29 1.14 0.29-4.49 0.66 0.17-2 56
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Table 5 .9  continued
Risk factor
Crude HR P value
Case definition 
HR 95% Cl
Variable adjusted for 
Centre
HR 95% Cl HR
Age group 
95% Cl
Serum Sodium concentration
<135mmol/L 3.55 0.11 3.54 0 73-17.08 3.22 0.67-1556 4.22 0.85-21.04
135-146 mmol/L 1 1 1 1
Missing info 1.77 0.46 1.85 0.38-8.94 2.73 0.54-13.78 2.23 045-10.92
Serum Calcium concentration
<2 mmol/L 1 1 1 1
>3 mmol/L 1.35 0.66 1.28 0.32-5.06 1.22 0.31-4.73 141 0.36-5.51
Missing info 0.83 0.78 0.75 0.19-3.03 0.92 0.24-3.59 0.77 0.19-304
Serum Chloride concentration
<95 mmol/L 1.63 0.67 1.43 0.14-14.87 1.76 0.18-17.34 1.38 0.13-14.34
95-105 mmol/L 1 1 1 1
>105 mmol/L 0.78 0.73 0.75 0.18-3.17 0.65 0.15-2.76 0.76 0.18-3.18
Missing info 0.71 0.61 0.65 0.17-2.50 0.78 0.21-2.89 0.64 0.17-2.47
Had early-onset neurological deficits 3.00 0.02 2.99 1.14-7.86 3.21 1.26-8.22 3.03 1.11-8.22
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Survivors who had tonic-clonic seizures in hospital were about 50% less likely to 
have late deficits than those who did not. A step wise decline in the hazard with 
increasing number of seizures was seen. A duration o f over 3 days for fevers to clear 
was strongly associated with a greater risk of deficits by about 3 times (P = 0.07). 
This effect reduced in magnitude when the number o f days for which patients were 
reportedly febrile were added, i.e. total fever clearance time. Hypoglycaemia was 
associated with a greater risk of deficits at the 23% level. The three-fold increase in 
risk persisted when case definition, centre and age were controlled for separately.
One survivor who was admitted with features of moderate to severe dehydration had 
a late-onset neurological deficit. As a result the hazard ratio was very large, 44.72 (P 
= 0.001). The adjusted estimates had very wide confidence intervals because 
comparison was made with a group in which there was no survivor with deficits, i.e. 
dehydrated and no late-onset deficits. Likewise, two survivors who had features of 
shock on admission, developed late-onset deficits. The comparison cell of shock and 
no deficits had no survivor that attended follow-up. Survivors who had been in coma 
for 5 or more days had a greater risk of deficits than those who had been in coma for 
1 to 2 days. This effect was similar but of less magnitude if those who had been in 
coma for 3 to 4 days were compared with the same referent group. The total coma 
recovery time showed a similar effect. The seizure stoppage time was a risk factor 
for deficits. The total seizure stoppage time showed a similar association though the 
study was not able to show if  they were real or could have occurred by chance.
The risk estimate for deficits among cases that were given the higher dose of quinine 
was compared with the standard dose of lOmg/kg. The crude hazard ratio was 0.31 
and did not change after adjusting for the other factors separately. Patients who 
received the lower dose had a greater potential for deficits compared to those who 
received the standard dose. The finding of deficits at discharge was associated with a 
three-fold risk of late-onset deficits (P = 0.02).
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5 .3 .3  Risk fa c to r s  determ ined  by m ultivariable su rv iv a l analysis
A model to determine the risk factors that are associated with late-onset deficits was 
constructed in a step-wise manner. The first variable inserted into the model was 
age, because a priori the hypothesis was that it influenced the risk for sequelae. Next 
centre was added, because it was an important confounding factor and adjusting for 
it allowed other unmeasured factors that are related to study site to be taken into 
account. These were followed by factors that were shown to be associated with the 
outcome up to the 15% alpha level. They remained in the model if their P value for 
the LR test was significant up to the 5% level or they were considered to be 
clinically significant. The next variables that were added to the model are those 
which have already been described in the literature as risk factors and listed in the 
plan of analysis at the onset. Likewise they remained in the model if they met the 
requirements above. Lastly, clinically relevant factors were added into the model if 
they had not already been selected by any of the above procedures. These were left 
in the model. Care was taken not to leave too many variables in the model since the 
number of events was small. In this way the models based on the Weibull 
distribution and shown in Table 5.10 were developed. Comparison models using 
Cox regression are given in Table D in Appendix V.
Model 1 in Table 5.10 shows two models. The difference between Model 1 and 2 is 
that the latter does not include clinically significant variables. The results o f both are 
fairly similar however, some values of the hazard ratios differ and the width of the 
confidence intervals are narrower in Model 2. Survival analysis takes the time to 
event into account. It is important for me to mention at this stage that in reality the 
time period that forms the analysis time is better described as the time to detection 
of the deficit and not purely the time to the manifestation of deficits. Patients who 
had deficits at discharge were not excluded from the denominator because a variable 
that had information on the presence or absence of early onset deficits was included 
into the model. This was done because it was o f  clinical value to the health 
practitioners to use that information to be able to predict the likelihood of late-onset 
deficits.
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Table 5.10: Risk factors for late-onset neurological sequelae by multivariable survival analysis 
using the Weibull distribution
Risk factor Hazard
Ratio'
Lower 
95% Cl
Upper 
95% Cl
LR test
Model 1 (n=90)>
Aged over ten years 1.84 0.51 6.67 0.34
Admitted to hospital before 0.69 (C* ) 0.54 38.62 068
Body temperature (C) 0.56
35.0-38.5 °C 1
38.6-39.4 °C 1.47 0.45 4.82
39.5-42.0 °C 3.19 0.39 26.11
Fever clearance time 0.08
1 day 1
2-3 days 0.87 0.22 3.36
4-9 days 7.52 1.11 50.69
Seizure stoppage time 0.06
1-2 days 1
3-48 days 4.56 0.54 38.62
No seizures recorded 7.92 1.09 57.40
Total coma recovery time (C) 0.67
1-2 days 1
3-4 days 2.72 0.48 15.37
5 and above 1.39 0.28 6.95
Was hypoglycaemic on admission 1.91 (C) 0.10 37.75 0.67
Had deficits at discharge 5.01 1.26 19.93 0.02
Model 2 (n=90)§
Aged over ten years 1.64 0.51 5.28 0.40
Fever clearance time 0.09
1 day 1
2-3 days 0.71 0.19 264
4-9 days 4.62 0.79 26.95
Seizure stoppage time 0.04
1-2 days 1
3-48 days 4.80 0.82 27.97
Missing 495 1.13 21.78
Had deficits at discharge 8.07 2.14 30.47 0.002
* Derived from a Weibull model and Includes clinically significant variables
* Adjusted for centre and using age as two categories
5 ‘C’ refers to clinically significant factors which were included in the model without being 
statistically significant.
* Derived from a Wcibull model and does not include clinically significant variables as in Model I.
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In Model 1, the duration taken for seizures to cease was independently associated 
with the detection of late-onset seizures. The hazard ratio increased with longer 
seizure stoppage time. The presence of deficits at discharge, i.e. early-onset deficits 
was also highly associated with late-onset deficits with a hazard ratio of about 5. 
Fever of durations over 3 days increased the risk of deficits by 7 fold. The risk of 
late-onset deficits in survivors who had been admitted to hospital before (a clinically 
relevant variable) was less than those who had not been admitted before. 
Hyperthermia and hypoglycaemia on admission were associated with HR of 3.19 
(95% Cl 0.39-26.11) and 1.91 (0.10-37.75) respectively though in both cases there 
was no statistical significance. Model 1 was repeated using age in three categories 
instead of two and the HRs were similar for all variables and as a result the findings 
are not summarised in the Table. To assess the fit of the Weibull model to the data, 
Cox-Snell residuals were used. A plot of the cumulative hazard H (obtained from the 
KM survival estimates) against the Cox-Snell residuals for Model 1 is given in 
Figure 5.2.
Figure 5.2: Cox-Snell residuals to evaluate the fit of the Weibull Model. Model 1 in Table 5.10
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The residual analysis of the fit of the Model shows that the Weibull distribution did 
fit the data but it was not a perfect fit. The model was redone without the clinically 
significant variables to give Model 2. The same goodness of fit test was performed 
and given in Figure 5.3 below.
Figure 5.3: Cox-Snell residuals to evaluate the fit of the Weibull Model. Model 2 in Table 5.10
On inspection the graphs showed that Model 2 was a better fit of the data than 
Model 1 in Table 5.10. It was therefore more appropriate to use the findings of 
Model 2 rather than Model 1. A graph o f the hazard function over analysis time for 
Model 2 showed that it increased rather than decreased, see Figure 5.4. This was in 
agreement with the shape parameter, p ,  which had a value of 1.78 (P = 0.001).
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Weibull regression
Figure 5.4: Graph of the hazard function of Model 2 in Table 5.10 over analysis time tin 
weeks).
The modelling process was repeated with Cox regression to see how this compared 
with the Weibull regression results. The findings Model lb (corresponding to Model 
1 of the Weibull model) and Model 2b (corresponding to Model 2 of the Weibull 
model) are given in Table D in the appendix. The HRs in Model lb were different 
for some categories and the confidence intervals wider. However, the HRs of 
Models 2 and 2b were agreeable though those of the former were more precise 
because of their narrower 95% Confidence Intervals. The test of the proportional 
hazard assumption (based on Schoenfeld residuals) did not show any violation of the 
assumption in the global or detailed tests (except one category). However the 
assumption that the baseline hazard was constant over time was violated. The 
goodness-of-fit plot of Model 2b was less compatible with the data than Model 2. As 
such, the results of Model 2 were more suitable.
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Chapter 6
6. DISCUSSION
6.1 Number of cerebral malaria cases enrolled during study period
The study set out to determine the natural history of neurological sequelae in 
children and adults in Uganda and elucidate any differences between the two groups. 
In order to do this, the number of patients needed to estimate effects with three-fold 
differences was calculated to be 364 patients (274 plus 90 patients to account for 
deaths and losses to follow-up). For this reason and others which have been 
mentioned in the methodology, a multi-centre study design was employed. Some 
benefits of using this approach will be highlighted later on. During fieldwork the 
study evolved to take into account some of the practical realities on the ground. One 
such reality was that far fewer than expected numbers of cerebral malaria cases 
occurred during the extended study period. A number of factors contributed to this 
situation. The study hospitals were selected from those with high “suitability scores” 
during the pre-study visit in July 2002 as shown in Table 3.2. One of the parameters 
included in the score was having more than 50 recorded cases of cerebral malaria 
per year. Mbale hospital (64 recorded cases of cerebral malaria out of 176 severe 
malaria admissions between January and December 1999) and Mutolere hospital (52 
recorded cases out o f 99 severe malaria admissions during the same period) met that 
requirement. The other two hospitals, Kabale hospital (10 recorded cerebral malaria 
cases out of 37 severe malaria admissions) and Kapchorwa hospital (no records on 
admissions that could be reviewed at that time) did not have records of sufficient 
numbers to receive a score on the scale. Anecdotal reports from the clinical and 
district health staff gave the indication that the frequency of cerebral malaria was 
higher than the records portrayed. Additionally both hospitals are prone to epidemics 
of malaria as has been documented by other researchers (Kiszewski and 
Teklehaimanot 2004). This potential that both hospitals had to contribute cases 
towards the study were taken into account, the more so since there was the 
possibility of epidemics in the area fuelled by the El Niño (ENSO) phenomenon 
during the study period.
Despite warnings by the government o f the impending heavy rains in 2002 (see 
newspaper clips o f these in Appendix VI) there was no epidemic of malaria at the
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study sites that year or the next. In addition, the occurrence of cerebral malaria in all 
four sites was lower than anticipated. One reason for this appears to have been 
overdiagnosis of cerebral malaria in those hospitals in the pre-study period. Patients 
that had been admitted to hospital with fever and impaired consciousness with a 
provisional diagnosis o f  “cerebral malaria” sometimes did not meet any of the 
requirements for the Eligibility checklist 1 and 2. This was more pronounced in 
Kabale and Mutolere hospitals where at the onset of the study it was observed that 
some patients who had features suggestive of cerebral malaria did not have 
demonstrable falciparum parasitaemia. And yet, these cases recovered on quinine as 
the sole definitive treatment. In Kabale hospital at the time there was a cross- 
sectional study on severe malaria and they noticed the same phenomenon. To begin 
with, little attention was paid to this and it is only after the first rainy season that we 
began to wonder why there was this trend. We decided that suspected cases of 
cerebral malaria would have serial smears at least six hours apart to increase the 
chances of finding parasitaemia. At the same time, the procedures in the laboratory 
for detecting malaria parasites were reviewed to find out if there were any reasons 
for the negative slides. I also arranged an exercise in which I got the laboratory staff 
at both Mutolere and Kabale hospitals to examine five slides made at Mbale 
hospital. In all cases, they were able to detect the presence or absence of malaria 
parasites and identity them to species. Next we examined the laboratory records to 
determine the proportion of slides that were positive in the preceding months. I also 
retrieved the case records for patients admitted with the diagnosis “severe malaria” 
and “cerebral malaria” for the period 1991 and 2002 during which there was a 
reported epidemic of malaria in the region. Examination of the case records for cases 
with “cerebral malaria showed that less than 50% of them could meet the 
requirements for any definition of cerebral malaria. I have described the process 
taken to arrive at this conclusion in Appendix VI.
It began to be clear that cerebral malaria had been over diagnosed. For example, 
unconscious patients were not regularly being lumbar punctured. Sometimes this 
was because of the lack of lumbar puncture needles or sterile implements. The 
features of meningitis o r encephalitis overlap with those of cerebral malaria and it is 
important to carry out a lumbar puncture to exclude them in a patient with non- 
traumatic coma. (Berkley, Mwangi et al. 1999). Blood glucose was not measured
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routinely and it is possible that those patients who were unconscious because of a 
low blood sugar may have been misclassified as cerebral malaria. Some children 
who were unconscious after convulsions i.e. the post-ictal phase may have been 
recorded as cerebral malaria as well. In a retrospective review of the case records of 
112 adults admitted to the Accident and Emergency Unit of Lagos University 
Hospital between January 1990 and June 1996, with a diagnosis of cerebral malaria, 
the authors found that 52 patients (46%) could fulfil the research definition for 
cerebral malaria. (Okubadejo and Danesi 2004). The likely diagnoses in those who 
were misdiagnosed include encephalitis (3 cases), meningitis (17 cases), septicaemia 
(23 cases), hypoglycaemia (6 cases), epilepsy (8 cases), chronic liver failure (2 
cases) and subarachnoid haemorrhage (1 case). It is precisely because of these 
differential diagnoses that procedures were put in place at the onset of the Uganda 
study to exclude them.
The problem of case numbers was not restricted to this study. Around the same 
period there was study on cerebral malaria in an endemic area of Tanzania. Makani 
el al. (2003) studied adult patients admitted with altered mentation to Muhimbili 
National hospital in Dar-es-Salaam, Tanzania from October 2000 to July 2001. One 
hundred and ninety-nine patients were admitted with a provisional diagnosis of 
cerebral malaria (mean age at admission was 34.5 years, 95% Cl 23.6-36.4). Only 
15 patients (7.5%) had detectable parasitaemia and only 2 patients (1%) met the 
WHO research definition for cerebral malaria. The authors suggest that the huge 
difference between the presumptive diagnosis and microscopy-based diagnosis may 
be because a) prior treatment with antimalarials may have reduced parasite densities 
without modifying the course of the disease, or b) that some slide-negative patients 
did actually have cerebral malaria (“slide-negative” cerebral malaria). This could 
have been the case in this study as well. In early 1999, an epidemic of cerebral 
malaria occurred in the south western areas of Uganda. Health centres and hospitals 
were overflowing with patients. Many of the sick died. In the months after that the 
health authorities sent out district education teams to educate people about malaria. 
Some vector control measures were put in place before the rainy seasons e.g. indoor 
spraying in schools. Antimalarials were distributed to health centres. In this way the 
population may have become sensitized of the need to beware of ‘fever’. As a result 
their health seeking behaviour may have changed making them seek treatment
earlier than was the case before. At the same time, the health personnel appear to 
have become more aggressive in their antimalarial prescribing habits. Widespread 
use of antimalarials may have prevented a proportion of people from developing 
severe disease and or modified the extent of parasitaemia without affecting the 
course of disease as described above. In this series, 83 cases reported use of an 
antimalarial in the month preceding admission, of which 50 cases were said to have 
used only chloroquine. If this trend of antimalarial use was the same in Kabale and 
Kisoro districts which have malaria transmission intensities that are similar to 
Kapchorwa, then antimalarial use cannot be modifying the course of progression to 
cerebral malaria in ill patients in the south-western part of the country and not in the 
eastern parts unless parasite resistance differs considerably or the strains of the 
parasite.
Antimalarial use in inadequate doses or via chloroquine resistance may be affecting 
the degree of parasitaemia by decreasing it without halting progress of disease. 
Sowunmi (1994) on the other hand suggests that chloroquine resistance of the 
malaria parasite due to the increased use of chloroquine could be one o f the reasons 
for the apparent increase in the number of adults with cerebral malaria in Ibadan, a 
malaria endemic area. Clearly this was not the case in this study though the findings 
in Ibadan cannot be extrapolated to the study sites because o f the different levels of 
malaria transmission. In these highland areas in which malaria parasitaemias may 
not reach the levels of endemic areas could widespread antimalarial use be causing 
‘slide-negative’ cerebral malaria as suggested in the Tanzanian study or could 
sequestration of parasites be more pronounced? A historical event may be of 
relevance here. Between 1959 and 1963, the Kigezi Malaria Eradication Project 
was implemented (Zulueta, Kafuko el al. 1961; Zulueta, Kafuko el al. 1964). By 
using a combination of insecticidal spraying of houses and mass distribution of 
chloroquine-pyrimethamine, malaria was eradicated from the region. However, at 
the end of the project imported cases of malaria were causing localised outbreaks. 
This past experience may be having current implications.
‘Aparasitaemic’ cerebral malaria is rare. Walker and Salako reported 5 children with 
cerebral malaria who were admitted with negative slides for P. falciparum (Walker, *
* Consisted of the current districts in the south western part of Uganda
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Sowunmi et al. 1992). Three were confirmed as cerebral malaria at post-mortem 
examination. The other two who survived had initial negative slides but further 
examination showed malaria pigment in white blood cells. One patient went on to 
have a positive smear for asexual forms of P. falciparum 12 hours later. A study of 
55 adults with CM in Bangladesh found that on admission 24 (44%) had parasite 
counts < 100/ mm1 (i.e. 100/pL) although the multiplication factor they used was 75 
(Waiz and Chakraborty 1990). They say in their article that cerebral malaria patients 
had on average lower parasite counts than patients with the other forms of severe 
malaria. For this reason, they suggest that the sequestration of malaria parasites in 
the brain may be reducing the parasitaemia detectable in the peripheral circulation.
To examine for these possibilities, a rapid malaria test (OptiMAL®) was used to 
assess patients who were slide negative and yet had features of altered mentation. 
One child admitted to Kabale hospital (December 2002) was assessed in this 
manner. Two thick smears were found to be negative for asexual forms of P. 
falciparum but the rapid test was positive for the same malaria species. By this time 
it was becoming evident that something was going on which we had not been 
prepared for. From then onwards cases with a presumptive diagnosis of cerebral 
malaria underwent microscopy and a rapid test. Despite this remedial action, it was 
not possible to find other cases of cerebral malaria maybe because it was too late 
into the study to do so.
During the pre-recruitment phase of the study health centres in the four study 
districts were sensitized about the project and on the need to refer suspected cases of 
cerebral malaria to the study hospitals if they were not able to manage them 
appropriately. District health teams were also alerted of the need to inform people 
during health education sessions of the importance of taking confused or 
unconscious patients to the nearest health centre or hospital as quickly as possible. 
In the course of the recruitment phase, leaflets were sent out to private clinics 
because it was thought that a small number of cases were going there for treatment. 
One of the popular private radio stations in Mbale town was used to make the 
residents aware that patients with cerebral malaria were being studied at the hospital 
and receiving optimal treatment that was given free-of charge. All these measures 
were employed to facilitate the referral of patients who were suspected of having
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CM to the study hospitals and to reduce the proportion of sick people who are not 
captured by the formal heath sector. On the other hand, because its clinical features 
are frightening, it may be that sufferers are more likely to be taken to hospital than 
those with the other manifestations of severe malaria. How these factors affected the 
numbers of patients with cerebral malaria seen at the study hospitals is not clear and 
whether they affected children and adults equally or not cannot be elucidated. In 
discussing and interpreting the findings, the biases due to the small sample size are 
taken into cognisance.
6.2 Cerebral malaria in children and adults
In the following subsections, the results related to cerebral malaria in children and 
adults are discussed. I will address the frequency of cerebral malaria and age-of- 
disease onset, giving reasons for relevant findings or their absence. A detailed 
discussion of the commonest presenting features namely, fever, seizures and altered 
mentation, follows in order to corroborate the findings with those of other studies. In 
this way, an idea of the limitations of the study can be appreciated before more 
specific aspects of the findings are interpreted. Where possible, the differences in the 
clinical features of CM between children and adults will be elaborated since they 
have a bearing on the risk factors for neurological sequelae.
6 .2 .1 F req u en cy  o f  ce reb ra l m alaria  (luring th e s tu d y  p e r io d
The proportion of cerebral malaria among falciparum malaria admissions aged 1 to 
70 years, and admitted during the 19 month period was 1.9% (100/5381). The 
proportion was higher at Kapchorwa hospital than at Mbale hospital. Likewise the 
incidence rate of 14 cases per 1000 falciparum admissions per year at Kapchorwa 
was higher than at Mbale hospital where it was 11 cases per 1000 falciparum 
admissions per year. These values are fairly similar to those observed at a) Mnero 
Hospital in Tanzania, in which the proportion of childhood cerebral malaria during 
the three year study period 1979-1981, was 0.8% i.e. 66 cerebral malaria cases from 
7915 falciparum malaria admissions (Schmutzhard and Gerstenbrand 1984); b) 
University of Calabar Teaching Hospital in Calabar, Nigeria, where the proportion 
was 0.9% i.e. 75 children (15 years and below) with cerebral malaria from 8341 
paediatric admissions with fever during the 30 month study period from January 
1986 to June 1988 (Ikpatt, Asindi et al. 1990); c) Mangochi District Hospital and
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Kamuzu Central Hospital in Malawi, where 199 children aged under five had CM 
(from 8600 children under five years of age admitted to both hospitals between 1 
January 1994 and 31 December 1994), giving a proportion of 2.3% (Nkhoma, 
Nwanyanwu el al. 1999). The occurrence o f cerebral malaria in these studies is 
similar even though the age groups and case definitions of cerebral malaria differ. 
Their values though are much smaller than the other studies that have been 
summarised in Chapter 2. The large variation in the frequencies of CM even 
between studies done in the same country illustrates the limitations of hospital-based 
studies in estimating the true occurrence of the disease in communities even if its 
occurrence is not equal. However, there have been no estimates of the incidence of 
cerebral malaria which would be the more ideal and comparable measure.
During the study period, the proportion of malaria admissions that were cerebral 
malaria was relatively higher in Kapchorwa hospital than Mbale hospital even 
though more numbers of CM cases were admitted to the latter. Malaria transmission 
is less stable in Kapchorwa than Mbale. A hospital-based study that used two 
hospitals in areas at different altitudes and different malaria endemicities (Kamuzu 
Central Hospital at 1,200m above sea level and Mangochi District hospital at 500m) 
found no difference in the proportion of CM among hospitalised children under five 
years of age between the two hospitals (Nkhoma, Nwanyanwu el al. 1999). The 
authors restricted their investigation to young children whereas if they had not, the 
proportion in the older age groups may have been different as the current study 
suggests. Snow el al. (1997) corroborate the findings here in a study at five sites in 
Kenya with different levels of malaria transmission. They noted that the period 
proportion of cerebral malaria declined significantly with increasing malaria 
transmission intensity.
Cerebral malaria frequency fluctuated during the study period from 1st January 2002 
to 31s1 July 2003. The first rainy season in Uganda which is usually March to May 
had a greater number of cases compared to the later rainy season of September to 
November. The weather data from Mbale and Kapchorwa show that the rainfall in 
the earlier season is higher than that in the later season and the maximum and 
minimum temperatures are higher by a degree or two from March to May compared 
to September to November. This can explain much of the monthly variation in the
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frequency of cerebral malaria. It is known that the occurrence of malaria in a 
population continues for one or two months after the end of the rains. Unfortunately, 
for this thesis, it was not possible to get the monthly frequencies of malaria 
admissions at the study sites and their weather indices for the study period to better 
explain the time variation in cerebral malaria admissions. The relationship between 
cerebral malaria occurrence and climate has been documented before in Tanzania 
where the seasons are similar to Uganda (Schmutzhard and Gerstenbrand 1984). 
Over the study period, the authors got the largest number of cerebral malaria cases in 
June (i.e. 15 cases) whereas in this study the largest number of CM admissions was 
in July 2002. Therefore it is very likely that most of the variation in frequency is 
explained by climate.
This study was hospital-based and the four sites are subject to different selective 
processes that affect the proportion of children with cerebral malaria who reach 
hospital. Factors such as distance to hospital, mode and cost of transportation to 
hospital, existence of user-charges at hospital, awareness of the need to take the 
patient to hospital, acceptance of conventional or tradition methods of treatment and 
the image of the hospitals, affect health-seeking behaviour. Three of the hospitals 
except Mutolere hospital, are government hospitals and were not charging user-fees 
at the time. St. Francis Hospital, Mutolere, is a missionary hospital and charges for 
its services, but it was the only hospital in the district that was known by the local 
population to be able to handle people who are very ill. Additionally, more than 95% 
o f  the population of Kisoro is Christian and would not have any religious reasons for 
not using the hospital. Despite making arrangements for cerebral malaria cases to be 
treated at no cost, the fact that it was known to be a charging facility will have made 
it less accessible than would have otherwise been the case. Kisoro hospital which is 
government-funded is about 15 km away from Mutolere hospital. It, at the time, did 
not have a functional laboratory and patients were managed according to 
presumptive diagnoses. The clinical staff there had agreed to refer patients to the 
study hospital and they were contacted often to find out if they were getting any 
suspected cases. Apart from a handful of suspicious cases who were not referred, 
cerebral malaria did not seem to occur in the numbers expected. Kabale hospital, 
which is situated in an area of similar malaria endemicity as Kisoro and Mutolere 
hospitals, was not getting cases of cerebral malaria either. Kabale hospital is the
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referral hospital for that region and was not charging user-fees. In fact, there were 
indications that the residents of Kabale town where the hospital is based preferred to 
take very ill relatives to private clinics that had the drugs to manage them (which is 
why leaflets describing the study and encouraging referrals were also sent out to 
private clinics). The PI visited one of the private clinics with admission facilities in 
the town to determine if this was the case and was told by the doctor that they did 
see patients with ‘cerebral malaria’. However, the diagnosis was made on the basis 
of altered mentation and a positive smear for P. falciparum and it was therefore not 
possible to confirm the claims. These observations suggested that in Kabale and 
Kisoro, outbreaks of severe malaria occur only during malaria epidemics.
The frequencies of cerebral malaria obtained here are probably underestimated. The 
denominators in most calculations of frequency are malaria admissions. If the 
diagnosis of severe malaria is presumptive (i.e. ‘clinical malaria’) and not 
microscopic then there is the issue of over-diagnosis of malaria. In addition, we 
know that a sizeable proportion of patients with severe malaria who require 
admission never get to hospital. This means that on the one hand there may be over­
diagnosis and on the other, under representation. The significance of these 
inaccuracies will differ from population to population, however, it is likely that the 
denominator is also underestimated. Consequently, the estimation of the proportion 
of cerebral malaria based on the values used here even though not a valid 
representation of the true frequency in the population is a good estimate.
6.2.2 A g e  o f  ce re b ra l m ala ria  cases on  a dm ission
The age-specific frequency of cerebral malaria was 1.4% of malaria cases admitted 
(46/3364) in children aged 1-4 years, 1.9% (72/3789) in those aged 1-9 years and it 
was 1.8% (28/1592) in those 10 years and above (up to 70 years). This fairly even 
occurrence in the three age groups does not persist when one compares them by 
study hospital. The 5-9 year and 10-70 year age groups had the higher proportion of 
cerebral malaria cases in Kapchorwa. The incidence rates showed this same trend. 
The rate in the 5-9 year group admitted to Kapchorwa hospital was almost twice that 
at Mbale hospital. Interestingly, the incidence in the under fives admitted to Mbale 
hospital is greater than in Kapchorwa hospital. In the 10-70 year group, the 
incidence of CM was slightly greater in Kapchorwa than Mbale. The median age on
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admission in Mbale was 48 months which was half the median age of 96 months 
found in Kapchorwa hospital. These differences were not unexpected. In fact, one 
reason for using hospitals situated in the highlands was to take advantage of this 
epidemiological observation in which the age distribution of cerebral malaria has 
been noted to be wider in areas with unstable malaria transmission (Newton, Hien et 
al. 2000). Examining studies that have looked at cerebral malaria in patients who are 
10 years or below, those who found that CM was commoner in young children 
under five years of age (i.e. number of CM  cases under five among total number of 
childhood CM cases) tend to be in areas with stable malaria transmission (Rothe 
1956; Commey, Mills-Tetteh et al. 1980; Schmutzhard and Gerstenbrand 1984; 
Ikpatt, Asindi et al. 1990; Bondi 1992; Steele and Baffoe Bonnie 1995; van 
Hensbroek, Palmer et al. 1997; Idro, Karamagi et al. 2004). Those who have found 
CM commoner in children 5 years and over compared to those below have tended to 
be among indigenous people in areas o f  unstable malaria transmission (Ahmad, 
Moonis et al. 1986; Ramble, Raut et al. 2002). A study done at Eldoret, in the 
highlands of Kenya (altitude of over 2000m above sea level) on 23 consecutive CM 
cases aged 1 to 12 years found that the median age on admission was 9 years (range 
2-11). The authors say that CM is one o f the leading forms of severe malaria during 
epidemics of “highland malaria” in that region and affects older children rather than 
those under five (Esamai, Nabakwe et al. 1999).
The available studies on CM in adults have been conducted in areas with both high 
malaria transmission (Elamin 1981; Olweny, Chauhan et al. 1986; Sowunmi, 
Walker et al. 1993) and low transmission (Waiz and Chakraborty 1990; Niyongabo, 
Deloron et al. 1994; Kochar, Shubhakaran et al. 2002; Mohanty, Mishra et al.
2003). The authors who have been able to study adult cases in high malaria 
transmission areas have attempted to give reasons why CM occurred in that age 
group since it is not a disease that is often found in indigenous adults living in 
hyperendemic areas. These include yet unidentified genetic and environmental 
factors that affect the acquisition of clinical immunity; the effect of good mosquito 
control and chemoprophylaxis in the Copperbelt cities in Zambia in the 1960s that 
may have slowed the development of malaria immunity resulting in an adult 
population who are still susceptible to  severe malaria; inadequate doses of 
chloroquine used to treat uncomplicated malaria which then progresses into severe
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malaria; increasing virulence of P. falciparum strains; and decreasing susceptibility 
of P. falciparum to chloroquine.
The basis for the relationship between age of disease and malaria transmission is an 
immunological one. It is thought that clinical immunity to severe forms of malaria 
develops rapidly in children resident in high transmission areas. Consequently by the 
age of ten, a child should have developed sufficient immunity to protect him or her 
from cerebral malaria and the other forms of severe malaria (Marsh, English el al. 
1996; Cegielski and Warrell 1997a; WHO 2000; Murphy and Breman 2001; Snow 
and Marsh 2002). Children resident in low transmission areas would take longer to 
develop the same repertoire of immune responses to offer similar protection. As a 
result, severe malaria occurs both in children and adults in malaria-epidemic prone 
regions (Kiszewski and Teklehaimanot 2004) and in adults whose previously 
competent immunity is diminished for one reason or the other as is the case in 
pregnant women (Foster 1996). This best explains why the CM cases admitted to 
Kapchorwa hospital, which serves a population living an area of unstable malaria 
transmission are older than those admitted to Mbale hospital. By design therefore, 
the multi-centre nature of this study has allowed both children (defined here as those 
under ten years of age) and adults (defined here as those aged ten years and above) 
with CM to be enrolled.
6 .2 .3  P resen tin g  c lin ic a l fe a tu re s  o f  ce reb ra l m alaria  in ch ild ren  a n d  adults
To ensure consistency and reduce interviewer bias, the ten common symptoms of 
severe malaria were listed and asked for using close-ended questions at Level 1. 
From these inquiries, fever (87 cases) was the commonest symptom reported 
followed by convulsions (75 cases). This is expected because one of the eligibility 
criteria was a history of fever or convulsions as they are the commonest symptoms 
that patients with cerebral malaria are likely to present with. Loss of consciousness 
(66 occasions) and confusion (56 occasions) were the next frequent, in some cases 
the latter described as preceding the former in a continuum of altered mentation. 
Loss of appetite and headache were mentioned in just over half of the cases and 
were more likely to be noted in adult cases than children (p<0.05). Adults are able to 
express their ‘dis-ease' more capably than children and consequently those 
symptoms that require one to complain or express, such as headache, are more likely
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to be mentioned by the adult cases than children. Other symptoms, cough, 
rigors/chills also differed significantly between children and adults (p<0.05).
Differences in the symptoms of cases seen at the two study hospitals are probably 
related to age because they also differed in a similar manner between children and 
adults (Kapchorwa cases on average being older than Mbale cases). A few additional 
symptoms were noted at Level 2 because at that level, doctors asked relatives for the 
main complaints their patients had before coming to hospital. These were general 
body weakness, loss of speech (aphasia), and pain in the neck, chest and abdomen. 
The loss of speech is a more specific indication of cerebral dysfunction but is a rare 
complaint. A detailed discussion of the three commonest symptoms, fever, altered 
mentation and convulsions follows because they are directly or indirectly on the 
postulated causal pathways for neurological sequelae.
6.2 .4  F ever
Axillary temperature was used to estimate the core body temperature as described in 
the methods section. Although this is not the best way of doing so, it was used 
because it was the safest and most convenient method in that setting. To improve the 
accuracy of measurements, digital thermometers were used instead of the mercury 
ones that are routinely used in Ugandan government hospitals. In addition, digital 
thermometers have built in timers enabling the nurse or doctor to consistently take 
the measurement for a uniform period of time in all cases. On the first measurement 
of body temperature, 63 cases had a normal body temperature and 37 had above 
normal temperatures. This contrasts with the proportion who gave a history o f fever. 
It is well known that the body temperature has diurnal variation and in malaria can 
fluctuate in a short span of time (Rooth and Bjorkman 1992). One accurate 
measurement is not a precise reflection of the true magnitude and impact of fever on 
the body. An average of several measurements would give a better representation of 
the true value. However, all study patients received the antipyretic paracetamol as 
part of their treatment. Other measures such as tepid sponging were also done. These 
interventions alter the degree of fever in patients at different rates. For these 
analyses it was decided to use the first measurements of temperature taken before 
antipyretics were given. In conjunction, the fever clearance time, which is the period 
from the onset of treatment to the time when the body temperature returns to normal
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levels (in this case 37°C) for 48 hours, was measured. This provides an estimate of 
the rate at which patients were able to get rid of their fevers having received 
appropriate doses of paracetamol. One advantage of using fever clearance times is 
that it does not depend on the precise temperature measurements but rather on a 
series of above normal values over time. A disadvantage of the fever clearance time 
is that it can only be calculated in patients that survive long enough to clear their 
fever for the specified duration. Axillary temperatures were measured six-hourly, 
although this was not always the case, and recorded in the CRFs to one decimal 
place as given by the digital thermometer.
The mean body temperature on admission for all cases (n=100) was 38.1 °C. The 
mean fever clearance time was 2.8 days (95% Cl 2.4-3.2) and the mean total fever 
clearance time was 5.5 days (95% Cl 4-6.1). Fifty percent of cases with fevers were 
able to clear their fevers within 2 days. There was no association between body 
temperature and the fever clearance time either as continuous variables (assessed by 
correlation and regression) or categorical ones (assessed by Fischer’s exact test). 
Walker et al. (1992) who studied 61 patients with cerebral malaria and a mean age 
of 5.7 years (±3.2), obtained a mean fever clearance time of 59.8 hours (±33.6) in 
fifty survivors which is similar to the value in this study. They do not mention the 
average core or body temperature of their patients neither do they state if an 
antipyretic was given to children with feversf.
Definite cases had a mean body temperature of 38.4°C (95% Cl 38.1-38.7) which 
was higher than the value for probable cases, 37.7 (95% Cl 37.4-38.1). The 
difference was statistically significant and may illustrate the severity of disease in 
the two groups. Patients with DCM had an average fever clearance time that was one 
day longer than patients with PCM, although the study was not able to detect it as 
significant at the alpha level. Unfortunately, Ramble et al. who also divided patients 
with CM in to definites and probables did not give the average body temperatures of 
patients to see how this compared (Ramble, Raut et al. 2002).
’ Tepid sponging and fanning were employed to cool patients with hyperpyrexia (>39°C) although the 
effectiveness of these methods is questionable.
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The mean body temperature was similar in cases seen at each study hospital as well 
as between children and adults. However the fever clearance time was different 
between children and adults and between study hospitals. Children took on average 
3 days to clear their fevers compared to adults who took l'/i days (P = 0.02). The 
cases admitted to Mbale hospital were younger than those at Kapchorwa, which 
influenced the fever clearance times of cases at both sites. The children examined at 
Ibadan by Walker’s group, had an average fever clearance time that was closer to 
that of the children in this study than adults. The difference noted here therefore may 
be a real one.
6 .2 .5  S e izu re  activity
Convulsions were more frequently reported among definite cases than probable ones 
(P = 0.06). There was no such difference between children and adults or between 
study hospitals. Of those with a history of seizures, referred to as reported seizures, 
41 cases (55%) also had seizures while in hospital that were seen by medical staff, 
referred to as witnessed seizures, and of those who did not have reported seizures, 
20 cases (80%) did not have witnessed seizures. These proportions are similar if one 
looks at children and adults separately and does not suggest that mothers may be 
over-reporting seizures in order to get more urgent treatment for their ill children. 
The proportion of children and adults who had witnessed convulsions was not 
significantly different (47 and 43% respectively). Febrile seizures are the 
commonest kinds of seizures in children aged less than five years but do not appear 
to have been responsible for seizure activity in this population. The only three 
children in this age group with hyperthermia had witnessed seizures. All three cases 
were definite cases. There was no association between age (as three categories) and 
temperature amongst cases who had seizures.
It is noteworthy that the clinical seizures described in this study are of the tonic- 
clonic type which are visible and easy to detect. The atonic or subtle kind in which 
there are underlying epileptiform brain discharges but no visible jerks are difficult to 
detect unless one has a high index of suspicion and EEG facilities. Worse still is the 
condition referred to be Crawley et al. as “electrographic status epilepticus” in 
which there are continuous electrical discharges lasting for 30 minutes or more on 
EEG with no apparent clinical manifestations (Crawley, Smith et al. 1996; Crawley,
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Smith et al. 2001). They go on to warn that subtle seizures may go undetected the 
more so in busy and understaffed health units where most children with CM are 
admitted. None of the study hospitals had access to EEG facilities and were all busy 
units; this may have resulted in an underestimation of the proportion of seizures in 
this case series and misclassification of some cases. The indications from the studies 
are that patients with “electrographic status epilepticus” or subtle fits have a poor 
prognosis if their situation is not managed with appropriate anticonvulsants. Ten 
study patients did not recover, of whom three had reported convulsions and one had 
both reported and witnessed convulsions. It is possible that seizures would have 
been recorded more frequently if there had been EEG facilities.
In the analyses the number o f  witnessed fits during the first episode of seizures was 
considered (one episode being any number of seizure events followed by a post-ictal 
phase). Among those who had witnessed fits there was no difference in the median 
number of fits in definite and probable cases. Nor was there a difference in the 
number between Mbale or Kapchorwa hospitals. The significant variation was 
between children and adults (P = 0.01). Children (n=34) had on average 3 (95% Cl 
2-4) witnessed seizures compared to 1 in adults (n=12). These findings were based 
on the number of fits in the first episode of seizures determined by a variety of 
clinical staff and are therefore subject to measurement errors that could have 
affected the accuracy of the numbers recorded. If seizures are an important risk 
factor in this population as has been shown in others then their greater occurrence in 
children will predispose them to the outcomes.
The proportion of children (age range 9 months to 11 years) with fits in a study done 
at Kilifi, in Kenya was 62% (40/65). The median number of seizures was 5 (range 1 
and over 20) during the entire clinical course of their illness. Eighteen children 
(28%) had one or more episodes of status epilepticus (Crawley, Smith et al. 1996). 
The limitation in making comparisons between other studies is the manner in which 
seizures are counted and over what period. Most studies simply note whether a 
patient has a seizure or not and only a few count the number of seizures (Ahmad, 
Moonis et al. 1986; Olweny, Chauhan et al. 1986; Molyneux, Taylor et al. 1989; 
Ikpatt, Asindi et al. 1990; Steele and Baffoc Bonnie 1995; Olumese, Gbadegesin et 
al. 1999; Kochar, Shubhakaran et al. 2002).
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The median o f the duration taken to control seizure activity in hospital, which 1 have 
called the seizure stoppage time, was 2 days for children and 1 day in adults (n=44). 
Although this difference was not statistically significant, it is further indication of 
the greater occurrence o f seizure activity (either as number of fits or number of days 
with fits) in children. The median total seizure stoppage time (n=81) which is a 
summation o f  the number of days with reported seizures and witnessed seizures was 
2 days for both children and adults. Adults were less likely to report seizures than 
children, 71%, (20/28) compared to 78% (56/72) respectively although on average 
they both had symptoms of seizures for a similar duration (median of 1 day and 
range of 1 -5 days).
6.2 .6  A  I te re d  m en ta t ion
All cases had some degree of altered mentation because this was one of the 
requirements for inclusion. Its depth ranged from confusion to unrousable coma. 
Patients who had unrousable coma were classified as DCM if they also met the other 
requirements. Two methods were used to determine coma depth on admission and to 
monitor progress. A simple tool that focussed on motor function by determining if a 
patient was able to localise a noxious stimulus or one of the coma scales, BCS or 
GCS, that assessed visual and verbal function in addition to motor function. The 
simple tool was employed because it could be used by both nurses and doctors, it 
was easy to teach, easy to learn and was sufficiently reliable and accurate for 
purposes o f monitoring the progress of an unconscious person (Stembach 2000).
Fifty-two cases were not able to localise pain at Level 1 (by a nurse) and seventy- 
five cases at Level 2 (by a doctor). The assessments by the nurses were usually done 
as soon as the patient was admitted (the target was to do so within 2 hours of 
admission) before the doctor’s assessment (the target was within 6 hours of 
admission). It is difficult to say whether the change in proportions was due to the 
experience o f the assessors or due to disease progression between one assessment 
and the next. To improve the reliability of assessments and reduce interobserver 
disagreement, there were training sessions for both nurses and doctors on how to use 
the simple tool and the two coma scoring methods (Rowley and Fielding 1991). The 
sessions were conducted by very experienced neurologists and repeatedly during the
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course of the study, the senior consultant paediatrician in Mbale and the PI while at 
any one of the study hospitals, observed how the clinical teams measured coma 
depth. New team members were trained on neurological assessments by either the PI 
or one of the senior clinicians.
At Level 1, the proportion of children that were not able to localise pain on the 
simple tool was 53% (38/72) which was slightly greater than the proportion of 
adults, 50% (14/28). At Level 2, the respective proportions were 81% (58/72) and 
61% (17/28) which was quite a large difference between both groups (P = 0.07). The 
BCS was used to assess children aged five years or below and the GCS was used for 
the older patients. On the BCS a score of 2 or less corresponds with unrousable 
coma, the depth required for DCM. On the GCS, the corresponding cut-off is not 
very clear. It appears to lie between 8 and 10. Using the lower value as the cut-off 
then a total of 50 cases were in unrousable coma on Day 0, their first measurement 
with either scale. This is lower than the number detected with the simple tool. 
Combining the scores from both scales, 67% of child cases (40/60) had scores 
corresponding to unrousable coma compared to 30% o f adult cases (8/27). The 
findings are that more adults were admitted in less severe coma than children. One 
reason for this is that adults with a history of convulsions even without the 
appropriate depth of coma are considered to have cerebral involvement (PCM) 
because of the relative rarity of other conditions that cause sudden convulsions in a 
non-epileptic adult. Checking for this among the adult cases who scored over 8 on 
the GCS, it was observed that of the five adult cases who scored 14 the highest score 
observed on first measurements, three had a history of seizures and another had both 
a history and one witnessed seizure (there was no score of 13 on first measurement). 
Fourteen adults scored between 9 and 12 and of these nine had a history of 
convulsions and twelve had witnessed seizures. Therefore, adults with altered 
mentation but could localise pain (a depth not associated with mortality or 
neurological sequelae) were likely to have seizure activity (a factor known to be 
associated with mortality and neurological sequelae) which made them fit the PCM 
case definition.
The duration taken to regain consciousness, the coma recovery time varied from a 
minimum of 1 day (cases that took less than 24 hours were categorised as one day)
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to a maximum of 12 days (n=67 survivors with complete information on coma 
duration). 22 cases (33% of 67 survivors) were conscious within two days. In two 
other studies, the corresponding figures were 74%, 22 patients out of 43 children 
(Commey, Mills-Tetteh el al. 1980) and 61%, 14 patients out of 23 children 
(Esamai, Nabakwe el al. 1999). The total coma recovery time which refers to the 
number of days before admission for which a person was not conscious plus those 
spent in hospital before regaining consciousness varied from 1 day to 15 days. Cases 
seen at Mbale hospital on average had a longer duration for both the coma recovery 
time and the total coma recovery time. Definite cases as would be expected, took 
longer to regain consciousness than probable cases but these differences were not 
large enough to be statistically significant. Children, like adults, took on average 3 
days to recover from coma. Quinine given at the referring health centre prior to 
admission could have improved the speed of recovery but the distribution of quinine 
use before admission was similar between children and adults, study hospitals, 
definite and probable cases. Therefore the differences in coma duration even though 
not large enough to be statistically significant in this study appear to be associated 
with some factors that are not related to quinine use.
6 .2 .7 M o r ta lity  a n d  P rognostic  fa c to rs
Ten cases died while in hospital and eight cases had their hospital stay terminated by 
a relative or attendant. As described in the results, it is more likely that those who 
were prematurely taken away survived meaning that the case fatality in this case 
series was 10%. This estimate is lower than most of those given in the background 
section of this thesis. Herein lies another limitation of hospital-based studies which 
are more likely to receive patients that are at the upper extreme of disease severity. 
Some of the studies on this disease have been done in research-oriented health units 
or large tertiary hospitals which could have been even less accessible to the 
catchment communities. In this study, much effort was put in encouraging relatives 
to take their unconscious patients to the study hospitals which invariably were the 
only health units with the facilities to handle their treatment adequately. This may 
have resulted in the enrolment of a more heterogeneous population of CM patients 
with respect to risk factors and severity. If  the sensitization of the health 
practitioners at the lower level health units influenced improved their speed of
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referral, then more cases may have gotten to hospital in time for medical 
intervention to achieve the desirable goal of a cure.
Anecdotal evidence from the hospital staff suggests that the interventions that had 
been put in place during site preparation caused a decrease in mortality attributable 
to clinical cerebral malaria. These interventions were; training of the staff for the 
project, better patient triage, increasing the availability of drugs and associated items 
such as intravenous giving sets, allowing study nurses to initiate treatment, and 
improving the speed of laboratory evaluations on a 24-hour basis. It cannot be 
ignored that the staff were more motivated because they were participating in an 
activity which they saw having beneficial results on their output. A study of this 
nature had not been carried out before at any of the study hospitals and additionally, 
most of the nursing and laboratory staff had not been on refresher training courses 
since their graduation. The combination of these had a positive impact on mortality 
due to cerebral malaria, and possibly severe malaria in general. It was because of the 
possibility of this kind of impact that district hospitals were chosen in preference to 
New Mulago hospital the only national referral unit.
Thirty-eight cases had received quinine at another health facility within 48 hours 
before admission, which is a useful intervention in reducing mortality. One case who 
died had been given quinine before admission whereas the others had not. The 
association between quinine use and mortality was demonstrated in both univariate 
and multivariate analyses. A positive history of quinine use within 48 hours before 
admission was a good prognostic factor. Although this association was based on 
very small numbers and was not significant at the 0.05 alpha level it is of clinical 
relevance. If it is beneficial for referring health units to give a dose of quinine 
(intramuscularly since the facilities for intravenous administration would not usually 
be available at lower levels) before sending the patient off to a higher level unit, then 
the pros and cons need to be evaluated. During my review of the literature on 
cerebral malaria I did not come across a study that has examined this link.
A greater proportion of deaths were children under five years (6 children / 10 
deaths). This is not a new finding and has been elaborated upon in Chapter 2 and can 
affect the rate of neurological deficits in children by decreasing the numbers at risk.
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Children aged under 3 years have been found to be at greater risk of mortality 
compared to those over that age (Walker, Salako et al. 1992; Jaffar, Van Hensbroek 
et at. 1997). The same trend was found in this study although the association was 
not an independent one in univariate analysis. Adjusting the crude OR association 
by case definition or centre, did not have any effect. The multivariate logistic 
models, Models 1, 2 and 3, showed a smaller OR in adults compared to children. In 
Model 3, which was restricted to definite cases, the association between age and 
mortality produced a P value that was almost significant at the 5% alpha level. The 
current study would only be able to detect as statistically significant a large 
difference between the two age groups which it almost did. A larger sample size 
would have elucidated this association.
Mortality was higher in Kapchorwa than in Mbale hospital. Mbale hospital is better 
equipped and better staffed than Kapchorwa but because it is a referral hospital it is 
very busy. It was not possible to confirm the diagnoses of all the deaths that 
occurred among patients admitted with non-traumatic coma during the study period. 
It is possible that a proportion of deaths were not captured by the study systems in 
place and if there was a non-random difference in the numbers between hospitals 
then the findings may not reflect the true values for hospital-specific mortality. In 
the multivariate model, Model 1, the OR was 1.63 (95% Cl 0.38-7.10) but this 
became larger, though even less precise, once the model was restricted to definite 
cases amongst whom the deaths occurred.
Cases that did not survive formed a special group in another way. As described in 
the methods section, a category that consisted of observations without values was 
created to enable consistent numbers of cases during the various kinds of analyses. 
Missing data at Levels 1 and 2 containing this category often were because of failure 
to obtain and/or record information in cases that died. This was not expected but 
makes sense because one of the issues that was stressed during the training sessions 
was that prompt and appropriate case management was of greater priority than 
collecting data. Team members were expected to diagnose (take relevant routine 
laboratory specimens to confirm presumptive diagnoses), and start treatment 
(definitive and supportive) after which they could collect any additional information 
that was for research purposes. This was stressed repeatedly and much time was
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spent on improving patient triage within the hospital as well as improving the 
movement of specimens to and results from the laboratories. If the cases that died 
presented in fulminating disease then the staff would not have had the opportunity to 
fill in their CRFs before their demise. This seems to have been the scenario.
Contrary to the literature, a history of any number of seizures was associated with a 
smaller OR for mortality than no such history. The same trend was found for 
witnessed seizures. These associations are based on small numbers and as explained 
earlier were not expected. Other studies have shown a greater frequency of 
convulsions (either witnessed or reported) in patients who did not recover from CM, 
which contradicts the results here (Endeshaw and Assefa 1990; Walker, Salako et al. 
1992; Jaffar, Van Hensbroek et al. 1997). If this is an error then it is due to failure to 
detect or record subtle seizures or ‘electrographic status epilepticus’. If on the other 
hand this is a reflection of the association between convulsions and mortality in this 
population then it could be because the patients who died did so before they were 
able to have fits. In other words, to have seizures they needed to survive for long 
enough for them to manifest. Though the numbers are small, the trend for both 
reported and witnessed seizures are in the same direction suggesting that some other 
factors may be at play that were not measured in the study. The manifestation of 
clinical seizures in hospital remained independently associated with the outcome in 
multivariable analyses, Models 1, 2 and 3.
The doctors usually examined the cardiovascular system in all study cases. For this 
purpose Littman® stethoscopes (paediatric and adult versions) which are renowned 
for their sensitivity were provided for this purpose. The detection of extra heart 
sounds such as, murmurs, thrills, bruit, third and fourth heart sounds were noted and 
their presence was associated with a greater risk of mortality compared to their 
absence. More deaths were noted in the category which had missing information on 
this variable. As explained previously, this is because of the practical reality of 
managing very sick children in a very busy setting. The patient may either have died 
before the doctor was able to carry out a complete examination of the body systems 
or the doctor may have carried out the examination but because o f the seriousness of 
the patient’s condition had to proceed with other aspects of case management and 
not had the opportunity to record his or her findings in the CRFs. Lacking
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information on the presence of heart sounds was associated with death by an OR of 
8.50 (95% Cl 8.50-1.75). The clinical value of this finding is limited, however in 
epidemiological terms it is relevant. If all the cases with missing data on this 
variable had extra heart sounds then the OR would be modified away from the null; 
conversely, if they did not have extra heart sounds then the OR would be modified 
towards the null. The common conditions that produce extra heart sounds when 
associated with cerebral malaria increase the likelihood of death. Thus, a clinical 
sign in the heart that is associated with increased mortality may have been missed in 
non-survivors*.
The association between random blood glucose on admission and mortality was one 
that had been anticipated because it had been documented previously in other studies 
(Brewster, Kwiatkowski et al. 1990; Endeshaw and Assefa 1990; Walker, Salako et 
al. 1992; Jaffar, Van Hensbroek el al. 1997) except one (Niyongabo, Deloron el al. 
1994). The largest study to-date on childhood cerebral malaria which examined the 
predictors of fatal outcome in 624 children found an OR of 5.8 (95% Cl 3.0-11.2) in 
children that had multiple episodes of hypoglycaemia i.e. blood glucose level < 2.2 
mmol/L (Jaffar, Van Hensbroek et al. 1997). The cut-off they used is the same used 
in this study. However, the results here are based on one random blood glucose 
measurement. Those without glucose measurements had the higher OR of 6.25 (95% 
Cl 0.64-61.00). Incidentally, the only study on adult CM found similar mean plasma 
glucose levels in fatal and non-fatal cases, and no case had hypoglycaemia i.e. < 
2.2mmol/l (Niyongabo, Deloron et al. 1994). When the crude OR was adjusted for 
age (as two categories) it did not affect the estimates.
Another factor that was associated with mortality was the parasite count on Day 0. 
Compared with those having counts in the lower category of 50,000 parasites/pL or 
less, the OR was 4.46 (95% Cl 0.78-25.67) for counts over the cut-off and 6.25 
(95% Cl 0.87-45.14) for those who did not have a count done. Again these values 
are based on small numbers making the estimates imprecise. However the trend of 
an increased risk with an increased degree of parasitaemia is one which is already 
documented although in studies that have been situated in areas of more stable
5 One child with CM (ID 2040) who had a murmur due to a cardiac lesion developed severe 
neurological sequelae
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malaria transmission where on average the patients have had higher parasite 
densities. Jaffar el al. (1997) obtained a smaller and more precise OR o f  2.2 (95% Cl 
1.2-3.8) using a cut-off of > 500,000/pL. It would not have been possible to use a 
similar one because only one case had a parasite count > 500,000/pL. The mean 
(geometric) parasite count in 85 cases evaluated for parasitaemia was 15,973/|iL 
(range 131-590,400). Although the mean parasite count in Kapchorwa was higher 
than in Mbale, 26,215/pL (95% Cl 10,581-64,956) compared with 12,683/pL (95% 
Cl 6,836-23,531), much higher parasite densities were expected. If  all fatal cases 
had been evaluated it is possible that this would raised the mean count because of 
the positive association between parasite density and mortality. Probable cases had a 
higher parasite count than defmites although the difference was not statistically 
significant. Adjusting for centre and age separately did not have any significant 
effect on the crude ORs. Adjusting for them simultaneously (and quinine use before 
admission) in the logistic model and using only definite cases, the OR for both 
comparison levels increased substantially.
Unlike the findings by other investigators already referred to in this section, this 
study was not able to find significant associations between mortality and a number 
of factors in univariate analysis. These are abnormal respiratory pattern, rapid pulse 
rate (> 160 beats/min), features of shock (cold peripheries), coma score of 0 or 1 on 
the BCS, white blood cell count > 15,000/|iL, severe anaemia (Hb < 5 g/dL), signs 
of decerebration or opisthotonus, creatininemia (> 265 pmol/1), bilirubinemia (> 50 
pmol/1), and blood lactates > 5mmol/l. The main reason for this is that the power of 
this study was very small and some o f the effects which are not very large would not 
have been detected.
6.3 Neurological sequelae in children and adults
The following paragraphs will concentrate on the neurological sequelae of cerebral 
malaria. The findings will be interpreted within the limitations o f  the study. To 
obtain a bearing on the validity of the results, the findings will be elaborated within 
the context of other studies and where possible some of the underlying reasons for 
any differences in sequelae in children and adults will be mentioned. Errors and 
biases that may have had an influence on the results will be described or referred to 
if already mentioned elsewhere.
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6.3.1 F requ en cy a n d  types o f  n eu ro lo g ica l seq u ela e
Sequelae were detectable in 35 survivors at discharge or follow-up (range 1 week to 
39 weeks) and were motor-sensory in 22 survivors, cognitive in 7 or a combination 
of both in 6 survivors. The frequency of sequelae here is higher than in other studies 
because of the lower mortality and the timing of neurological assessment. In this 
study the first check for deficits was carried out at discharge (median duration of 
hospital stay was 7 days for survivors, range 3-48) at which time 23 survivors had 
noticeable neurological abnormalities. Some of the abnormalities that were later on 
detected as sequelae, developed during disease. There is no standard definition for 
the neurological sequelae of CM and that is why it was very important to have one 
for this study that was able to give a point during recovery at which the presence of 
neurological dysfunction became a complication/s. That point was when 
consciousness was regained (BCS = 5/5 or GCS > 14/15) because it is by this time 
that a survivor can be discharged home in which case any aspect of neurological 
function that is still impaired will become a deficiency to the individual and may 
even be incapacitating.
Twenty-two cases with sequelae (detected at discharge and follow-up) were treated 
at Mbale hospital (i.e. 31% of all Mbale cases) and thirteen cases at Kapchorwa 
hospital (i.e. 43% o f  all Kapchorwa cases). On the other hand, the proportion of 
survivors with sequelae at discharge who were treated at Mbale hospital was 27% 
(17/70) which was slightly higher than at Kapchorwa hospital, where the value was 
23% (6/30). The proportion of cases that attended follow-up visits was significantly 
higher in Kapchorwa (92%, 24/26) than Mbale hospital (44%, 28/64) which will 
have resulted in an inaccurate estimate of the number of Mbale cases that developed 
deficits after discharge. The major reason for the higher follow-up rate in 
Kapchorwa is that it was possible to arrange for a nurses to visit the homes of 
children who failed to come for their scheduled visit. In Mbale it was not possible to 
do so. Instead, announcements were aired on one of the radio stations with wide 
coverage in the district reminding parents (without using personal identifiers) whose 
children had been enrolled into the study to bring them for follow-up. All survivors 
were included into the study after obtaining informed consent. During this process 
and at discharge, the need to attend follow-up was emphasised. It was also made
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clear that a refund for transportation costs (to and fro) would be given at each visit. 
Mbale district has a better transportation network (roads and public transport) than 
Kapchorwa. The populations in both districts are fairly similar socio-economically 
and any constraints operating at this level would have been random. An idea of the 
factors that prevented parents from bringing their children for visits comes from the 
findings made by the nurse/s who made home visits. Some parents did not have any 
money to make the trip to hospital; some mothers were very busy and could not find 
the time to make the long journey to hospital; and some did not have any special 
reason. Fortunately, none of those who had not come for their scheduled visits at 
Kapchorwa and were later traced and assessed, had gross or worrying sequelae. It is 
clearly essential in studies of this sort to make provision for home visiting for 
follow-up.
Overall, the frequency of sequelae among survivors tended to be higher in the older 
ages, 28% (11/40) in 1-4 year group, 54% (13/24) in 5-9 year group and 42% 
(11/26) in > 10 years (not statistically significant). At discharge the frequencies were 
20% (8/40), 38% (9/24) and 23% (6/26) respectively (not statistically significant). If 
survivors that attended one or more follow-up visits were the denominator then the 
frequencies of deficits detected during follow-up in the three age groups were, 24% 
(5/21) in young children, 41% (7/17) in older children and 50% (7/14) adults (P 
value not significant). Nineteen survivors aged 1-4 years (48%, 19/40), 7 survivors 
aged 5-9 years (29%, 7/24) and 12 survivors aged > 10 years (46%, 12/26) did not 
come back to hospital after discharge. Even with these losses to follow-up they did 
not substantially change the frequency of sequelae by age group from the frequency 
at discharge. If there had been fewer losses, and if the findings of the nurses during 
the tracing of subjects lost to follow-up in Kapchorwa can be extrapolated to Mbale, 
then there is little reason to expect the age trend in the occurrence to be very 
different from what was found. The data rather suggest that any change in the 
frequency or persistence of sequelae by age occurs between those above and below 5 
years. This hypothesis could usefully be addressed in a larger study.
I think is important to consider age-group frequencies of sequelae in the context of 
age-group mortality. Young children had a lower frequency of deficits but a higher 
frequency of mortality. This may indicate that the age groups with lower mortality
2 3 0
have a greater number of survivors at risk for complications. Hospital-based studies 
are prone to selection bias and if cases with severe disease (such as very deep coma 
or have additional conditions) are selectively more likely to be brought (or referred) 
to hospital then a larger number of survivors who would have had less severe illness 
are being excluded and not studied. Unfortunately, my study did not have sufficient 
power to make comparisons between those with severe and less severe disease in 
order to examine this hypothesis. One objective of this study was to elucidate the 
frequency differences of the neurological sequelae of CM in Ugandan children and 
adults. This could not be achieved with the sample size.
The types of deficits seen in this group are similar to those that have been described 
in other study populations. They ranged from mild severity to incapacitating. The 
motor-sensory deficits, which were detected by clinical examination and a number 
of tests, affected muscle tone and power, tendon reflexes, cranial nerves, 
coordination, vision and speech. Cognitive deficits were more difficult to detect. 
Their examination focussed on language, verbal comprehension, attention and 
memory using a combination of a primitive tool with two versions, one each for 
children and adults, and clinical assessment. The detection methods were not very 
sensitive or specific but for practical purposes in the setting o f  the study, some 
means of screening and differentiating survivors who ‘potentially’ had 
complications from those were ‘potentially’ free from complications had to be 
devised. Much information was gathered by taking a detailed history of the 
condition of the subject while at home. Mothers were asked to compare the state of 
the child or in the case of an adult case, a close relative that usual lives with him or 
her, before and after the episode of cerebral malaria. A list of closed-ended questions 
was used for this purpose as well as open-ended ones. The role of recall bias is 
likely to be small because it was not likely that the changes in behaviour once 
noticed would be forgotten within the short span of time between discharge and 
follow-up.
Sequelae occurred in 19 definite cases and 16 probable cases and were of even 
frequency in the two groups. Twenty-five children (71%) and ten adults (29%) were 
detected to have deficits (amongst a total of 35 cases with sequelae). However, the 
proportion of children who were detected to have deficits, 37% (25 of 72 child
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cases), was not much different from that of adults, 36% (10 of 28 adults cases). Most 
of the adult cases, 7 cases, were seen at Kapchorwa hospital. Examination of the 
types of deficits found in children and adults did not show any trend.
6.3 .2  N a tu ra l h is to ry  and  tim in g
At the onset of the study, the terms ‘early-onset’ and ‘late-onset’ neurological 
sequelae were used to define the timing of the sequelae of CM. It is now apparent 
that the latter term is misleading because some of motor-sensory sequelae that were 
detected during the follow-up period had persisted right from the illness itself (5 
cases of 23 with motor-sensory deficits at discharge). In some instances new deficits 
were detected on the visits (5 cases) i.e. truly Mate-onset’.
Eighteen survivors (78% of 23 cases with motor-sensory deficits at discharge) who 
had deficits at discharge did not have them at the first (median 5 weeks after 
discharge) or second (median 9 weeks after discharge) visit. The manner in which 
follow-up assessments were conducted did not allow the true timing of the onset of 
deficits to be determined. Instead, their ‘onset’ was determined by the timing of the 
detection procedure. At the beginning of the study, follow-up assessments of 
survivors were not regular because i) the PI was very busy shuttling between study 
hospitals to make sure that cases were being enrolled and managed in the right way 
and ii) the cognitive tools were not developed until later. It was during this period 
that some o f  the survivors were lost to follow-up. The majority of subjects with 
deficits improved during the follow-up period a finding that has been observed in 
other samples followed up over a similar time frame (Molyneux, Taylor el al. 1989; 
Brewster, Kwiatkowski el al. 1990; van Hensbroek, Palmer el al. 1997). There did 
not appear to be any difference in the natural history of sequelae in children and 
adults. It is not possible to say whether this null result is a real one or due to the 
small sample and large numbers of losses to follow-up.
6.3 .3  In d e p e n d e n t risk fa c to rs  f o r  early  on se t n eu ro lo g ica l seq u e la e  in children  
a n d  a d u lts
Among ninety survivors of cerebral malaria who were admitted during the study 
period a number of factors were highly associated with early-onset neurological 
sequelae. Some of these factors were independently associated with the outcome in
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univariate analysis and even in multivariable analysis. Before going into a 
discussion of these factors, 1 would like to say that splitting the outcome into early 
and ‘late’ onset was relevant for several reasons. Firstly, the underlying causal 
mechanisms for neurological dysfunction may be different or have different levels of 
importance. Secondly, the associations with the two kinds of outcome are subject to 
different biases such as losses to follow-up which affects Mate-onset’ deficits mostly. 
Ascertainment of the outcomes, involved different procedures; at discharge, motor- 
sensory deficits were looked for whereas during follow-up, both motor-sensory and 
cognitive deficits were sought. Finally, it is of clinical value to have an idea of the 
predictors of the two outcomes separately in order to develop appropriate 
interventions.
Factors that were independently associated with early-onset sequelae in univariate 
analyses are quinine use within 48 hours before admission, enlarged spleen, duration 
of coma (coma recovery time), and white blood cell count on admission. A longer 
duration of coma is a known risk factor for neurological deficits and has been 
documented in studies on this topic (Bondi 1992; Carme, Bouquety el al. 1993; van 
Hensbroek, Palmer el al. 1997) except in one investigation (Idro, Karamagi el al.
2004). In my small study a coma duration of 5 days or more was associated with a 6- 
fold increase in risk compared to < 2 days. The brain injury that manifests as 
neurological sequelae is said to occur during coma. Consequently, longer exposure 
to coma will predispose to neurological deficits, as this study shows. In the 
multivariate logistic models, the coma recovery time remained highly associated 
with the outcome with little change in the OR for the three comparison categories 
after adjusting for the other variables. The association with the white blood cell 
count is not clear though. The study in The Gambia found a significantly higher 
white blood cell count in survivors with sequelae and those without (van Hensbroek, 
Palmer el al. 1997).
Quinine use prior to admission and splenomegaly have not been identified by other 
researchers. Quinine in above normal doses is known to have side effects that affect 
neurological function viz. headache, dizziness, visual disturbances (optic atrophy in 
severe cases), convulsions, tinnitus and deafness. This is one of the reasons why a 
history of quinine use is a contraindication for giving a loading dose at the
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commencement of intravenous therapy. Fourteen cases (median age 6 years, range 
1-18 years) had a history of quinine use and early-onset sequelae. One of these cases 
received a loading dose of quinine on admission and had deficits in tone, tendon 
reflexes, and ataxia. Of the three cases with visual impairment at discharge, two of 
them had received quinine in the 48 hours prior to admission. These findings do 
suggest a role for quinine when given prior to admission. Apart from this, there was 
no association between quinine administered in hospital and early deficits.
The detection of a palpable spleen (> 1cm below the left costal margin, maximum 
was 5 cm), produced an OR of 3 (95% Cl 1-9) in univariate analysis. This value 
increased significantly in the logistic models. Ramble et al. (2002) found enlarged 
spleens in 8 Indian children (53%) aged between 1 and 12 years whereas Waiz and 
Chakraborty (1990) found the same feature in only 7% of their sample of 55 older 
cases of CM. Olweny et al. (1986) found splenomegaly less common in Zambian 
adult patients with cerebral malaria than controls who had other forms of malaria 
suggesting a protective effect. Nacher et al. (2001) on the other hand did not find 
this effect in their case-control study and on the contrary found it significantly 
associated with cerebral malaria. These studies have been in different 
epidemiological settings and they indicate that the role of the spleen in cerebral 
malaria, either beneficial or deleterious, is still not clear. An animal model has 
suggested its involvement in cytoadherence (David, Hommel et al. 1983) which 
would support its role as a risk factor for early-onset deficits.
Seizures in this case series were not found to be significantly associated with 
neurological complications. This is in contrast to the study done in New Mulago 
hospital (Kampala, Uganda) which found multiple seizures to be independently 
associated with neurological deficits (Idro, Karamagi et al. 2004). The largest and 
most reliable study on CM neurological sequelae also found a relationship between 
multiple seizures and outcome (van Hensbroek, Palmer et al. 1997). This finding 
therefore needs to be evaluated in a larger study in the Ugandan population before a 
valid conclusion can be drawn. The effects of total fever clearance time and 
haemoglobin concentration in the model are difficult to interpret. The perception of 
fever as a symptom is subjective. The ORs for total fever clearance time imply lower 
relative risks with longer duration of fever (as symptom and sign). The small
2 3 4
number of survivors with the outcome did not allow confounding and interaction to 
be properly assessed which may responsible for these findings. The method used to 
estimate the haemoglobin concentration is not an accurate one but it was the only 
method routinely available in the hospitals. In retrospect, to rely on this was an 
oversight.
Age, categorised as two groups, was not associated with the outcome in univariate 
or multivariate analyses. However, using the three age groups, older children were 
more likely to be at risk than young children. The confidence intervals for the OR 
for adults was very wide and did not give an indication as to whether their risk was 
higher or lower. One of the study objectives was to determine if the risk factors for 
sequelae differed between children and adults. To do this, a model restricted to each 
group would have had to be developed. This was not possible because of the small 
numbers of children and adults with the outcome.
6.3.4 In d ep en d en t risk fa c to r s  f o r  ‘la te -o n se t’ n eu ro lo g ica l sequ elae  in 
ch ild ren  a n d  adults
The reasons for using survival analysis have been highlighted elsewhere in this 
thesis. Taking ‘time-to-event’ in to account allowed better appreciation of the data 
and had not been tried before on this outcome. In conducting the analyses, the 
underlying parameter for the risk of the outcome, the hazard, was not constant over 
the period of follow-up. Contrary to what was initially thought as the reason for this, 
the declining likelihood of developing deficits over time having survived, the 
outcome ascertainment process introduced a different reason. Rather than ‘time-to- 
event’ the hazard represented ‘time-to-detection’. This is why the baseline hazard 
function increased over the follow-up time especially when the majority of events 
‘occurred’ i.e. the first ten weeks. Taking cognizance of this, the results need to be 
interpreted with caution.
In this sample, a seizure stoppage time of more than 2 days compared to the referent 
group, 1-2 days, produced a HR of 4.80 (95% Cl 0.82-27.97) in the more robust 
model, Model 2, that did not include the clinically relevant variables. Survivors that 
did not have seizures had a HR of 4.95 (95% Cl 1.13-21.78). This implies that 
detection and development of sequelae is more likely in these two groups than in the
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referent group. The numbers of events in the two seizure groups are small and as a 
result the findings are questionable and difficult to interpret. Whereas fever was not 
a determinant for early-onset deficits, a fever clearance time of more than 3 days 
was a risk factor for this outcome. This was not unexpected since it has already been 
identified as a risk factor by other researchers.
Survivors that had deficits at discharge were 8 times more likely to have late-onset 
deficits. This finding follows on from the natural history of neurological sequelae. It 
is of clinical importance for two reasons. First and foremost it emphasises the need 
for all survivors of CM to be examined for neurological dysfunction before they are 
sent home. Secondly, survivors who have detectable deficits at the time of discharge 
require follow-up. Adults had a larger HR than children but this was not statistically 
significant. The differences in the determinants of late-onset sequelae between 
children and adults could not be examined because of the small sample size.
Two biases that affect the internal validity of the above results are the influence o f 
losses to follow-up and the reliability of the methods used to determine the presence 
o f the outcome (motor-sensory and cognitive deficits). As mentioned before, efforts 
were made to facilitate survivors to come for outpatient reviews. It is more likely 
that survivors that did not do so were free from overt neurological complications. If 
this was the case, their exclusion affected the precision of the risk estimates. The 
reliability of the cognitive tool is low. It was used as a screening tool and not as a 
confirmatory one. It may have been more prudent not to combine subjects that were 
identified by the cognitive tool with those that had clinically detectable deficits. 
However, the reason for doing so was that the a priori one of the study objectives 
was to elucidate the determinants of neurological sequelae, without separating them 
into their broad types.
6.4 Methodological issues and Study limitations
In the following paragraphs I will highlight some aspects of the study methodology 
that had an effect on the results and give some factors that influence the 
interpretation and validity of the findings.
236
6.4.1 S tu d y  design, sam ple s iz e  a n d  p o w er
The major reason for embarking on this study was to investigate if there were 
differences in the characteristics o f the neurological sequelae of cerebral malaria in 
children and adults in Uganda. This meant that sufficient numbers of children and 
adults needed to be enrolled in the study and followed up. A multi-centre design was 
chosen based on information obtained from hospital records and discussions with 
medical practitioners at potential sites. Study hospitals were situated in areas of low 
malaria transmission intensity or close to such areas in order to capture adult cases 
of cerebral malaria. Even with all the measures put in place to facilitate patient 
enrolment, the numbers remained low, far less than the records had showed. The 
design had to evolve from four-sites into two-sites with a longer recruitment phase. 
The small sample that was eventually obtained could not power the study to detect 
some of the effects which were envisaged or sought. This constraint was not limited 
to this study alone, as has been described previously.
6.4.2 M easurem en t o f  ex p o su re  and detec tion  o f  o u tco m es
Age-of-onset of disease was the exposure of interest. Its measurement was based on 
information provided by a relative, who was often the patient’s mother, that brought 
the patient to hospital. Two sources of information were used; i) reported age and ii) 
date of birth. Often the sources corroborated, at times only one source was given and 
in a few instances they did not match to within 3 months. More reliance was placed 
on the date of birth when it did not match with the given age. It is unlikely that recall 
bias affected age measurements and if it was present, did not have much impact on 
the analyses because age was used as a categorical variable.
The outcomes of interest were the three main complications of cerebral malaria 
namely, mortality, early-onset and late-onset neurological sequelae. Mortality was 
ascertained in hospital. A few cases were taken away from hospital without being 
discharged and their outcome with regard to survival had to be inferred from the 
data. Early-onset deficits were detected by physical examination. Motor-sensory 
deficits were sought at this level using a structured data-extraction questionnaire 
which the study doctors had been trained to complete. This method had a high 
sensitivity for detecting overt deficits but a low sensitivity for subtle deficits which
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mostly went undetected, but are probably less worrying. Late-onset deficits 
comprised motor-sensory and cognitive sequelae. The examining doctors were 
aware of the study hypothesis but the influence that this source of bias had was 
reduced by standardising the assessment process and using structured 
questionnaires. The cognitive tool though not an accurate and reliable instrument 
was the best-available objective method that could be used in the setting at that time.
6.4 .3  R o le  o f  m ea su rem en t erro r
This type o f error will have affected the clinical and laboratory data that accrued 
during the study more so because it involved more than one study site. In 
anticipation of this, a number of measures were put in place to eliminate it or reduce 
its magnitude. These include, training of team members in data collection and 
measurement procedures, standardisation of clinical assessments and laboratory 
evaluations, implementing quality control in the laboratory, using accurate and 
reliable equipment where possible, using similar reagents at the study sites, and 
taking repeated measures. Despite these, some measurement error will still have 
remained but was minimal since a number of valid associations that have been 
identified elsewhere were seen.
6 .4 .4  R o le  o f  m isd a ss if ica tio n  b ias
This bias mostly affected information on the outcomes and some of the explanatory 
variables. The result was a type II error that made it more difficult to find effects 
unless they had a large magnitude.
6 .4 .5  C o n fo u n d in g  a n d  In teraction s
The small sample size and low frequency of the outcomes limited the ability to 
control for confounders and test for interactions. For example, there was an 
interaction between centre and age which was not accounted for in the analyses. 
Nonetheless, identifying some of the determinants of neurological sequelae was one 
of the study goals and did not require having to control for all possible confounders 
or assess all the potential interactions.
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6.4.6 O th er ca u ses o f  n eu ro lo g ica l dysfunction  in the study po p u la tio n
There are other non-traumatic conditions that can lead to neurological deficits in the 
study population. These include sickle-cell anaemia, HIV infection and AIDS, 
cardiovascular accidents, and epilepsy. It was important to ensure that the sequelae 
identified were a consequence o f cerebral malaria and not due to these other 
diseases. A history of any neurological dysfunction or epilepsy was a reason for 
exclusion in the selection criteria. HIV infection was checked in a subset of the cases 
and found to be present in a small number of subjects (5 cases were sero-positive 2 
of whom had deficits). However, they were asymptomatic and unlikely to be 
manifesting the neurological complications of HIV which more commonly occur 
later in the natural history of the disease (Brew 1993b; a; Brew and Currie 1993) 
when other symptoms of HIV infection would be emerging. Anti-retroviral therapy 
can cause neurological complications as well but is not accessible to the majority of 
the community.
Tests for sickle cell disease (SCD) were not carried out because of the unavailability 
of the necessary reagents. The number of positive tests for homozygous 
Haemoglobin S (HbS) which is responsible for SCD at the laboratory in Mbale is on 
average one or two cases per week (personal communication from the Senior 
Laboratory Technologist). It is unlikely that any of the one hundred cases falls into 
this category because the abnormal red blood cells (sickle-shaped) would have been 
seen in the thin films that were examined to type malaria parasites. In addition, the 
doctors were aware of the need to exclude this diagnosis and would have identified 
subjects with features of SCD during the clinical assessments or follow-up.
6 .4 .7  G en era lisab ility  o f  th e  s tu d y  results
The results documented here are a good representation of the features of CM and its 
neurological sequelae in children and adults in the population from which the 
sample was selected. I say this because even with the low enrolment rate, the 
magnitude of sampling error within the catchment area of the hospitals was probably 
small. The majority of patients that did not reach the government health sector are 
likely to have been those that were very ill and died. Those that did get to any of the 
lower health units within the catchment area of the study hospitals would have been
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recorded or known to the medical staff at the unit. The surveillance system to track 
down ‘clinical cerebral malaria’ during the study involved visiting these units (and 
private-owned ones), communicating with their staff and liaising with the district 
public health teams who visit the health centres and communities regularly. This did 
not find that much ‘clinical cerebral malaria’ was ending up elsewhere even with the 
tendency towards overdiagnosis. Those patients who are taken to traditional healers 
or private health units (very few in Kapchorwa) limit the generalisability of the 
results to the population that is managed at government units. The proportion of 
losses to follow-up in Mbale also affects the generalisability of the results on ‘late- 
onset’ deficits in that area but not those of the other outcomes. The improved quality 
of care and diagnosis that were provided to the study cases means that the situation 
in which cases were managed is not what may be found in other hospitals in the 
country. This is another limitation to the generalisability of the results. However, if 
the picture seen here is better than what is found in other hospitals then it does mean 
that the complications of cerebral malaria i.e. death and sequelae, are higher in other 
hospitals, and the findings here are underestimates of the frequency of sequelae of 
cerebral malaria.
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7. CONCLUSIONS
This small-scale multi-centre study of one hundred patients was able to determine 
that the proportion o f cerebral malaria among malaria admissions was 1.9% 
(72/3789) in children and 1.8% (28/1592) in adults admitted to the study hospitals. 
The case fatality ratio was low, 10%, and young children under five years of age at 
the time of admission had the higher mortality. Thirty-five survivors were detected 
to have neurological sequelae of either the motor-sensory (22 survivors) or cognitive 
(7 survivors) or both (6 survivors). The proportion of survivors with neurological 
sequelae was slightly higher in adults, 42% (11/26) than children, 38% (24/64). The 
more striking age difference was the frequency of sequelae among survivors aged 
under five, 28% (11/40), and those aged 5 to 9 years, 54% (13/24). The types of 
sequelae identified in survivors at discharge and during follow-up were described in 
detail and there was no difference between types in children and adults. Deficits 
were present in twenty-three survivors at discharge (motor-sensory sequelae only) 
and 19 survivors that attended review visits (motor-sensory and cognitive sequelae). 
Deficits involving muscle tone (detected in 18 survivors), tendon reflexes (14 
survivors) and muscle power (12 survivors) were the commonest at discharge, 
occurring in combination. Cranial nerve deficits occurred in 4 survivors and 
impaired vision in 3 survivors. Many of the deficits improved within ten weeks post­
discharge though a few survivors with severe impairment still had them at the 
follow-up visits and new ones were detected. Impaired muscle strength (5 cases) 
was the commonest motor-sensory sequelae detected during follow-up. The 
commonest cognitive deficit either reported by mothers of survivors or detected by 
the cognitive tool was memory impairment which was found in 10 survivors. Other 
deficits either occurring singly or in combination were post-cerebral malarial 
seizures (2 survivors who attended follow-up), impaired speech (2 survivors), 
attention deficit-disorder (2 survivors) and problems with language and verbal 
comprehension (2 survivors). The natural history of sequelae did not differ between 
children and adults.
Some important determinants of the three outcomes of interest namely, mortality, 
deficits at discharge (early-onset deficits) and deficits during follow-up (Mate-onset’
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deficits) were identified by multivariate analyses. Those independently associated 
with mortality were quinine use within 48 hours prior to admission, seizures while 
on the ward and parasite count on admission. Quinine use within 48 hours prior to 
admission, duration of coma, duration of fever (days with a history of fever plus 
days in hospital with a high temperature) and splenomegaly were independently 
associated with early-onset deficits. The detection and development of late-onset 
deficits was associated with duration with elevated body temperature, duration taken 
to cease having seizures and the presence of neurological deficits at discharge. It 
was not possible to examine the determinants for the outcomes in children and 
adults separately.
7.1 Practical study benefits
The scientific contribution that this study has made on the topic has been elaborated 
in the preceding chapters. There were some benefits of the study that require 
mentioning because they are of practical value. I list them below:
1. Mortality of cerebral malaria dropped during the study. This observation was 
based on anecdotal evidence from experienced clinical and nursing staff. The 
interventions that resulted in this beneficial effect have been mentioned.
2. The management of cerebral malaria at the study hospitals was standardised and 
adapted from International manuals to create guidelines suitable for the local 
setting. These adapted guidelines have been incorporated into the Ministry of 
Health (MOH) guidelines for the management o f  severe malaria in Uganda (a 
copy of poster is in Appendix VI).
3. The use of the parasite count as a diagnostic and monitoring laboratory test has 
become more popular at the study hospitals. The Standard Operating Procedures 
(SOP) for diagnosis of malaria developed by the MOH recommends the 
estimation of the parasite count but its use was not widespread. The experience 
of its benefits in this study are an example that is being used in seminars and 
conferences for Laboratory practitioners around the country.
4. There is now an increased awareness of the neurological sequelae of cerebral 
malaria amongst the study team members and the parents of survivors. As a 
result, survivors are now asked to return for review in the outpatient clinics 
which was not usually the practice.
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5. Experienced nurses can now make a thick smear for diagnosis and initiate 
appropriate treatment for cerebral malaria at the units that participated in the 
study. Prior to this, they had to wait for a doctor to request a blood smear and 
prescribe quinine before commencing treatment. As a consequence, patients get 
adequate treatment faster, which is one of interventions recommended for 
malaria control, namely “Prompt diagnosis and treatment”.
6. The staff at the participating hospitals have picked up an interest in malaria 
research. A study of this quality and nature had not been conducted at any of the 
sites before, and possibly none of the neighbouring district hospitals. Much of 
the medical research is carried out at the bigger teaching hospitals and yet the 
majority of the population visit their nearest district hospital. Having been 
through this project, seen that it is possible and gained some research skills, 
some staff are keen to develop, seek funding and conduct their own studies.
7. Diagnostic and laboratory equipment that were procured by the funds for the 
study have remained at the study hospitals. The hospital administrators have 
committed themselves for their usage in the units where they were placed during 
the study.
7.2 Areas for future research
In the course of this research project a number of areas for further study have been
identified. These are listed below:
1. Contrary to the findings by other researchers, seizures were not associated with 
an increased risk of mortality or neurological sequelae. Subtle seizures may be 
occurring undetected and subsequently remaining untreated which can lead to 
poor prognosis if there is a link between seizure activity and death or 
complications.
2. There is need to elucidate the relationship between malaria parasite density and 
the manifestations o f severe malaria in the south-western region of Uganda, 
specifically Kabale and Kisoro districts. These are areas that are prone to malaria 
epidemics with populations that are not immune to malaria. The expectation in 
such groups is high parasite counts because of their immunological naivety. This 
did not appear to be the case and there may be factors responsible for this. It is 
important to study this to improve the methods for diagnosis and determine if 
there are any implications for treatment.
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3. The cognitive tool developed for detecting cognitive dysfunction requires more 
piloting to determine its usefulness in Uganda. At present, no tool exists for that 
purpose and yet as has been shown here, survivors o f cerebral malaria do have 
cognitive sequelae that need to be managed. The tool is the foundation upon 
which more sensitive ones can be developed.
4. A number of patients that were tested for HIV-1 had discordant results on two 
ELISA tests. This has major implications for practical HIV control in Uganda 
because more often than not, one ELISA test is used at many of the district 
hospitals for screening for HIV. Why was this the case and does the combination 
of severe malaria (cerebral malaria in my study) and HIV have any impact on the 
diagnosis of the other, in the Uganda population.
5. The spatial risk factors for cerebral malaria require examination. Factors such as 
altitude, distance to health centre, and clustering o f patients, to mention a few 
will help determine the populations are risk and very importantly the locations of 
patients that are not being captured by the health systems. In the course of my 
fieldwork, I collected dried blood spots from children along the slope of the 
Elgon ranges in Kapchorwa district. I intend to use these specimens to find out 
the altitudinal limits of malaria in the area at that time. I have also been able to 
obtain digital maps of Mbale and Kapchorwa districts and will use them to 
examine if the cases enrolled in this study had any obvious spatial 
characteristics.
6. There appears to be some important differences in the characteristics and 
complications o f cerebral malaria in younger and older children, and adults in 
Uganda. A confirmatory study on this topic is needed and can help to shed more 
light on the pathogenesis of disease, brain injury and neurological sequelae with 
the objective of improving case management and prevention of complications. 
To do this, there is need to improve the sampling fraction and study a greater 
proportion of patients with cerebral malaria. A further study should not focus on 
cerebral malaria alone but should include the other central nervous system 
infections and compare the determinants of their early complications. This study 
has demonstrated that a major risk factor for the detection and development of 
deficits within ten weeks after discharge is the presence of neurological 
complications at discharge. The challenge therefore for the future, is to find 
interventions that reduce mortality and prevent the immediate complications.
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Appendix I: Data collection tools, Information sheets, Consent forms
Copies of the following data collection tools are included here. They have been 
printed separately to maintain their layout and as a result the page numbers do not 
follow from the rest of this document. The following are contained herein.
>  Checklist 1 and Form 1
> Checklist 2 and Forms 2, and 3
> Observation chart
>  Forms 4, child and adult versions
> Forms 5, child and adult versions
> Information sheets (English and translated)
> Consent forms (English and translated)
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A p p e n d i x  II: Aide memoirs
Copies of aide memoirs used are provided here (except the guidelines for the 
management o f cerebral malaria which are listed in the methodology). They have 
been printed separately to maintain their layout and as a result the page numbers do 
not follow the rest of the document.
>  How to measure blood pressure using an automatic sphygmomanometer
>  How to measure blood glucose using a glucometer
>  Evaluations o f the patient with cerebral malaria
3 3 6
Measurement of Blood pressure using the Automatic 
Inflation BP Machine
Procedure
1. Remove tight clothing from the patient's upper arm
2. Place the arm in a position that allows the upper arm to be 
at the same level with the heart
3. Put the arm through the cuff making sure that the marker 
is above the brachial artery
4. Pull the end of the cuff and tighten it around the arm 
making sure that it is not too tight then lock it in place.
5. Connect the cuff to the monitor
6. Set the Inflation control switch to 140 (if a child) or 170 (if 
a adult).
7. Press the ON/OFF button
8. Wait for the v symbol to appear on the screen then press 
the start button
9. Make sure the patient does not move the arm or body 
while the measurement is taking place
10. Note the systolic and diastolic blood pressure and the 
pulse rate.
11. If there is an error, repeat the process again.
Important
1. Remove tight clothing before taking a measurement so that 
the measurement is accurate.
2. The cuff should be placed about two centimetres above the 
elbow and at the same level with the patient’s heart.
3. Make sure that the tubing is not bent
4. Measurement should be taken when the patient is not 
moving because the machine is sensitive to movements.
5. Do not talk while taking the measurement because the 
machine is sensitive to noise.
6 Wait for 2-3 minutes before repeating a measurement
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Measurement of Blood glucose using a glucometer
Supplies needed
1. Advantage glucometer
2. Advantage II glucose test strips
3. Blood lancet
4. Swab
Procedure
1. Gentle squeeze some blood into one of the fingers of the 
left hand
2. Clean the tip of the finger with the swab
3. Turn the glucometer on and check that it is working well
4. Insert a test strip into the socket with the metallic strips 
going in first and the blue end facing you
5. Replace the cap on to the tin of strips immediately
6. Insert the lancet with a quick jab into the side of the finger 
near the tip
7. Squeeze the tip of the finger to obtain a small drop of 
blood
8. Place the drop of blood on to the edge of the yellow 
window of the test strip
9. Allow the blood to cover all of the yellow area
10. The glucometer will make a beep and start measuring the 
glucose level in the sample.
11. Note the reading. If there is an error, repeat the above 
process again.
Important
1. Do not leave the tin o f test strips open otherwise the strips 
will loose their effectiveness
2. Touch the edge of the yellow window with the drop of blood; 
do not put the drop on top of the yellow window
3. Cover the entire yellow window with blood otherwise the 
reading will be incorrect
4. Do not drop the glucometer. If this occurs accidentally, the 
glucometer has to be calibrated again
5. Calibrate the glucometer before using a new tin of test 
strips
3 3 8
Evaluation of the patient admitted with cerebral malaria
Day 0 (admission) Day 1 Dav 2 Dav 3 Day 4
Complete Checklist 1 Complete Checklist II Fill Form 3 Fill Form 3 Fill Form 3
Complete Form 1 Complete Form 2 Fill observations chart Fill observations chart Fill observations 
chart
Do random glucose 
estimation
Do LP and CSF analysis Take thick smear for parasite 
count
Take thick smear for 
parasite count
Take thick smear for 
parasite count
Fill observations chart Take thick smear for parasite 
count
Take 4 bloodspots on 
filter paper
Take thick smear for 
screening with Field’s stain
Collect 3mls (adult) or 1 ml (child) 
into EDTA vacuette for 
haematological indices
Take thick smear for 
parasite count with Giemsa
Collect 2mls (adult) or 1 ml (child) 
into Plain vacuette for serum 
storage
Take thin smear for parasite 
typing
Do urinalysis with Multistix
Take 4 bloodspots on filter 
PaPer
Fill observations chart
Day 5 Day 6 Day 7 (completes quinine 
therapy)
1 month post-discharge 2 months post­
discharge
Fill Form 3 Form 3 Fill Form 3 2nd Neurological 
assessment
3rd Neurological 
assessment
Fill observations chart Fill observations chart Fill observations chart Take 4 bloodspots on 
filter paper
Take 4 bloodspots on 
filter paper
Take thick smear for 
parasite count
Take thick smear for parasite 
count
Administer Information sheet
Obtain informed consent
Take thick smear for parasite 
count
Take 4 bloodspots on filter 
paper
Complete Form 4 -  1st 
Neurological assessment
Appendix III: Protocols for Laboratory evaluations
The procedures contained in this appendix have been mostly taken or adapted to suit 
the local setting from Laboratory Practice in Tropical Countries, Part 1 
(Cheesbrough 1998).
> Blood smear for malaria
> Parasite count
> Haemogram
>  Cerebrospinal fluid analysis
>  Urinalysis
>  HIV test
>  Dried Blood spots
> Storage of serum
3 4 0
Making blood smears (Capillary blood method)
A) Thick smear
1. Get a sterile lancet, swabs of cotton, 70% v/v alcohol, clean slide and disposable 
pair of gloves.
2. Clean the slide until it is grease-free. Put on the gloves.
3. Cleanse the lobe o f  the finger (3rd or 2nd fingers) using a swab moistened with 
70% v/v alcohol. Allow the area to dry.
4. Use a sterile lancet, prick the lateral aspect of the finger. Wipe the first drop of 
blood that comes from the site with a clean swab of dry cotton. Squeeze gently to 
obtain a large drop o f  blood.
5. Touch the centre o f  the slide onto the drop of blood. Immediately use a spreader 
to spread the blood over the slide until it is a thin film that covers about 2/3rd of the 
slide (or 2cm in diameter). The depth of the film should be “thin” enough to allow 
one to see print if the slide is placed on a book.’
6. Label the slide with the patient’s study number, age, ward and Day of 
management (i.e. Day 0, 1 etc) on the frosted part of the slide. Use a pen with 
permanent ink (diamond pens that can write on glass were used to label slides that 
were not frosted).
7. Place the slide horizontally in a safe place and allow to air dry.
B) Thin smear
1. Get the items stated in 1 above including coverslips.
2. Follow steps 1 to 4 above
3. Touch the non-frosted end of the slide onto the drop of blood. Place the slide on a 
flat surface. Use a coverslip to make a thin smear by touching the coverslip to the 
drop of blood at an angle between 30° to 60° and sliding it forwards towards the 
frosted end. The smear should have a tail and head and should cover at least 2/3rd of 
the slide.
4. Follow steps 6 to 7 above.
It was important to mention this because there was the tendency among nurses to make a thick 
smear as thick as possible in the belief that this was preferred.
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F i x a t i o n  o f  t h i n  b l o o d  f i lm s
1. Get absolute methanol (methyl alcohol), disposable gloves and the dry thin smear 
to be fixed.
2. Place the slide horizontally on a staining slide rack over the sink.
3. Apply a small drop of methanol onto the thin film.
4. Allow to stand for 1 -2 minutes
Staining malaria parasites
A) Field's stain: was used to screen thick smears for malaria parasites.
1. Get Field’s stain A and B, clean water, disposable gloves and the dry thick smear 
to be stained.
2. Dip the slide into the container with Field’s stain A until it covers all of the smear. 
Leave it inside for 5 seconds. Upon taking it out, drain off the excess stain by 
touching a corner of the slide against the side of the container.
3. Rinse the slide gently with clean water. Drain of the excess water
4. Dip the slide into the container with Field’s stain B as above for 3 seconds.
5. Rinse the slide gently with clean water, wipe the back of the slide and stand 
upright in a draining rack. Allow to air dry or alternatively dry under a light bulb as 
a second option.
13) Field’s stain: was used to stain thin films to identify the species of malaria 
parasite
1. Get Field’s stain A and B, buffered water (pH 7.1-7.2), clean water, disposable 
gloves and fixed-thin smear for staining.
2. Prepare dilute Field’s stain B by mixing 1ml of stain with 4ml of buffered water.
3. Place the smear on a staining rack over the sink.
4. Cover the slide with about 'A ml of diluted Field's stain B
5. Add immediately an equal volume of Field’s stain A and mix with the diluted 
Field’s stain B. Leave to stand for 1 minute.
6. Rinse the stain off with clean water. Wipe the back of the slide and place it in a 
draining rack to air dry.
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C) Giemsa staining technique for thick smear (10 minute staining technique).
1. Get Giemsa (Rapid) stain, buffered water (pH 7.1-7.2), disposable gloves and the 
dry thick smear for staining.
2. Dilute the Giemsa stain by adding 45ml of buffered water to 5 ml of Giemsa stain 
(1 in 10 dilution). Mix gently.
3. Place the slide in a shallow tray face downwards and pour the diluted stain into 
the tray. Leave the slide for ten minutes.
4. Rinse the slide with clean water to flush off any excess stain. Wipe the back of the 
slide and place on a draining rack to air-dry.
Mounting smears w ith DPX
1. Get DPX mountant, coverslips, disposable gloves and smears to be mounted
2. Using a dropper, place a drop of DPX onto a clean coverslip.
3. Place the slide (smear side downwards) onto the coverslip making sure that there 
are no bubbles of air in the mountant.
4. Wipe the back of the slide and leave to air-dry
Reporting blood films for malaria parasites 
A) Thick film
1. Apply a drop of immersion oil on to the completely dry smear or if mounted onto 
the coverslip.
2. Carry out a preliminary examination using the lOx and 40x objectives 
(microscope). Determine the most suitable parts of the film for estimating parasite 
density and examine the white blood cells for quantity and type.
3. Change to lOOx objective and examine the selected part of the film
4. Examine for malaria parasites by looking at 100 high power fields (hpf).
5. Report the approximate number of parasites (trophozoites) according to either the 
plus sign scheme (for screening purposes only) or the parasite count scheme (for 
monitoring purposes)
6. If not parasites are seen after looking at lOOhpf report the film as “No MPs seen”+ *
* It was not routine to repeat smears when parasites were not found.
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B) Thin film
1. Apply a drop of oil onto the lower third of the film.
2. Examine the film with lOx then 40x objective. Check staining, morphology and 
distribution of the cells. Focus on parts of the film in which the RBCs are just 
touching each other and not overlapping.
3. Identify the species of plasmodia by looking at the ring forms, appearance of 
PRBCs (size, shape, Schuffner’s dots, and number of parasites per cell), and 
presence of gametocytes and schizonts.
4. Use the lOOx objective to confirm the findings in 3 above. Also note the 
distribution of white blood cells and the shape of the RBCs.
F.stimating the Parasite density 
A) Plus sign scheme
This scheme is recommended by WHO for estimating the degree of parasitaemia as 
follows (WHO 1991):
Parasites Plus sign
I-  10 perlOOhpf +
I I -  100 per lOOhpf ++
1-10 in every lhpf +++
>10 in every lhpf ++++
B) Parasite count scheme
This scheme assumes that there are 8000 white blood cells per microlitre (Warhurst 
and Williams 1996). This standard white blood cell count is used to determine the 
parasite count as follows:
1. Count the number of malaria parasites per 200 white blood cells*.
2. Multiply this number by 40 to obtain the estimated number of malaria parasites 
per microlitre (mm3). *
* In situations in which the parasitacmia is very high and the number of parasites per hpf are too 
many to count, one local adaptation developed at Makerere University is to divide each hpf into 
quarters and count the number of parasites and WBCs per quarter; then multiply the number per 
quarter in lOOhpf by 4.
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W h i t e  b l o o d  c e l l  c o u n t
Total and differential white blood cell counts were carried out with the Visual 
method (Dacie and Lewis 1991). This involved the following steps:
1. Make a 1 in 20 dilution of blood by adding 20pL of blood to 0.38 ml of diluting 
fluid into a plastic tube.
2. Cork the tube and mix thoroughly.
3. Fill the improved Neubauer counting chamber with the mixture using a pipette.
4. View the preparation with 4x objective and count the number of leucocytes.
5. Count the number of cells in 4 squares 1mm2 (N) then divide by 4 (N/4) to get the 
average per 1mm2 (equivalent to 0.1 pL). The calculate cell count as
cells/L = [number of cells counted divided by volume counted (|iL)] x dilution x 106
(i.e. N/4 x 1/0.1 x 20 x 106 = N x 50 x 106/L)
Normal range: Total white cell count is 4,500-10,000/juL in both males and females. 
Differential is Neutrophils 50-70% (2,500-7,000), Eosinophils 1-3% (100-300), 
Basophils 0.4-1% (40-100), Lymphocytes 25-35% (1,700-3,500) and Monocytes 4- 
6% (200-600).
Haemoglobin concentration estimation
Sahli’s acid-haematin method using Sahli’s tube was used to estimate the blood Hb 
concentration in g/dL. The procedure was: 1/10 N.HC1 was pipetted into Sahl tube 
to the’ 20’ mark. 20 pi whole blood was added and mixed. The mixture was left to 
stand for 10 minutes. Then, diluted with more 1/10 N.HC1 until colour matches with 
the standard. Hb. concentration was read off the scale at the meniscus in g./dl.
Normal range: 12-14 g/dL in children, 14-18 g/dL in adult males, 12-16 g/dL in 
adult females.
Platelet count
Plates are estimated from a well-prepared thin blood smear. Platelets are counted in 
10 microscopic fields using x40 objective. Average number of platelets in the fields
is assessed.
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Interpretation: The platelets count is reported as:
a) Adequate - if average count is 8-25 in 10 fields
b) Inadequate - if average count is 0-5 in 10 fields.
Blood film
The thin film made to identify malaria parasites was used to report on the blood 
picture. The size, shape, distribution and texture of red blood cells were examined. 
Red blood cells were not quantified.
F.rvthrocvte sedimentation rate
This was estimated using the Westergren method.
1. Use blood that is collected not more than 6 hours ago.
2. Mix the blood sample thoroughly and draw it up into the Westergren tube to the 
200 mm mark.
3. Place the tube vertically on the stand. Leave for one hour and read the height of 
the clear plasma above the upper limit of the column of sedimenting cells. ESR is 
this measurement (Westergren 1 hr).
Normal range: 4mm/lhr (up to 10) in males and 6mm/lhr (up to 12) in females. 
Blood glucose estimation
Blood glucose was measured at the bedside with a portable glucometer (Accu 
Chek® Advantage II®). Confirmatory measurements were carried out using the 
colorimetric method. Glucose oxidase ( GOD) Peroxidase method uses 4 ml of 
colour producing reagent (containing the active ingredients (above) plus a 
chromogen orthodianisidine) mixed with 40 pi serum or plasma. The colour 
developed is read colorimetrically after 10 minutes and compared to standard 
solution of glucose treated in the same way. Calculations are made against the 
standard. Results are recorded as millimoles of glucose/L
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Cerebrospinal fluid analysis
Procedures for CSF analysis include:
• Appearance
• Biochemical chemical tests
• White blood cell counts
• Assessing for Micro-organisms
Appearance
1. Normal - clear and colourless
2. Turbid - purulent appearance due to pyogenic meningitis
3. Blood - due to traumatic LP or recent subarachnoid bleeding
4. Xanthochromic - yellowness due to subarachnoid haemorrhage 
Biochemical Tests
1. CSF sugar
Preformed using the blood sugar method (Glucose-oxidase). A double amount of 
specimen is used because of low CSF glucose levels. Results are reported in 
mmol/L.
Normal values are approximately 2/3 blood glucose levels.
2. CSF protein.
The Trichloroacetic Acid colorimetric method is used (5% w/v).
Protein standards ranging from 10-100mg/dl are prepared. 0.8 ml of a 1/10 dilution 
of CSF is mixed with 2.4ml of Trichloroacetic acid. The standards are treated in the 
same way. The turbidity developed after 5 minutes is read colorimetrically. The 
concentration o f protein in the test is CSF is calculated by comparing the test 
readings with the standard readings. Result multiplied by dilution factor. Results are 
expressed as mg/dl.
Normal ranges o f  CSF protein=15 - 45 mg/dl.
3. White blood cell (wbc) count:
WBC count is performed using Neubauer counting chamber. A dilution of 1:5 is 
made of CSF with diluting fluid. Counting of white cells is done as in white blood 
cell count using whole blood. Calculation are made taking care of the dilution factor, 
volume of CSF used and number of cells counted.
wbc/mm3 = Number counted per mm3 x volume x dilution.
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4. Micro-organisms
The presence of micro-organisms is demonstrated using specific staining 
procedures.
a) Gram stain for bacteria
b) India blue negative staining for crytococcal meningitis.
c) Ziehl Neelsen stain-for Acid-Fast bacteria 
Results are read microscopically
Normal findings: There should he no micro-organisms in a normal CSF 
Urinalysis
Bayer® Multistix 10SG reagent strips were used for urinalysis. Specific items 
measured are: pH, protein, sugar (glucose), ketones, bilirubin, urobilinogen, blood, 
leucocytes, specific gravity, and nitrite.
HIV test
HIV-1 was measured with ELISA (Welcozyme HIV-1 Recombinant) and Western 
blot methods.
Dried Blood snots
Four large drops of blood were placed on a square piece of Waterman paper divided 
at one edged into four strips. After forming dried blood spots (DBS) each piece was 
placed in a plastic bag and sealed. They were stored in large plastic zipper bags 
containing silica gel crystals (colour coded type).
Storage of serum
Whole blood was placed in centrifuge tubes (2 ml for adults and 1 ml for children) 
and centrifuged to separate cells and serum. Serum was then decanted into serum 
tubes and stored at minus 70°C. At the end of the study the specimens were transport 
from study hospital in dry ice to UVRI for storage at a central point.
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Electrolytes
Electrolytes were measured in the stored sera with Vitalab Selectra E analyzer (vital 
scientific®.
Normal ranges: Sodium 135-146 mmol/L, Calcium 2-3 mmol/L, Chloride 95-105 
mmol/L.
Sickling test
A screening Sickle cell test is performed using Sodium metabisulphite, 2% solution, 
which is a reducing agent, enhancing the formation of a sickle shape of red cells in a 
reduced oxygen tension. A drop o f  blood is mixed with 2 drops 2% of Sodium 
metabisulphite on a glass slide and covered with a coverslip. The edges of the 
coverslip are sealed with Vaseline or wax and the preparation is incubated at 37°C 
for not less than 30 minutes. The preparation is examined microscopically under x 10 
and x40 objectives. The presence o f a number of sickle shaped cells is indicative of 
Sickle-cell trait or Sickle-cell disease. Longer incubation period may be necessary in 
case of Sickle-cell. It was not possible to do Haemoglobin Electrophoresis.
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Appendix IV: Pictures used for assessment of adult patients
Sketches o f objects that were easy to identify by adult subjects are shown here
> Lion, Dog, Cow, Goat, ‘Matooke’ (Bananas), Hen, Chair, Table, Bicycle, Cup.
> Elephant, Cat, Snake, Monkey, Pineapple, Tree, Pot, Car, Hoe, Cup
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Lion
Cow


Bicycle
Elephant
Snake
Monkey
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Pineapple
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Appendix V: Tables
> Table A: Table o f the odds of mortality
>  Table B: Table of the odds of early-onset neurological sequelae
> Table C: Cox regression models for risk factors for mortality
> Table D: Cox regression model for risk factors for late-onset sequelae
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T a b l e  A :  T h e  o d d s  o f  m o r t a l i t y  f o r  e x p l a n a t o r y  v a r i a b l e s  u s e d  in  u n i v a r i a t e
a n a l y s e s  ( N = 1 0 0 )
Variable No. of
observations
No. of 
deaths
No. of 
survivors
Odds Lower 
95% Cl
Upper 
95% Cl
Demographic & History information
Centre
(Mbale/Kapchorwa)
70/30 6/4 64/26 0.09/0.15 0.04/0.05 0.21/0.44
Age (less than 10 
years/10 and above)
72/28 8/2 64/26 0.13/0.08 0.06/0.02 0.26/0.32
1-4 years 46 6 40 0.15 0.06 0.35
5-9 years 26 2 24 0.08 0.02 0.35
10 and above 
Seizures within 24 hours 
prior to admission
28 2 26 0.08 0.02 0.32
None 24 5 19 0.26 0.10 0.70
1-3 seizures 43 2 41 0.05 0.01 0.20
4-20 seizures 33 3 30 0.10 0.03 0.33
Quinine given prior to 
admission (No/Yes)
62/38 9/1 53/37 0.17/0.03 0.08/0.00 0.34/0.20
Previous medical 86/14
admission to hospital
(No/Yes)
Clinical examination on admission
9/1 77/13 0.12/0.08 0.06/0.01 0.23/0.59
Able to localise painful 
stimuli at Level 1 
(No/Yes)
Coma depth measured 
on Blantyre Coma Scale
52/48 7/3 45/45 0.16/0.07 0.07/0.02 0 34/0.21
0-2 31 4 27 0.15 0.05 0.42
3-5 10 0 10 0.00 - -
No
Score/Missing
info
Coma depth measured 
on Glasgow Coma Scale
59 6 53 0.11 0.05 0.26
3-8 19 2 17 0.12 0.03
9-12 22 0 22 0.00 - -
13-15 5 0 5 0.00 - -
No
Score/Missing
info
Body temperature
54 8 46 0.17 0.08 0.37
35.0-38.5 °C 63 6 57 0.11 0.05 024
38.6-39.4 °C 28 2 26 0.08 0.02 0.32
39.6-42 0°C 9 2 7 0.29 006 1.38
Moderate -  severe 
anaemia (No/Yes)
51/49 6/4 45/45 0.13/0.09 0.06/0 03 0.31/025
Clinical signs of jaundice 
(No/Yes)
86/14 10/0 76/14 0.13/0.00 007/0 00 025/0 00
Clinical signs of 
moderate -  severe
92/8 9/1 83/7 0.11/0.14 005/002 0 21/1.16
dehydration (No/Yes)_________
Table c o n t in u e d  o v e r le a f
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T a b le  A  c o n t in u e d
Variable No of No. of No. of Odds Lower Upper
observations deaths survivors 95% Cl 95% Cl
Shock (Unlikely/Likely) 
Presence of extra heart
95/5 10/0 85/5 0.12/0 00 0.06/0.00 0.23/0.00
sounds
No 72 4 68 0.06 0.02 0.16
Yes 13 1 12 0.08 0.01 0.64
Missing 15 5 10 0.50 0.17 1.46
Pulse pressure
20-39 mmHg 14 1 13 0.08 0.01 0.59
40-79 mmHg 17 1 16 0.06 0.01 0.47
Missing info 69 8 61 0.13 0.06 0.27
Respiratory abnormality 
(No/Yes)
58/42 6/4 52/38 0.12/0 11 0.05/0.04 0.27/0.29
Respiratory distress (Not 
likely/Likely)
95/5 10/0 85/5 0.12/0.00 0.06/- 0.23/-
In-hospital non-laboratory information
First episode of 
witnessed seizures 
(none/any number)
9/1 45/45 020/0.02 0.10/0.00 0 41/0.16
None 54 9 45 0.20 0.10 0.41
1-3 seizures 31 1 30 0.03 0.00 0.24
4-20 seizures 15 0 15 0.00 - -
Seizure stoppage time
1 day 24 1 23 0.04 0.01 0.32
2 days 12 0 12 0.00 - -
3 48 days 10 0 10 0.00 - -
No seizures 54 9 45 0.20 0.10 0.41
Total seizure stoppage 
time
1 days 23 2 21
2 days 25 0 25
3-48 days 33 2 31
No seizures 19 6 13
Duration of unrousable
coma
Notin
unrousable
26 0 26 0.00 ■
coma on 
admission 
For less than 
48 hours
35 2 33 0.06 0.01 0.25
For 48 hours or 25 0 25 0.00 - -
more
Missing info 14 8 6 1.33 046 384
Coma recovery time
1-2 days 25 1 24 004 0.01 0.31
3-4 days 33 0 33 0.00 • •
5 and above 14 0 14 0.00 - -
Missing Info 28 9 19 0.47 0.21 1.05
Total coma recovery time
1-2 days 31 5 26 0.19 0.07
3-4 days 28 0 28 0.00 • •
5 and above 30 0 30 0.00 - -
Missing info 11 5 6 083 0.25 2.73
T a b le  c o n t in u e d  o v e r l e a f
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T a b le  A  co n t in u e d
Variable No. of No. of No. of Odds Lower Upper
observations deaths survivors 95% Cl 95% Cl
Fever clearance time
1 day 31 5 26 0.19 0.07 0.50
2-3 days 40 4 36 0.11 0.04 0.31
4-9 days 25 1 24 0.04 0.00 0.31
Missing info 4 0 4 0.00 - -
Total fever clearance 
time
1-4 days 39 7 32 0.22 0.10 0.50
5-6 days 32 2 30 0.07 0.02 0.28
7-20 days 29 1 28 0.04 0.00 0.26
Quinine loading dose 
prescribed on admission
No 78 6 72 0.08 0.04 0.19
Yes 5 1 4 0.25 0.03 2.24
Missing 17 3 14 0.21 0.06 0.75
Total amount of quinine 
given on Day 0
225 -  569 mg 40 4 36 0.11 0.04 0.31
570-1800 mg 41 2 39 0.05 0.01 0.21
Missing info 19 4 15 0.27 0.09 0.80
Duration of hospital stay
Less than 6 36 10 26 0.38 0.19 0.80
days
6 to 8 days 50 0 45 0.00 . _
More than 8 
days
14 0 14 0.00 " "
Laboratory based information
Random blood glucose 
on admission 
(>2.2/s2.2mmol/L)
92/8 10/0 82/8 0 12/0.00 0.06/- 0.24/-
Less than 5 
mmol/L
22 2 20 0.10 0.02 0.43
5 -  6.9 mmol/L 26 1 25 0.04 0.01 0.30
7 and above 22 1 21 0.05 0.01 0.35
Missing info 30 6 24 0.25 0.10 0.61
Parasite count 100
50,000 
parasites/pL 
and below
52 2 50 004 0.01 0.16
> 50,000 
parasites/pL
33 5 28 0.17 0.07 0.46
Missing info 15 3 12 0.25 0.07 0.89
Parasite clearance time
1 day 35 2 33 0.06 0.01 0.25
2 days 35 4 31 0.12 0.05 0.37
3-4 days 12 0 12 000 - -
Missing info 18 4 14 0.29 009 0.87
Haemoglobin
concentration
3.0-9.9 g/dL 38 4 34 0.12 0.04 0.33
10.0-15.0 g/dL 30 2 28 0.07 0.02 0.30
Missing info 32 4 28 0.14 0.05 0.41
Table continued overleaf
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T a b le  A  c o n t in u e d
Variable No. of
observations
No. of 
deaths
No. of 
survivors
Odds Lower 
95% Cl
Upper 
95% Cl
HIV infection
No 32 4 28 0.14 0.05 0.41
Yes 5 0 5 0.00 - .
Missing 63 6 57 0.11 0.05 0.24
Serum Sodium 
concentration
<135 mmol/L 33 4 29 0.14 0.05 0.39
135-146 20 1 19 0.05 0.01 0.39
mmol/L
>146 mmol/L 8 1 7 0.14 0.02 1.16
Missing info 39 4 35 0.11 0.04 0.32
Serum Calcium 
concentration
<2 mmol/L 15 0 15 0.00 - -
2-3 mmol/L 12 1 11 0.09 0.01 0.70
>3 mmol/L 26 3 23 0.13 0.04 0.43
Missing info 47 6 41 0.15 0.06 0.34
Serum Chloride 
concentration
<95 mmol/L 4 0 4 0.00 - -
95-105 mmol/L 10 2 8 0.25 0.05 1 18
>105 mmol/L 36 2 34 0.06 0.01 0.24
Missing info 50 6 44 0.14 0.06 0.32
White blood cell count
2000-4700 25 2 23 0.09 0.02 0.37
cells/L
4701-6700 26 1 25 0.04 0.01 0.30
cells/L
6701-27000 25 3 22 0.14 0.04 0.46
cells/L
Missing info 24 4 20 0.20 0.07 0.59
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T a b i c  B :  T h e  o d d s  o f  e a r l v - o n s e t  n e u r o l o g i c a l  d e f i c i t s  f o r  e x p l a n a t o r y  v a r i a b l e s
u s e d  in  u n i v a r i a t e  a n a l y s e s  ( N = 9 0 )
Variable No. of
observations
No.
with
deficits
No.
without
deficits
Odds Lower 
95% Cl
Upper 
95% Cl
Demographic & History information
Centre 64/26 17/6 47/20 0.36/0.30 0 21/0.12 0.63/0.75
(Mbale/Kapchorwa) 
Age (less than 10 64/26 17/6 47/20 0.36/0.30 0.21/0.12 0.63/0.75
years/10 and above) 
1-4 years 40 8 32 0.25 0.11 0.54
5-9 years 24 9 15 0.60 0.26 1.37
10 and above 26 6 20 0.30 0.12 0.75
Seizures within 24 hours 19/71 2/21 17/50 0.12/0.42 0.03/0.25 0.51/0.70
prior to admission 
(None/Any number) 
None 19 2 17 0.12 0.03 0.51
1-3 seizures 41 11 30 0.37 0.18 0.73
4-20 seizures 30 10 20 0.50 0.23 1.07
Quinine given prior to 53/37 9/14 44/23 0.20/0.61 0.10/0.31 0.42/1.18
admission (No/Yes) 
Previous medical 77/13 18/5 59/8 0.31/0.63 0.18/0.20 0 52/1.91
admission to hospital 
(No/Yes)
Clinical examination on admission
Able to localise painful 65/25 17/6 48/19 0.35/0.31 0.20/0.12 0.61/0.79
stimuli at Level 2 
(No/Yes)
Coma depth measured 
on Blantyre Coma Scale 
(cases aged 5 yrs and 
below)
0-2 26 6 20 0.30 0.12 0.75
3-5 10 3 7 0.43 0.11 1.66
No 6 0 6 - - -
Score/Missing
info
Coma depth measured 
on Glasgow Coma Scale 
(cases aged over 5 
years)
3-8 17 6 11 0.54 0.20 1.47
9-12 22 6 16 0.38 0.15 096
13-15 5 0 5 - - -
No 4 2 2 1.00 0.14 7.10
Score/Missing
info
Body temperature
35.0-38.5 °C 57 17 40 0.43 0.24 0.75
38.6-39.4 °C 26 5 21 0.24 0.09 0.63
39.5-42.0 °C 7 1 6 0.17 0.02 1.38
I 'a b le  c o n t in u e d  o v e r le a f
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T a b le  Ü c o n t in u e d
Variable No of
observations
No.
with
deficits
No.
without
deficits
Odds Lower 
95% Cl
Upper
95% Cl
Moderate -  severe 45/45 12/11 33/34 0.36/0.32 0.19/0.16 0.70/0.64
anaemia (No/Yes) 
Clinical signs of jaundice 76/14 19/4 57/10 0.33/0.40 0.20/0.13 0.56/1.28
(No/Yes)
Clinical signs of moderate 83/7 22/1 61/6 0.36/0.17 0.22/0.02 0.59/1.38
-  severe dehydration 
(No/Yes)
Shock (Unlikely/Likely) 85/5 23/0 62/5 0.37/- 0.23/- 0.60/-
Presence of extra heart 
sounds
No 59 22 37 0.60 0.35 1.01
Yes 9 1 8 0.13 0.02 1.00
Missing 3 0 3 - - -
Pulse pressure
20-39 mmHg 13 2 11 0.18 0.04 0.82
40-79 mmHg 16 3 13 0.23 0.07 0.81
Missing info 61 18 43 0.42 0.24 0.73
Respiratory abnormality 52/38 14/9 38/29 0.37/0.31 0.20/0.15 0.68/0.66
(No/Yes)
Respiratory distress (Not 85/5 22/1 63/4 0 35/0.25 0.21/0 03 0.57/2.24
likely/Likely) 
Presence of 57/33 10/13 47/20 0 21/0.65 0.11/0 32 0.42/1.31
Organomegaly (No/Yes) 
Enlarged spleen (No/Yes) 72/18 15/8 57/10 0.26/0.80 0.15/0.32 0.46/2.03
Enlarged liver (No/Yes) 72/18 18/5 54/13 0.33/0.38 0.20/0.14 0.57/1.08
In-hospital non-laboratory information
First episode of 45/45 11/12 34/33 0.32/0.36 0.16/0.19 0 64/0.70
witnessed seizures 
(none/any number) 
None 45 11 34 0.32 0.16 0.64
1-3 seizures 30 5 25 0.20 0.08 0.52
4-20 seizures 15 7 8 0.88 0.32 2.41
Seizure stoppage time 
1-2 days 35 8 27 0.30 0.13 0.65
3-48 days 10 4 6 0.67 0.19 2.36
Total seizure stoppage 
time
1-2 days 46 9 37 0.24 0.12 0.50
3-48 days 31 11 20 0.55 0.26 1.15
Duration of unrousable 
coma
Notin 26 6 20 0.30 0.12 0.75
unrousable 
coma on 
admission 
For less than 33 8 25 0.32 0.14 0.71
48 hours 
For 48 hours or 25 9 16 0.56 0.25 1.27
more
Missing info 6 0 6 . . .
f a b le  c o n t in u e d  o v e r le a f
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T a b le  B  c o n t in u e d
Variable No. of
observations
No.
with
deficits
No.
without
deficits
Odds Lower 
95% Cl
Upper 
95% Cl
Coma recovery time
1-2 days 24 4 20 0.20 0.07 0.59
3-4 days 33 9 24 0.38 0.17 0.81
5 and above 14 8 6 1.33 0.46 3.84
Missing Info 19 2 17 0.12 0.03 0.51
Total coma recovery time
1-2 days 26 3 23 0.13 0.04 043
3-4 days 28 5 23 0.22 0.08 0.57
5 and above 30 15 15 1.00 0.49 2.05
Missing info 6 0 6 - - -
Fever clearance time
1 day 26 9 17 0.53 0.24 1.19
2-3 days 36 6 30 0.20 0.08 0.48
4-9 days 24 6 18 0.33 0.13 0.84
Missing info 4 2 2 1.00 0.14 7.10
Total fever clearance 
time
1-4 days 32 12 20 0.60 0.29 1.23
5-6 days 30 5 25 0.20 0.08 0.52
7-20 days 28 6 22 0.27 0.11 0.67
Quinine loading dose 
prescribed on admission
No 72 22 50 0.44 0.26 0.73
Ves 4 1 3 0.33 0.03 3.20
Missing 14 0 14 0.00 - -
Dose of quinine given on 
DayO
3-8.9 mg/kg 7 3 4 0.75 0.17 3.35
9.0-10.9 mg/kg 19 7 12 0.58 0.23 1.48
11.0-20.9 18 5 13 0.38 0.14 1.08
mg/kg
Missing info 46 8 38 0.21 0.10 0.45
Duration of hospital stay
Less than 6 26 4 22 0.18 0.06 0.53
days
6 to 8 days 50 12 38 0.32 0.17 0.60
More than 8 14 7 7 1.00 0.35 2.85
days
Laboratory based information
Random blood glucose 82/8 21/2 61/6 0.34/0.33 0 21/0.07 0.57/1.65
on admission 
(>2.2/s2.2mmol/L)
Less than 5 20 6 14 0.43 0.16 1.12
mmol/L
5 -  6.9 mmol/L 25 5 20 0.25 009 0.67
7 and above 21 9 12 0.75 0.32 1.78
Missing info 24 3 21 0.14 004 048
Parasite count
50,000 50 12 38 0.32 0.17 0.60
parasites/pL 
and below
> 50,000 28 8 20 0.40 0.18 0.91
parasites/pL
Missing info 12 3 9 0.33 009 1.23
Fable continued overleaf
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T a b le  B c o n tin u e d
Variable No. of
observations
No.
with
deficits
No.
without
deficits
Odds Lower
95% Cl
Upper 
95% Cl
Parasite clearance time
1 day 33 11 22 0.50 0.24 1.03
2 days 31 5 26 0.19 0.07 0.50
3-4 days 12 4 8 0.50 0.15 1.66
Missing info 14 3 11 0.27 0.08 0.98
Haemoglobin
concentration
3.0-9.9 g/dL 34 9 25 0.36 0.17 0.77
10.0-15.0 g/dL 28 10 18 0.55 0.26 1.20
Missing info 28 4 24 0.17 0.06 0.48
HIV infection
No 28 4 24 0.17 0.06 0.48
Yes 5 1 4 0.25 0.03 2.24
Missing 18 39 0.46 0.26 0.81
Serum Sodium 
concentration
<135 mmol/L 29 6 23 0.26 0.11 0.64
135-146 19 2 17 0.12 0.03 0.51
mmol/L
>146 mmol/L 7 2 5 0.40 0.08 2.06
Missing info 35 13 22 0.59 0.30 1.17
Serum Calcium 
concentration
<2 mmol/L 15 2 13 0.15 0.03 068
2-3 mmol/L 11 1 10 0.10 0.01 078
>3 mmol/L 23 5 18 0.28 0.10 0.74
Missing info 41 15 26 0.58 0.31 1.09
Serum Chloride 
concentration
<95 mmol/L 4 1 3 0.33 0.03 3.20
95-105 mmol/L 8 1 7 0.14 0.02 1.16
>105 mmol/L 34 6 28 0.21 0.09 0.52
Missing info 44 15 29 0.52 028 0.96
White blood cell count
2000-4700 23 9 14 0.64 0.28 1 49
cells/L
4701-6700 25 2 23 0.09 0.02 0.37
cells/L
6701-27000 22 7 15 0.47 0.19 1.14
cells/L
Missing info 20 5 15 0.33 0.12 0.92
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T a b i c  C': C o x  r e g r e s s i o n  m o d e l s  o f  r i s k  f a c t o r s  f o r  m o r t a l i t y  i d e n t i f i e d  h v
l o g i s t i c  r e g r e s s i o n  ( c o m p a r e  w i t h  T a b l e  5 .3 )
Risk factor HR P-value' Lower 
95% Cl
Upper 
95% Cl
Model 1 (N= 100)
Aged ten years and above 0.60 0.521 0.13 2.87
Managed in Kapchorwa hospital 1.48 0.549 0.41 5.36
Quinine given prior to admission 0.17 0.093 0.02 1.35
Had seizures while on the ward 0.13 0.051 0.02 1.01
Model 2 (N=58)T
Aged ten years and above 0.41 0.333 0.07 2.48
Managed in Kapchorwa hospital 2.52 0.237 0.54 11.72
Quinine given prior to admission 0.15 0.081 0.02 1.27
Had seizures while on the ward 0.08 0.019 0.01 0.67
Model 3 (N=58)* 
Aged ten years and above 0.32 0.231 0.05 2.05
Managed in Kapchorwa hospital 2.51 0.242 0.54 11.70
Quinine given prior to admission 0.17 0.104 0.02 1.44
Had seizures while on the ward 0.10 0.032 0.01 0.82
Parasite count
s 50,000 parasites/pL 1
> 50,000 parasites/pL 4.39 0.085 0.81 23.62
Missing info 4.54 0.108 0.72 28.67
Calculated from the Wald test
* Variables from Model I but restricted to d e f in i te  cases 
! Model fitted by adjusting for case definition at the onset
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T a b i c  D :  C o x  r e g r e s s i o n  m o d e l s  o f  r i s k  f a c t o r s  f o r  l a t c - o n s e t  n e u r o l o g i c a l
s e q u e l a e  ( c o m p a r e  w  i t h  T a b l e  5 . 1 0 )
Risk factor HR P value Lower 
95% Cl
Upper
95% Cl
Model 1b (n=90)4
Aged over ten years 3.51 0.093 0.81 15.17
Admitted to hospital before 0.39 0.414(C) 0.04 3.77
Body temperature (C)
35.0-38.5 °C 1
38.6-39.4 °C 0.83 0.795 0.20 3.47
39.5-42.0 °C 3.77 0.349 0.23 60.72
Fever clearance time
1 day 1
2-3 days 0.76 0.737 0.16 3.68
4-9 days 18.91 0.014 1.83 195.48
Seizure stoppage time
1-2 days 1
3-48 days 3.63 0.269 0.37 35.81
No recorded seizures 8.27 0.071 0.84 81.74
Total coma recovery time (C)
1-2 days 1
3-4 days 2.28 0.451 2.67 19.51
5 and above 2.40 0.381 0.34 17.11
Was hypoglycaemic on admission 5.77 0.377 (C) 0.12 282.80
Had deficits at discharge 9.89 0.006 1.94 50.45
Model 2b (n=90)*
Aged over ten years 1.98 0.264 0.60 6.61
Fever clearance time
1 day 1
2-3 days 0.81 0.757 0.21 3.08
4-9 days 5.50 0.066 0.90 33.77
Seizure stoppage time
1-2 days 1
3-48 days 488 0.079 0.83 28.56
Missing 5.27 0.031 1.16 23.92
Had deficits at discharge 7.37 0004 1.90 28.62
' Adjusted for centre and using age as two categories
1 Includes clinically significant variables (marked as C); Global test of proportional hazards (PH) 
assumption, chi2 (6.69), d f  (13) and P value 0.917. The category of body temperature 38.6-39.4 “C 
violated the PH assumption.
• Does not include clinically significant variables as in Model lb.; Global test of proportional hazards 
(PH) assumption, chi2 ( 1.64), df (7) and P value = 0.977. None of the categories violated the PH 
assumption
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Appendix VI: Figures
> Figure A: Logistic regression diagnostic plot assessing the goodness-of-fit of 
Model 1 in Table 5.3.
> Figure B: Logistic regression diagnostic plot assessing the goodness-of-fit of 
Model 2 in Table 5.3.
> Figure C: Logistic regression diagnostic plot assessing the goodness-of-fit of 
Model 3 in Table 5.3.
> Figure D: Logistic regression diagnostic plot assessing the goodness-of-fit of 
Model la in Table 5.6.
>  Figure E: Logistic regression diagnostic plot assessing the goodness-of-fit of 
Model 2a in Table 5.7.
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Figure A: Logistic regression diagnostic plot o f Hosmer and Lemeshow 
influence (H-L dx2) for 100 eases of cerebral malaria (represented as index 
numbers from 1 to 100) assessing the goodness-of-fit of Model I in Table 5.3.
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Figure B: Logistic regression diagnostic plot o f llosmer and l.cmeshow 
influence (H-L dx2) for 58 definite cases of cerebral malaria (represented as 
index numbers between I to 100) assessing the goodncss-of-fil of Model 2 in 
Table 5.3.
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Figure (': Logistic regression diagnostic plot of Hosmer and l.emeshoiv 
influence (H-L d\2) for 58 definite cases of cerehral malaria (represented as 
index numbers between 1 to 100) assessing the goodness-of-fit of Model 3 in 
Table 5.3.
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Figure I): Logistic regression diagnostic plot of Hosmer and Lemeshcm 
influence (H-L dx2) for 90 survivors of cerebral malaria (represented as index 
numbers between I to 10») assessing the goodness-of-fit of Model la in Table
5.6
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Figure K: Logistic regression diagnostic plot of Hosmer and l.cmcshow 
influence (H-L dx2) for 90 survivors of cerebral malaria (represented as index 
numbers between 1 to 10») assessing the goodness-of-fit of Model 2a in Table
5.7
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Appendix VI: Miscellaneous items
The following items can be found in this appendix:
> Newspaper cuttings of warnings on the heavy rains in 2002
> Findings of the exercise to validate the diagnoses o f cerebral malaria recorded in 
the inpatient registers of patients admitted between 1st January 1999 and 31st 
December 2000.
>  Poster on guidelines for the ‘Management of the Patient with severe malaria’ for 
use at hospitals in Uganda that I played a role in developing for the Ministry of 
Health, Uganda and the Malaria Consortium, East Africa Office.
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Clips from The N ew  Vision newspaper warning the public of the impending 
heavy rains during the rainy season, Scntemhcr-Deccnihcr 2002.
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The findings of an exercise to validate the diagnoses of cerebral malaria 
recorded in the inpatient registers o f patients admitted to Kabalc hospital 
between 1st January 1999 and 31st December 2000.
After noticing the scarcity of patients with features of cerebral malaria, an exercise 
to verify the recorded diagnoses of cerebral malaria in the inpatient register was 
embarked upon. To do this, a scoring system that ranked the quality of the diagnosis 
was devised and it incorporated information from the history, clinical examination 
and laboratory. 1 called this the “cerebral malaria diagnosis” scale and its 
components are shown in Table E below. A definite case of cerebral malaria would 
score between 11 and 16 (the maximum score on the scale). The higher the score the 
more aspects of the research definition that were met. A probable case o f  cerebral 
malaria (i.e. practical definition), would score between 5 and 10 and anything 
between 0 and 4 was unlikely to be cerebral malaria. This scoring system enabled 
one to examine the retrospective records and come to some estimate of the accuracy 
of a diagnosis of CM even if the records are scanty. This “cerebral malaria 
diagnosis” scale had been tried on a random selection of cases admitted to New 
Mulago hospital. Of thirty-five cases with a final diagnosis of cerebral malaria 
admitted in 1999 (selected to coincide with one of the years of the epidemic of 
malaria in the highland areas of Uganda), 4 cases (11%) scored 11-12 (i.e. DCM) 
and 28 cases (80%) scored 5-10 (i.e. PCM); and 3 cases scored 3-4 (i.e. unlikely to 
be CM). The scale was used to determine how many of the patients admitted to 
Kabale with a final diagnosis of cerebral malaria in their notes could meet the 
requirements on the scale. The years used are 1999 and 2000 because that was the 
time when an epidemic of malaria took place there. This exercise showed, see Table 
F, that few patients whose files I was able to examine with a diagnosis o f  cerebral 
malaria (or severe malaria) met the requirements on the scale. This was an indication 
that cerebral malaria even during the time when there was an epidemic of malaria in 
the region was being over diagnosed.
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T able E: The cerebral malaria diagnosis scale; a scoring system for the retrospective diagnosis of cerebral malaria,
Characteristic Components Score Dmax Dmint Pmin* Nmint
A Symptoms provided in history 1 Loss of consciousness 1 1 1 1
2. Afebrile convulsions (<10yrs) 1
3. Convulsions (>10yrs) 1 1
4. Confusion (>10yrs) 1
5 None 0 0
B. Level of consciousness (sign) 1. Unrousable coma 3 3 3
2. Unconscious but able to localise pain 2
3 Confusion 1 1
4. Not documented / Conscious 0 0
C Blood smear for P. falciparum 1. Positive 2 2 2
2. Negative 1 1
3. None 0 0
D. Exclusion of other causes of altered mentation 1. Normal CSF 2 2 2
2. Normal random blood sugar 1 1
3. Not post-ictal coma 1 1
4. Normal urine 1 1
5. None 0 0 0
E. Treatment regimen prescribed 1 Quinine only 2 2
2. Quinine and antibiotic(s) 1 1 1
3. Other regimen 0 0
F. Clinical suspicion 1. Cerebral malaria 2 2 2
2. Severe malaria 1 1
3 Other diagnosis / None 0 0
Total 16 11 5 0
* Maximum score for definite cerebral malaria
* Minimum score for probable cerebral malaria 
: Minimum score for probable cerebral malaria
* Minimum score for 'not likely to be cerebral malaria'
Tabic F: The scores obtained from patient records retrieved from Kabalc 
hospital who were recorded as having a Final diagnosis of ‘cerebral malaria’ 
from l ” January 1999 to 31’1 December 2000.
Month/Year
No.
recorded
with
diagnosis 
of CM'
Kabale Hospital admissions
No. whose No. with scores 5-16 
records were 
available
1999
January 1 0 0
February 0 0 0
March 2 1 1
April 0 0 0
May 0 0 0
June 1 1 1
July 0 0 0
August 0 0 0
September 2 2 2
October 1 0 0
November 1 0 0
December 2 0 0
2000
January 0 0 0
February 2 2 0
March 0 0 0
April 2 0 0
May 3 3 0
June 1 1 0
July 1 0 0
August 2 1 0
September 10 9 1
October 5 1 0
November 1 0 0
December 5 4 1
Total 42 25 6
% of total 100 59.5 14.3
% where records available NA 100 24
Examined all Files with a linal diagnosis of severe malaria
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Poster on guidelines for the ‘Management of the Patient with Severe M alaria1 
for use at hospitals in Uganda that 1 played a role in develoning for the 
Ministry of Health. Uganda and the Malaria Consortium. East Africa Office.
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